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Abstract 
Objectives: To assess the potential of measurements of pH, exudate composition and 
temperature in wounds to predict healing outcomes and to identify the methods that 
are employed to measure these characteristics of wounds. 
Method: Systematic review 
Background: Worldwide, wounds continue to pose immense challenges for patients, 
carers, researchers, practitioners and health services. A cutaneous wound is a 
disruption in the integrity of the skin caused by pathologic processes. Wound healing 
aims to restore the anatomic continuity and function of the skin and requires 
synchronised efforts from numerous different cell types. The ability to indicate wound 
healing potential is of great interest for medical, legal and financial reasons as it offers 
the possibility to detect healing complications earlier and, hence, facilitates the 
application of more efficient and appropriate interventions. As traditional methods of 
wound measurement are prone to subjective interpretation, this systematic review 
explored measures of pH, exudate composition and temperature in wounds as 
objective and valid indicators of wound healing outcomes.  
Results: A total of 24 studies, 3 for pH (mean quality score 54.48%), 12 for exudate 
composition (mean quality score 46.54%) and 8 for temperature (mean quality score 
36.66%), were assessed as eligible for inclusion in this review. Despite the emergence 
of promising findings, there was insufficient evidence to confidently recommend the 
use of any of these measures as predictors of wound healing.  
Conclusion: pH measurement appeared as the most practical method for use in clinical 
practice to indicate wound healing outcomes. Further research is required to increase 
the strength of evidence in this field of research and to develop a greater 
understanding of the dynamics of wound healing. With this advanced knowledge, the 
value of measuring pH, exudate composition and temperature in wounds should 
become more apparent and a valid indicator for wound healing outcomes may be 
revealed.      
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Chapter 1. Background 
1.1. Introduction 
This chapter is an introduction to the concepts of wounds and wound healing. 
Beginning with an overview of the epidemiology of wounds, incidence and prevalence 
of wounds will be discussed, followed by a review of the literature exploring the 
burden of wounds in relation to both financial and human costs. A brief history of the 
management and treatment of wounds will then be summarised in order to 
acknowledge the foundations from which advances in wound care practices have 
arisen. The next section of this chapter will focus on the biology of skin and cutaneous 
wound healing detailing, the normal anatomy of the skin, the types and characteristics 
of wounds, the process of normal wound healing, the pathophysiology of impaired 
wound healing, aspects of wound healing measurement, and particular indicators of 
wound healing. Finally, with the importance of monitoring wound healing established, 
the specific biomarkers pH, exudate composition and temperature will be explored in 
wounds.  
 
1.2. Wounds: The significance of the problem 
Every person will inevitably experience a wound at some point in their lifetime 
(MacDonald & Ryan 2010). All wounds have the potential to result in a multitude of 
problems, however non-healing wounds present the most significant challenges 
worldwide (Sen et al. 2009, World Health Organisation 2010). Nevertheless, 
considering that surgical site infections remain the most expensive post-surgical 
complication (Sen et al. 2009), it is evident that acute wounds, indicated in patients 
with surgical or traumatic wounds, abrasions, or superficial burns (Sen et al. 2009), 
also have a grave potential to cause substantial problems specifically when exposed to 
infection. Non-healing wounds seldom appear in individuals that are otherwise healthy 
(Sen et al. 2009). As a consequence, these wounds are more typically viewed as a co-
morbidity, that is the association of two distinct diseases in the same person at a rate 
greater than that likely by chance, and as such, Sen et al. (2009) argue that the true 
impact of non-healing wounds is diminished. Non-healing wounds can be a major 
burden on patients, families, care providers, and healthcare organisations profoundly 
impacting a patients’ quality of life (Herber et al. 2007, Gorecki et al. 2009), increasing 
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risks of complications, and significantly adding to healthcare costs (Bowler et al. 2001, 
Dow 2003). 
 
1.3. Prevalence and Incidence 
The epidemiology of wounds is considered a vast topic due to the great variations in 
wound aetiology (Leaper & Harding 1998). A wound may result from physical, 
mechanical or thermal damage, or an underlying medical or physiological disorder 
(Thomas 1990) with wound types ranging from burns, non-healing and non-surgical to 
surgical, incisional or excisional (Leaper & Harding 1998). Wound types may also vary 
depending on geography as differences are noted between countries, between wound 
care services or even within hospitals due to differing practices between surgeons due 
to a multitude of reasons (Leaper & Harding 1998, World Health Organisation 2010). 
For example, a cross-sectional study of 238 healthcare providers conducted to 
compare the wound healing knowledge and practices between nurses and doctors in a 
general hospital compared with two centres specialising in the field of wound care, 
found medical staff dominated wound care decision-making in specialised groups, 
while the nurse and tissue viability nurse together shared decision-making 
responsibility in non-specialised areas (Ashton & Price 2006). In general, wound care 
practices demonstrated a lack of up-to-date evidence-based care as the specialised 
group claimed that their primary rationale for dressing choice in practice was based on 
clinical effectiveness (n=28) and the non-specialised clinicians identified availability 
(n=21) as their primary reason for dressing choice (Ashton & Price 2006). Differences 
were also noted between sources of knowledge, in that the specialised group favoured 
post-graduate study courses and research reports, while the non-specialised clinicians 
identified colleagues such as the tissue viability nurse and those in the dermatology 
department as good sources of information (Ashton & Price 2006).  
 
Wounds exist and are managed in a wide variety of settings such as hospitals, long-
term care facilities and the community, as well as developed and developing countries 
(World Health Organisation 2010). Differences in wound care practices, availability of 
resources, population demographics, and recording or auditing of prevalence and 
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incidence of wounds varies greatly across settings due to numerous factors (World 
Health Organisation 2008, World Health Organization 2009, World Health Organisation 
2010). Considering the current emphasis on ‘gold standard’ practices, as much of the 
world remains rural, despite rapid urbanisation, and most populations in are poor, the 
majority of wounds occur away from elite urban hospitals or specialised centres and 
will never receive this kind of elite and expensive model (World Health Organisation 
2010). This example demonstrates just one of the many factors contributing to 
inconsistencies in wound care provision worldwide.  
 
Taking account of the multifaceted nature of issues inherent in the prevention, 
management and treatment of wounds, it is vital to understand the incidence and 
prevalence of wounds in order to improve the quality of wound care provision (Posnett 
et al. 2009). Incidence can be defined as the number new cases of a disease or 
condition which occurred within a specified time period, whilst prevalence is the 
number of cases of a disease or condition present at a particular time in a certain 
population (Timmreck 2002). 
 
Globally, it is estimated that 187 to 281 million surgical operations are performed 
annually, equating to one operation each year for every 25 people (World Health 
Organization 2009). This figure is seen to be higher in wealthier countries such as 
Australia where there is one elective surgical operation for every 12.4 people 
(Australian Institute of Health and Welfare 2010). Good wound care is vital for all types 
of wounds as any wound is at risk of bacterial contamination and has the potential to 
become non-healing (Posnett et al. 2009). As mentioned, surgical-site infection is a 
common source of hospital-acquired infection and is a major issue for hospitals 
(Posnett et al. 2009) due the negative impact on patient morbidity and mortality 
(Astagneau et al. 2001). Although all major European countries record the incidence of 
surgical wound infection for a range of surgical procedures, these results, with national 
rates of surgical wound infection ranging from 1.7% to 3.6%, are difficult to analyse 
due to differences in the procedures included, surveillance periods and incomplete 
reporting of all healthcare services (Posnett et al. 2009). A prospective study by Moro 
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et al. (2005) discovered high occurrence rates of surgical site infections in a 
convenience sample of surgical patients admitted to 31 public hospitals over a one-
month period. Of the 6,167 operative procedures studied, 290 infections were 
recorded (4.7 per 100 procedures), 206 (71%) being surgical site infections (3.3 per 100 
procedures; 95% confidence interval, 2.9–3.9), of which 135 (65.5%) were superficial 
infections, 53 (25.7%) were deep infections, 12 (5.8%) were organ–space infections, 
and type was unrecorded in 6 (2.9%) cases (Moro et al. 2005). Moro et al. (2005) 
expressed that the significantly higher rates of surgical-site infections recorded was 
due to a strength of this study that related to follow-up period. Following hospital 
discharge, 95% of patients were actively monitored for up to 30 days for all types of 
operations and for up to one year following operations involving implantation (Moro 
et al. 2005). As mentioned, research studies may be difficult to analytically compare 
due to intrinsic differences between wound-related research. Demonstrating the 
variances in results associated with sample demographics, procedures, and 
surveillance periods, Moro et al. (2005) reported that the occurrence of surgical 
wound infection was significantly more common among patients older than 64 years 
(risk ratio 1.6; 95% confidence interval 1.2–2.3) and among patients undergoing 
operative procedures at the highest risk for endogenous contamination such as dirty 
operations (risk ratio 9.41; confidence interval 95%, 6.01-14.74) and contaminated 
operations (risk ratio 5.48; confidence interval 95% 3.75-8.03), non-elective operations 
(risk ratio 1.8; confidence interval 95%, 1.3 to 2.4), operations lasting more than one 
hour, and for procedures involving a surgical drain (risk ratio 2.2; confidence interval 
95%, 1.6-2.9). 
 
In Europe, research has been conducted to examine the prevalence of wounds and 
wound care provision for people across a broad range of settings, such as hospitals, 
community services and long-term or residential care facilities, encompassing a wide 
array of wound aetiology. In the UK, a wound care audit of hospital and community 
healthcare services serving a population of approximately 590,000 reported the 
prevalence of patients with at least one chronic or acute wound was 3.7 per 1000 
(2199/590,000), with these figures adjusted for underreporting (Drew et al. 2007). Of 
the 2199 patients identified with existing wounds, 79% were cared for in community 
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clinics, long-term care facilities or in their homes and 21% were cared for in the acute 
hospital. When examining wound type in particular, 43% of patients had a surgical or 
trauma wound, 18% had pressure ulcers and 39% had either leg or foot ulcers (Drew et 
al. 2007). In a similar study conducted in the UK across all healthcare settings in a 
primary care catchment area comprising of approximately 488,000 people, Vowden et 
al. (2009) reported that the prevalence of people with wounds was 3.55 per 1000 
covered population, with the majority of wounds being surgical or trauma (48%), leg or 
foot (28%), and pressure ulcers (21%). Of the 1735 people recorded with wounds, 
approximately 68% of these patients were being cared for in the community (Vowden 
et al. 2009). Prevalence of wounds among hospital inpatients was just above 30%, with 
11.6% being pressure ulcers and 66% of these hospital-acquired pressure ulcers 
(Vowden et al. 2009). Both of these studies find that wound care provision is most 
prevalent in the community and similarly describe surgical or traumatic wounds as the 
most prevalent wound aetiology next to leg or foot ulcers. 
 
At European level, a point prevalence study conducted in two Danish hospitals and 
their respective municipalities covering a population of approximately 445, 000 people 
reported a prevalence of 33% patients treated in the hospitals with wounds, of which 
acute wounds were most common at 25%, compared to a much lesser prevalence of 
pressure ulcers at 3.3%, leg ulcers at 1.7% and foot ulcers at 1.3% (Gottrup et al. 2013). 
In the municipalities, a prevalence of patients reported with one or more wounds was 
2.8 per 1000 population, of which acute or surgical wounds were most prevalent (1.0 
per 1000), followed by pressure ulcers (0.7 per 1000), leg ulcers (0.5 per 1000), foot 
ulcers (0.3 per 1000) and other wounds (0.3 per 1000). These results reveal significant 
differences in the types of wounds cared for in the two different settings, community 
versus hospital, revealing a higher prevalence of surgical wounds cared for in hospitals 
compared to the municipalities, 76% versus 35% respectively, and a higher prevalence 
of chronic wounds cared for in the municipalities, in particular pressure ulcers, 24%, 
and leg ulcers, 19%, compared with 10% and 5.1% in the hospitals, respectively 
(Gottrup et al. 2013).  
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These studies both individually and combined provide insightful data into the 
prevalence of wounds. From these study findings, the importance of optimal standards 
in wound care practice is clear for all healthcare providers across all settings. 
Furthermore, this information provides valuable data for healthcare budgeting bodies 
to aid decisions for allocation of financial funds. 
  
Concerning the incidence of chronic wounds, this problem is escalating and has been 
described as a ‘silent epidemic’ (Sen et al. 2009). In the industrialized world, almost 1-
1.5% of the population experience a problem wound (Gottrup 2004), with this figure 
stipulated to increase owing to changing demographics demonstrated in the rising 
number of elderly individuals (Government of Ireland 2012) and the concurrent 
increase in comorbidities, such as diabetes, obesity, venous hypertension, and 
peripheral vascular disease (Whelton et al. 2007, World Health Organisation 2008, Gist 
et al. 2009, Morgan et al. 2009, Zhang et al. 2010, Carter 2014, Dee et al. 2015). In the 
developing world, appropriate management of wounds and non-healing wounds is 
also of major concern where the main challenges are related to the causes for the 
deficits in healthcare services, of which are subsequently linked to poverty and social 
unrest (MacDonald & Ryan 2010) 
 
In North America, between 5 and 7 million non-healing wounds are reported to occur 
each year (MacDonald & Ryan 2010), with an estimated 2.5 million people affected by 
leg ulcers (Phillips et al. 1994). A Swedish study examining hospital and community 
health services found a prevalence of non-healing wounds of 2.4 per 1000 persons, for 
a population of 288, 433 (Lindholm et al. 1999).  
 
Examining the community setting alone, an Irish study by (Skerritt & Moore 2014) 
found the most common wounds were types of non-healing wounds such as, leg 
ulcerations, accounting for 60% (n=112), of which 55% were venous leg ulcers, 3% 
were arterial, 8% were mixed arterial/venous, 2% neuro-ischaemic and 32% were 
unclassified, and pressure ulcers, accounting for 22% (n=42) of patients. Of the 
remaining patients with wounds, 16% had an acute surgical or traumatic wound, 1% 
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had either a fungating breast wound or a radiation burn, and only 1% had a diabetic 
foot wound (Skerritt & Moore 2014). The significance of the high prevalence of non-
healing wounds in the community reported in this study by Skerritt & Moore (2014) is 
further realised when considering the community has been reported as the most 
typical setting for the majority of wound care provision (Drew et al. 2007, Vowden et 
al. 2009). 
 
Burns are the fourth most common form of trauma worldwide, after traffic accidents, 
falls, and interpersonal violence (World Health Organisation 2008, Peck 2011). 
Globally, burns and fires account for over 300,000 deaths each year, however, the vast 
majority of burns do not result in fatal consequences (World Health Organisation 2008) 
meaning that these victims survive with burn wounds. Risk factors for burns include 
those associated with socioeconomic status, race and ethnicity, age, and gender, in 
addition to factors relating to geographical region of residence, intent of injury, and co-
existing disease (Peck 2011). Globally, incidence rates of burn injuries are lowest in 
high-income countries and most predominant in low- and middle-income countries 
which account for more than 95% of all fire-related burn injuries (Mock et al. 2008). In 
Germany, a retrospective study involving analysis of a database from a single centre 
compared thermal burn injury patients admitted to a burn intensive care unit during 
the period between the years 1991 and 2000 (n = 911) to those admitted between 
2001 and 2010 (n = 695) (Theodorou et al. 2013). The findings revealed that the 
severity of burn injuries during the last two decades has declined (Theodorou et al. 
2013). In the bivariate analysis, significant differences were found between the earlier 
and later time periods in terms of mean age (39.8 years compared to 44.0 years), burn 
size of total body surface area (23.2% compared to 18.0%), size of third degree burns 
(9.6% compared to 14.9%), burn severity scores (6.3 compared to 6.0), length of stay in 
the burn intensive care unit (19.1 days compared to 18.8 days) and mortality rate 
(18.6% compared to 15.0%) (Theodorou et al. 2013). These differences could relate to 
a range of interventions introduced in higher income countries in more recent years 
such as fire safety education, promotion and legislation (Mock et al. 2008). The vast 
majority of burn wounds occur in low- and middle-income regions of the world where 
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access to treatment and wound care supplies may be limited and where burn wounds 
are more likely to cause further poverty for the victim (Mock et al. 2008). 
 
International and Irish prevalence and incidence data clearly highlight the significance 
of wounds within the broader context of the health service and in relation to global 
health issues. These findings emphasise the importance of optimal practices in wound 
care to healthcare professionals and policy makers, and indicate the value of 
continuous education and the creation of strategies in the prevention and 
management of wounds. Global figures allow for comparison of incidence and 
prevalence rates of various types of wounds between regions. Furthermore, these 
findings are of benefit to healthcare expense budgeters as these figures can signify 
where financial support and investment is needed. 
 
1.4. Financial Impact 
Within a context of heightened pressure on healthcare budgets and staff resources 
(Gottrup et al. 2013), the financial burden of wounds is becoming increasingly 
significant particularly considering the changing global demographics such as the 
ageing population, increasing incidence of diabetes (World Health Organisation, 2008, 
Zhang et al., 2010), and increasing prevalence of risk factors associated with chronic 
illnesses (Whelton et al., 2007, Morgan et al., 2009, Dee et al., 2015, Carter, 2014). 
Despite the widespread acknowledgement of the magnitude of problems associated 
with wounds (Drew et al. 2007, Sen et al. 2009, World Health Organisation 2010, 
Serena 2014, Skerritt & Moore 2014), current and precise details of the global burden 
of wounds remains unknown (McDonald 2009).  
 
In the UK based study by Drew et al. (2007), the cost of wound care in a local 
population in the years 2005 to 2006 was estimated from GBP£15 million to GBP£18 
million (GBP£2.5–3.1 million per 100,000 population), equating to 2-3% of the local 
health-care budget. This estimation included resource costs such as nursing time, 
wound dressings and materials, in addition to hospitalisation costs (Drew et al. 2007). 
Based on the findings of another similar UK study that involved a primary care area 
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encompassing three hospitals in two acute trusts, nursing homes, district nurses and 
residential homes, Vowden et al. (2009) approximated the attributable cost of wound 
care in the region at GBP£9.89 million (GBP£2.03 million per 100,000 population), 
equating to 1.44% of the local health-care budget. Likewise, in this study the estimated 
costs included resource costs such as dressings, valued at GBP£1.69 million, nursing 
time, equalling 45.4 full-time nurses valued at GBP£3.076 million, and hospitalisation, 
equating to 60–61 acute hospital beds valued at GBP£5.13 million (Vowden et al. 
2009). These findings suggest that the most important components of costs are due to 
wound-related hospitalisation and nurse time. Considering the findings, Vowden et al. 
(2009) concluded that in order to reduce costs resulting from wounds, care pathways 
need to be put in place to avoid hospitalisation and to avoid the development of 
hospital-acquired pressure ulcers. Both of these studies highlight the areas of wound 
care that are attribute to the most significant expenditure and, in addition, emphasise 
the significance of the financial costs inflicted by such wound care provisions. 
 
In the community setting in Ireland, wound care costs have been presented in terms of 
community nurse time. Based on the findings of a community based cross-sectional 
study involving a defined population of 118, 379 persons and an active nursing 
caseload of 3596 community patients, Skerritt & Moore (2014) attributed a total of 
374 nursing hours to wound care provision when allowing time for both travel and 
wound management. This amount of time is significant as, when considering the 
number of community nurse staff working in the defined area, these hours equate to 
more than 100% of the nurses’ workload (Skerritt & Moore 2014). 
 
Examining the financial impact solely specific to non-healing wounds, the cost of 
managing these types of complex wounds is higher due increased length of treatment, 
frequency of therapy, staff time and wound care products (Ragnarson Tennvall & 
Hjelmgren 2005, Tennvall et al. 2006). In Europe, the estimated cost of treating non-
healing wounds is between £GBP 2.5-3.1 million per annum, representing between 2–
3% of healthcare funds (Posnett et al. 2009), and in the USA, more recent figures 
approximated costs at $US 6-15 billion annually (Markova & Mostow 2012). 
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Interestingly, in a study examining the costs of the diabetic foot, Driver et al. (2010) 
proposed significantly higher expenses of almost $US 39 billion from diabetic foot 
ulcers alone, thus demonstrating the considerable limitations with many of the 
available health economics studies and resulting conflicting findings. In the UK the 
estimated cost of treating venous leg ulcers alone has been reported as between £GBP 
300-600 million per year (Hall et al. 2014).  
 
In Ireland, there similarly exists limited comprehensive data relating to wound care 
costs. Nevertheless, the management of non-healing wounds has been estimated at 
€285.5 million per year to the Irish Health Service Executive (McDermott-Scales et al. 
2009). The substantial financial burden of non-healing wounds in Ireland can be 
acknowledged when considering that the approximated overall cost for the 
management of pressure ulcers alone, one of most prevalent types of wounds 
managed in Ireland (Moore & Cowman 2005, Skerritt & Moore 2014), is €250,000,000 
(Gethin et al. 2005). Between the financial year of 2002-2003, Gethin et al. (2005) 
conducted this retrospective cost analysis of pressure ulcers in one acute hospital and 
estimated the total cost of treating one patient with three stage 4 pressure ulcers was 
€119, 094 and, from an audit of 78 patients with pressure ulcers, the estimated cost of 
treating 13 of these patients who presented with stage 4 pressure ulcers was €1.5 
million.  
 
Despite the broad range of findings presented in relation to the cost of wounds, it is 
clear that wounds result in significant financial expenditures each year worldwide. 
Besides the financial cost for society and healthcare systems, wounds also result in 
significant costs for the individual and their significant others, of which can be related 
to finances as well as quality-of-life.  
 
1.5. Individual and Social Impact 
In addition to financial implications to the health service and economy, any wound can 
significantly affect a person’s life and cause prolonged periods of disability as well as 
pain and discomfort (MacDonald & Ryan 2010). Quality of life is a broad, 
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multidimensional term used to refer to factors such as gender, age, ethnicity, and 
religious beliefs (World Health Organisation 1997). Health-related quality of life refers 
more specifically to the impact of health and ill-health on a person’s physical and social 
functioning and their psychological well-being (Price & Krasner 2012). However, it 
must be acknowledged that when assessing quality of life in healthcare both terms 
‘quality of life’ and ‘health related quality of life’ appear to be used interchangeably 
(Jabir & Dziewulski 2015).  
 
Non-healing wounds in particular can profoundly impair patients’ quality of life 
through the numerous complications such as pain, social isolation, restricted mobility, 
and sleeping problems (Herber et al. 2007, Gorecki et al. 2009), to name but a few. 
Non-healing wounds frequently prevent a person from performing basic everyday 
activities, which can suppress levels of productivity and quality of life (Sen et al. 2009), 
and can lead to further co-morbidity (MacDonald & Ryan 2010). In addition, these 
types of non-healing wounds are associated with higher rates of mortality (Escandon 
et al. 2011).  
 
A Dutch study by Iversen et al. (2009) found diabetic patients with foot ulcers were at 
an increased risk of mortality compared to diabetic patients without foot ulceration 
(49% mortality over 10 years compared with 35.2% mortality, respectively). A recent 5-
year follow-up study by Winkley et al. (2012) emphasised the significance of the 
emotional status of the diabetic person, as a 2-fold increase in mortality at five years 
was found for those who had depressive symptoms at the time of the presentation of 
the first diabetic ulcer. These studies demonstrate the considerable support that is 
required by patients with these wound types as well as the importance of early 
detection and treatment of depression. 
 
Examining the impact of pressure ulcers on health-related quality of life, a systematic 
review of 31 studies, ten qualitative and twenty-one quantitative, with a combined 
sample size of 2,463 patients (Gorecki et al. 2009) identified key themes ranging from 
issues of physical restrictions, financial impact, social isolation, the impact of wound 
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symptoms, body image, and self-concept, the patient and healthcare provider 
relationship, and pressure ulcer knowledge (Gorecki et al. 2009). As this review 
included patients with significantly varied demographics in terms of age and condition, 
the results may not be consistent across all the study participants, such as the frail 
elderly compared to the younger patients with spinal-cord injury, and therefore may 
have limitations in terms of generalisability. Nevertheless, these findings are valuable 
as they highlight the immense impact of pressure ulcers on health-related quality of 
life.   
 
In relation to the impact of leg ulceration on patients' health-related quality of life, a 
systematic review of qualitative, quantitative and mixed method studies published 
between 1990 and 2006, similarly concluded that the impact of living with a chronic 
ulcer is burdensome, with individuals reporting pain, restrictions on their physical and 
social lives, and negative impacts on their sense of wellbeing (Herber et al. 2007). 
 
Due to the nature of burn injuries, these wounds have been described as similar to a 
non-healing wound (Timmons 2006). Furthermore, these wounds may also be 
problematical at the acute phase due to a number of potentially fatal complications 
such as shock, infection, respiratory distress and multiple organ failure (Stavrou et al. 
2014). A burn wound can be one of the most devastating injuries a person can 
experience in their lifetime (Van Loey & Van Son 2003). In a burn centre in Shanghai, a 
cross-sectional study of twenty patients who survived more than two years with 
extensive burn involving 70% total body surface area (TBSA) (Xie et al. 2010). 
Conducted between 1997 and 2009, this study aimed to evaluate the long term health-
related quality of life (HRQoL) of patients surviving severely extensive burn wounds 
and to identify the clinical predicting factors correlated with HRQoL (Xie et al. 2010). 
When compared to populations norms, HRQoL scores were found to be significantly 
lower in areas relating to physical functioning, role limitations due to physical 
problems, pain, social functioning and role limitations due to emotional problems (Xie 
et al. 2010). Despite the fact that a trend of gradual improvement was noted over 
time, issues of poor physical and psychological condition remained (Xie et al. 2010). In 
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relation to health-related quality of life, many themes emerged from this study that 
highlight the similarities between burn injuries and non-healing or chronic wounds. 
 
Regardless of variations in wound type, patient type or study location, these data 
confirm the impact of a wound has on a person’s quality of life can be immense. In 
order to address the potential multitude of requirements of each individual patient, 
health services, healthcare professionals, and budget holders must acknowledge the 
need for a dynamic and personalised approach to care as evident in the research.  
 
The diversity and extent of wound complications make them common and often 
difficult clinical problems (Leaper & Harding 1998). Considering that every person will 
at some stage experience a wound (MacDonald & Ryan 2010), the significance of the 
normal wound healing process is acknowledged as all wounds have the potential to 
result in problems and become non-healing (Sen et al. 2009, World Health 
Organisation 2010). Non-healing wounds and burn injuries in particular can be a major 
financial burden on the healthcare system and the individual (Sen et al. 2009). In 
addition to financial burdens, wounds can weigh heavily on an individual’s social and 
psychological well-being and substantially impact their quality of life (Herber et al. 
2007, Gorecki et al. 2009, Xie et al. 2010). Every member in the system of care for 
patients with wounds requires an awareness of the basic epidemiology of wounds in 
order to overcome the multitude of issues and to deliver optimal clinical care.  
 
1.6. History of Wound Management and Treatment 
Wound management and treatment practices date as far back as ancient and even 
primitive times (Forrest 1982) with ancient practices often based on spiritual or 
magical beliefs (Daunton et al. 2012, Salvo et al. 2015). The first known recording of 
wound management described issues relating the control of infection in wounds 
(Leaper & Harding 1998). Many forms of animal, plant, and mineral substances were 
documented as being used for cleansing wounds such as milk, water, wine, vinegar or 
oil, as well as for dressing and treating wounds such as faeces, animal fat, butter, bark, 
meat, honey, astringents, herbs, mouldy bread, various resins and minerals, wool 
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boiled in water or wine, adhesive tapes, gauze, silk (Forrest 1982, Daunton et al. 2012), 
and bandaging with leaves or grasses (Forrest 1982).  
 
In the last century, a deeper knowledge of the mechanisms governing wound healing 
has led to advances in wound treatment and management. Pivotal developments were 
noted with discoveries such as the concept of moist wound healing (Winter 1962), the 
use of anti-microbial agents such as silver (Wright et al. 2002) and iodine (Mertz et al. 
1999), compression therapy techniques (O'Meara et al. 2012, Wong et al. 2012), skin 
grafting, hyperbaric oxygen therapy (Malda et al. 2007, Eskes et al. 2013) and negative 
pressure wound therapy (Chariker et al. 1989, Argenta et al. 2006, Xie et al. 2010). 
Continued progressions are the result of combined efforts from multidisciplinary 
sectors such as medicine, electronics, chemistry and biology (Salvo et al. 2015). Despite 
these advances, wound treatments remain varied globally due to a multitude of 
reasons such as socioeconomics (Benskin 2013), education, traditions and 
religion/beliefs. As much of the world remains resource poor, access to emerging and 
often expensive treatments are typically limited to populations in the developed 
world. The majority of research conducted over the previous decade has focused on 
modulating the signalling molecules that control the complex wound-healing cascade, 
such as growth factors and cytokines, in order to improve healing and prevent scarring 
(Gantwerker & Hom 2011). 
 
1.7. Wounds and Wound Healing 
A wound is described as a break in normal anatomic structure and function caused by 
pathologic processes originating internally or externally to the involved organ or 
organs (Lazarus et al. 1994). Therefore, a cutaneous wound can be described as a 
disruption in the integrity of the skin (Schultz et al. 2003) and is generally termed as 
either acute or chronic (Health Service Executive 2009). These terms describe either a 
physiological mode of healing, acute wound healing, or a pathologically delayed mode 
of wound healing, chronic wound healing (Schreml et al. 2010a). Applicable to all types 
of wounds, burns, and ulcerations, wound healing is a physiological process where the 
body replaces and restores the function of damaged tissue (Flanagan 1996). Acute 
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wounds generally result from surgery or trauma and have a relatively short healing 
time, however, burns often behave more like non-healing wounds due to the area of 
tissue damage (Timmons 2006). Wound healing is generally categorised as primary, 
secondary or delayed primary (Thomas 1990, Leaper & Harding 1998).The initiation 
and subsequent process of healing is dependent on a multitude of components such as 
local wound factors, systemic mediators, potential underlying diseases and the type of 
skin injury (Schreml et al. 2010a). In order to acknowledge and appreciate 
developments in the field of wounds research and practice, a basic knowledge of the 
skin anatomy and the wound healing process is fundamental.      
 
1.7.1. Skin Anatomy: An overview 
The skin is composed of two main layers, the epidermis and the dermis, which lie 
above a layer of subcutaneous fat (William et al. 2016), the hypodermis (Timmons 
2006). The relative thickness of these layers varies considerably depending on the 
body region, the epidermis being thickest on the palms and soles, approximately 1.5 
mm, the dermis thickest on the back, approximately 30–40 times thicker than the 
overlying epidermis, and the subcutaneous fat most abundant on the abdomen and 
buttocks and scarcest on the nose and sternum (William et al. 2016). 
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Figure 1. Structure of the skin (London Health Sciences Centre 2009) 
 
1.7.1.1. Skin Structure  
The Epidermis  
The epidermis is a stratified squamous epithelium, with several well defined layers, the 
stratum corneum (horny layer), stratum lucidum (clear layer), stratum granulosum 
(granular layer), stratum spinosum (prickle cell layer), and stratum basale (basal layer) 
(Timmons 2006). The principal cell type, keratinocytes, make up 95% of the epidermis 
and are produced by cell division in the deepest layer of the epidermis, the stratum 
basale (Gantwerker & Hom 2011). Melanocytes, and Langerhans cells make up the 
majority of the remainder of the cells (William et al. 2016). As keratinocytes replicate 
they move older cells toward the surface, undergoing a complex series of 
morphological and biochemical changes while in transit, progressively losing their 
nucleus and becoming more flattened and ovoid in shape (Timmons 2006). This 
process of terminal differentiation, or keratinization, produces a surface layer of tightly 
packed dead cells named the stratum corneum (Graham-Brown & Burns 2011). In 
health, the epidermis completely regenerates every 48 days maintaining a constant 
epidermal thickness as the rate of cell production equals that of cell loss (Gantwerker 
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& Hom 2011). Epidermal kinetics are regulated by numerous growth stimulators and 
inhibitors (William et al. 2016). The features of this differentiation process are 
genetically controlled with genetic mutations accountable for a variety of diseases 
(William et al. 2016) . The stratum basale contains projections that interdigitate down 
with similar structures reaching from the dermis below forming rete ridges 
(Gantwerker & Hom 2011). Newly healing wounds and skin grafts initially lack these 
rete ridges and are therefore susceptible to shear trauma (Gantwerker & Hom 2011). 
The epidermis also contains essential appendages, the eccrine sweat glands, the 
apocrine glands, the pilosebaceous unit, comprising of a hair follicle with an associated 
sebaceous gland, and the nails (Graham-Brown & Burns 2011). The pilosebaceous unit 
and rete ridges contain epithelial stem cells that are essential to the reepithelialisation 
process, as they are relatively undifferentiated, have a great proliferation potential, 
and have a high ability for self-renewal. Consequently, destruction of these stem cells, 
often seen in burn wounds, impedes the skins ability to heal normally (Gantwerker & 
Hom 2011). Eccrine sweat glands cover almost all the human body surface and play an 
important role in body temperature regulation secreting a hypotonic liquid substance, 
sweat, that is composed of water, electrolytes, lactate, urea and ammonia (Graham-
Brown & Burns 2011). These glands consist of a secretory coil in the dermal layer and a 
duct that conveys the sweat to the epidermal surface (Graham-Brown & Burns 2011). 
The stimulation of these glands is controlled by the sympathetic nervous system, 
however the neurotransmitter is acetylcholine (Graham-Brown & Burns 2011).  
 
The Dermis 
Below the epidermis is a layer of connective tissue called the dermis (William et al. 
2016). This layer, which forms the bulk of the skin, interdigitates with the epidermis via 
upward projections called the dermal papillae (Graham-Brown & Burns 2011) and 
delivers support and nutrients to the epidermis (Timmons 2006).The dermis comprises 
two layers, the papillary layer and the reticular layer (Timmons 2006). It is made up of 
a network of interlacing fibres, mainly collagen, and to a lesser amount, elastin, 
embedded in a ground substance of glycosaminoglycans (Graham-Brown & Burns 
2011). These protein fibres provide the dermis great strength and elasticity (Graham-
Brown & Burns 2011). The dermal layer receives the major blood supply for the skin 
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and features dermal appendages such as the apocrine glands, eccrine glands, and hair 
follicles (Gantwerker & Hom 2011). The three main cells of the dermis are the 
fibroblasts, which synthesise the dermal connective tissue matrix, the mast cells, in 
which granules contain substances such as histamine, prostaglandins, leukotrienes, 
and eosinophil and neutrophil chemotactic factors, and the macrophages, which 
phagocytose cellular debris and extracellular material (Graham-Brown & Burns 2011). 
 
1.7.1.2. Skin Function 
The main functions of the skin are protection, sensation, thermoregulation, excretion, 
metabolism, and non-verbal communication (Timmons 2006). The skin serves as the 
body’s main protective barrier to the penetration of external agents such as, 
microorganisms, ultraviolet light (Graham-Brown & Burns 2011), and toxic substances 
(Timmons 2006). An antibacterial defence is provided by the components of skin 
secretions and the associated acidic pH of the skin surface, a physical protective layer 
is provided by the structure of stratum corneum with its tightly packed cells (Graham-
Brown & Burns 2011), and a protective effect against ultraviolet damage is provided by 
the melanin pigments (Meredith & Riesz 2004). The dendritic Langerhans ’ cells of the 
skin provide immunological mechanisms of defence against ‘foreign’ material and are 
involved in the inflammatory response such as seen in allergic contact dermatitis 
(Graham-Brown & Burns 2011). In addition, the skin protects against the outward loss 
of vital bodily substances (Timmons 2006), largely due to the composition of the 
stratum corneum with its overlapping cells and intercellular lipid (Graham-Brown & 
Burns 2011), The sensation function is owed to the nerve endings present in the skin 
that transmit signals of pain, temperature, pressure and touch (Timmons 2006). The 
skin plays a vital role in thermoregulation as it responds to cold by vasoconstriction, 
reducing the blood flow to the skin and hence decreasing the loss of heat from the skin 
surface, and to heat by vasodilatation, increasing the blood flow to the skin and hence 
increasing the loss of heat from the skin surface (Graham-Brown & Burns 2011). 
Perspiration is also a key feature of thermoregulation where the production of sweat 
from the skin and subsequent evaporation assists in cooling of the body (Graham-
Brown & Burns 2011). The skin’s excretory function involves the secretion of waste 
products in the form of sweat containing water, urea, and albumin, and the secretion 
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of a lipid-rich product, sebum, which lubricates the skin (Timmons 2006, Graham-
Brown & Burns 2011). The skin also functions in metabolism as vitamin D 
(cholecalciferol) is formed by the action of ultraviolet light on dehydrocholesterol 
(Timmons 2006, Graham-Brown & Burns 2011). As a surface organ, the skin also plays 
an essential role in social interaction and sexual attraction (Graham-Brown & Burns 
2011), and can convey changes in mood as well as signal inner body changes and 
general well-being (Timmons 2006). 
 
As stated by Graham-Brown & Burns (2011), it is vital to have some knowledge of the 
normal structure and function of any organ prior to attempting to understand the 
abnormal. Therefore, an overview of normal structure and function of the skin has 
been presented. Leading on from this, the normal physiology of wound healing will be 
described before considering the pathophysiology of impaired wound healing.  
 
1.7.2. Types of Wound Healing 
Wound healing is typically categorised as by primary intention, secondary intention or 
delayed primary intention (Thomas 1990, Leaper & Harding 1998). Each of these 
modes of healing have certain distinct features, hence it is important to appreciate 
these differences when seeking to understand the broader context of wound healing.   
 
1.7.2.1. Primary intention healing 
Primary healing occurs in immediately sutured surgical wounds and follows an 
uncomplicated, well-approximated and non-infected healing process (Gantwerker & 
Hom 2011). The edges of the wound are brought together using materials such as 
staples, sutures or adhesive strips and subsequent healing requires only minimal new 
connective tissue deposition and minor epidermal cell migration to fill and cover the 
area of tissue loss, respectively (Leaper & Harding 1998).  
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1.7.2.2. Secondary intention healing 
Healing by secondary intention occurs in a wound too large for the edges to be 
approximated and requires both a new epidermal surface and a new connective tissue 
matrix (Leaper & Harding 1998). The basic mechanisms of secondary intention healing 
are similar to that of primary intention however, a significant difference is the duration 
of time for healing (Thomas 1990). The result of this increased time for healing is that 
the wound is more susceptible to infection and healing complications (Gantwerker & 
Hom 2011). Cutaneous wounds that do not destroy subepidermal appendages, such as 
the pilosebaceous unit, will epithelialise rapidly due to the store of epidermal cells 
present in these appendages from where they migrate out and cover the denuded 
area (Leaper & Harding 1998). With wounds involving greater depth of the dermal 
connective tissue loss, epithelial cells must migrate from the wound edges, connective 
tissue must be deposited in greater volumes and the process of wound contraction 
may be required (Leaper & Harding 1998). 
 
1.7.2.3. Delayed primary healing 
Healing by delayed primary intention is less common than the other methods of 
healing described and is generally indicated where primary closure is predicted to be 
unsuccessful, possibly due to the presence of infection, an inadequate blood supply, or 
the requirement of excessive tension during wound closure (Thomas 1990). This 
method involves gently filling the wound with dressings to keep it open for 
approximately three to five days at which stage it is undressed and the edges are 
sutured closed as in primary intention closure. The rationale for this method of closure 
is to optimise the inflammatory response, increase angiogenesis at the wound edges 
and encourage natural decontamination of the wound (Leaper & Harding 1998). 
    
1.7.3. Normal Wound Healing 
Successful wound healing involves completion of four overlapping phases conceptually 
defined as haemostasis, inflammation, proliferation, and remodelling, and commences 
the moment the injury to the tissue occurs (Mehmood et al. 2014). The initial injury 
results in an outflow of blood and lymphatic fluid activating both intrinsic and extrinsic 
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clotting mechanisms (Mercandetti 2015). In the first phase, haemostasis is achieved as 
injured blood vessels constrict, platelets are triggered by exposed thromboplastic 
tissue products to release clotting factors, essential growth factors and cytokines, and 
platelet aggregation forms an initial haemostatic plug which is subsequently converted 
into a stable clot or thrombus (Lorenz & Longaker 2008).  
 
Within the first six to eight hours, the second phase of healing, inflammation, is 
underway (Mercandetti 2015), signalled by an influx of neutrophils, macrophages and 
lymphocytes to the wound site (Gantwerker & Hom 2011). Neutrophils are the first 
leucocytes to migrate into the wound to remove foreign materials, bacteria and 
damaged tissue by phagocytosis (Diegelmann & Evans 2004), reaching their maximal 
numbers at 24 to 48 hours and reducing at 72 hours (Mercandetti 2015). 
Macrophages, a key cell to the wound-healing process, are attracted to the wound site 
by the by-products of neutrophil apoptosis (Gantwerker & Hom 2011). These cells 
continue to phagocytose tissue and bacterial debris whilst also releasing multiple 
growth factors and cytokines (Diegelmann & Evans 2004). In acute wounds, this 
inflammatory phase is usually restricted to a few millimetres of the injury site, lasts 
approximately three to five days, and is characterised by visible erythema, oedema, 
increased heat (Hart 2002), pain and exudate due to the increased blood flow to the 
area and the vessel wall permeability (Timmons 2006).  
 
Following successful completion of this phase of wound cleaning, the proliferative 
phase, also known as the granulation (Mercandetti 2015) or repair phase (Gantwerker 
& Hom 2011), begins as fibroblasts move into the wound in response to growth factors 
such as platelet-derived growth factor (PDGF) and transforming growth factor beta 
(TGF-𝛽) (Ballas & Davidson 2001). These fibroblasts synthesise and secrete 
extracellular matrix products (Lorenz & Longaker 2008). Capillary budding and 
extracellular matrix production begin to fill the debrided wound space and 
epithelialization commences as keratinocytes proliferate near the edges of the wound 
(Gantwerker & Hom 2011). A layer of uninfected exudate covers the wound providing 
an important moisture layer containing essential growth factors (Gantwerker & Hom 
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2011). Angiogenesis, influenced by vascular endothelial growth factor (VEGF) and basic 
fibroblast growth factor (FGF), begins as new vasculature sprout from existing blood 
vessels surrounding the wound (Mercandetti 2015). The granulation tissue now 
consists of fibroblasts, new budding vessels, and immature collagen (collagen type III) 
(Gantwerker & Hom 2011). Myofibroblasts, differentiated fibroblasts with contractile 
function, begin to draw the wound edges together (Gantwerker & Hom 2011). The 
succession of these sub-phases of fibroplasia, matrix deposition, angiogenesis and re-
epithelialisation may last up to 4 weeks in the clean, uncontaminated, ‘normal healing’ 
wound (Mercandetti 2015).  
 
The final phase of remodelling or maturation is the longest of all four phases, 
continuing for up to two years following injury (Lorenz & Longaker 2008), results in the 
final appearance of the wound (Gantwerker & Hom 2011). This phase begins with the 
replacement of the provisional extracellular matrix and type III collagen with type I 
collagen, as well as apoptosis of the remaining cell types of the previous phases 
(Gantwerker & Hom 2011). The conversion of type III collagen to type I collagen 
dramatically increases the tensile strength of the wound (Gantwerker & Hom 2011). 
The metabolic activity of the tissue declines with the reduction in the cell density of 
macrophages, fibroblasts and myofibroblasts, along with the cessation of outgrowth of 
new blood capillaries which subsequently moderates the blood flow to the area 
(Leaper & Harding 1998). In scar tissue, the dermal collagen fibres formed are much 
smaller and random in appearance and will only regain a maximum tensile strength of 
approximately 80% of normal skin (Diegelmann & Evans 2004). The new collagen 
matrix becomes cross-linked and organized (Diegelmann & Evans 2004). The final 
result of wound healing is a scar, which is brittle, less elastic than unaffected skin, and 
lacks hair follicles and sweat glands (Lorenz & Longaker 2008).  
 
Oxygen and healing 
Oxygen is a fundamental requirement for the survival of cells in the human body 
(Nagoba et al. 2015). As adequate oxygenation is vital in the process of wound healing 
(Nagoba et al. 2015), it is therefore important to briefly note its role in wounds. Since 
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the 1960s, when it was identified that adequate wound oxygenation could improve 
formation of granulation tissues and synthesis of collagen (Yip 2015), the role of 
oxygen in wound healing has been studied extensively (Thomas 1990). Oxygen is 
essential to many critical mechanisms in wound healing, including inflammation, 
angiogenesis, epithelialization, collagen synthesis, and bacterial destruction 
(Gantwerker & Hom 2011). The energy to conduct these mechanisms is primarily 
acquired from the oxidation of substrates, such as carbohydrate, protein or fat, which 
must be present in adequate concentrations in the cell to allow optimal functioning 
(Leaper & Harding 1998).  
 
Research has however produced varied and often conflicting findings regarding the 
effects of oxygen in wound healing (Thomas 1990). Some published reports suggest 
that tissue hypoxia stimulates angiogenesis during wound healing and that hypoxia 
enhances angiogenic cytokines (Semenza 2010). Despite these statements, it is 
generally accepted that oxygen is essential at certain stages in wound healing, 
although  the optimal oxygen milieu during repair process continues to remain unclear 
(Sano et al. 2012). 
 
In understanding oxygen in wound healing, an important theory to note is the Bohr 
effect. In 1904, the Danish physiologist Christian Bohr and his co-workers first 
described the Bohr effect whereby a rise in partial pressure of carbon dioxide (pCO2) 
decreases the affinity of haemoglobin to oxygen and favours oxygen release from 
haemoglobin (Sreekumar 2010). It is interesting to note that the Bohr effect has a 
direct relation to pH changes as carbon dioxide released from the tissues dissolves in 
water to form carbonic acid, subsequently dissociating into H+ and HCO3- ions 
(Sreekumar 2010), reducing the pH level and consequently lowering the affinity of 
haemoglobin to oxygen, as in the Bohr effect (Sreekumar 2010). 
 
1.7.4. Impaired/ Altered Wound Healing 
This efficient and highly controlled repair process can be affected by many factors 
(Vowden 2011) and interruption can result in altered or impaired wound healing 
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(Gethin 2007). The terms chronic, delayed, stalled, recalcitrant, difficult, fail to respond 
(Harding et al. 2011a), non-healing (Gottrup et al. 2010), hard-to-heal (Vowden 2011), 
or complex (Hall et al. 2014) are used interchangeably throughout the research to 
describe these types of wounds. These wounds are usually defined as those that fail to 
follow an orderly and timely sequence of healing (Gottrup et al. 2010). Time to healing, 
such as in terms of days or weeks, is not an appropriate parameter used in isolation to 
define a wound as chronic or non-healing. Schultz et al. (2005) characterised these 
types of wounds by duration, failure to heal in an orderly timely fashion, alkalinity and 
the presence of cellular senescence (an irreversible arrest of cell proliferation arising 
from oncogenic stresses) (Campisi & d'Adda di Fagagna 2007). The term ‘non-healing’ 
has been recommended to replace the multitude of labels applied to these types of 
wound (Ashby et al. 2010, Gottrup et al. 2010) and will therefore be adopted as the 
main term of reference throughout this document.   
 
Non-healing wounds can be superficial-, partial-, or full-thickness skin loss wounds that 
heal by secondary intention (Hall et al. 2014). Many factors can interrupt the complex 
sequence of healing events and lead to pathologic responses (Diegelmann & Evans 
2004). Factors can be local, such as the presence of foreign materials, tissue 
maceration, ischaemia, and infection, or systemic, such as increased age, malnutrition, 
diabetes, and renal disease (Harding et al. 2002). Furthermore, a reduction in tissue 
growth factors, an imbalance in protease production and inhibition, and the presence 
of cellular senescence also appear to negatively influence normal wound healing 
(Harding et al. 2002). Such factors may lead to a protracted and delayed progression 
through the phases of healing resulting in prolonged inflammation and a non-healing 
wound (Gantwerker & Hom 2011).    
 
In preventing and managing chronic wounds, it is crucial to identify and apply timely, 
safe, and effective interventions aided by the use of appropriate equipment, such as 
support surfaces, footwear, and skin and wound care products (van Rijswijk & Gray 
2012). Wound measurement is recognised as a vital tool in this process, in addition to 
playing a crucial role in various other aspects of wound care, such as financial, 
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scientific, research and legal (Gethin 2006, European Wound Management Association 
2008, Health Service Executive 2009, Wendelken et al. 2011).   
 
1.7.5. Wound Healing Measurement 
Considered a routine part of patient assessment, wound measurement can offer 
valuable information about the wound bed and the surrounding skin, and indicate the 
progress of wound healing (Romanelli et al. 2002b, Gethin 2006). Accurate wound 
measurement can assist in determining appropriate treatment plans (Wendelken et al. 
2011) and is considered integral for comparing and analysing treatment regimen 
outcomes (Romanelli et al. 2002b). In addition, continuous wound measurement can 
signal wound healing ability (Gethin 2006) and thus facilitate earlier provision of more 
appropriate interventions, such as in wounds that require more aggressive treatments, 
referral to specialist services or those that require a palliative approach (Wendelken et 
al. 2011). Predicting wound healing is especially important in the current healthcare 
environment in which cost-containment has become a major concern (Sen et al. 2009, 
Health Service Executive 2013b).  
 
In order to obtain measurements that specify the various characteristics of the wound 
bed and the surrounding skin, different methods of non-invasive and invasive 
measurements have been created and tested (Romanelli et al. 2002a). In clinical 
practice, wound assessments are generally conducted on the basis of clinical 
experience relying on very basic, low-tech equipment in order to make objective 
measurements (Romanelli et al. 2008). Traditional methods of wound assessment 
include scaling systems (Cukjati et al. 2001), simple linear measurements, and wound 
tracings, the latter of which is currently considered the gold standard and the most 
commonly employed in research (Wendelken et al. 2011). Despite this, these simple 
techniques are often based on subjective interpretation of the wound (Cukjati et al. 
2001) and can lead to bias in the measurement results (Fette 2006). Therefore, it is 
important that measuring techniques and instruments are used that have strength in 
relation to the constructs of validity, accuracy, reliability, reproducibility and usability 
(Fette 2006).  
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There has been a surge of interest in recent years to develop advanced methods to 
objectively measure wound healing (Romanelli et al. 2002b). Such advancements have 
been permitted due to new scientific knowledge, techniques and materials, in addition 
to a greater understanding of the aspects of wound healing. Developments in wound 
healing measurement techniques have been focused on obtaining more in-depth 
insights of the tissue repair process and monitoring the living skin and wound in real 
time (Romanelli et al, 2002b). Nevertheless, there remains a lack of accurate diagnostic 
instrumentation that can be routinely implemented in the clinical setting. Factors such 
as the level of patient intervention and the potential for harm to the wound, may 
preclude the regular clinical use of certain available wound measurement tools (Lait & 
Smith 1998), in addition to numerous other limitations such as local financing and 
availability (World Health Organisation 2010).    
 
In wound assessment, analysis of two distinct groups of parameters namely, 
dimensional parameters and chromatic parameters, have been considered necessary 
to characterise of the level of tissue damage (Romanelli & Dini 2009). Measurement 
techniques to determine the area or extent of a wound can be divided into categories 
of contact or non-contact (Gethin 2006). Contact techniques include ruler technique, 
depth gauges, moulding materials, liquids, surface contour tracings, and non-contact 
techniques include ultrasound, laser triangulation, photogrammetry, stereo-
photogrammetry, video image analysis and magnetic resonance imaging (Gethin 
2006). A wound can also be described by various parameters such as duration, oxygen 
and blood perfusion, rigidity, inflammation, and pain, including reference to coexisting 
systemic factors, however, a complete and holistic patient assessment is essential and 
should provide the foundation to all wound assessments (Romanelli et al. 2008).  
 
Measuring wounds in research requires clear documentation of the choice, definition 
and reporting of outcomes or endpoints, described as the measurable objective of an 
evaluation or study objectives (Gottrup et al. 2010, Gethin et al. 2015). Complete 
wound closure/healing is a common endpoint in wound research (Gottrup et al. 2010) 
and is defined by the US Food and Drug Administration (2006) (FDA) as “skin re-
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epithelization without drainage or dressing requirements confirmed at two consecutive 
study visits two weeks apart” (p. 12). Other primary and secondary endpoints common 
in studies reporting on healing in pressure ulcers, leg ulcers and diabetic foot ulcers 
include reduction rate, wound closure, healing time, change in wound condition, 
biomarkers and bacteriology, circulation, infection signs, symptoms and signs, dressing 
performance, quality of life, costs and resources used (Gottrup et al. 2010). To confirm 
these physical endpoints, the European Wound Management Association (EWMA) 
recommends that wound healing is established through the use of photographs by a 
blinded observer (Gottrup et al. 2010) 
 
The ability to measure progress towards wound healing is of great importance in 
providing valuable information for the assessment of a wound, as well as, the selection 
and analysis of treatment regimens (Gethin 2006). Furthermore, wound measurement 
can offer an accurate record required for numerous purposes, medical, legal and 
financial, for example, in cases where reimbursement is being sought for specialised 
wound care treatments (Wendelken et al. 2011). In conclusion, it is evident that high 
quality wound measurement can have significant implications for wound outcomes, 
patient outcomes, health service outcomes  (Gethin et al. 2015). 
 
1.8. pH  
The pH measurement is a negative logarithm of the activity of hydrogen ions in an 
aqueous solution employed to convey acidity and alkalinity on a scale of 0 to 14 
(Romanelli et al. 2002b). The neutral point is 7, below 7 is acidic (a higher hydrogen 
concentration), and above 7 is alkaline (a lower hydrogen concentration) (Gethin 
2007). It is worth noting that actual acidity increases much more rapidly than might 
appear in the simple numerical logarithmic scale (Barrett et al. 2009), for example a pH 
of 6 has ten times as many hydrogen ions as a pH of 7, representing a ten-fold increase 
in hydrogen ion concentrations (Marieb & Hoehn 2007). pH is balanced in the body by 
the buffering capacity of fluids that have the ability to bind or release H+ in solution, 
and thus keeping the pH of the solution relatively constant despite the addition of 
substantial amounts of acid or base (Barrett et al. 2010).  
44 
 
Due to the organic acid secretion of keratinocytes, the surface of intact skin has a 
naturally acidic pH ranging from 4 to 6 (Zlotogorski 1987, Lambers et al. 2006, Schmid-
Wendtner & Korting 2006). The acidic skin pH is also contributed to the secretions 
from sebaceous and sweat glands (Schmid-Wendtner & Korting 2006) which include 
various acids, such as amino acids, lactic acid, and fatty acids (Ehlers et al. 2001). The 
first documented description of this acidic environment dates back to the year 1892 
(Schneider et al. 2007) and has since been supported by numerous other works (Blank 
1939, Zlotogorski 1987, Schmid-Wendtner & Korting 2006). As a key feature in the 
maintenance of cutaneous homeostasis, the acid mantle of the skin forms a defence 
against pathogenic microorganisms (Ehlers et al. 2001) and inhibits the activity of 
digestive enzymes (Schultz et al. 2005). Underlying the skin, the pH of the tissue is 
more neutral, with a pH of 7.4, meaning that a break in the integrity of the skin surface 
in the form of a wound will cause exposure of this tissue and lead to disturbances in 
the skins delicate acidic milieu (Schneider et al. 2007). pH influences every biochemical 
activity in wound healing with values varying dependant on the stage of healing and 
the time course (Schneider et al. 2007). During the normal healing of acute wounds, an 
initial temporary physiological acidosis occurs resulting from various factors such as, 
the generation of organic acids (Schneider et al. 2007). This acidic environment is 
considered favourable for inducing proliferation of fibroblasts (Liu et al. 2002, 
Schneider et al. 2007), promoting epithelization and angiogenesis (Nagoba et al. 2008), 
controlling bacterial colonization (Jones et al. 2015) and facilitating the release of 
oxygen from oxyhaemoglobin (Leveen et al. 1973). In contrast, alkalinity can have an 
adverse effect on the wound tissue by depriving the wounds of oxygen (Leveen et al. 
1973) and providing an environment more favourable for bacterial growth (Nagoba et 
al. 2015). It is therefore evident that even minor fluctuations in pH can induce 
dramatic changes in the wound.  
 
It has been suggested that monitoring surface pH may produce objective measured 
readings of the condition of the wound bed and denote the stage of healing (Gethin 
2007). pH can be measured by examining the extractable water-soluble components of 
the skin preferably using potentiometric methods, particularly with flat glass 
electrodes, because of their increased accuracy compared with colorimetric methods 
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(Ehlers et al. 2001, Schmid-Wendtner & Korting 2006). Measurement of pH using a flat 
glass electrode is a non-invasive technique which requires careful moistening of the tip 
of the electrode with distilled water prior to application to the skin or wound 
(Romanelli et al. 2002b). In the past, non-invasive measurement of body surface pH 
has been used to assess the barrier properties of the stratum corneum and to examine 
the correlation between alterations in skin surface microflora and the development of 
dermatological conditions (Romanelli et al. 2002b).  
 
To examine the effect of changes in pH on wound healing and the potential of using 
the Bohr effect to increase the availability of oxygen to the wound tissues, Leveen et 
al. (1973) conducted a detailed and multi-faceted study involving both in vitro and in 
vivo experiments. Numerous interesting results emerged from these clinical trials 
which employed wound serums, human wounds, animal organs and mouse subjects. 
The majority of surface wounds examined were recorded with alkaline pH levels in the 
region of 8, owed to a respiratory alkalosis due to the loss of carbon dioxide from the 
wound surface (Leveen et al. 1973). Significant quantities of histotoxic ammonia were 
also recorded on most surface wounds (n=121, 89.9%) further contributing to the 
alkalinity of the wound, however this ammonia appeared non-toxic in an acid medium. 
Consequently, Leveen et al. (1973) proposed the chemical acidification of wounds as a 
most effective method of reducing the toxicity of the ammonia formed by urease 
producing organisms. Other remarkable results emerged such as the effects of pH on 
oxygen dissociation where a dramatic five-fold increase in the release of oxygen 
occurred as a result of a reduction of only 0.9 pH units. This study found wound 
acidification increased the partial pressure of oxygen (pO2) in the wound surface by 
means of a shift in the oxyhaemoglobin-haemoglobin dissociation curve (Bohr Effect), 
whereas an increase in pH due to the presence of ammonia was found to impair 
oxygenation of the wound (Leveen et al. 1973). Appreciating the results of this study, 
Wilson et al. (1979) adopted the principle by Leveen et al. (1973) that prolonged 
chemical acidification of wound surfaces improves healing rates by increasing cellular 
oxygen availability and examined it in the treatment of varicose ulcers. Wilson et al. 
(1979) constructed a study of two parts, firstly, to examine the effect of different 
preparations on ulcer surface pH and, secondly, to determine whether the acidification 
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of leg ulcers promotes healing. Using a buffered acidic preparation that was confirmed 
in the first stage of the study to have a superior prolonged effect of lowering ulcer 
surface pH, the controlled clinical trial of 36 patients with varicose leg ulcers revealed 
that healing rates achieved with the buffered material were significantly better than 
those achieved with the unbuffered ointment, irrespective of differences in pre-
treatment ulcer surface pH values. These results support the principle that prolonged 
chemical acidification of wound surfaces increases healing rates (Sharpe et al. 2009). 
 
In a more recent study to explore the relationship between pH and cell behaviour, the 
effects of pH on the attachment, proliferation and migration of keratinocytes and 
fibroblasts were investigated using in vitro and ex vivo skin growth models. 
Interestingly, the findings show that keratinocytes are tolerant to extremes in pH, 
display a migratory phenotype at a high pH, proliferate at a range of pH levels and 
differentiate at a low pH (Sharpe et al. 2009). Optimal pH for both keratinocyte and 
fibroblast proliferation was found between pH 7.2 and 8.3, and the migration of 
keratinocytes from ex vivo skin explants was optimal at a pH of 8.55. These findings 
suggest a high pH could be beneficial for increased epithelial growth and improved skin 
graft take, however, may, conversely, create an environment more susceptible to 
microbial infection (Sharpe et al. 2009). 
 
On the premise that lowering wound pH may reduce protease activity as well as 
increase fibroblast activity and oxygen release in wounds, an open label, non-
randomised prospective study was conducted to analyse the effects of a two-week 
treatment with a Manuka honey dressing on the changes in surface pH and size of non-
healing ulcers (Gethin et al. 2008). Following the two weeks of honey treatment, 
results from the seventeen participants with twenty ulcers recorded using a glass 
surface electrode and a pH meter set showed statistically significant decreases in 
wound pH (P < 0.001) and reductions in wound size. Wounds with a pH less than 7.6 
showed a 30% decrease in size compared to wounds with a pH of 8 or above which 
failed to decrease in size (Gethin et al. 2008). A reduction in 0.1 pH unit was associated 
with an 8.1% reduction in wound size (p < 0.012) (Gethin et al. 2008). Although these 
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findings appear to conflict with those published by Sharpe et al. (2009), it is well 
established that wound healing is a complex process influenced by many factors and 
therefore research results may vary due to numerous differing variables between 
these two studies such as wound type and research methodology. For example, Sharpe 
et al. (2009) used keratinocytes seeded in 96-well plates at a density of 5000 cells ⁄well 
and fibroblasts at a density of 2000 cells ⁄well in vitro and in an ex vivo skin growth 
model whereas Gethin et al. (2008) used in vivo non-healing leg ulcers to examine the 
effects of pH. Due to the lack of previous studies on pH and honey dressings, Gethin et 
al. (2008) determined by a priori calculation using a resource equation that a sample of 
only eleven patients was sufficient for their study. Nonetheless, this sample size is 
considered relatively small and, due to the lack of previous research conducted in this 
area, would require further larger research to support these findings. Other limitations 
include the lack of a control group which limits the external validity of the findings, the 
short trial duration of two weeks without a follow-up period and the low frequency of 
pH measurement which was only recorded at the start of the study and at two-weeks. 
Although Gethin et al. (2008) also acknowledge some of these limitations, their study 
produced interesting findings that will contribute to this field of inquiry and provides a 
foundation for further research.  
 
Although an elevated alkaline pH appears to exhibit lower healing rates compared to a 
pH is closer to neutral (Leveen et al. 1973), due to the complex nature of wound 
healing optimal levels of pH for tissue repair may vary. The interaction between the 
acidic wound bed and the wound healing process is believed to relate to the potential 
to increase tissue oxygen availability through oxygen dissociation and to reduce the 
histotoxicity of bacterial end products, hence encouraging wound healing (Romanelli 
et al. 2002b). Schneider et al. (2007) describe that where wound healing is delayed, the 
pH can fluctuate becoming increasingly alkaline. Environments of non-healing wounds 
have been reported in the range of pH 7.15 to 8.93 (Gethin 2007) and it is at this stage 
that synthesis of extracellular molecules is impaired and the healing process is stalled 
(Jones et al. 2015). The presence of bacterial colonisation, particularly staphylococcus 
aureus, is suggested to delay wound healing (Schierle et al. 2009, Zhao et al. 2012). 
Interestingly, the body’s innate defence reaction to fight bacteria with an invasion of 
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neutrophils, seen clinically in the wound as pus, appears to move the pH value towards 
an acidic milieu (Schneider et al. 2007). As the wound advances through the process of 
healing, the pH moves to neutral and eventually returns to acidic (Schneider et al. 
2007, Percival et al. 2014a). 
 
In conclusion, the correlation between wound healing and wound bed pH has received 
much attention in scientific research. Despite varied research reports, it is evident that 
wound pH is a critical factor in the biochemical processes fundamental to wound 
healing, and as such, presents as significant feature of both diagnostic and theranostic 
interest (Gethin et al. 2015). 
 
1.9. Exudate 
Exudate is derived from fluid that has leaked out of blood vessels and contains a 
variety of substances including water, electrolytes, nutrients, inflammatory mediators, 
white cells, protein-digesting enzymes, growth factors and waste (World Union of 
Wound Healing Societies 2007). Inflammation, initiated by the initial wounding injury, 
causes increased capillary permeability which promotes the leakage of fluid from the 
blood vessels (World Union of Wound Healing Societies 2007). In the first two to three 
days following wounding, platelets and fibrin may be present but reduce as 
haemorrhage ceases (White & Cutting 2006). Due to its component parts, exudate has 
a high protein content with a specific gravity above 1.020 (Cutting 2003). The fluidity of 
exudate allows these factors to move to wounded areas to promote healing (Adderley 
2010). Although most exudate is produced during the inflammatory and proliferative 
stages of wound healing, the volume produced will vary depending on both the stage 
of the healing and the type of wound, in relation to aetiology, location, size, 
environment and compounding pathological processes (Cutting 2003, World Union of 
Wound Healing Societies 2007). Different types of exudate may be seen in wounds 
such as, serous (clear, watery consistency), fibrinous (contains fibrin protein strands), 
purulent (contains pyogenic organisms and other inflammatory cells), haemo-purulent 
(contains neutrophils, dead or dying bacteria and inflammatory cells) or haemorrhagic 
(friable capillaries result in exudate with blood is the major component) (Cutting 2003). 
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The moisture provided to the wound from exudate is seen as an important factor in 
wound healing. Until the late 1950s, it was generally believed that a wound should be 
kept as dry as possible in order to prevent bacterial infection (Thomas 1990). Winter 
(1962) advocated moist wound healing listing the benefits as improving healing rates, 
reducing pain and discomfort, and decreasing rates of wound infection. These reports 
by Winter (1962) rejecting the concept that dry wound environments promote wound 
healing has been confirmed by numerous subsequent studies (Dyson et al. 1988, 
Dyson et al. 1992, Svensjö et al. 2000, Hackl et al. 2014). Thomas (1990) argue that dry 
conditions cause the wound to dehydrate and produce a scab of dried serous exudate 
and devitalised dermis, of which forms a natural barrier that impedes the migrating 
epidermal cells, forces them to move deeper below the drying eschar, and results in 
prolonged healing time and unnecessary loss of healthy tissue.  
 
In a comparative study to explore the effects of moist and dry conditions on dermal 
repair in a porcine model, Dyson et al. (1988) found moist wound conditions superior 
in reducing both the inflammatory and proliferative phases of dermal repair when 
compared to dry wound conditions. Four years later, the same researchers performed 
another comparative study to examine the effect of moist and dry conditions on the 
process of angiogenesis during dermal repair. From analysis of 108 wounds from nine 
pigs (54 wounds exposed to dry conditions and 54 wounds exposed to moist 
conditions), Dyson et al. (1992) showed that the wounds healing in a moist 
environment had a greater rate of revascularisation of which occurred in a more 
orderly fashion than those in a dry environment. Furthermore, compared to the moist 
wounds, the decline in vessel number from the peak was slower in the dry wounds 
(Dyson et al. 1992) thus indicating a delayed progression into the remodelling phase of 
healing.  
 
A moist wound environment aids de-sloughing (removal of dead proteins) of a wound 
through the process of autolysis by endogenous proteases present in exudate (Cutting 
2003). In a healthy wound, these proteases assist in wound bed preparation and 
degradation of extracellular matrix components, such as collagen, fibronectin, elastin, 
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laminin and proteoglycan, prior to wound closure and remodelling (Cutting 2003). The 
level and duration of protease expression is strictly controlled by either plasmin 
activation or by the presence of tissue inhibitor of metalloproteinases (TIMPs) 
(McCarty & Percival 2013).  
 
It is now also acknowledged that acute wound fluid supports the stimulation of 
fibroblasts and the production of endothelial cells as it is rich in leukocytes and 
essential nutrients (Dowsett & Newton 2005). In a healing wound, exudate appears to 
promote healing and its production generally reduces as a wound heals, however in 
wounds not healing as expected, exudate production may continue, become excessive, 
and cause negative effects (World Union of Wound Healing Societies 2007). Evidence 
suggests that there are significant differences between acute and chronic wound fluid 
(Wysocki et al. 1993, Grinnell & Zhu 1994, Yager et al. 1996, Trengove et al. 1999, 
Baker & Leaper 2000, Thamm et al. 2013). 
 
Examining the differences between acute and chronic wounds, Trengove et al. (1999) 
firstly analysed wound fluids taken from 22 acute surgical wounds and 25 chronic 
wounds and, secondly, compared the levels of proteases in wound fluids taken from 15 
venous leg ulcers during a non-healing and healing phase. Findings from the first part 
of the study showed matrix metalloproteinase activity to be significantly elevated by 
30 fold in chronic wounds (median 22.8 microg MMP Eq/ml) compared to acute 
wounds (median 0.76 microg MMP Eq/ml) (p < 0.001) (Trengove et al. 1999). Using a 
small subset of the study sample, analysis of fluids from 3 acute and five chronic 
wounds showed an inverse correlation between tissue inhibitor of metalloproteinase-1 
levels and protease levels (p = 0.02, r = - 0.78) (Trengove et al. 1999). In addition, this 
study reported significantly higher degradation of epidermal growth factor in chronic 
wound fluid samples (mean 28.1%) compared to acute samples (mean 0.6%), which 
was also found to correlate with the epidermal growth factor activity of these wound 
fluid samples (p < 0. 001, r = 0.64) (Trengove et al. 1999). In the second part of the 
study, data from non-healing and healing leg ulcers displayed significantly decreasing 
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levels of matrix metalloproteinase activity as chronic leg ulcers progressed in healing (p 
< 0.01) (Trengove et al. 1999).  
 
Acknowledging the differences in chronic and acute wound fluid, Thamm et al. (2013) 
compared keratinocyte migration and proliferation under the influence of acute 
wound fluid and chronic wound fluid and reported findings indicating that chronic 
wound fluid can lead to a permanent degradation of extracellular matrix, and hence, 
inhibit wound healing. Acute wound fluid resulted in a positive impact on keratinocyte 
proliferation in contrast to chronic wound fluid which had an anti-proliferative effect 
(Thamm et al. 2013). Chronic wound fluid also appeared to significantly impair 
keratinocyte migration compared to acute wound fluid which resulted in an 
undisturbed wound closure (Thamm et al. 2013). Furthermore, matrix 
metalloproteinase (MMP-9) expression was substantially upregulated by chronic 
wound fluid compared with acute wound fluid (Thamm et al. 2013).  
 
Despite numerous research studies, the current understanding of exudate remains 
limited (Lloyd Jones 2014). Nevertheless, more is presently known about proteases 
present in wound fluid than any other biomarker of wound healing and as such have 
gained substantial interest due to their significant impact in wound healing (Harding et 
al. 2011b). (Harding et al. 2011b). Proteases, also known as proteinases or peptidases, 
are a very extensive family of enzymes that perform both degradative and synthetic 
functions (Rao et al. 1998). Proteases are divided exo- and endopeptidases depending 
on their action at or away from the protein termini, respectively (Rao et al. 1998). Exo-
proteases remove amino acids from the ends, either the N- or C-terminus, of proteins, 
and endo-proteases, cleave bonds within protein (Falanga 2002). Proteases are further 
classified into four groups, serine proteases, aspartic proteases, cysteine proteases, 
and metalloproteases, based on the type of functional group at the enzyme’s active 
site (Rao et al. 1998). Metalloproteinases are the most significant in wound healing 
because of their properties of being able to cleave collagens and other extracellular 
matrix components (Gibson et al. 2009). To date, twenty-three human 
metalloproteinases have been identified (Gibson et al. 2009), and among those of 
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particular focus of research in wounds are MMP-1 (fibroblast collagenase), MMP-2 
(gelatinase A), MMP-8 (neutrophil collagenase), and MMP-9 (gelatinase B) (Falanga 
2002). Other essential metalloproteinases in wound healing include MMP-12, MMP-
10, and MMP-3 (Falanga 2002). Many of these peptidases require a metal ion, such as 
zinc or calcium, for their activity (Gibson et al. 2009).  
 
Metalloproteinases are critical to normal tissue repair playing an essential role in at 
least five major processes, removal of damaged extracellular matrix and bacteria, 
degradation of capillary basement membrane for angiogenesis, migration of epidermal 
cells, contraction of scar extracellular matrix and remodelling of scar extracellular 
matrix (Gibson et al. 2009). As stated, protease expression is strictly controlled by 
either plasmin activation or by tissue inhibitor of metalloproteinases (TIMPs) (Gibson 
et al. 2009). As precisely controlled protease functioning facilitates wound healing, a 
large body of evidence now exists suggesting that disturbances relating to 
metalloproteases can also substantially impair normal wound healing (Wysocki et al. 
1993, Grinnell & Zhu 1994, Trengove et al. 1999, Gibson et al. 2009, Thamm et al. 
2013) by causing ‘off target’ destruction of proteins, such as growth factors, receptors 
and extracellular matrix proteins, that are essential for healing (Gibson et al. 2009). 
These activities contribute to a poorly developed extracellular wound matrix which, in 
turn, hinders the migration of the epidermal cells across the surface of the wound to 
complete the healing process (Dowsett & Newton 2005). 
 
Although the molecular pathophysiology of wound healing is not fully understood, 
disruption of the intricate molecular processes involved leads to the formation of a 
non-healing wound (Trengove et al. 1999). In addition, excessive amounts of exudate 
resulting in moisture leaking from the wound bed onto the peri-wound skin causes 
maceration and excoriation (Dowsett & Newton 2005). As some bacterial species 
thrive in a moist environment, for example, two of the most common wound 
pathogens, staphylococcus aureus and pseudomonas aeruginosa, excessive wound 
fluid may also increase the risk of bacterial infection (Cutting 2003).  
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In a study examining samples of blood and wound fluid from acute and chronic 
wounds, mastectomy and leg ulcer wounds, respectively, it was found that enzymes in 
chronic wound fluid were five- to tenfold that of acute wound fluid and contained both 
activated enzyme and proenzyme species (Wysocki et al. 1993). In a similar study, 
levels of metalloproteases, MMP-2 and MMP-9, were found to be elevated more than 
ten- and twenty-five fold, respectively, in fluids of non-healing pressure ulcers 
compared with the fluids from healing wounds (Yager et al. 1996). In addition, fluids 
from pressure ulcers contained significantly more collagenase complexed with the 
inhibitor, tissue inhibitor of metalloproteinase (TIMP) (Yager et al. 1996). This study 
demonstrated an imbalance between the levels of metalloproteinases and their 
inhibitors in the fluids of non-healing pressure ulcers, suggesting this as the main 
reason for elevated levels of metalloproteinases and the resulting barrier to healing 
(Yager et al. 1996). Similarly, Bullen et al. (1995) reported that TIMPs are decreased 
and MMP-9 levels are increased in non-healing wounds. In addition, further studies 
have found low levels of the natural inhibitor of neutrophil elastase in chronic wounds 
compared to acute wounds (Grinnell & Zhu 1994, Rao et al. 1995).  
 
In conclusion, the correlation between wound fluid and wound healing has received 
much attention in scientific research for both its positive and negative influences on 
wound healing. Reviewing the evidence, it is apparent that wound fluid is a critical 
factor in the biochemical processes fundamental to normal wound healing, such as 
demonstrated in studies comparing dry and moist or wet wound healing 
environments. Measuring and analysing the components and quantity of wound 
exudate may therefore assist in revealing the condition of the wound and provide 
valuable data for researchers, practitioners and wound-product developers. 
 
1.10. Temperature  
Temperature plays a crucial role in the appropriate functioning of every system in the 
body, with every activity within the body dependant on an appropriate temperature 
(Jain & Shakya 2014). Temperature is therefore recognised for its importance in 
wounds and wound healing (Khan et al. 2004). Humans are homeotherms, that is, they 
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able to sustain an average, relatively constant body temperature of 37 °C (±0.5°C) 
despite changes in environmental temperatures (Jain & Shakya 2014). In the human 
body, surface temperature is the outcome of a thermal balance between energy 
supplied from the core and perfusion and energy lost to the environment through 
conduction, radiation, evaporation, and convection (Charkoudian 2003, Fierheller & 
Sibbald 2010). Skin temperature is influenced by both internal (physiological) and 
external (environmental) factors and, as such, can be considerably affected by 
variations in ambient temperature, surface moisture, body location, and blood flow 
(Romanovsky 2014). Temperature can be referred to in terms of the degree Celsius (°C) 
or the Kelvin (K)(Houdas & Ring 2013). The degree Celsius (°C) is the hundredth part of 
the difference between the temperature of melting ice at 0°C and that of boiling water 
at 100 °C, at the standard pressure of 1013 millibars, and, the Kelvin (K) similarly has 
the same value as the degree Celsius however, the point of zero corresponds to -
273.5°C (Houdas & Ring 2013). Wound temperature has been recorded using either of 
two clinical techniques, the absolute temperature, also referred to as thermodynamic 
temperature, of the wound (McGuiness et al. 2004), or the temperature of the wound 
relative to the adjacent intact skin (Armstrong & Lavery 1997, Fierheller & Sibbald 
2010, Romano et al. 2011, Kruse et al. 2015), however no standard criterion for 
measuring skin temperature yet been established (Dini et al. 2015). Furthermore, no 
reference range exists for body surface temperatures (Fierheller & Sibbald 2010). 
Armstrong & Lavery (1997) reasoned that, due to the underlying disease processes of 
various wounds that affect lower limb perfusion and temperature regulation, it is 
difficult to identify an absolute skin temperature level that could be regarded normal 
or one that could be employed as a universal reference. The latter of these 
measurement techniques is based on the grounds that, under normal circumstances, 
the temperature of any site on the human body is comparable to a symmetrical site 
(Fierheller & Sibbald 2010).  
 
Temperature is suggested to influence wound healing by affecting local blood flow 
(Khan et al. 2004) and lymphocyte extravasation, whilst it is also an established marker 
of infection and suggested to be an early indication of wound chronicity (Nakagami et 
al. 2010). Although the relationship between temperature and wounds is not yet fully 
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understood (Khan et al. 2004), its effect can be acknowledged at either a purely 
chemical level or at a more physiological level (Khan et al. 2004). Exploring the effect 
of heat on accelerating chemical reactions, an in-vitro study demonstrated that 
hyperthermia increases polymorph chemotaxis and phagocytosis, as well as fibroblast 
proliferation (Xia et al. 2000). At a more physiological level, increased temperature in 
acute wounds is suggested to enhance local dermal blood flow, increasing 
subcutaneous oxygen tensions, and thus creates an environment conducive to wound 
healing (Khan et al. 2004).  
 
Khan et al. (2004) designed a study to explore the direct effect of topical radiant 
heating (TRH) on wound healing at a physiological and cellular level using experimental 
bandages placed over split-thickness skin graft donor site wounds of twelve patients 
undergoing graft harvesting. The six participants in the experimental group underwent 
intermittent wound heating for five hours (three one-hour heating cycles at 38°C, 
separated by two one-hour rest intervals), whilst the other six participants in the 
control group received no radiant heating (Khan et al. 2004). Using laser Doppler 
imaging and immunohistochemical analysis of skin biopsies, TRH was found to 
significantly increase local dermal blood flow (P <0.001) by up to 100% in both injured 
and intact skin, and was furthermore associated with a significant (P <0.05) increase in 
CD3 immunoreactivity (Khan et al. 2004). These findings suggest that topically 
increasing the temperature of wounds may enhance local innate immunity within the 
wound and thus create an enhanced wound healing environment. 
 
Acknowledging the issues of impaired angiogenesis and reduced granulation tissue 
formation associated with inadequate wound healing in diabetic patients, a 
prospective randomised study was carried out to examine the local use of insulin in 
wounds of diabetic patients in correlation to an increase in temperature in wound 
healing (Martinez-Jimenez et al. 2013). In addition to standard care, the wounds of 
eight diabetic patients presenting with full-thickness wounds, five due to necrobiosis, 
one due to trauma, and two due to post-neoplasm resection, were treated with an 
administration of insulin to only half of the wound surface. Using thermography and 
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biopsy specimens to record the presence of fibrosis, changes in temperature, and 
amount of blood flow, significant differences were found between the areas treated 
with insulin and the areas receiving standard care only. The number of vessels (insulin: 
96 ± 47 versus no-insulin: 32.88 ± 45; p < 0.026), the percentage of fibrosis (insulin: 
44.42 ± 30.42 percent versus no insulin: 12.38 ± 36.17 percent; p < 0.047) and the 
mean temperature (insulin: 1.27 ± 1.12°C versus no-insulin: 0.13 ± 1.22°C; p < 0.001) 
were all significantly different between sides, and thus demonstrated a correlation 
between increased temperature and increased angiogenesis and fibrosis. 
 
Although warmer temperatures appear beneficial in wound healing faster, these 
temperatures should not vary significantly between the peri-wound area (Kruse et al. 
2015). Significant differences in temperature between the wound and the peri-wound 
area in addition to abrupt increases in chronic wound temperatures, are commonly 
acknowledged to signal infection (Fierheller & Sibbald 2010). 
 
In a study investigating the use of thermography to detect latent inflammation and 
predict prognosis in chronic wounds, results from a cohort of 35 participants with 
stage II–IV pressure ulcers on the torso (21 recorded with low temperature ulcers and 
14 with high temperature ulcers) found that ulcers with high temperatures healed 
more slowly when compared to low temperature ulcers. The relative risk for delayed 
healing in high temperature pressure ulcers was reported as 2.25 (95% confidence 
intervals; 1.13–4.47, p=0.021). Nakagami et al. (2010) suggested that the higher 
temperature in wound sites when compared to their surrounding skin may indicate the 
presence of critical colonisation. 
 
On the other hand, hypothermia has been considered detrimental to successful wound 
healing and has been correlated with increased wound infection rates (Kurz et al. 
1996). In surgical patients, hypothermia has been suggested to increase susceptibility 
to perioperative wound infections due to the effects of vasoconstriction and impaired 
immune function (Cuthbertson & Tilstone 1967, Kurz et al. 1996). As well as impaired 
local immunity, wound hypoxia owed to reduced temperatures and blood flow may 
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compromise wound tensile strength, independent of wound infection, due to the 
oxygen-dependent nature of enzymes involved in the process of collagen cross-linkage 
(Jonsson et al. 1991, Khan et al. 2004).  
 
In 1982, an large experimental study on the effects of wound cleansing found that 
wounds took forty minutes to regain pre-cleansing temperatures and three hours to 
re-establish pre-cleansing normal rates of mitotic and leucocytic activity (Myers 1982, 
cited in Thomas, 1990). A more recent study similarly exploring the impact of certain 
treatment practices on wounds, examined the influence of dressing changes on 
wound-bed temperatures of patients with traumatic or surgically debrided wounds. 
From a total of 133 dressing episodes, an infrared body surface scanning device 
recorded temperatures just below 33°C (mean of 32.7°C) immediately after dressing 
removal, a reduction of 2°C following the dressing-change procedure (mean of 29.9°C) 
and 30 minutes on average (mean of 23 minutes) following dressing reapplication for 
pre-procedural temperature return (McGuiness et al. 2004). In light of evidence 
detailing the crucial role of temperature in wound healing, these findings that 
demonstrate the significant impact of treatment interventions on wound temperature 
are considered of great importance.  
 
The quantitative measurement of local skin and wound temperature has been 
suggested as an aid in the assessment and diagnosis of wound and surrounding skin 
infection (Fierheller & Sibbald 2010). In addition, temperature measurements are 
regarded as valuable in assessing and monitoring the stage of wound healing 
(Martinez-Jimenez et al. 2013) and in predicting future wounds (Armstrong & Lavery 
1997). Despite this, the measurement of the surface temperature of the human body 
is not routinely undertaken in the majority of clinical environments (Romanelli et al. 
2002a). This is not because the measurement of temperature lacks clinical significance, 
but is because it is challenging to accurately obtain. The subjective nature of 
determining skin temperature changes by touch of hand in a physical assessment has 
limited diagnostic accuracy (Romanelli et al. 2002a). Equally, conventional mercury or 
electronic thermometers are difficult to attach to the body surface, require significant 
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amounts of time to equilibrate, and are prone to low readings because of poor surface 
contact (Romanelli et al. 2002a). The infrared method is fundamentally different from 
the numerous other techniques of body surface temperature measurement in that 
there is no temperature device to heat. Recognized as a reliable, highly technical 
diagnostic tool, a handheld infrared thermometer records and interprets variations in 
temperature on the surface of the skin in colour or shades of grey and has the 
potential to provide an objective, quantitative measurement of skin surface 
temperature (Romanelli et al. 2002a). Increasingly, studies encompassing aspects of 
temperature recording in wounds have adopted infrared thermography as the 
measuring tool, such as in studies reporting on post-operative temperature changes in 
surgical wounds (Romano et al. 2011, Windisch et al. 2015).  
 
1.11. Summary  
This chapter introduced the topic of wounds and wound healing, with specific 
attention to aspects of measurement and particular biomarkers in relation to wound 
healing. Worldwide, wounds continue to pose immense challenges to patients and 
their carers, researchers, practitioners and health services. A wound, described as a 
break in normal anatomic structure and function caused by pathologic processes 
(Lazarus et al. 1994), includes injuries such as burns, non-healing, non-surgical, and 
surgical wounds (Leaper & Harding 1998). The epidemiology of wounds varies greatly 
across the world due to numerous factors such as wound care practices, availability of 
resources and population demographics (World Health Organisation 2008, World 
Health Organization 2009, World Health Organisation 2010). Independent of these 
factors, the intrinsic biological features of wounds and wound healing remain the 
same. Wound healing is the result of an immense number of interconnected biological 
processes which are coordinated over a temporal sequence in reaction to injury and 
microenvironment (Sen et al. 2009). In order to provide essential data to address 
medical, legal and financial matters, the ability to measure the progression towards 
wound healing is of great importance. Therefore, achieving an in-depth understanding 
of certain significant factors in wound healing such as wound pH, exudate composition 
and temperature may lead to the attainment of such valuable data. 
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1.12. Conclusion 
Despite advances in wound research, many aspects of the complex processes involved 
in wound healing remain unknown. Much of the wound research conducted over the 
previous decade has focused on modulating the signalling molecules that control the 
complex wound-healing cascade, such as growth factors and cytokines, in order to 
improve healing (Gantwerker & Hom 2011). Factors of temperature, pH and exudate 
composition have significant influences in the wound healing process. It is therefore 
evident that further examination of these factors is important to gain greater insights 
into the intricate nature of wounds and wound healing.  
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Chapter 2. Methodological Issues in Systematic Reviews 
2.1 Introduction 
In this chapter, health research and the concept of evidence-based practice within the 
field of healthcare and nursing will be discussed. Following this, the role of systematic 
review will be explored and the processes involved in conducting such a review will be 
described. Due to the significant implications associated with bias in research, an in-
depth discussion will be presented relating to the risk of bias within individual studies 
as well as within systematic reviews. Finally, the processes of meta-analysis and meta-
synthesis will be explored within the context of quantitative and qualitative research in 
systematic reviews.  
 
2.2. Nursing Research and Evidence Based Practice  
2.2.1. Research in Healthcare  
Medical and health research has contributed significantly to improvements in human 
health and wellbeing worldwide (Dyke & Anderson 2014). Much of the major early 
advances in medical knowledge and practices followed significant observations by 
medical practitioners, such as the observations on smallpox in the late 1700s and the 
subsequent discovery of the smallpox vaccination by John Savage and Thomas Jamison 
in the early 1800s (Gandevia 1957). Although research in the field of biomedical and 
health sciences is not a new phenomenon, the previous few decades have seen an 
increase in the demand for the use of research to support clinical practice rather than 
relying on clinical experience, intuition, or traditional practice (Sim & Wright 2000). 
Growing demands for research in health care can be linked to advances in technology, 
rising public expectations of the healthcare services, and government policies that are 
increasingly focused on improving cost-effectiveness, enhancing clinical care, and 
reducing the burden of ill-health (Sim & Wright 2000).      
   
2.2.2. Nursing Research in Ireland 
Since the formation of the Department of Health in Ireland in 1947 (Department of 
Health 1953) and the establishment of the Health Act in 1970 (Government of Ireland 
1970), continuous endeavours have been made to provide the health service with high 
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quality patient care at its core (Department of Health 1994, Department of Health and 
Children 2001, Murphy 2005, Department of Health and Children 2008). In 1998, the 
report of ‘The Commission on Nursing’ stated that a culture of research and critical 
analysis was vital to create a context of research and evidence-based practice which 
could facilitate nurses to improve their outdated, and possibly unsafe, practices 
(Government of Ireland 1998). The report identified concerns that practices in nursing 
at the time were mechanistic and task-orientated (Government of Ireland 1998), with 
such ritualistic practices recognised as having the potential to seriously threaten 
patient safety (Trinder 2000). In 2003, a research strategy report for nursing and 
midwifery was published in Ireland identifying a need for the foundations of nursing 
and midwifery practice to be strengthened and constantly substantiated in order to 
meet requirements of an increasingly complex healthcare environment and to achieve 
high quality standards (Department of Health and Children 2003). Today, nurses in 
Ireland are required to deliver care in accordance to the ‘Code of Professional Conduct 
and Ethics for Registered Nurses and Registered Midwives’ (Nursing and Midwifery 
Board of Ireland 2014). This document not only emphasises the importance of 
research in nursing but also makes particular reference to the implementation of 
evidence-based practice. 
 
2.2.3. Evidence-based Practice 
Since the introduction of evidence-based practice in the latter part of the twentieth 
century, interest in this concept has continually grown to become a key element in the 
creation of new practices, policies and protocols worldwide (Rycroft-Malone et al. 
2004, Pearson et al. 2007). Stemming from the earlier concept of ‘evidence-based 
medicine’, the term evidence-based practice allowed other disciplines, within and 
outside of the medical field, to adopt the idea of ‘evidence-based’ by creating a generic 
title (Trinder 2000). 
 
Sackett et al. (1996) defined evidence-based practice as “the conscientious, explicit and 
judicious use of current best evidence in making decisions about the care of the 
individual” (p. 71). Evidence-based practice is a systematic process in clinical decision-
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making that integrates individual clinical expertise with best available evidence in 
order to ensure the most consistent and best possible patient care is provided 
(Pravikoff et al. 2005). Cluett (2006) described the aim of evidence-based practice 
simply as doing “the right thing, at the right time, for the right person” (p.35). Gerrish 
& Lacey (2010) summarised the process of evidence-based practice into eight linear 
stages; identify a problem in practice, formulate a question arising from the identified 
problem, identify the relevant available evidence, appraise the evidence, develop 
guidance to implement in practice, instigate change in practice, and finally, evaluate 
the impact of this process of change.      
 
The roots of contemporary evidence-based medicine may have stemmed from work 
published in 1972, “Effectiveness and Efficiency, Random Reflections on Health 
Services”(Cochrane 1972), by the British epidemiologist Archibald Cochrane. At the 
time, Archibald Cochrane criticised the grounds on which medical practices and 
interventions were conducted and suggested that there was a lack of good evidence to 
uphold their use or effectiveness (Metzdorff 2013). The importance of evidence-based 
practice in nursing and healthcare is apparent when considering the fluctuations in the 
current economic climate (International Council of Nurses 2010, Department of 
Finance 2014), the complexity of modern health systems (Health Service Executive 
2008, Schwartz et al. 2011, Health Service Executive 2013a), limited resources to solve 
problems (Marquis & Huston 2012), and the discontinuous and profound changes 
confronting nurses in the health service (Hurley & Linsley 2007, Department of Health 
2012, Health Service Executive 2013b). In the Irish context, the ‘Code of Professional 
Conduct and Ethics for Registered Nurses and Registered Midwives’ acknowledges 
evidence-based practice for nurses and midwives in areas such as patient safety, 
patient values, standards of care, and quality of practice, and thus reflects the 
significance of this concept in nursing (Nursing and Midwifery Board of Ireland 2014). 
Achieving evidence-based practice can be hindered by various obstacles which may 
relate to the nature of the evidence and its presentation, the organisational setting, 
and the knowledge and skillset of the individual professional (Gerrish & Lacey 2010). 
Doody & Doody (2011) supported this notion emphasising that evidence-based 
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practice remains dependent on the nurse’s ability to gather and appraise the available 
evidence on which to base their care. 
 
Naturally, there have been criticisms of evidence based practice. Indeed, some 
disagreements exist regarding the beneficial assertions of evidence-based practice, 
which dismiss it on the grounds of philosophical and practical flaws (Cohen & Hersh 
2004). Cohen & Hersh (2004) suggest that for evidence-based practice to be of benefit, 
the theory and practice must encompass new methods of study design and knowledge 
integration, whilst acknowledging the needs of both patients and healthcare 
professionals. 
 
2.3. Systematic Reviews: Rationale and Methodological Issues  
2.3.1. Rationale for Systematic Reviews 
In the previous few decades, there has been a significant growth in the publication of 
clinical research (Druss & Marcus 2005, Ghersi & Pang 2009, Smith et al. 2011) 
presenting great potential for the use of these findings. About twenty thousand 
journals publish approximately two million articles every year (Mulrow 1994, 
O'Mathuna 2010), with the growth rate in scientific and traditional scientific 
publications ever increasing (Larsen & von Ins 2010). The need for and importance of 
primary research is clearly evident so as to empirically investigate informal 
observations (Fitzgerald & Rumrill 2005). On the other hand, production of such high 
volumes of research mean it is impossible for practitioners to acknowledge all the 
information available as individual pieces of work (Smith et al. 2011). This poses great 
challenges to nurses who are required to use the best available research evidence in 
practice and care delivery (Haynes et al. 1996, Nursing and Midwifery Board of Ireland 
2007, Lo Biondo-Wood & Haber 2013). However, relying on individual, most recent or 
best known studies, or expert opinion of research findings can carry numerous risks 
such as those related to low statistical power, researcher or expert bias, contextual 
variability, and methodological and theoretical incompleteness (Sheldon 2005).  
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Low statistical power due to low sample size of studies, small effects or both, 
negatively affects the likelihood that a nominally statistically significant result actually 
reveals a true effect (Button et al. 2013). Divided into two categories, the first category 
associated with low statistical power in research designs relates to issues that 
contribute to producing unreliable findings even when the research conducted is 
otherwise perfect, in other words, without biases that could create spurious 
statistically significant results (Button et al. 2013). These issues comprise of the low 
probability of discovering true effects, the low positive predictive value when an effect 
is declared, and an overstated estimate of the magnitude of the effect when a true 
effect is revealed (Button et al. 2013). The second category relates to issues that 
reflect biases that are often inherent in studies of low power or that become worse in 
small, underpowered studies (Button et al. 2013) such as, publication bias, selective 
data analysis bias and selective outcome reporting bias, the likelihood of to providing 
wide ranges of estimates of the magnitude of an effect, known as ‘vibration of effects’, 
and lower quality study design (Button et al. 2013). Researcher or expert bias describes 
where researchers may wrongly or inappropriately weigh certain evidence due to 
personal opinion or reason (Sheldon 2005). For instance, different researchers will 
prefer unique conclusions and therefore may dissimilarly interpret the same evidence 
and present the findings as positive or negative on the grounds of their own personal 
belief or opinion on the subject. Contextual variability refers the effect of contextual 
factors on the impact of an intervention, for example, where an intervention may be 
effective in one context but not in another (Sheldon 2005). The effects of contextual 
factors have been explored in various areas of research such as behaviour (Dirks et al. 
2012) and memory (Lohnas et al. 2011, Scullin et al. 2013). For example, a study 
conducted to examine the association between variations in the contextual factors and 
the success of quality improvement interventions found that contextual factors such as 
leadership from top management, organizational culture, data infrastructure and 
information systems, and years involved in quality improvement affected the success 
of the quality improvement initiatives (Kaplan et al. 2010).  
 
Considering all of these various issues, the need to make research more accessible, 
informative and reliable for practitioners and consumers has resulted in efforts to 
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systematically synthesise healthcare research (Sambunjak & Franic 2012). 
Interestingly, it should be remembered that research has always been synthesised, 
either formally or informally, and weighted by experts, local practice, marketing, 
journal impact factor or citation figures (Sambunjak & Franic 2012). However, due to 
the high risk of error and resulting weak outcomes of this sort of unstructured 
synthesis (Sambunjak & Franic 2012), the need for a more structured, rigorous and 
reliable review method is evident.  
 
A well conducted systematic review can yield multiple outcomes such as, decreasing 
the effect of possible errors in single studies, exploring and resolving different or 
conflicting findings across similar studies, and producing greater understanding of 
topics through merging of study findings (Egger et al. 2003, Sambunjak & Franic 2012). 
Furthermore, systematic reviews can recommend further research through identifying 
gaps in the evidence or, conversely, through identifying where current evidence is 
sufficient and further research is not presently justifiable (Egger et al. 2003, Sambunjak 
& Franic 2012). Systematic reviews can also support policymakers and practitioners by 
critically appraising and disseminating key aspects of large, complex bodies of research 
(Victor 2008).  
 
Fitzgerald & Rumrill (2005) suggest that systematic reviews can overcome many of the 
deficiencies of single research studies. Statistical power, the probability of identifying 
variances in an outcome measure or the relationship between variables where they 
actually exist in nature, can be increased through the method of systematic review, 
which, as mentioned, is often a statistical limitation inherent in single research studies 
due to small or inadequate sample sizes (Fitzgerald & Rumrill 2005). Quantitative 
reviews overcome this statistical limitation of primary research by essentially 
combining the sample sizes of the single primary research studies to produce a larger 
cumulative sample size, which consequently increases the level of statistical power 
(Fitzgerald & Rumrill 2005). Nevertheless, the improved power can also be a detriment 
as it allows for the detection of small biases as well as small effects, and hence it can 
permit even minor biases to result in an apparent effect.  
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In recognizing that all studies have failings, due care must therefore be taken in 
conducting any systematic review (National Health and Medical Research Council 
2000). Systematic reviews can allow disciplines to acknowledge the research in their 
field in terms of quality and quantity and can prevent possible unnecessary duplication 
of research (Victor 2008). The rationale for the systematic review method is to 
appraise and synthesise research in a transparent and rigorous way so as to improve 
the validity and reliability of the results (Victor 2008) and ultimately overcome the 
influence of bias apparent in informal review techniques (White & Schmidt 2005).  
 
2.3.2. Systematic Review: Definition and Background  
Systematic reviews have attracted increased attention over recent years and are now 
regularly published in academic journals (Sambunjak & Franic 2012). Systematic 
reviewing is a comprehensive, critical and rigorous process of ascertaining and 
synthesising research (Victor 2008). The purpose of a systematic review is to evaluate 
and interpret all the available research evidence relevant to a particular question 
(National Health and Medical Research Council 2000). The central characteristics of a 
systematic review outlined by Higgins & Green (2011) comprise a clear set of 
objectives, a pre-defined study eligibility criteria, a well-defined replicable 
methodology, a comprehensive, exhaustive systematic search strategy, a validity 
assessment of the study findings, and a synthesis and systematic presentation of the 
included studies. 
 
A major driving force in systematic reviews was the creation of the Cochrane 
Collaboration, named after Archibald Cochrane (Metzdorff 2013). To this day, the 
Cochrane Collaboration supports collaborative review groups in conducting, sustaining 
and promoting systematic reviews of the effects of health care interventions (Higgins 
& Green 2011) and aims to provide health professionals with good quality information 
to inform clinical decision-making (Moore & Cowman 2008). The Cochrane 
Collaboration has become the world leader in the development and maintenance of 
high quality systematic reviews (Moore & Cowman 2008). The main output of the 
Cochrane Collaboration is the Cochrane Library which includes six databases that 
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contain different types of independent evidence to inform healthcare decision-making, 
the ‘Cochrane Database of Systematic Reviews’, ‘Cochrane Central Register of 
Controlled Trials (CENTRAL)’, ‘Cochrane Methodology Register (CMR)’, ‘Database of 
Abstracts of Reviews of Effects (DARE)’, ‘Health Technology Assessment Database 
(HTA)’, and the ‘NHS Economic Evaluation Database (EED)’, and an additional seventh 
database that provides information about Cochrane groups, ‘About The Cochrane 
Collaboration’ (Cochrane Library 2015). Several other bodies exist that support, 
promote and disseminate systematic reviews such as the ‘Campbell Collaboration’, the 
‘Centre for Reviews and Dissemination (CRD)’, and the ‘National Institute for Clinical 
Excellence (NICE)’ (Reeves et al 2002). The Joanna Briggs Institute also promotes 
systematic reviews for evidence-based nursing (O'Mathuna 2010).  
 
Systematic reviews use a hierarchy system of research designs that represents 
stronger and weaker evidence (Dijkers & NCDDR Task Force on Systematic Review and 
Guidelines 2009). Sackett (1989) outlined a simple hierarchy of evidence from high to 
low as; large randomized trials with clear-cut results, small randomized trials with 
uncertain results, non-randomized trials with concurrent or contemporaneous 
controls, nonrandomized trials with historical controls, and case series with no 
controls. Since then, different versions of this hierarchy of evidence classification 
system have been published and presented in different forms such as, simple 
descriptive cataloguing tables or pyramid-shaped pictorial displays (Glover et al. 2006, 
Melnyk & Fineout-Overholt 2011, Lo Biondo-Wood & Haber 2013, University of New 
Hampshire 2015) (see Appendix 1 and 2). This historical hierarchy of evidence and 
more recent hierarchy frameworks have however been criticised for having several 
weaknesses, such as a disregard for advances in research methodology over the 
previous fifty years (Dijkers & NCDDR Task Force on Systematic Review and Guidelines 
2009). Another characteristic of a systematic review is the possibility of incorporating a 
meta-analysis (White & Schmidt 2005). A meta-analysis is a structured technique of 
merging the results of numerous studies that address a set of related hypotheses 
(Moore 2012). The results of meta-analysis are typically visually displayed using forest 
plots with pooled point estimate and a rhombus, or ‘diamond’, to represent its 
confidence interval (Sambunjak & Franic 2012). 
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2.3.3. Systematic Review versus Literature Review 
Other techniques of synthesising and interpreting previous literature exist such as 
narrative literature reviews, empirical literature reviews, and scoping literature 
reviews (Rumrill et al. 2010).  
 
In comparison to a systematic review, a narrative literature review describes a more 
traditional literature review that is generally not systematic or transparent in its 
synthesis techniques (Popay et al. 2006). Narrative literature reviews are usually 
conducted by an experts in the particular field of study (Bettany-Saltikov 2010a) with 
the aim of restructuring existing literature to create new perspectives (Rumrill et al. 
2010). The study selection, analysis methods, and conclusions drawn in narrative 
literature reviews are often quite subjective and therefore exhibit many shortcomings 
(Fitzgerald & Rumrill 2005). Experts and reviewers can be influenced by conscious or 
unconscious personal theories, needs and beliefs (Hemingway & Brereton 2009, 
Bettany-Saltikov 2010a). Indeed, as reviewers develop a traditional literature reviews 
they may unknowingly build a case to support their personal beliefs through selectively 
citing appropriate studies (Hemingway & Brereton 2009). As mentioned, those 
involved in developing a review or commissioned to conduct a review are typically 
chosen due to their accumulated experience and professional opinions (Hemingway & 
Brereton 2009).  
 
Unlike a traditional literature review, empirical literature reviews gather, generate, 
codify, and analyse numeric data that represent the frequency of themes, subjects, 
authors, and/or methods in existing literature, and present summaries in measureable 
terms using descriptive and inferential statistics as opposed to in words such as in 
narrative reviews (Rumrill et al. 2010).  
 
Another technique to review research is a scoping literature review. Scoping literature 
reviews tend to be non-systematic, focus on the breadth of the literature, utilise wide-
ranging sources information including ‘grey’ literature research, and usually do not 
critically evaluate the quality of the literature or studies included (Rumrill et al. 2010). 
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Scoping reviews ascertain the size and nature of the evidence base for a specific 
subject field, which can sequentially be utilised to determine gaps in the literature and 
recommend areas requiring future primary research (Centre for Reviews and 
Dissemination 2008). Scoping literature reviews may be beneficial for both those 
planning primary studies as well as those planning a more systematic reviews, for 
example, by assessing aspects such as the feasibility of conducting a full systematic 
review (Centre for Reviews and Dissemination 2008). 
 
As concerns exist that narrative reviews may reveal more about their authors’ own 
personal beliefs and conclusions rather than being an objective overview of all the 
available evidence, systematic reviews have been developed to minimise the risk of 
bias and to make explicit what many narrative reviews fail to describe (O'Mathuna 
2010). Systematic reviews however do not guarantee validity, and subsequently, 
nurses seeking to use any form of review, systematic, narrative or otherwise, must 
have the ability to critically appraise the review’s quality (O'Mathuna 2010). 
 
2.3.4. Steps in conducting a Systematic Review 
The process of conducting systematic reviews has been well documented and, 
although different authors describe various numbers of steps in the review process 
(National Health and Medical Research Council 2000, Khan et al. 2003, White & 
Schmidt 2005, Popay et al. 2006, Centre for Reviews and Dissemination 2008, Victor 
2008), there is general agreement of the main elements involved (Popay et al. 2006). It 
is therefore considered possible to synthesis the various accounts of the process into 
an outline of these main steps: 
 Identify the review focus and available evidence  
 Formulate the review question and protocol 
 Identify primary and secondary outcomes 
 Identify inclusion and exclusion criteria  
 Search strategy  
 Study selection 
 Data extraction  
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 Quality appraisal  
 Data analysis and synthesis 
 Reporting and dissemination  
 
2.2.4.1. Identify the Review Focus and the Available Evidence 
In any discipline, an essential component of sound research is the investigators’ in-
depth knowledge of the existing literature in their field of study (Bellini & Rumrill 
2009). An incremental step in building new knowledge is setting the proposed question 
within the context of the existing knowledge and relating the rationale, conceptual 
framework, and purpose of the investigation to the relevant previous works (Rumrill et 
al. 2010).  Before the review question is clearly specified, conducting a mapping 
exercise of all the available relevant evidence can assess the need for, guide, and 
refine the systematic review by way of revealing the types of interventions that have 
been evaluated, the sorts of study designs used, and assess the volume of potentially 
relevant literature (Popay et al. 2006). A brief scoping literature search, which 
identifies broad themes and patterns in a research area (Rumrill et al. 2010), could 
support this process.  
 
2.2.4.2. Research Question 
One of the most critical, and possibly the most difficult, part of any research design is 
formulating the research or review question (Blaikie 2007). A clear and unambiguous 
research question should evolve from the information gathered from identifying the 
review focus and evidence as well as from the guidance of co-authors and significant 
researchers in the subject field (White & Schmidt 2005).  
 
Systematic review questions should inspire answers that will provide meaningful 
information that can be utilised to guide decision-making (Centre for Reviews and 
Dissemination 2008). Blaikie (2007) describes three types of questions, ‘how?’, ‘what?’ 
and ‘why?’ ‘How’ questions relate to interventions and outcomes, ‘what’ questions 
seek descriptive answers in the form of characteristics and/or patterns of association, 
and ‘why’ questions seek reasons for the presence of these characteristics and/or 
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patterns of association (Blaikie 2007). Using a PICO model, the review question can be 
framed in terms of the population, intervention(s), comparator(s) and outcomes of the 
research studies for inclusion in the review (Centre for Reviews and Dissemination 
2008). However, not all the elements of the PICO model will be relevant for all review 
questions, for example not every review question will articulate the type of study 
design to be included (Centre for Reviews and Dissemination 2008). The PICO model is 
more specifically designed for questions related to therapeutic interventions (Khan et 
al. 2003). Other designs of review may simply present review questions in general 
terms and, more often, the actual question is discussed by the review team and an 
objective(s), framed by the population, the intervention and the outcome(s) of interest 
are agreed (Centre for Reviews and Dissemination 2008). Nonetheless, the PICO 
framework is important as it determines the types of research studies that are of 
interest for those undertaking systematic reviews (Bettany-Saltikov 2010a). In the case 
of qualitative studies, a separate framework, similarly so-called by its acronym namely 
PEO, is more typically applied (Khan et al. 2003). This PEO model frames the review 
question in terms of the population, exposure and outcomes (Khan et al. 2003). 
Subsequent to the formulation of a research question, refinement of the elements of 
the question, together with study design, will determine the specific inclusion criteria 
for the selection of studies for the review (Centre for Reviews and Dissemination 
2008). 
 
Once a review question is established, a protocol is usually constructed outlining in 
detail the technical methods to be followed in the proposed systematic review (Victor 
2008) which include decisions about the review question, primary and secondary 
outcomes, inclusion/exclusion criteria, search strategy, study selection, data 
extraction, quality assessment, data synthesis and dissemination procedures (Centre 
for Reviews and Dissemination 2008, Bettany-Saltikov 2010a, Harris et al. 2014). A 
well-constructed protocol specifying the methods in advance of conducting the review 
reduces the risk of introducing bias, although if modifications are necessary they 
should be clearly justified and documented in the review (White & Schmidt 2005, 
Centre for Reviews and Dissemination 2008). 
 
72 
 
2.2.4.3 Primary and Secondary Outcomes 
A key component of any well-formulated review question is reference of the particular 
outcomes of interest of the review (O'Connor et al. 2011). Outcome variables of 
interest can also be referred to as end points (CONSORT Group 2016). These main 
outcomes of interest must be prioritised with respect to the review question and 
should be chosen as those that are the essential outcomes for decision-making as 
opposed to chosen on the basis of any expected or observed magnitude of effect or of 
the likelihood to have been addressed in the studies to be reviewed (O'Connor et al. 
2011). These main outcomes must be further prioritised into primary and secondary 
outcomes, of which the former are the outcomes that would be anticipated to be 
analysed should the review find relevant studies and the latter are the remainder of 
the main outcomes not selected as primary outcomes on the basis that they are less 
important but may however assist in explaining effect or establishing intervention 
integrity (O'Connor et al. 2011). In addition, conclusions about the effects of the 
interventions under review will be based principally on the primary outcomes 
(O'Connor et al. 2011).  
 
2.2.4.4. Inclusion and Exclusion Criteria  
A key distinguishing feature that separates a systematic review from other types of 
reviews is the pre-specified eligibility criteria, that is, the criteria for including and 
excluding studies in the review (Higgins & Green 2011). These specific criteria are 
designed to increase the likelihood that the evidence will appropriately answer the 
review question (Victor 2008). The development of inclusion and exclusion criteria 
should be determined in the protocol development stage (Torgerson 2003, White & 
Schmidt 2005). The eligibility or inclusion/exclusion criteria are based on the key 
components of the review question such as types of study design, types of participant, 
types of intervention, types of control, and types of outcome (White & Schmidt 2005). 
Elaborating the core elements of the question assists the process of identifying studies 
to include in the review whilst also increasing the transparency of the selection 
decisions made to the consumers of the review (Popay et al. 2006). Criteria should not 
exclude research based on the language of publication, although, retrieving and 
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reviewing articles in foreign languages requires considerable resources and therefore is 
not always feasible (White & Schmidt 2005, Moore 2012).  
 
2.2.4.5. Search Strategy 
Another one of the main differences between a systematic review and the more 
traditional, narrative, non-systematic review is the exhaustive literature search that 
must identify all primary studies exploring the review question in order to produce an 
objective answer (Sambunjak & Franic 2012). The search strategy should be as 
comprehensive as possible in order to minimise bias (Victor 2008) that may arise by 
inclusion of only particular types of evidence, such as may occur due to the presence 
of pre-formed opinions (Centre for Reviews and Dissemination 2008). This step of the 
systematic review requiring location and retrieval of all relevant literature is 
challenging yet vital to the success of a systematic review, as the literature obtained 
provides the information on which the evidence, conclusions and recommendations 
are established (Smith et al. 2011). In this regard, this process of formulating the 
search strategy may benefit from the assistance of an experienced librarian (Mead & 
Richards 1995). Finally, it is also essential from the outset of the review that the 
reviewer bear in mind the scope, the comprehensiveness and the time available to 
conduct the search (Smith et al. 2011).   
 
Citation searching is an important procedure in addition to database and hand 
searching (Greenhalgh & Peacock 2005). Relevant studies may be found by manually 
searching reference lists of identified relevant studies, known as backward citation 
searching, or by finding the articles that have cited the included studies, known as 
forward citation searching (Bates 1989). Citation indexes, such as Science Citation 
Index or Science Citation Index Expanded, can assist this process of identifying 
additional studies for inclusion in a review (Higgins & Green 2011). 
 
Various forms of evidence can be included which encompass published and 
unpublished research, as well as ‘grey’ literature such as, government documents, 
theses, conference papers, and research studies in progress (Victor 2008). As forms of 
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‘grey’ literature may not be peer-reviewed, some reviewers do not include these forms 
of evidence (White & Schmidt 2005). Despite this, others suggest that including ‘grey 
literature’ may add richness to the review and minimise bias (Benzies et al. 2006). In 
addition, it is also suggested to minimise avoid over-representation of studies with 
statistically significant findings which may produce inaccurate estimates of effect sizes 
(McAuley et al. 2000, Conn et al. 2003). 
 
Methods for identifying applicable research studies include searching databases and 
research registers, citation tracking, and contacting academics and specialists in the 
field of interest (Victor 2008). A high-quality electronic search is vital to ensure the 
accuracy and completeness of research article retrieval for use in a systematic 
reviewing (Volpato et al. 2014). Nonetheless, the process of devising search terms for 
use in electronic research databases can often be quite complex and require careful 
testing to improve the rate of retrieval (White & Schmidt 2005, Victor 2008). The 
balance between sensitivity, the power to detect all relevant research on a particular 
topic of interest, and specificity, the ability to eliminate irrelevant studies (Victor 
2008), is important to ensure that all relevant research is included in the review (White 
& Schmidt 2005). In addition to the creation of database-specific search terms, the 
quality of retrieved information also depends on the researchers’ knowledge of each 
database’s controlled retrieval language and searching tools in order that to search 
results can be adjusted to meet the needs for specificity or exhaustiveness in 
information retrieval (Volpato et al. 2014). As differences have been claimed in the 
data retrieval between the various databases (Brazier & Begley 1996, Michaleff et al. 
2011, Elsevier 2015), at least seven electronic databases should be searched, for 
example, CINAHL, MEDLINE, EMBASE, Cochrane Library (Thomas et al. 2004). CINAHL® 
Plus with Full Text is a privately owned database (Lawrence 2007) delivering full text 
for more than 760 journals and indexing for more than 5,000 journals dating back to 
the year 1937 from the areas of nursing, biomedicine, health sciences librarianship, 
alternative/complementary medicine, consumer health and seventeen allied health 
disciplines (EBSCOhost 2016). In total, the database contains more than four million 
records and also offers access to health care books, nursing dissertations, certain 
conference proceedings, standards of practice, educational software, audio-visuals and 
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book sections (EBSCOhost 2016). Lawrence (2007) describes CINAHL as a powerful and 
valuable indexing tool particularly in the field of nursing and nursing research. Focusing 
more on biomedicine and, to a lesser extent, life sciences, MEDLINE is a bibliographic 
database produced by the U.S. National Library of Medicine and forms the primary 
component of PubMed (Young & Duffull 2011, U.S. National Library of Medicine 2015). 
Generally dating from the year 1946 to the present, MEDLINE offers over 22 million 
journal article references from more than 5,600 worldwide journals (U.S. National 
Library of Medicine 2015). Comprising of over 30% of journal titles not covered by 
MEDLINE, EMBASE is another large database that references more than 8,500 journal 
titles which span sixty subject fields (Elsevier 2015). EMBASE has a broad biomedical 
scope and has a particular focus on the coverage of pharmacology, pharmaceutical 
science and clinical research that represent over 70% of EMBASE content (Elsevier 
2015). EMBASE also includes basic biomedical science, veterinary science and allied 
health topics (Elsevier 2015). As mentioned, the Cochrane Library is the main output of 
the Cochrane Collaboration and comprises of six databases that contain different types 
of independent evidence to inform healthcare decision-making, as well as a seventh 
database that provides information about Cochrane groups (Cochrane Library 2015). 
The Cochrane Library contains more than five thousand full-text reviews on the 
effectiveness of healthcare interventions and also includes critical assessments of 
systematic reviews, of which are updated regularly (Cochrane Library 2015). The 
Cochrane Database of Systematic Reviews (CDSR) is a prominent resource for 
systematic reviews in health care and includes Cochrane reviews and protocols 
prepared by Cochrane Review Groups, all of which are peer-reviewed.  
 
Considering the differences in the focuses across the numerous electronic data 
resources alongside the subsequent variation in contents, the databases employed in a 
data search should be carefully selected in relation of the review’s topic of interest and 
ideally not restricted to language-specific databases (Sambunjak & Franic 2012). In this 
regard, designing a search strategy that searches only one electronic database may 
reduce the likelihood of retrieving all the relevant data and, in turn, increase the risk of 
bias. In sum, it is imperative that the researcher acknowledge that the quality of any of 
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the conclusions made following a review are only as good as the quality of the 
processes employed to search and retrieve the evidence (Bettany-Saltikov 2010b).  
 
2.2.4.6. Study Selection  
The objective of study selection is to ensure that all applicable research is 
encompassed in the review (Centre for Reviews and Dissemination 2008). The process 
of study selection needs to be clear, objective, limit potential judgement errors and 
documented succinctly to ensure that the process can be easily replicated (Centre for 
Reviews and Dissemination 2008). It is imperative that the inclusion criteria is based on 
the appropriateness of the study, not the availability of research, and that the 
inclusion criteria is not modified for reasons that no studies were found meeting the 
pre-established criteria, frequently referred to as an ‘empty shell review’ (White & 
Schmidt 2005).  Based on the pre-established eligibility criteria, a minimum of two 
authors should first independently decide which research studies are to be included 
and excluded, and then jointly agree on the chosen studies for the review (White & 
Schmidt 2005, Centre for Reviews and Dissemination 2008).  
 
The Centre for Reviews and Dissemination (2008) describe that electronic database 
searches are usually conducted in two stages. The first stage involves selecting studies 
based on titles and abstracts, when available, and rejecting studies that are obviously 
not relevant and those that refer to the subject of interest but lack one or more of the 
eligibility criteria (Centre for Reviews and Dissemination 2008). Finally, full research 
papers should be obtained for studies that appear to meet the eligibility criteria in 
order to conduct a detailed evaluation (Centre for Reviews and Dissemination 2008). 
The study selection procedure must then be documented accordingly so as to increase 
the transparency of the process (Centre for Reviews and Dissemination 2008) for 
which a flow diagram, such as the PRISMA diagram, has been recommended as a 
valuable visual aid to clearly present the process of article selection throughout the 
review (Liberati et al. 2009).  Liberati et al. (2009) recommend detailing the unique 
search records identified, duplicate or supplementary articles present, articles 
excluded following preliminary screening, articles obtained for comprehensive 
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evaluation, potentially eligible but not obtained articles, articles obtained but not 
meeting inclusion criteria along with the primary reasons for exclusion, and the final 
articles chosen for inclusion in the review. Although Liberati et al. (2009) acknowledge 
that the flow diagram layout may vary to suit each individual review, it is imperative 
for clarity that reviewers remain consistent with their reporting style within the chosen 
design such as with the use of terms such as, counts of citations, records, publications, 
or studies. 
 
2.3.4.7. Data Extraction 
Once the final list of studies for inclusion in the review is determined, the process of 
data extraction is commenced (Centre for Reviews and Dissemination 2008). This step 
involves obtaining all core information about each study’s characteristics and findings 
(Centre for Reviews and Dissemination 2008) and inputting this information into either 
a paper data extraction form or an electronic data extraction spreadsheet (White & 
Schmidt 2005). Data extraction is preferably conducted by at least two other authors 
independently in order to reduce the risk of transcription error (Magarey 2001, White 
& Schmidt 2005, Sambunjak & Franic 2012). Data are generally extracted using pre-
established templates (Centre for Reviews and Dissemination 2008) which typically 
include;  
 Authors names, 
 Study date, design and setting, 
 Study geographical location, 
 Inclusion/exclusion criteria, 
 Sample size, 
 Intervention details, 
 Outcome measures, 
 Analysis, 
 Results, 
 Author’s interpretations (White & Schmidt 2005, Wright et al. 2007, Centre for 
Reviews and Dissemination 2008, Harris et al. 2014). 
 
78 
 
Prior to use in the entire review, data extraction templates should be carefully 
designed and piloted (Centre for Reviews and Dissemination 2008) in order to ensure 
their usability. 
 
2.3.4.8. Quality Appraisal 
Quality appraisal is a significant phase of the systematic review where individual 
studies are critically appraised prior to any conclusions being drawn from the body of 
evidence (Victor 2008). This essential process seeks to ensure that the systematic 
review is constructed on the highest quality evidence available and that the quality of 
studies included is clearly conveyed to the review consumer so as to indicate the 
strength of evidence for any recommendations that are made (National Health and 
Medical Research Council 2000). Furthermore, quality appraisal aims to predict how 
close to ‘truth’ and how relevant the findings will be to the review focus by considering 
particular factors such as, appropriateness of study design to the research objective, 
risk of bias, various study quality issues, outcome measures, statistical issues, 
intervention and reporting quality, and generalisability (Centre for Reviews and 
Dissemination 2008). The quality of research relates to the risk of bias in the design 
and conduct of a study, and differs from the quality of reporting which refers to the 
sufficiency and comprehensiveness of reporting (Sambunjak & Franic 2012). As critical 
appraisal can never be completely objective, this process is often conducted by at least 
two reviewers in order to reach an agreement on the quality of the studies (Sambunjak 
& Franic 2012). Several quality scales and checklists have been developed to assist in 
this process (Wright et al. 2007, Victor 2008) such as the CONSORT checklist and the 
STROBE statement (see Appendix 3 and 4). The choice of quality critiquing scales 
should be chosen depending on the type of research evidence for inclusion in the 
review (Victor 2008) and justification documented accordingly by the reviewing author 
(Sambunjak & Franic 2012). Although these tools are useful, White & Schmidt (2005) 
emphasise the importance of also applying common sense when critically evaluating 
the evidence.    
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2.3.4.8.1. Suitability of Study Design 
In quality appraisal of the study design, the reviewer must evaluate whether the design 
complements the research question, the aims and the objectives (Centre for Reviews 
and Dissemination 2008) rather than evaluating the choice of study design by relying 
on hierarchy of evidence frameworks, such as created by Sackett (1989). These 
frameworks do not acknowledge variations in quality that may exist among studies of 
the same design and do not provide an adequate assessment of study quality (Centre 
for Reviews and Dissemination 2008). The design of a study may be devised on the 
basis of ethical requirements and, where randomised controlled trials may possibly 
have been conducted, other designs such as quasi-experimental or observational may 
have to be employed (Centre for Reviews and Dissemination 2008). In the area of 
health sciences research, the majority of studies do not use an experimental design 
(Polgar & Thomas 2008). For example, Bloch (1987) reported that of the 757 articles 
published on back pain interventions in 1985, only eight used a randomised controlled 
trial design or an experimental design. Randomised controlled trials (RCTs) are 
commonly referred to as the ‘gold standard’ in research evidence (Sullivan 2011), a 
standard described as a method, procedure, or measure that is the most widely 
accepted as being the best available (National Health and Medical Research Council 
2000). Despite this, the Centre for Reviews and Dissemination (2008) point out that 
even RCTs can be instigated in such a way that results have the potential to be 
seriously biased.  
 
2.3.4.8.2. Risk of Bias 
There are two broad categories of error, namely, systematic error and random error 
(Malone et al. 2014). Systematic error, or bias, should not be confused with random 
error, or imprecision (Higgins & Green 2011, Malone et al. 2014). In same study 
replications, the presence of bias would produce the wrong answer on average 
whereas, the presence of imprecision, as a result of sampling variation, would produce 
different effect estimates even if they would yield the right answer, on average 
(Higgins & Green 2011). Bias refers to “a consistent deviation from the truth” (Moore 
2012)(p. 2799) due to  poor study design or conduct in relation to data collection, 
analysis, interpretation, publication or review (Centre for Reviews and Dissemination 
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2008). Imprecision can be lessened by increasing sample size, in contrast to bias which 
will remain irrespective of sample size (Bruce et al. 2008).  
 
Higgins et al. (2011a) refer to the concept of bias in terms of “risk of bias”, instead of 
just bias, because, although there might be an error in the design of a study, the error 
may not be significant and as such the study outputs may not be biased. Incomplete 
reporting of data is a significant challenge in the assessment of risk of bias (Higgins & 
Green 2011). Although numerous other biases exist which may relate to particular trial 
designs, specific circumstances, and particular clinical settings (Higgins & Green 2011), 
the key biases typically identified within studies are selection bias, performance bias, 
detection bias, attrition bias (Magarey 2001, Wright et al. 2007, Centre for Reviews 
and Dissemination 2008, Higgins & Green 2011) and reporting bias (Higgins & Green 
2011). 
 
2.3.4.8.3. Outcome Measures 
Outcomes are simply what a researcher identifies as that which their study intends to 
measure (Glynn 2006). Outcomes must be clearly defined so that is possible to assess 
whether the appropriate data collection methods are implemented or whether the 
study researched what it proposed to research (Glynn 2006). In addition, it is 
important to consider the reliability or validity of the outcome measure(s) employed 
when appraising the quality of a study (Centre for Reviews and Dissemination 2008). It 
is also vital that the measurement tool is fully understood to enable comparison and 
that the outcomes are relevant and significant to both the intervention and the 
evaluation (Centre for Reviews and Dissemination 2008). For example, a multicentre 
randomized controlled trial conducted in England to examine the effectiveness and 
cost-effectiveness of antimicrobial silver-donating dressings in the treatment of leg 
ulcers identified the primary outcome of the study as complete ulcer healing at twelve 
weeks (Michaels et al. 2009). 213 participants with venous leg ulcers of greater than 
six-weeks duration were randomised to receive treatment with either silver-donating 
dressings (n=107) or non-silver dressings (n=106), worn beneath compression therapy, 
with the choice of the specific dressing the responsibility of the clinician (Michaels et 
81 
 
al. 2009).The study reported no significant differences (p > 0.05) between the silver-
donating dressings group and the non-silver dressings group in relation to complete 
ulcer healing, 59.6% and 56.7% respectively, time to ulcer healing and ulcer recurrence 
rates within one year, and subsequently concluded that the routine use of silver 
dressings cannot be justified (Michaels et al. 2009). Although the use of complete 
healing as an outcome or endpoint is in line with guidelines as per regulatory bodies 
(Food and Drug Administration 2006), this endpoint does not provide sufficient data to 
support the conclusions made as the intended use of silver in wound management is 
not to promote wound healing but to control or reduce the bioburden which can 
subsequently lead to wound healing (Leaper 2012). In this regard, a reduction in 
wound infection is suggested as a more relevant and significant outcome to both the 
intervention and the evaluation in this study. 
 
2.3.4.8.4. Intervention 
The next step involves assessing the quality of the intervention and its 
implementation, and essentially refers to whether the proposed intervention has been 
implemented suitably (Centre for Reviews and Dissemination 2008). Assessing the 
quality of the intervention can be straightforward for some studies, but may be 
difficult for studies where there is no preliminary research to indicate a particular way 
the intervention should be administered, or where the intervention requires a 
technical skill (Centre for Reviews and Dissemination 2008). An example of this may be 
where specific skills are required to carry out particular wound care treatments 
(Gottrup et al. 2010). Assessment of the quality of an intervention should examine 
whether the intervention has been appropriately defined (Centre for Reviews and 
Dissemination 2008) and the degree to which the predefined methods or elements of 
the intervention are executed as proposed, as intervention variations can substantially 
effect the study findings (Higgins & Green 2011). In studies where the intervention is 
dependent on the skill of the intervention provider it may be appropriate to examine 
whether a performance skill was measured (Centre for Reviews and Dissemination 
2008). An example of this is demonstrated in a multi-centre, prospective, cluster 
randomised controlled trial of repositioning for the prevention of pressure ulcers, 
which compared the incidence of pressure ulcers among older persons in long-term 
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care hospitals that were nursed using two different repositioning regimes (Moore 
2009). Following the provision of education training sessions to staff members to be 
involved in delivering the study intervention, patient repositioning, a trial monitoring 
protocol was established which entailed the researcher visiting the selected wards at 
randomly appointed times to conduct spot-checks on compliance with the 
repositioning schedule, along with an assigned staff member on each ward to ensure 
continuous compliance with repositioning and data collection procedures (Moore 
2009).   
 
2.3.4.8.5. Reporting 
Quality of reporting relates to the standard to which a study comprehensively reports 
relevant and essential study data, and does not necessarily signify the quality of the 
underpinning methods or data of the study (Centre for Reviews and Dissemination 
2008). Inadequate or poor quality reporting can pose considerable challenges in the 
appraisal of a study due to insufficient reliable data on which to base study conclusions 
and formulate recommendations (Moher et al. 2007). As it is important to distinguish 
between failure to report a criterion and failure to meet a criterion, the Centre for 
Reviews and Dissemination (2008) recommend that a strategy for managing poor 
reporting should be decided when planning quality assessment. For example, a 
criterion can be described under a number of subcategories such as in the appraisal 
tool by (Glynn 2006) that employs using a yes, no, unclear, or a not applicable rating. 
 
2.3.4.9. Sensitivity Analysis 
Sensitivity analysis can indicate the robustness of findings, the type of studies included 
and the methods used in a review (Centre for Reviews and Dissemination 2008). In a 
systematic review, as lower quality studies do not carry the same weight as higher 
quality studies, Sambunjak & Franic (2012) suggest performing a sensitivity analysis so 
that the studies are not only critically appraised but the results of this appraisal are 
integrated into the analysis and interpretation of review findings. A possible technique 
for performing a sensitivity analysis involves firstly including only the high-quality or 
low risk of bias studies in the primary meta-analysis and then exploring the differences 
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in summary estimates as a result of including the low-quality or high risk of bias studies 
(Sambunjak & Franic 2012). A sensitivity analysis can also be useful in determining the 
effect of the inclusion or exclusion of ‘grey literature’ (Centre for Reviews and 
Dissemination 2008). Furthermore, in determining whether to include or exclude 
potentially relevant studies which fail to report sufficient data to decide their eligibility 
in a review, a sensitivity analysis can check what influence these studies would have on 
the results of the review (Centre for Reviews and Dissemination 2008). Centre for 
Reviews and Dissemination (2008) caution that consideration must be given in 
attributing reasons for differences, as a study may vary in ways other than the issue 
being examined in the sensitivity analysis.  
 
2.3.4.10. Data Analysis and Synthesis  
Data analysis and synthesis involves aggregating the findings from the individual 
studies included in the review to produce a final total account on the clinical 
effectiveness, feasibility, suitability and meaningfulness of the intervention, activity or 
the subject of the review focus (Hemingway & Brereton 2009). Combining the results 
of studies generally involves either using a narrative form or by using the best evidence 
synthesis (White & Schmidt 2005). The data may be analysed and synthesised using 
quantitative or qualitative methods depending on the type of studies included in the 
review (Magarey 2001). For example, a statistical method known as meta-analysis can 
be used for combining, analysing and summarizing quantitative data of studies 
assessing homogenous quantitative evidence for clinical effectiveness (Magarey 2001, 
Hemingway & Brereton 2009). This method of pooling of data in meta-analysis is, 
however, not always appropriate or possible (White & Schmidt 2005), for example, 
when reviewing evidence from diverse non-randomised study types (Sterne et al. 
2011b). In such reviews that encompass studies producing non-homogenous 
quantitative data, narrative summaries may be suitable (Hemingway & Brereton 2009). 
Narrative synthesis, a summary and discussion of findings (Sambunjak & Franic 2012), 
is also commonly used to analyse and synthesise in systematic reviews of quantitative 
evidence where trial data is limited or non-existent (Victor 2008). In relation to 
qualitative research, the Centre for Reviews and Dissemination (2008) outlined some 
proposed techniques for synthesis of qualitative evidence specifically, meta-
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ethnography, thematic analysis/synthesis, grounded theory (constant comparative 
method), qualitative research synthesis/ qualitative meta-synthesis, content analysis, 
case survey, qualitative comparative analysis, qualitative research synthesis/ 
qualitative meta-summary, and narrative synthesis. However, due to the rapid 
expansion in the development of methods to analyse and synthesise qualitative 
research, a lack of standard terminology has resulted (Campbell et al. 2011). The terms 
meta-ethnography, meta-interpretation, meta-analysis, narrative synthesis, meta-
synthesis and other descriptors are reported to be widely used to describe similar 
approaches or, conversely, the same terms frequently employed to describe different 
approaches (Campbell et al. 2011). In this regard, Campbell et al. (2011) advises 
exploring beyond these labels when searching and reviewing qualitative research. Of 
the methods mentioned, meta-ethnography has been identified as the most 
commonly used (Dixon-Woods et al. 2007) and has been evaluated as an effective 
method for synthesising qualitative research (Campbell et al. 2011). Meta-ethnography 
is a term used to characterise a set of techniques for synthesising an understanding 
from ethnographic accounts and involves the selection, comparison and analysis of 
qualitative studies to create new interpretations or concepts (Noblit & Hare 1988). 
Core features of this technique include reading and re-reading studies, deciding how 
studies are connected through defining central concepts and comparing and 
contrasting them, interpreting studies into one another and synthesising the 
interpretations to identify concepts which go beyond individual accounts and that can 
be utilised to create a new understanding (Centre for Reviews and Dissemination 
2008). 
 
Narrative and quantitative synthesis methods are not mutually exclusive and, as 
suggested by the Centre for Reviews and Dissemination (2008), elements of narrative 
synthesis can be beneficially integrated into a review that is primarily quantitative in 
focus, equally as statistical analyses can be incorporated into a review that is primarily 
narrative in approach. However, it is essential that both quantitative and narrative 
synthesis evolve from a clear and detailed descriptive summary of the included studies 
(Centre for Reviews and Dissemination 2008). 
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2.3.4.10.1. Systematic Review of Quantitative Research 
Quantitative research is philosophically grounded in the positivist tradition which 
proposes scientific truths exist and can be studied (Gerrish & Lathlean 2015), and 
denotes research designs and methods that yield numerical data (Gerrish & Lacey 
2010) referred to as statistical evidence (Clair et al. 2014). Quantitative research tests 
objective theories by examining the relationship among variables (Polit et al. 2002). 
Quantitative research falls into four main designs, namely, descriptive, correlational, 
experimental and quasi-experimental (Grove et al. 2013, Borbasi & Jackson 2015). 
 
In a systematic review of quantitative research, a meta-analysis of quantitative data 
can be conducted where appropriate (White & Schmidt 2005). The term ‘meta-
analysis’ was originally coined in 1976 by an American social scientist and statistician 
named Gene V. Glass, (O'Rourke 2007). Glass (1976) defined meta-analysis formally as 
the statistical analysis of a large compilation of analysis data from separate studies 
with the intention of integrating the results. Meta-analysis has more recently been 
described as a quantitative statistical exercise which involves drawing together the 
results of several independent studies that engage a set of connected research 
hypotheses (Moore 2012). The data are then reanalysed to calculate a pooled estimate 
of effect, an estimate of the strength of the relationship between two variables, and a 
confidence interval (CI), an indication of the reliability of the estimate of effect (Higgins 
& Green 2011, Moore 2012). A meta-analysis can increase power, improve precision, 
answer questions not posed by single studies, and resolve disagreements between 
conflicting study findings (Higgins & Green 2011).  Power is defined as the probability 
of a statistical study to reliably reject a false null hypothesis (Moore 2010) and 
precision is defined as the extent to which repeated tests produce unchanged findings 
in conditions that remain unchanged (Moore 2012). 
 
In a systematic review, it may not always be appropriate to conduct a meta-analysis, 
such as in situations where the differences between studies have not occurred only by 
chance but due to other factors (Moore 2012). This necessitates that specific 
consideration must be given to particular study designs, within-study biases, 
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differences across studies, and reporting biases, in order to reduce the potential for 
findings that are significantly misleading (Higgins & Green 2011). By carrying out an 
accurate and detailed quality appraisal, data can be generated to examine 
heterogeneity and inform decisions concerning suitability of meta-analysis (Khan et al. 
2003).  
 
Heterogeneity is defined as ‘the differences in study populations or in methodologies 
used to study them that may have the effect of reaching differing conclusions’ (Moore 
2012)(p. 2799). Moore (2012) advises that a meta-analysis is performed only where 
the included studies are relatively alike, or homogenous, in order that the findings of 
the analysis will yield beneficial information. The chi-square test is a typically used test 
to determine heterogeneity between studies with results reported as I2, where I2 
describes the degree of variability in effect estimates in studies that is as a result of 
heterogeneity rather than chance (Moore 2012).  If a meta-analysis is conducted which 
comprises of studies that are too diverse, no meaningful data may be extracted from 
the analysis (Deeks et al. 2011). Essentially, combining poor quality or diverse studies 
will inevitably yield poor quality review results (Higgins & Green 2011, Moore 2012, 
Sambunjak & Franic 2012). In such cases where meta-analysis is deemed 
inappropriate, a thorough narrative summary with a thoughtful discussion of primary 
study results can provide a more meaningful approach (Sambunjak & Franic 2012). 
 
Moore (2012) describes three types of data most typically seen as relevant for 
conducting meta-analysis, dichotomous or binary data, continuous data, and survival 
or time to event data. For outcomes measured on a dichotomous scale, common 
approaches to summarise data are the use of the odds ratio (OR), relative risk (RR) or 
risk difference (RD), whereas, for outcomes measured on a continuous scale, the 
weighted mean difference (WMD) is commonly used (Moore 2012). Dichotomous or 
binary scales measure data that can only take two possible values, such as healed or 
not healed, whereas continuous scales measure data that can take any value within a 
range such as percentage reduction in wound size (Moore 2012). In studies where the 
outcome of interest is to determine the time duration before an event occurs, data are 
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measured using survival or time to event scales and may be summarised using hazard 
ratios (HRs) (Moore 2012). 
 
The results of a meta-analysis can be displayed graphically, easing the interpretation 
and comparison of the findings of individual studies for the review reader (Evans 
2000), such as in the form of forest plots (Sambunjak & Franic 2012). In a typical forest 
plot, the results of component studies are presented as squares centred on the point 
estimate of the result of each study with horizontal lines that run through the squares 
typically indicating 95% confidence intervals (CI) of the estimates (Lewis & Clarke 2001, 
Sambunjak & Franic 2012). The area of each square indicates the weight and relative 
contribution of the study to the overall meta-analysis (Moore 2012). The overall 
estimate and confidence interval from the meta-analysis is represented as a diamond 
at the bottom of the graph (Lewis & Clarke 2001, Sambunjak & Franic 2012). The 
centre of the diamond represents the pooled point estimate, and its horizontal tips 
indicate the confidence interval (Lewis & Clarke 2001, Sambunjak & Franic 2012). 
When using risk difference (RD), the vertical line of no effect at zero indicates that 
there is no statistically significant difference between the study groups, whereas when 
using odds ratio (OR), risk ratio (RR) or relative risk, a vertical line at one indicates no 
statistically significant difference (Moore 2012). Where the points of the diamond are 
clear of the line of no effect, the overall meta-analysed outcome suggests that there is 
statistical difference between the control and experimental groups (Lewis & Clarke 
2001). Conversely, where the vertical line of no effect cuts through the diamond, the 
overall result suggests that there is no statistically significant difference (Moore 2012, 
Sambunjak & Franic 2012).  
 
The advantage of displaying results using a forest plot is that it provides a clear view of 
the information from the meta-analysis in the form of a simple visual representation 
depicting the amount of variation between the study results as well as an estimate of 
the overall result of the studies combined (Lewis & Clarke 2001).  
 
88 
 
2.3.4.10.2. Systematic Review of Qualitative Research 
Qualitative research is a research methodology that encompasses various investigative 
approaches that essentially seek to understand through means of exploring human 
beliefs, experiences, motivations, perceptions, behaviours, and intentions (Parahoo 
2014), in contrast to precise measurement and statistical analysis inherent in 
quantitative research methodology (Ryan et al. 2007). This methodology poses 
significant challenges in systematic reviewing (Dixon-Woods et al. 2001) as qualitative 
research follows the naturalistic paradigm, assuming that multiple realities exist 
whereby such realities are the creation of the research participants (Ryan et al. 2007). 
 
In complex and dynamic healthcare environments, there exist growing demands for 
answers to increasingly complicated questions regarding aspects of healthcare such as, 
the of nature and significance of problems, the nature of proposed interventions, the 
differential impact of interventions, cost-effectiveness and acceptability (Mays et al. 
2005). Such demands from practitioners, policy-makers and managers highlights the 
need to synthesise high-quality evidence that not only includes quantitative research 
findings but also qualitative research findings (Mays et al. 2005). In spite of this, many 
current methods for systematic review continue to focus on quantitative forms of 
evidence (National Health and Medical Research Council 2000, Higgins & Green 2011). 
It is however increasingly acknowledged that excluding qualitative research from 
systematic reviews may lead to the exclusion of valuable evidence (Sheldon 2005, 
Dixon-Woods et al. 2007, Korhonen et al. 2013, Petticrew 2015). The Cochrane 
Collaboration (2015) acknowledged the potential value for qualitative research in the 
formation of the ‘Cochrane Qualitative & Implementation Methods Group’ that 
focuses on the methods and processes involved in the synthesis of qualitative research 
along with its integration with the Cochrane intervention reviews of effects (Noyes et 
al. 2011). 
 
Several terms are used when referring to a systematic review of qualitative studies, 
such as meta-synthesis, meta-analysis, meta-ethnography, narrative synthesis and 
meta-aggregation, which are used synonymously by some, and conversely recognised 
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as significantly different by others mainly due to the different methods employed 
(Korhonen et al. 2013). Meta-synthesis is commonly described as a critical review of 
topically related primary qualitative studies involving analysis, interpretation, and 
comparison or integration of qualitative findings or processed data (Jones 2004, Kent 
& Fineout-Overholt 2008, Finfgeld-Connett 2010, Korhonen et al. 2013). Qualitative 
meta-synthesis is dissimilar to quantitative meta-analysis of data in that the technique 
has an interpretive rather than an aggregating intent (Walsh & Downe 2005), as the 
synthesist’s interpretation is of the interpretations made by the original authors of the 
primary data of the constituent studies (Zimmer 2006).  
 
In the field of healthcare, the primary aim of many meta-syntheses is to interpret 
isolated qualitative findings in a meaningful manner in order to inform health-related 
policies and improve patient care (Kent & Fineout-Overholt 2008). Various diverse 
methods have been developed for conducting qualitative meta-syntheses (Barnett-
Page & Thomas 2009), for example, Critical Interpretive Synthesis (CIS) (Dixon-Woods 
et al. 2006). The method selected to conduct a meta-synthesis of qualitative research 
will depend on the research question, the phenomenon of interest, along with the 
specific methods employed in each individual study (Centre for Reviews and 
Dissemination 2008). Conflicting views exists that argue the suitability and feasibility of 
combining qualitative studies of different theoretical assumptions and methods within 
a single meta-synthesis (Mays et al. 2005, Zimmer 2006, Centre for Reviews and 
Dissemination 2008), where it has been suggested that attempts to aggregate 
qualitative research destroys the integrity of the individual studies (Sandelowski et al. 
1997). Challenges of including different types of qualitative research in meta-synthesis 
may relate to the varied forms of knowledge within the individual studies possibly due 
to different epistemological commitments inherent in the methodologies (Dixon-
Woods et al. 2001, Zimmer 2006). Choice of method in qualitative research is often 
determined by a particular theoretical perspective of which include a range of designs 
such as interviews, direct observation, analysis of written, audio or visual evidence 
such as recorded speech or behaviour (Centre for Reviews and Dissemination 2008). 
Despite these views, some review teams and researchers consider that combining 
qualitative data from multiple theoretical and methodological traditions adds strength 
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to a review (Dixon-Woods et al. 2004, Centre for Reviews and Dissemination 2008, 
Song et al. 2010, Noyes et al. 2011). As mentioned, a significant acknowledgement of 
the contribution that qualitative data may provide to systematic reviews was by the 
Cochrane Collaboration where they proposed the use of qualitative research to inform, 
enhance, extend, and supplement reviews (Noyes et al. 2011). In agreement, the 
Centre for Reviews and Dissemination (2008) similarly advise encompassing qualitative 
research in reviews of effectiveness suggesting that this type of evidence can enhance 
the utility of reviews through numerous ways such as, shaping questions of importance 
for review consumers, understanding the mechanisms behind effectiveness or 
ineffectiveness of heterogeneous results, identifying elements that influence the 
implementation of an intervention, detailing the experience of participants receiving 
certain interventions, and presenting the participants’ subjective evaluations of 
outcomes. 
 
Conflicting opinions exist regarding the assessment of qualitative research which 
debates whether the concepts of quality used for qualitative research should be similar 
to, equal to, or diverse from those used for quantitative research (Spencer et al. 2003, 
Centre for Reviews and Dissemination 2008). In answer to this, Spencer et al. (2003) 
recommend that qualitative research is appraised on its ‘own terms’ considering the 
principles that are fundamental to its purpose, nature and conduct. Account must be 
taken of the particular method of data collection and methodological approach being 
used when applying critical appraisal criteria as more tailored criteria will assist to 
distinguish fatal from minor flaws in the design, conduct, and reporting of qualitative 
research (Dixon-Woods et al. 2001).  
 
There are many quality appraisal frameworks and checklists for reviewing qualitative 
literature (Spencer et al. 2003, Barnett-Page & Thomas 2009, Harden & Gough 2012). 
In fact, there exists more than one hundred sets of proposals on quality in qualitative 
research (Dixon-Woods et al. 2004). Despite this, only a subset of these have been 
reviewed (Spencer et al. 2003), of which five have been specifically designed for use in 
systematic reviews (Centre for Reviews and Dissemination 2008). Quality appraisal 
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instruments developed for qualitative research share some basic elements, such as the 
requirement for research to have been conducted ethically, the consideration of 
relevance to inform practice or policy, the use of appropriate and rigorous methods 
and the clarity and coherence of reporting (Cohen & Crabtree 2008). Considering the 
benefits provided by such instruments, there exists however a common consensus 
amongst qualitative researchers regarding the invaluable importance of expert 
judgement in appraising the quality of studies (Noyes et al. 2011).  
 
In relation to the synthesis of qualitative research, a number of different methods have 
been proposed, of which many are based on approaches used in primary research, 
including, meta-ethnography, thematic analysis/ synthesis, grounded theory (constant 
comparative method), qualitative research synthesis: qualitative meta-synthesis, 
content analysis, case survey, qualitative comparative analysis, qualitative research 
synthesis: qualitative meta-summary, and narrative synthesis (Centre for Reviews and 
Dissemination 2008). Despite the numerous suggested methods of meta-synthesis, 
insufficient evaluation has been conducted regarding the relative strengths and 
weaknesses of these methods and few guidelines exist for judging quality (Centre for 
Reviews and Dissemination 2008). 
 
Notwithstanding acknowledgement by many review teams and researchers of the 
importance of qualitative research to systematic reviews, the methods for conducting 
quality appraisal of individual studies and meta-synthesis as well as for performing 
meta-synthesis are not fully developed, well established or sufficiently evaluated 
(Centre for Reviews and Dissemination 2008). Nevertheless, qualitative research and 
meta-synthesis may provide meaningful data independent of quantitative research as 
well as offering data that may enrich quantitative systematic reviews so as to better 
inform policy developers and thus improve practices. 
 
2.3.4.11. Reporting and Dissemination  
Reporting is an important stage of the review process as it is suggested that the quality 
of reporting may affect the readers’ interpretation of the results (Centre for Reviews 
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and Dissemination 2008). As consumers knowledge regarding review topics can vary 
greatly in addition to their levels of engagement with the published report, the need to 
clearly highlight any limitations of the review in the conclusion is emphasised, for 
example where the quality of the primary studies is poor (White & Schmidt 2005). The 
use of summary tables and figures can enhance the presentation of results in 
structured and clear format to supplement textual commentary (Smith et al. 2011). 
 
The review may take on different formats depending on where it is to be submitted, 
for example a commissioning body may require a structure of a comprehensive report 
whereas a journal may request a concise article which omits important details of the 
review methods as a consequence of journal-style space restrictions (Centre for 
Reviews and Dissemination 2008). Irrespective of the format, a detailed report should 
be carefully drafted and, if relevant, additional information conveyed as available 
through either the journal or the review author, to facilitate the reader to reproduce 
the study if so desired (Centre for Reviews and Dissemination 2008). Systematic review 
reports generally include an introduction, the methodological design, discussion of the 
evidence, detailed report of the results, and conclusions and recommendations (Victor 
2008). To improve the reporting of systematic reviews and meta-analyses, the PRISMA 
Statement is recommended for reviews of various types of research and, in particular, 
evaluations of interventions (Moher et al. 2009). The PRISMA Statement consists of a 
27-item checklist for reporting systematic reviews and a four-phase flow diagram for 
presenting search strategies (see Appendix 5 and 6). 
 
Centre for Reviews and Dissemination (2008) describe dissemination as a formulated 
and active process that strives to ensure that the target audience connects with the 
research and can understand it. As an integral part of the review process, 
dissemination should be considered from the early stages in order to allow time to 
facilitate planning and development, to allocate responsibilities, and to ensure that 
adequate resources are available for proposed dissemination activities (Centre for 
Reviews and Dissemination 2008).  
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2.3.5. Risk of bias in studies and in systematic reviews 
2.3.5.1. Risk of bias in conducting systematic reviews 
An awareness of the risk of bias in the context of research publication and review is 
imperative when conducting a systematic review. Understanding research bias allows 
reviewers to critically and independently assess the scientific literature and reduces 
acceptance of interventions that are suboptimal and may potentially cause harm 
(Pannucci & Wilkins 2010). Some dominant types of bias are publication bias, time-lag 
bias, citation bias, language bias and outcome reporting bias (Moore 2012), multiple 
publication bias and location bias (Song et al. 2010, Sterne et al. 2011b). 
 
2.3.5.1.1. Publication bias  
Study publication bias occurs where study findings are published or not published 
depending on the nature of the findings (Dwan et al. 2008), and can be due to the 
tendency of authors to submit, or the publishers to accept, positive as opposed to 
negative findings (Malone et al. 2014) or findings that are, or are not, statistically 
significant (Song et al. 2010). Publication bias is also seen where positive or more 
significant findings are published earlier, and are published in journals with higher 
impact factor (Dubben & Beck-Bornholdt 2005). This is of importance as the validity of 
research synthesis that is based on published literature will be compromised where 
the published studies consist of a biased selection of all studies that have actually been 
carried out (Song et al. 2010). Publication bias can be detected using direct or indirect 
evidence (Møller et al. 2005). Examples of indirect evidence include observations of an 
excessively high proportion of positive findings in the published literature, in addition 
to larger effect size in small studies as compared with large studies (Song et al. 2010). 
It is worth noting that this evidence is so-called ‘indirect’ as factors other than 
publication bias may similarly cause such observed disparities (Song et al. 2010). In a 
systematic review of studies of which analysed the publication of clinical trials reported 
that 74% (20/27) of trials with positive results were published in full compared to only 
41% (16/39) of trials with null or negative results. Another study in this systematic 
review similarly reported that 72% (55/76) of trials with positive results were 
published in full compared to only 33% (18/54) of trials with null or negative results 
(Hopewell et al. 2007b). On the other hand, direct evidence of publication bias involves 
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comparing published and unpublished studies by following a random or an exhaustive 
sample of initiated studies through to completion and finally assessing the patterns of 
publication (Møller et al. 2005). In addition, a funnel plot may be used to detect the 
presence or absence of this publication bias where it is suspected (Moore 2012, 
Malone et al. 2014). 
 
Funnel plots 
Originating in educational research and psychology, funnel plots are basic scatter plots 
of the treatment effects estimated from individual studies on the horizontal axis 
against a certain measure of study size on the vertical axis (Egger et al. 2003). The 
name funnel plot is owed to the fact that, in the absence of bias, the graph appears as 
a symmetrical inverted funnel because the treatment effect estimates from smaller 
studies scatter more widely at the base of the graph, with the spread narrowing with 
increasing precision among larger studies (Sterne & Egger 2001, Sterne et al. 2011b). In 
contrast, where bias exists, an asymmetrical funnel plot will appear with a gap in a 
bottom corner of the graph, for example, if smaller studies without statistically 
significant effects remain unpublished (Sterne et al. 2011b). Where the asymmetry of a 
funnel plot is more noticeable, the likelihood of a substantial amount of bias is 
increased (Sterne et al. 2011b). 
 
Despite their value, there are some limitations to the use of funnel plots that must be 
considered when conducting and reviewing systematic reviews as publication bias 
does not necessarily produce asymmetry in funnel plots (Sterne et al. 2011a). The 
Cochrane Handbook for Systematic Reviews of Interventions notes that in the absence 
of any intervention effect, selective publication based on the p value alone will lead to 
a symmetrical funnel plot in which studies on the extreme left or right are more likely 
to be published than those in the middle, and hence produce bias in the estimated 
between-study heterogeneity variance (Sterne et al. 2011b). 
 
In an updated systematic review, Dwan et al. (2013) reviewed and summarised the 
empirical evidence from twenty cohort studies that assessed study publication bias or 
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outcome reporting bias in randomised controlled trials, of which, fifteen studies in 
particular examined aspects of publication bias. Of the included studies, twelve studies 
demonstrated consistent evidence of an association between positive or statistically 
significant results and publication (Dwan et al. 2013). Of note is that only nine of these 
empirical studies considered whether a study was put forward for publication and only 
seven achieved all four of the criteria for studies investigating study publication bias 
namely, inception cohort, complete follow up of all trials, publication established 
through personal contact with the researcher, and definition of positive and negative 
results clearly defined (Dwan et al. 2013). In six empirical studies, follow up of trials 
was less than 90% and in two empirical studies, the definition of positive and negative 
findings was unclear (Dwan et al. 2013). The total number of empirical studies 
examining study publication bias published in each cohort differed widely from 21% to 
93% and, of the nine cohorts that considered what proportion of trials with positive 
and negative results are published, results varied from 60% to 98% and from 19% to 
85%, respectively (Dwan et al. 2013). From the findings of this review, Dwan et al. 
(2013) concluded that there was direct evidence of study publication bias due to the 
strong association found between studies that report positive or significant results and 
their likelihood of publication.  
 
In an earlier systematic review of twenty-six studies that assessed the impact of 
publication bias, Dubben & Beck-Bornholdt (2005) investigated whether there is 
preferential publication of positive papers on publication bias. Reports for publication 
bias were evaluated using a funnel plot. In contrast to the conclusions by Dwan et al. 
(2013), this study analysis found no evidence of publication bias in reports on 
publication bias. However, this study highlighted a lack of definition and consistency in 
relation to the concepts of ‘positive’ and ‘significant’ findings amongst studies, noting 
that some studies referred to ‘significant’ by grouping studies that were reported to 
have statistically significant findings with those reported to have findings of great 
importance in contrast to the remainder which were referred to as ‘not significant’ 
(Dubben & Beck-Bornholdt 2005). Furthermore, as this systematic review involved only 
twenty-six studies, the power to detect asymmetry by means of a funnel plot was low. 
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2.3.5.1.2. Time-lag bias 
Time-lag bias stems from an acknowledged concern that non-significant research 
findings take longer to appear in the literature than more statistically significant 
findings (Misakian & Bero 1998).  An awareness of all the research, statistically 
significant and non- statistically significant, is fundamental in order to accurately 
interpret the strength and direction of the evidence, as omission of some evidence 
could potentially lead to inappropriate decisions or recommendations (Moore 2012).  
 
Hopewell et al. (2007a) in their systematic review of two studies with a cumulative 
number of 196 trials, found that trials with positive results, referred to as those with 
statistically significant findings in favour of the experimental arm of the study, were 
published in around four to five years, whereas trials with null or negative results, 
referred to as those that were not statistically significant or that were statistically 
significant in favour of the control arm, took around six to eight years to be published. 
 
In an earlier prospective study involving 109 randomised trials enrolling 43708 
patients, Ioannidis (1998) found that the median time from the start of the study to its 
publication was statistically significantly longer for negative findings compared to 
positive findings in favour of the experimental arm, 6.5 years versus 4.3 years, 
respectively (P<.001; hazard ratio (HR) 3.7; 95% confidence interval (CI) 1.8-7.7). This 
study also found positive trials were submitted for publication statistically significantly 
quicker following completion than were negative trials, median of 1 year versus 1.6 
years respectively (P=0.001), and were published quicker following submission, median 
of 0.8 years versus 1.1 years (P=.04) (Ioannidis 1998). A retrospective study by Stern & 
Simes (1997) involving analysis of 520 eligible studies similarly described that positive 
results took a statistically significantly shorter time to be published compared to those 
with negative results, a median of 4.8 versus 8.0 years, respectively, and furthermore, 
studies that produce inconclusive results had even longer time periods to publication 
when compared to studies with negative results.  
 
97 
 
2.3.5.1.3. Citation bias 
Citation bias exists where particular publications are included or excluded for citation, 
such as by authors of research review studies (Moore 2012), because of the direction 
or nature of their findings (Egger et al. 2003). Sterne et al. (2011b) advise against 
scanning reference lists of articles to identify additional studies of possible relevance 
to a systematic review as this method may be quite subjective and may produce a 
biased sample of studies. 
 
In a cohort study of therapeutic intervention studies included in meta-analyses 
published in the Cochrane database between January and March 2010, Jannot et al. 
(2013) identified 89 research questions addressed in 458 eligible articles and found 
that statistically significant studies were cited twice as often as non- statistically 
significant studies (multiplicative effect of significance: 2.14, 95% confidence interval 
(CI): 1.38-3.33). The relationship between the statistical significance of each study and 
the number of received citations were assessed between the years 2008 and 2010 
(Jannot et al. 2013). Jannot et al. (2013) suggest that this positive relationship may be 
partly due to the higher impact factor of journals where statistically significant studies 
are published (adjusted multiplicative effect of significance: 1.14, 95% confidence 
interval (CI): 0.87-1.51) and as consequence of these findings, caution that treatments 
may seem more effective than in actuality. Similarly, a cohort study of 448 original 
research articles published in 1996 in four psychiatric journals concluded that highly 
visible publications may attract more attention even if the statistical reporting quality 
is poor, and thus the number of citations of an article is more likely to reflect the 
impact factor of the journal of publication and the level of active interest in the 
research question as opposed to the reporting quality (Nieminen et al. 2006). 
Published in 2007, a further report of this same cohort study focused on the existence 
of preferential citation of statistically significant articles found that, of the 368 articles 
which employed statistical significance testing, 287 (77.8%) had p<0.05 and of these, 
the median number of citations for papers reporting ‘significant’ and ‘nonsignificant’ 
results were 33 and 16, respectively (Nieminen et al. 2007). These findings suggested 
that studies with more statistically significant findings, p<0.05, are cited more often 
based on their p-value rather than inherent scientific value (Nieminen et al. 2007). 
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2.3.5.1.4. Language bias 
Language bias occurs when study inclusion is limited to only those published in a 
particular language as this deliberately excludes potentially important evidence (Egger 
et al. 2003). Bettany-Saltikov (2010b) described that positive results are more likely to 
be published in the English language and Egger et al. (1997) found that results of 
randomised controlled trials which were statistically significant were more likely to be 
published in an English language journal. Manual searches of numerous medical 
journals published in different languages is therefore recommended to assist in 
reducing such bias (Egger et al. 1997, Sterne et al. 2011b). 
 
In a study examining the influence of trials published in non-English languages on 
combined estimates and conclusions of published meta-analyses, Juni et al. (2002) 
examined meta-analyses that involved at least five trials with binary outcomes and 
were based on comprehensive literature searches without language restrictions. 
Comparing estimates of treatment effects from trials published in non-English 
languages to those from trials published in English, and assessing the impact of 
restricting meta-analyses to trials published in English, Juni et al. (2002) found, 
surprisingly, that excluding trials published in languages other than English had 
generally minimal effect on summary treatment effect estimates. Overall, 159 of the 
303 meta-analyses identified had conducted comprehensive literature searches, of 
which fifty meta-analyses included 485 English and 115 non-English language trials. 
Juni et al. (2002) reported that in 29 (58.0%) of the meta-analyses, the change in effect 
estimates after exclusion of non-English language trials was less than 5% and in the 
remaining meta-analyses, 5 (10.0%) demonstrated more benefit and 16 (32.0%) less 
benefit after exclusion of non-English language trials. This study revealed that non-
English language trials tended to be of lower methodological quality, included fewer 
participants (median 88 versus 116, P = 0.006) and were more likely to produce 
statistically significant results at P < 0.05 (41.7% versus 31.3%, P = 0.033) with 
estimates of treatment effects on average 16% (95% CI : 3–26%) more beneficial in 
non-English-language trials than in English-language trials (Juni et al. 2002).  
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In contrast, a study of 229 randomised controlled trials published between 1989 and 
1994 to compare completeness of reporting, design characteristics, and analytical 
approaches between trials published in English and non-English languages (French, 
German, Italian, and Spanish), argued that there is strong evidence to demonstrate 
that all trial reports should be included in systematic reviews irrespective of the 
language of publication (Moher et al. 1996). Moher et al. (1996) found no statistically 
significant differences between trials published in English (133 trials) and non-English 
languages (96 trials) for any single item in the completeness of reporting scale 
(randomisation, double-blinding, withdrawals), or for the overall completeness of 
reporting score (maximum possible score was 51% for trials in English compared to 
46.2% for trials in other languages; 95% CI : -1.1 to 10.5)(Moher et al. 1996). However, 
differences were noted in that non-English language trials were more likely to have 
adult participants, employ two or more interventions, compare two or more active 
treatments without an untreated control group, and to clearly report a pre-specified 
primary outcome or any rationale for sample size estimation (Moher et al. 1996). 
Despite similar results found in respect to completeness of reporting, the substantial 
differences noted in relation to study methods and study quality reported between 
trials published in English and non-English languages indicate that inclusion of all 
relevant articles, both English and non-English, is likely to increase precision and 
reduce systematic errors (Moher et al. 1996). 
 
Despite the evident conflicting evidence regarding language bias, this type of bias 
remains a significant factor that must be considered when assessing and synthesising 
evidence in research. Whilst there is research that suggests there may only be a 
minimal effect by excluding non-English publications, the importance of non-English 
language trials is difficult to predict for individual systematic reviews and, therefore, 
comprehensive literature searches supported by thorough quality assessments are 
essential to consider the contribution of all relevant trials, independent of language of 
publication (Juni et al. 2002). 
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2.3.5.1.5. Outcome reporting bias 
Outcome reporting bias has been well documented (Chan et al. 2004, Dwan et al. 
2013) and is where study outcomes are selectively reported depending on the nature 
and sway of the finding (Egger et al. 2003). A retrospective comparative study of 47 
Cochrane reviews with prior protocols revealed indirect evidence for possible selective 
reporting bias for systematic reviews in that 43 of the reviews contained a major 
change between the protocol and the full publication, such as the addition or deletion 
of outcomes (Silagy et al. 2002). Only 1 of the 47 reviews remained unchanged 
compared with the published protocol, 3 had only minor changes, and, of the 
remaining 43, many had changes in 5 or more sections compared with the published 
review (Silagy et al. 2002). The extent to which these changes to protocol reflect bias is 
not clear (Liberati et al. 2009) and requires a detailed examination of the types of 
changes made followed by an independent judgement as to the effects of such 
changes on the final review (Silagy et al. 2002). For example, Silagy et al. (2002) 
describe that certain modifications may enhance the quality of the study, such as 
inclusion of more detail in the background section or increased comprehensiveness of 
the search strategy, however, other modifications due to conscious or unconscious 
previous awareness of results may cause concern for introducing a possibility of bias, 
such as the addition or deletion of certain elements of the review, or activities that 
lead to a narrowing of the scope of the review.      
 
2.3.5.1.6. Multiple publication bias 
Multiple publication bias is the converse of bias due to unpublished studies in that the 
studies are published several times (National Health and Medical Research Council 
2000). Multiple publication, also known as duplicate publication, can result in an 
inaccurate weighting of a study’s results (Choi et al. 2014). For example, in a review of 
the effect of the drug ondansetron on postoperative vomiting involving 84 randomised 
controlled trials, Tramer et al. (1997) found that 17% of the full report of trials and 28% 
of patient data had duplicate reports. Nine trials of the oral medication suspension 
were published as 16 reports, and a further 19 trials of intravenous medication 
suspension were published as 25 reports (Tramer et al. 1997). As a consequence, there 
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was a reported 23% overestimation of the efficacy of ondansetron as a result of 
inclusion of this duplicate data in the meta-analyses (Tramer et al. 1997).  
 
In a further study, Choi et al. (2014) estimated from their review of meta-analysis 
written exclusively by Korean authors, that 6 (6.9%) of the 86 analysed meta-analyses 
included duplicate publications, 6 of the 1,194 articles (0.5%) used in the meta-
analyses were duplicate publications and that these duplications were typically related 
to disaggregation and overlapping publications. Interestingly, following examination of 
one of the meta-analysis it was found that the inclusion of the duplicate data increased 
the mean effect size and fail-safe number such that the mean effect size without 
duplicated data was 2.0054 (95% confidence interval (CI): 1.8553, 2.1554) compared to 
an increase to 2.1394 (95% CI: 1.6248, 2.6570) with duplicated data (Choi et al. 2014).  
 
Avoiding multiple publication bias may however be extremely challenging as, due to 
variations in study presentation such as in terms of title, authors, and reporting style, 
identifying duplicate publications can be difficult or even impossible and may require 
contact with the relevant research authors in order to confirm or rule-out duplication 
(Sterne et al. 2011b). Tramer et al. (1997) noted from their study that one multicentre 
trial had published four separate reports with different first authors and, moreover, 
four pairs of identical trials had been published that did not share a single common 
author. The evidence presented here suggests that meta-analyses should be 
interpreted cautiously and that systematic reviews, in turn, must consider the 
possibility of duplicated studies in order to control the risk of multiplication bias. 
 
2.3.5.1.7. Location bias 
Location bias can refer to the location of publication associated with the direction or 
strength of the study findings, the journal’s editorial policy or readers’ preference 
(Song et al. 2010), the accessibility of studies based on variable indexing in electronic 
databases, or the geography of countries publishing studies (Sterne et al. 2011b).   
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In a series of trials, Pittler et al. (2000) examined the relationship between trial 
outcome, methodological quality and sample size with the characteristics of the 
journals in which the trials were published. Analysis of 351 trials in the field of 
complementary and alternative medicine demonstrated that studies yielding 
statistically significant results were more prominent in low and non-impact factor 
journals than in high-impact mainstream medical journals, and that high impact factor 
journals reported equal numbers of positive and negative trials (Pittler et al. 2000). In 
addition, the quality of the research trials was also associated with the journal of 
publication as quality scores of trials of positive results were significantly lower in 
those published in non-impact factor (P<0.02) compared to high impact factor journals 
(Pittler et al. 2000). 
 
Another example of location bias is where certain countries publish studies with more 
statistically significant results compared to other countries (Sterne et al. 2011b). A 
study involving 657 article abstracts published between January 1966 and June 1995 
taken from the electronic database Medline, found research conducted in certain 
countries was consistently favourable of the treatment, namely acupuncture, when 
compared to the non-acupuncture treatment methods (Vickers et al. 1998). Vickers et 
al. (1998) found most notably that studies in East Asia and Eastern Europe reported 
the treatment to be superior to the control treatment in all 36 trials conducted in 
China and in 10 out of the 11 trials conducted in Russia/USSR. Such publication of 
unusually high ratios of positive results in particular countries is suggestive of location 
bias. 
 
Interesting findings in relation to location bias were also noted from a study by King 
(2004) which was conducted in order to measure the quantity and quality of published 
science research. King (2004) revealed that the countries that occupied the top eight 
places in the science citation rank order produced about 84.5% of the top 1% most 
cited publications between 1993 and 2001 (King 2004). Another substantial finding of 
this analysis was that although only thirty-one countries were included in this analysis, 
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these countries produced almost 98% of the world’s most cited papers meaning that 
the remaining 162 countries contributed only 2% (King 2004).  
 
Location bias is also related to accessibility of studies depending on various indexing in 
databases (Sterne et al. 2011b). Numerous studies have found statistically significant 
differences in retrieval of research papers from electronic by databases demonstrating 
that searching only one database can fail to identify all relevant articles (McDonald et 
al. 1999, Sampson et al. 2003, Whiting et al. 2008, Slobogean et al. 2009). Searching a 
range of databases is therefore recommended in order to achieve a comprehensive 
search (McDonald et al. 1999, Whiting et al. 2008) and, hence, reduce risk of location 
bias.  
 
In a study of eight systematic reviews and their database searches, Whiting et al. 
(2008) found no single search that identified all of the studies that had been included 
in the reviews. Databases searched comprised of MEDLINE, EMBASE, BIOSIS, Science 
Citation Index, LILACS, Pascal, and CENTRAL. Variations in studies contained in the 
databases were noted such that EMBASE, Science Citation Index, and BIOSIS contained 
studies that were not in MEDLINE. LILACS contained studies that were not on any 
other database, eight studies termed as ‘gold standard’ were not found in any of the 
databases, and another 22 studies were not identified by any of the electronic search 
strategies (Whiting et al. 2008). 
 
In conclusion, location of trials in terms of journal type and impact factor, geography of 
publishing countries, and accessibility relating to variable indexing in electronic 
databases must be considered in examining research literature and constructing 
systematic reviews. In addition, searching a range of databases is required to produce 
comprehensive search findings (McDonald et al. 1999) along with consideration of 
‘grey literature’ sources (Whiting et al. 2008), in order to reduce risk of location bias. 
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2.3.5.2. Risk of Bias within primary research studies 
Higgins et al. (2011b) recognise potential biases that can influence the relevance of the 
results achieved in a study, of which would also impact the quality of the systematic 
reviews and meta-analysis. Although various types of quantitative research are 
included in this systematic review, randomised controlled trials are one of the main 
types of studies included in many systematic reviews, hence, the types of biases 
associated with these studies will be explored. 
The main biases associated with randomised controlled trials can be categorised as: 
 Selection bias; 
 Performance bias; 
 Detection bias; 
 Attrition bias;  
 Reporting bias 
 
2.3.5.2.1. Selection bias 
Selection bias refers to systematic differences between the study groups relating to 
the allocation of participants to either the intervention or control group (Higgins et al. 
2011b). This type of bias describes when subjects are not representative of the 
population to which the findings will be applied (Petrie & Sabin 2009). In both 
randomised controlled trials and clinical studies all eligible participants should have an 
equal chance of receiving the intervention (Gottrup et al. 2010). The risk of selection 
bias is assessed by the quality of sequence generation and concealment (Sambunjak & 
Franic 2012). Generation of allocation sequences and concealment of allocation 
sequences are the two interrelated steps of randomisation (Juni et al. 2001). 
Generation of allocation sequences are deemed adequate if sequences prevent 
selection bias through selection methods based on some chance (random) process 
(Higgins et al. 2011b) such as computer-generated random numbers, table of random 
numbers, drawing of lots, or tossing a coin, whereas are deemed inadequate if 
sequences could be related to prognosis by selection methods such as case record 
number, date of birth, or year of admission, and so on (Gottrup et al. 2010). In the 
same way, Gottrup et al. (2010) describe that concealment of allocation sequences can 
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be deemed adequate if participants and the researchers enrolling participants are not 
able to anticipate group allocation, for example, by employing central randomisation 
or by using sequentially numbered, sealed, opaque envelopes. Concealment of 
allocation it is deemed inadequate if participants and the researchers enrolling 
participants can anticipate group allocation due to procedures based on inadequate 
generation of allocation sequences such as an open allocation schedule or by using 
unsealed or non-opaque envelopes (Gottrup et al. 2010). In seeking to prevent 
selection bias, allocation concealment appears the more important of these two steps 
that protects the assignment sequence before and until allocation, and can always be 
implemented (Schulz et al. 1995). A double-blind trial prevents participants, care 
providers, and study outcome evaluators from knowledge of treatment allocations 
(Schulz et al. 1995). Double-blinding seeks to prevent ascertainment bias, and protects 
the sequence after allocation but, in contrast to allocation concealment, cannot always 
be implemented (Schulz et al. 1995).  
 
Schulz et al. (1995) assessed the methodological quality of 250 trials from 33 meta-
analyses from the Cochrane Pregnancy and Childbirth Database and examined the 
association between dimensions of trial quality and estimated treatment effects. 
Failure to prevent foresight of treatment allocation was associated, on average, with 
an exaggeration of treatment effects by 30–40% when compared with trials in which 
researchers reported adequately concealed treatment allocation. Of the 250 trials 
examined, steps taken to conceal treatment allocation schedules were identified as 
adequate in 79 of the trials, inadequate in 21, and unclear in 150 (Schulz et al. 1995). In 
addition, this study found that trials which were not double-blinded yielded larger 
effects (Schulz et al. 1995). Similarly, in a study examining fourteen meta-analyses of 
190 randomized controlled trials, Kjaergard et al. (2001) found that intervention 
effects were exaggerated in small trials with insufficient allocation sequence 
generation (ratio of odds ratios, 0.46 [95% CI: 0.25-0.83]; P=0.011), inadequate 
allocation concealment (ratio of odds ratios, 0.49 [CI: 0.27-0.86]; P=0.014), and no 
double blinding (ratio of odds ratios, 0.52 [CI: 0.28-0.96]; P=0.01) when compared with 
large trials. Trials with adequate generation of the allocation sequence, adequate 
allocation concealment, or adequate double blinding did not differ significantly 
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depending on study size (Kjaergard et al. 2001). Kjaergard et al. (2001) concluded that 
despite the considerable overlap between generation of allocation sequence and 
allocation concealment, the results of this study appear to indicate that both factors 
independently influence the estimated intervention effect. 
 
Comprehensive reporting of the methods of randomisation is essential so that the 
reader can consider the likely magnitude for all potential sources of bias and the likely 
direction of the bias (Higgins & Green 2011). An example described by Higgins et al. 
(2011b) is that if all methodological limitations of studies are to be anticipated to bias 
the study findings in the direction of a lack of effect and the evidence shows that the 
intervention is effective, then it is possible to conclude that the intervention is 
effective regardless of the existence of these potential biases. 
 
2.3.5.2.2. Performance Bias 
Performance bias is defined as any difference between the subject groups in the 
treatment received apart from the intervention being examined (Magarey 2001). A 
means of managing performance bias is by blinding the participants and the personnel 
involved in the study (Higgins et al. 2011b). After enrolment into the study, blinding of 
study participants and personnel may reduce the risk that knowledge of which 
intervention was received, rather than the intervention itself, and can also ensure that 
the compared groups receive a similar amount of attention, ancillary treatment and 
diagnostic investigations (Higgins et al. 2011b).  
 
The risk of performance bias can be assessed by examining the blinding of participants 
and personnel in a study (Sambunjak & Franic 2012). Gottrup et al. (2010) state that 
avoiding performance bias is particularly challenging in studies of interventions in 
wound management as bias may be introduced if treatment interventions are not used 
appropriately, such as in line with the manufacturer’s instructions or as appropriate to 
the wound condition. Furthermore, as randomised controlled trials require the same 
treatment to be provided for the duration of the study, enforcing this purist approach 
can be particularly troublesome in wound care as it opposes the fundamental need to 
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modify the treatment depending on the wound condition (Gottrup et al. 2010). A 
balance between maintaining a purist approach and being practical about the 
provision treatments in routine clinical practice must therefore be adopted (Gottrup et 
al. 2010). As mentioned by Higgins et al. (2011b) blinding is not always possible, and 
this is particularly relevant in wound care due to the nature of wound care devices 
such as with the use of topical negative pressure devices (Rhee et al. 2014) or 
particular wound dressings (Miller et al. 2010). Other fields of research similarly 
experience such challenges, for example, in research involving major surgery as it is 
typically impossible to blind participants and assessors to whether such an 
intervention has or has not been carried out (Higgins et al. 2011b) 
 
2.3.5.2.3. Detection bias 
Detection bias refers to variances in the evaluation of outcomes, where methods used 
to assess the findings of the study are different for subjects in the treatment groups 
compared to subjects in the control groups (Evans 2000). Blinding of outcome 
assessors to which intervention was received as opposed to the intervention itself may 
reduce the risk of detection bias that affects outcome measurement, particularly in the 
assessment of subjective outcomes (Higgins et al. 2011b). Subsequently, risk of 
detection bias is assessed by the blinding of assessors to which groups participants 
have been allocated (Magarey 2001). 
 
In the study by Kjaergard et al. (2001) examining the effect of the methodological 
quality of trials on the overall estimate of effect, no differences between large and 
small trials were reported when blinding was adequate. However, compared to large 
trials, odds ratios were exaggerated by 48% in small trials without double blinding 
(p=0.01). These results suggest that non-blinding may lead to an exaggerated estimate 
effect in smaller trials when compared to large trials.  
 
2.3.5.2.4. Attrition bias 
Attrition bias refers to any systematic differences between groups of a study that can 
be owed to protocol deviations or loss to follow-up (Juni et al. 2001, Egger et al. 2003). 
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Deviations from protocol may relate to the violation of eligibility criteria and non-
adherence to treatments (Juni et al. 2001). Loss to follow up is associated with 
participants becoming unavailable for involvement in study requirements at some 
point during the study due to reasons such as refusal to continue participating in the 
study (also referred to as drop outs), an inability to be contacted, or overriding clinical 
decisions dictating that the assigned interventions be ceased (Juni et al. 2001). All 
randomised participants should be included in a study’s analysis and remain in their 
originally allocated groups, regardless of their adherence to the study protocol, thus 
avoiding selection bias (Juni et al. 2001). Nevertheless, Juni et al. (2001) state that in 
certain incidences some patients may have to be excluded from the analysis and, 
where this occurs, it is imperative that the study report the proportion of participants 
that were not included in the analysis and discuss the possibility of attrition bias. 
Sambunjak & Franic (2012) recommend that risk of attrition bias can be assessed by 
completeness of outcome data. 
 
2.3.5.2.5. Reporting bias 
Reporting bias, also known as outcome reporting bias or selective reporting, refers to a 
type of ‘within-study publication bias’ where there are systematic differences between 
reported and unreported research results (Higgins et al. 2011b). Risk of reporting bias 
is assessed by completeness of reporting (Sambunjak & Franic 2012). 
 
In a pilot study, Hahn et al. (2002) compared the outcomes, analysis and sample size 
reported in protocols with the actual published results in order to assess within-study 
reporting. From 41 replies from researchers of 56 projects, 15 studies were completed 
and published at the time of the pilot study and were further investigated (Hahn et al. 
2002). Of these fifteen studies, six specified primary outcomes of interest with only 
four consistent with the report, and eight studies had a protocol but this was only 
followed in one study (Hahn et al. 2002). This data supports the belief that adherence 
to study protocol is not consistent however does not determine the effect or 
possibility of bias resultant from such inconsistencies. 
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In the study by Dwan et al. (2013) reviewing evidence from a cohort of studies 
examining study publication bias or outcome reporting bias in randomised controlled 
trials, three of the studies found statistically significant outcomes were more likely to 
be comprehensively reported when compared to non-significant outcomes (range of 
odds ratios: 2.2 to 4.7). In another study, Kirkham et al. (2010) also demonstrated, 
through a sensitivity analysis, that outcome reporting bias affected the treatment 
effect estimate in a substantial proportion of systematic reviews. From all eligible 
trials, 157 of the 283 reviews (55%) failed to include complete information data 
regarding the review primary outcome of interest and Kirkham et al. (2010) identified 
clear evidence to suggest that in six per cent of the 2486 assessable trials researchers 
had measured and analysed the review primary outcome but did not report or only 
partially reported the results. The sensitivity analysis undertaken for 81 reviews with a 
single meta-analysis of the primary outcome of interest revealed that the treatment 
effect estimate was reduced by 20% or more in 19 (23%) and, of the 42 meta-analyses 
with a statistically significant result, only eight (19%) became nonsignificant following 
adjustment for outcome reporting bias and 11 (26%) would have overestimated the 
treatment effect by 20% or more (Kirkham et al. 2010).  
 
2.3.6. Managing risk of bias in systematic reviews 
Although it has been stated that systematic reviews of randomised controlled trials 
and the trials themselves provide the most reliable evidence about the effects of 
healthcare interventions, causal inferences from such studies can be undermined by 
weaknesses or errors in design, conduct, analyses, and reporting, and result in 
exaggerated intervention effect, bias (Higgins et al. 2011a). These biases, which can be 
related to over- or under-estimations of the true intervention effects, are usually 
difficult to assess in terms of the extent to which they affect the results (Higgins et al. 
2011a). On this note, there is now substantial evidence of poor quality reporting in 
both randomised controlled trials (Schulz et al. 1995, Juni et al. 2001, Kjaergard et al. 
2001) as well as systematic reviews (Hemels et al. 2004, Dixon et al. 2005, Moher et al. 
2007), which consequently diminishes the potential usefulness of findings and the 
recommendations made (Liberati et al. 2009). 
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In seeking to avoid bias in systematic reviews, certain strategies and various tools have 
been developed in an attempt to improve the accuracy and clarity of assessing risk of 
bias and quality in studies (Sanderson et al. 2007, Liberati et al. 2009, Moher et al. 
2010, Higgins et al. 2011a, von Elm et al. 2014). Strategies suggested to limit the risk of 
bias in systematic reviews include acknowledging grey literature in search strategies 
(Egger et al. 2003, Hopewell et al. 2007b), the use of trial registries (Liberati et al. 2009, 
Sterne et al. 2011b), a well-designed and conducted search strategy (Egger et al. 2003), 
and thorough critical appraisal of included studies and the systematic review itself 
(Song et al. 2010). 
   
Sterne et al. (2011b) advise that one way of avoiding bias in systematic reviews is 
through the inclusion of grey literature, such as unpublished trials, however caution 
that the inclusion of such data from unpublished studies can itself introduce bias. In 
general, more published literature is included in reviews than unpublished literature 
(Hopewell et al. 2007b). Sterne et al. (2011b) suggest that the reluctance to include 
grey literature in systematic reviews is due to the absence of peer-review of 
unpublished literature. In addition, reluctance may be due to the many other 
challenges inherent with obtaining and including such literature that typically exists in 
large volumes as this can significantly increase workloads and costs of funded reviews 
(Benzies et al. 2006). Nevertheless, Sterne et al. (2011b) suggest that opinions of 
systematic reviewers and editors appear to be changing as there seems to be an 
increased acceptance for the inclusion of grey literature. 
 
Hopewell et al. (2007b) conducted a review of five eligible studies that compared the 
effect of the inclusion and exclusion of grey literature on the findings of a cohort of 
meta-analyses of randomized trials. Data combined for three of the five studies in this 
review showed that published literature tended to be larger and showed overall larger 
treatment effects (9%) than those trials found in the grey literature (ratio of odds 
ratios 1.09; 95% (CI): 1.03-1.16). The definition of grey literature adopted for this study 
was based on each individual study’s definition and ‘The Luxembourg Convention’ 
definition which describes grey literature as that which is produced in print or 
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electronic formats by all ranks of governmental, academics, business and industry 
without the control of commercial publishers (Hopewell et al. 2007b). The types of 
grey literature found in this study were abstracts (55%), unpublished data (30%), book 
chapters (9%), unpublished reports, pharmaceutical company data, in press 
publications, letters and theses (Hopewell et al. 2007b). Furthermore, this study found 
insufficient evidence to suggest that there was a difference in the methodological 
quality of unpublished compared to published trials (Hopewell et al. 2007b). Overall 
there were more published trials included in the meta-analyses than grey trials 
(median 224 (IQR 108-365) versus 45 (IQR 40-102)) and published trials had larger 
sample sizes on average (Hopewell et al. 2007b). This study highlights factors that 
support the inclusion of grey literature in systematic reviews and opposes excluding 
unpublished literature as this may increase the risk of publication bias. 
 
Another strategy to reduce risk of bias in systematic reviews is the use of trial registries 
(Higgins & Green 2011). Liberati et al. (2009) recommend the publication of research 
study protocols in order to reduce the likelihood of biased post-hoc decisions in review 
methods, such as selective outcome reporting. The publication of research protocols 
restricts bias by explicitly detailing a priori hypotheses that will be tested and the 
methodological approaches that will be used, without prior knowledge of findings 
(Silagy et al. 2002). Despite the fact that subsequent changes to the protocol may 
improve the overall study, the researchers must clearly rationalise these decisions and 
document these reasons in the final review (Silagy et al. 2002) as this allows readers to 
independently assess possible bias. The ultimate aim of trial registries is to improve 
research transparency and to uphold the validity and strength of scientific evidence 
(World Health Organisation 2016). 
 
Song et al. (2010) describe two main issues of bias that can be introduced at the stage 
of literature searching namely, limited searching of the various research sources and 
low sensitivity within electronic search strategies. Decisions in conducting searches can 
introduce bias into the review and result in unintentional influences imposed by search 
limitations (Centre for Reviews and Dissemination 2008). For example, limiting the 
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search to electronic databases only which are comprised mainly of references to 
published journal articles, could result in the review being at risk of publication bias 
(Centre for Reviews and Dissemination 2008). Similarly, restricting searches in terms of 
language of publication can also introduce language bias (Centre for Reviews and 
Dissemination 2008). Although it is argued that systematic reviews of randomised 
controlled studies must search comprehensively in order to avoid publication biases 
(Higgins & Green 2011), the benefits of comprehensive searching for non-randomised 
controlled studies are unclear. Higgins & Green (2011) suggest that inclusion of 
difficult to find studies may introduce bias as the difficulty in finding these studies may 
reflect a poor design or a small sample size.  
 
To attempt to avoid bias in the literature, research tools and guidelines have been 
developed to aid researchers reporting and assessing the quality of both individual 
studies and systematic reviews. In relation to individual studies, the CONSORT 
statement (Moher et al. 2010) (see Appendix 3) and the STROBE statement (von Elm et 
al. 2014) (see Appendix 4) have been developed, the former more specifically for 
randomised controlled trials and the latter for observational studies in epidemiology. 
In relation to systematic reviews, the GRADE guidelines (Guyatt et al. 2008) (see 
Appendix 7), the AMSTAR tool (see Appendix 8) and the PRISMA statement (Liberati et 
al. 2009) (see Appendix 5) have been developed to improve the reporting of systematic 
reviews as well as to assess their quality. 
 
First published in 1996 and subsequently updated in 2001 and 2010, the CONSORT 
(Consolidated Standards of Reporting Trials) statement now comprises of a 25 item 
checklist and a flow diagram which together aim to improve the quality of reporting as 
well as the critical appraisal and interpretation of randomised controlled trials (see 
Appendix 3) (Moher et al. 2010). The CONSORT statement is essentially to support 
researchers in reporting randomised controlled trials (Moher et al. 2010). However, 
the implementation of the CONSORT checklist tool is encouraged as an aid for 
reviewers and editors to assess comprehensiveness of reporting and which may result 
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in improvements in the clarity and transparency of such published trials (Moher et al. 
2010).  
 
In relation to observational studies, the Strengthening the Reporting of Observational 
Studies in Epidemiology (STROBE) Initiative developed a 22 item inclusion checklist, the 
STROBE Statement, to promote accurate and complete reporting for three main study 
designs, cohort, case control, and cross-sectional studies (see Appendix 4) (von Elm et 
al. 2014). Eighteen items are common to all three study designs relating to the title, 
abstract, introduction, methods, results, and discussion sections of articles, and four 
are specific to either cohort studies, case control, or cross-sectional studies (von Elm et 
al. 2014). Like the CONSORT statement, The STROBE Statement was developed to 
assist reporting of observational studies, analysis of studies prior to publication, and 
critical appraisal of published articles (von Elm et al. 2014). von Elm et al. (2014) 
maintain that the STROBE checklist of items is not an attempt to apply a rigid format to 
study reporting, however insist that all relevant sections should be addressed in a 
transparent and sufficiently detailed manner. Although the STROBE Statement was not 
developed as a tool for assessing the quality of published observational research, von 
Elm et al. (2014) suggest that adopting this checklist may increase transparency of 
issues such as confounding, bias, and generalisability, and as such may reduce 
exaggerated reporting and improve the overall methodology and quality of studies. 
 
As mentioned, specific tools have been developed to support to the quality of 
reporting in systematic reviews and to aid the critical appraisal of these reviews. The 
GRADE approach, an acronym referring to the ‘Grades of Recommendation, 
Assessment, Development, and Evaluation’, offers a framework for rating the quality 
of evidence and grading strength of recommendations in systematic reviews that 
examine alternative management strategies or interventions (see Appendix 7) (Guyatt 
et al. 2011a). The GRADE system classifies quality of evidence in one of four levels, 
high, moderate, low, and very low, and divides recommendations into two grades of 
namely strong or weak (Guyatt et al. 2011b). In addition to acting as a rating system, 
the GRADE approach offers a transparent and structured process for creating and 
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presenting evidence summaries for systematic reviews and guidelines as well as for 
conducting the steps required in developing recommendations (Guyatt et al. 2011a). 
Subsequently, clear assessment of the quality of evidence produced by systematic 
reviews will aid reduction of risk of bias, risk of publication bias, imprecision, 
indirectness and inconsistency (Higgins & Green 2011). 
 
The AMSTAR, a measurement tool for the 'assessment of multiple systematic reviews' 
consists of an 11 item checklist to assess the methodological quality of systematic 
reviews (see Appendix 8) (Shea et al. 2007). Based on existing tools, the development 
of the AMSTAR tool sought to improve and updating existing instruments, and to 
provide a validated and useable model (Shea et al. 2009). Shea et al. (2009) propose 
that AMSTAR has good agreement, reliability, construct validity, and feasibility to 
assess the quality of systematic reviews. Although the AMSTAR is proposed mainly as a 
tool to assist review consumers to critically appraise systematic reviews, researchers 
may benefit from adopting this tool when conducting systematic reviews to improve 
the quality of reporting and the evidence produced. Existing criticisms of the AMSTAR 
checklist argue that some checklist items assess the quality of reporting more than the 
actual methodological quality of a systematic review, and that certain items are 
difficult to interpret (Faggion 2015).  
 
Due to advances and emerging issues in the field of research, the QUOROM (Quality of 
Reporting of Meta-Analysis) statement, a reporting guide which was originally 
developed in 1996 and published in 1999, was updated and expanded to form the 
PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 
(Liberati et al. 2009). The PRISMA Statement consists of a 27-item checklist and a four-
phase flow diagram that can also be used as a framework for reporting systematic 
reviews of all types of research, particularly evaluations of interventions (see 
Appendices 5 and 6) (Moher et al. 2009). The main aim of PRISMA is to promote the 
clarity and transparency of reporting of systematic reviews (Moher et al. 2007), and 
although PRISMA is not intended nor has it been advised to be used as a quality 
assessment tool (Liberati et al. 2009), inconsistencies in the reporting noted through 
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critical appraisal of systematic reviews using this tool may reveal methodological flaws 
(Moher et al. 2009) and, hence, indicate a risk of bias.  
 
In summary, the evidence presented suggests that adopting particular strategies, such 
as the inclusion of relevant grey literature, and employing suitable tools or checklists 
when conducting systematic reviews will improve both the reporting and the quality of 
a review and, in turn, minimise the risk of bias. Furthermore, knowledge and 
application of these various strategies and tools may assist the critical appraisal of 
systematic reviews. All of these methods are expected to minimise the risk of bias in 
the literature and ultimately produce higher quality evidence for use in practice.  
 
2.4. Ethical Issues 
Although formal ethical approval is not required to conduct a systematic review, the 
review author has a responsibility to conduct the review process and report the review 
findings in an ethical manner. In the field of healthcare, the reviewer must 
acknowledge the principles of medical ethics, namely autonomy, beneficence, non-
maleficence and justice (Beauchamp & Childress 2001), as well as ethical principles 
within the Nuremberg Code (1947) cited in (Shuster 1997), the Helsinki Declaration 
(1964) (World Medical Association General Assembly 2008), and current ethical 
guiding documents relevant to the topic of interest. In Ireland, nurses conducting any 
form of research must adhere to documents produced by the of the Nursing and 
Midwifery Board of Ireland namely, ‘The Code of Professional Conduct and Ethics for 
Registered Nurses and Registered Midwifes’ (Nursing and Midwifery Board of Ireland 
2014) and ‘Guidance to Nurses and Midwives Regarding Ethical Conduct of Nursing 
and Midwifery Research’ (Nursing and Midwifery Board of Ireland 2007). In conducting 
a systematic review, ethical assessment must be carried out adequately to ensure the 
ethical and methodological quality of the studies included, which will consequently 
represent the ethical quality of the systematic review itself (Vergnes et al. 2010). 
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2.5. Summary  
In summary, this chapter introduced the concept of health research and evidence-
based practice and set the context to explore the systematic reviewing process. The 
most significant challenges and issues in research and systematic reviews were 
examined which included an in-depth examination of the risks of bias within both 
individual studies as well as within systematic reviews.  
 
In the field of healthcare, the value of systematic reviews is increasingly apparent as 
strong demands remain on healthcare practitioners to base decision-making on the 
best available evidence and to continually review their practices in line with current 
and emerging research (Pearson et al. 2007). A well conducted systematic review can 
reduce bias, resolve conflicting reports, produce more in-depth understandings of 
topics, and identify insufficiency or sufficiency in available evidence (Evans 2000, Egger 
et al. 2003, Sambunjak & Franic 2012). Research informs nursing decisions, actions and 
interactions with patients (Doody & Doody 2011) , hence the value of the systematic 
review is clear. Furthermore, systematic reviews are fundamental to policy 
development, program planning, and creation of future research questions (Thomas et 
al. 2004). Systematic reviews are essentially research studies that employ precise, 
evidence-based, transparent and reproducible techniques, of which sets them apart 
from traditional narrative reviews. Although systematic reviews are important due to 
the immense volume of healthcare research, it is acknowledged that not all reviews 
are equally reliable (O'Mathuna 2010). In essence, a well conducted systematic review 
of high quality primary research evidence is both favourable to the reviewing author 
and beneficial to patient care (White & Schmidt 2005). In this regard, careful 
consideration and awareness of the risk of bias in research is essential in conducting 
any systematic review such as publication bias, outcome reporting bias, time lag bias, 
citation bias, language bias, multiple publication bias and location bias. In addition, an 
awareness of the risk of within study bias is also crucial, such as those particular to 
randomised controlled trials namely selection bias, performance bias, detection bias, 
attrition bias and reporting bias. The systematic review methodology can make explicit 
what other review methodologies fail to describe but as such does not guarantee 
validity (Magarey 2001). A well conducted systematic review in combination with the 
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reader’s ability to critically quality appraise offers a strong basis for the generation of 
new evidence, enhanced practice and improved patient care. 
 
2.6. Conclusion  
Systematic reviews are research studies that employ rigorous, evidence-based, 
transparent and reproducible methods making them very different from other forms 
of traditional reviews (Lang 2004). A well conducted systematic review can produce 
multiple outcomes and can reveal areas requiring further research (Egger et al. 2003, 
Sambunjak & Franic 2012). Acknowledging that all studies have flaws, due care must 
be taken in conducting any systematic review (National Health and Medical Research 
Council 2000) and the reviewer must be skilled in assessing the data as even flawed 
studies can produce important information (Hemingway & Brereton 2009). In 
conclusion, the rationale for the systematic review method is to improve the validity 
and reliability of research results (Victor 2008) and to overcome the influence of bias 
apparent in informal review techniques (White & Schmidt 2005). In this way, 
systematic reviews will support the creation of evidence required to enhance best 
evidence-based practice so as to better inform clinical decision-making and ultimately 
lead to improve clinical outcomes. 
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Chapter 3. Methods employed in this systematic review 
3.1. Introduction 
Two of the main characteristics of a systematic review are a clearly defined set of 
objectives with pre-established eligibility criteria for selection of research studies and a 
distinct, reproducible methodology (Green et al. 2011). As every step in the process of 
a systematic review must be transparent (Higgins & Green 2011), the aim of this 
chapter is to make explicit the methodology employed in this particular review by 
presenting the research question, identifying the objectives and outcome measures, 
describing the target population and interventions that were researched, and clearly 
outlining the eligibility criteria. The search strategy will also be described and the 
databases searched and search terms used, identified. A Gantt chart employed to 
manage the timeframe for this systematic review is presented in Appendix 9 to 
illustrate the start and finish dates of the main elements of this. Lastly, this chapter will 
report on how the data were collected and analysed. 
 
3.2. Questions 
For the purposes of this systematic review the questions under exploration are:  
1. What is the potential of measures of pH, temperature and exudate composition 
to predict of wound healing? 
2. What are the methods used to measure pH, exudate composition and 
temperature in wounds which offer the most benefit in clinical practice? 
 
3.3. Objectives 
3.3.1. Primary objectives 
1. To assess the clinical significance of the measurement of pH, exudate 
composition and temperature in terms of predicting healing outcomes in 
wounds.  
2. To explore the measurement of pH, exudate composition and temperature in 
wounds, so as to identify what methods of measurement are employed and to 
ascertain the validity of such measurement techniques or tools. 
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3.3.2. Secondary objectives 
In addition to the primary objectives, the secondary objective of this review is: 
 To develop recommendations for practice pertaining to the use of pH, exudate 
composition and temperature measurement in wounds to indicate healing 
outcomes. 
 
3.4. Outcome measures 
The primary outcomes of interest for this review are: 
 Objective measures of pH, exudate composition and temperature as predictors 
of wound healing outcomes  
 Objective measures of the current methods used for the measurement of: 
o Wound pH 
o Wound exudate composition 
o Wound temperature 
 
3.5. Criteria for selecting studies for this review 
3.5.1. Types of studies 
Randomised controlled trials and all types of quantitative primary research studies 
were considered for this review. No restriction was applied in terms of dates of 
publication. However, due to time and financial limitations, English-language only 
studies were included for review. The author acknowledges this as a limitation which 
must be recognised when appraising the review findings and the conclusions made. 
 
3.5.2. Types of participants 
Studies eligible for inclusion in this review were those involving all types of 
participants, people or patients of any age or in any setting, with an existing or an 
intentionally provoked wound defined as “a break in the epithelial integrity of the skin” 
(p.2) (Enoch & Price 2004). Research involving in vivo and human participants were 
included whereas in vitro and animal studies were excluded. The interest of this 
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systematic review related to wounds in living humans and thus provides the rationale 
for the exclusion of in vitro and animal studies.  
 
3.5.3. Types of interventions 
Studies describing the following interventions were eligible for inclusion in this review. 
 Exploration of the clinical significance of the measurement of pH, exudate 
composition or temperature to predict wound outcomes.  
 Examination of the validity and reliability of techniques or tools to measure 
exudate composition, pH or temperature in wounds. 
 Analysis of the feasibility of techniques or tools to measure exudate 
composition, pH or temperature in wounds. 
 
3.6. Search methods for identification of studies 
A scoping literature search was conducted to identify broad themes and patterns in 
relation to the specific subject of interest of this review. As recommended by Mead & 
Richards (1995), a search strategy was then formulated with the assistance of an 
experienced librarian. Between December 2015 and January 2016, the systematic 
literature search was conducted using the devised search terms that consisted of 
various formulations of the words: 
 Skin temperature, ulcer temperature, wound temperature, cutaneous 
temperature 
OR 
 Wound fluid, exudate, exudates and transudates 
OR 
 Hydrogen-ion concentration, pH 
AND 
 Leg ulcer, varicose ulcer, venous stasis ulcer, venous hypertension ulcer, stasis 
ulcer, ischaemic ulcer, ischemic ulcer, ischemic wound, ischaemic wound, 
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arterial insufficiency ulcer, arterial insufficiency wound, pressure ulcer, 
decubitus ulcer, bedsore, bed sore, pressure area, laceration wound, laceration 
injury, foot ulcer, plantar ulcer, diabetic feet, diabetic foot, feet ulcer, burn 
wound, burn injury, wounds and injuries, wound. 
 
Using these predetermined search terms, electronic searches were undertaken by 
inputting suitable combinations of the terms into the following online research 
databases available through the researcher’s college library: 
 MEDLINE PubMed; Full text coverage dates back to the year 1809. 
 OVID Embase; Full text coverage dates back to the year 1947. 
 EBSCO Cinahl; Full text coverage dates back to the year 1937. 
 The Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane 
Library); Available since January 2008. 
See Appendices 10 and 11 for examples of electronic searches conducted for the 
purpose of this review, namely in the databases PubMed and Cinahl, respectively. 
 
A search was also undertaken using the following clinical trial registries: 
 ClinicalTrials.gov; Available since February 2000 to present. 
 WHO International Clinical Trials Registry (ICTR); Latest version. 
 The EU Clinical Trials Register; Available since May 2004 to present. 
 The Cochrane Wounds Group Specialised Register; Latest version. 
 
Reference lists of all the included studies and other relevant publications, such as 
systematic reviews and guidelines, were examined to ensure completeness of the 
search strategy. Once all the search results were retrieved, the study titles and 
abstracts were scrutinised for potential relevance and then screened systematically 
using the pre-determined exclusion and inclusion criteria. As described by Magarey 
(2001), this produced an assortment of studies that were either definitely for inclusion, 
possibly for inclusion, and definitely for rejection. For studies that were definitely or 
possibly for inclusion, the full research articles were obtained and examined against 
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study eligibility criteria prior to deciding on the final group of articles for inclusion, as 
recommended by Higgins & Green (2011). In cases where studies were unavailable 
through the researcher’s library and other accessible sources, the study authors were 
contacted directly via email if possible or, where necessary, the articles were 
purchased. The search process was conducted by one other reviewer independently in 
order to increase the validity of the results (Torgerson 2003). Consensus was required 
between all reviewing authors regarding the final studies for inclusion prior to 
commencing data extraction. 
 
Finally, the search process was displayed using the PRISMA (Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses) flow diagram (Liberati et al. 2009) in order 
to increase the transparency of the search strategy. This is a visual framework that 
depicts the flow of information through the different phases of the systematic review 
by presenting the number of records identified, included and excluded, and the 
rationale for exclusions (Liberati et al. 2009). The search strategy for each subject of 
measurement namely pH, exudate composition and temperature, are presented 
individually using this concise graphical framework as detailed in Appendix 12 to 15. 
 
3.7. Data extraction, analysis and synthesis 
Following the screening and selection of all the studies suitable for inclusion in the 
review, data extraction was conducted. For the purpose of this systematic review, data 
were extracted using a data extraction table adapted from the Cochrane Handbook 
(Higgins & Green 2011) (see Appendix 16).  
In relation to this review, the following specific information was extracted: 
 Author, date of study, title 
 Source or journal title  
 Study methodology and design  
 Study objectives 
 Geographical location  
 Study settings 
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 Exclusion and inclusion criteria  
 Sample characteristics and size  
 Study procedure 
 Measurement equipment & other materials  
 Data analysis  
 Results  
 Conclusions 
 
Once the data were extracted, quality appraisal of the included studies was conducted 
using the Evidence Based Literature (EBL) Critical Appraisal Checklist devised by Glynn 
(2006) (see Appendix 17). Employing this checklist, each study was appraised under 
the following domains: 
 Population 
 Data Collection 
 Study design 
 Results 
 
Each domain of the Evidence Based Literature (EBL) Critical Appraisal Checklist by 
Glynn (2006) has a number of subcategories, and each is assessed using a yes, no, 
unclear, or a not applicable rating. Calculation for each section’s quality is as follows: 
Yes + No + Unclear= Total (Y+N+U=T). In cases where Yes/Total (Y/T) <75% or No + 
Unclear/Total (N+U/T) > 25% then one could conclude that the section identified 
significant omissions and that the quality of the study was questionable. As it is 
important to examine the overall quality as well as the individual section quality, the 
calculation for the total validity was as follows: (Y+N+U=T). In cases where Yes/Total 
(Y/T) ≥75% or No + Unclear/Total (N+U/T) ≤ 25% then one could confidently conclude 
that the study was of sound quality. 
 
Given that the search strategy did not yield any eligible randomised controlled trials 
for inclusion in this systematic review, data synthesis was performed by means of a 
structured narrative summary of each of the included studies arranged by concept, pH, 
exudate composition and temperature. Using data tables, the measurement 
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techniques and statistical analysis of each study were outlined. With reference to the 
outcomes of interest for this review, data tables were used to delineate the pertinent 
results of each study, which were followed by narrative descriptions to explore the 
results and develop conclusions. 
 
3.8. Summary  
The purpose of this systematic review was to develop an in-depth knowledge of pH, 
exudate composition and temperature in wound healing, as well as the tools and 
techniques use in their measurement. This review aimed to assess the clinical 
significance of the measurement of pH, exudate composition and temperature in 
wounds to indicate wound healing outcomes, to determine the relative significance of 
the measurement of one biomarker over another, to explore the measurement 
methods used and to develop recommendations for clinical practice and further 
research. 
 
The search strategy was conducted through the researcher’s college library using the 
electronic databases, The Cochrane Wounds Group Specialised Register, The Cochrane 
Central Register of Controlled Trials (CENTRAL), MEDLINE Pubmed, OVID Embase, and 
EBSCO Cinahl. A search of clinical trial registries was also undertaken using 
ClinicalTrials.gov, WHO International Clinical Trials Registry (ICTR), and The EU Clinical 
Trials Register. In addition, the reference lists of the studies selected for inclusion in 
the review as well as other relevant publications, such as previous systematic reviews 
and current guidelines, were checked for other potentially relevant literature so as to 
ensure comprehensiveness of the original search. 
 
All quantitative original human research studies published in the English-language only 
were considered for inclusion and analysis in this review. Once the final studies for 
inclusion in this review were agreed upon, data were extracted from each of the 
studies using a data extraction table adapted from the Cochrane Handbook (Higgins & 
Green 2011). A quality appraisal checklist, the EBL Critical Appraisal Checklist (Glynn 
2006), was employed to assist the quality appraisal of the included studies. With the 
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aid of concise data extraction tables, data synthesis and data analysis was presented 
by means of structured narrative summaries with respect to the outcomes of interest 
of this systematic review. 
 
3.9. Conclusion 
The main objective of this systematic review was to develop a greater understanding 
of the clinical significance of the measurement of pH, exudate composition and 
temperature in wound healing. To achieve this objective, a search strategy was created 
and executed to retrieve all the applicable original quantitative research papers which 
were then data extracted, quality appraised and analysed to produce an amalgamation 
of findings so as to facilitate the exploration of the significance these findings in 
wounds. 
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Chapter 4. Results 
4.1. Introduction 
In this chapter, the findings of this systematic review will be described in detail 
arranged in order of the studies’ topic of interest, pH, exudate composition and 
temperature. With the aid of search strategy flowcharts, the results of each of the 
search strategies will be described individually in terms of the quantities of articles 
initially retrieved and then successively excluded or included. A brief rationale will be 
provided for the research papers excluded from this review. The studies chosen for 
inclusion will be collectively described by topic in terms of study designs, geographical 
location, study settings, populations, sample size and interventions, followed by an 
individual summary of the methods of each study. The studies will then be quality 
appraised with the aid of the EBL Critical Appraisal Checklist devised by Glynn (2006) 
(see Appendix 8) and the studies designs will be displayed on an adapted research 
design pyramid that represents a relative hierarchy system of stronger and weaker 
evidence. Lastly, a summary of the results will be constructed taking into account the 
outcome measures of interest for this systematic review. 
 
4.2. Search Strategy: Results  
As detailed in chapter 3, a search strategy was performed to explore the measurement 
of pH, exudate composition and temperature in wounds. In this section, the literature 
retrieved from this search will be described individually in order of subject, namely, 
pH, exudate composition and temperature, with the aid of flow charts to outline the 
quantities of articles at the progressing stages of the search strategy and data tables to 
display the titles of the articles included as well as those excluded in the review, with 
the rationale for exclusion, following reading the full-text papers.  
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4.2.1. pH 
Following the search strategy conducted to retrieve studies involving pH measurement 
in wounds, a total of 4707 records were obtained (see Figure 2 and Appendix 12). 
Duplicate research works were removed to leave 4402 articles. Eligibility screening by 
means of a thorough review of the titles and, where further confirmation of eligibility 
was required, a review of the abstracts, reduced the number of remaining studies to 6 
articles. Following in-depth reading and examination of the full-text versions of these 6 
articles, 3 articles were considered suitable for inclusion and 3 were excluded on the 
basis of not meeting eligibility criteria.  
 
128 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. pH search strategy using the PRISMA 2009 Flow Diagram 
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4.2.1.1. Included Studies for pH  
Of the 6 full-text articles assessed for eligibility, 3 primary research articles meeting the 
inclusion criteria, were selected for this review (see Table 1). 
 
Table 1. Included studies for pH 
Author(s) (Publication Year) Study Title 
Gethin G. T., Cowman S. & Conroy R. M. 
(2008) 
The impact of Manuka honey dressings on 
the surface pH of chronic wounds 
Ono S., Imai R., Ida Y., Shibata D., 
Komiya T. & Matsumura H. (2015)  
Increased wound pH as an indicator of local 
wound infection in second degree burns. 
Shukla V. K., Shukla D., Tiwary S. K., 
Agrawal S. & Rastogi A. (2007)  
Evaluation of pH measurement as a method 
of wound assessment 
 
4.2.1.2 Excluded Studies for pH 
Three papers were excluded on the grounds of failure to meet eligibility criteria. 
Reasons of exclusion comprised of papers being unavailable through accessible 
libraries or to purchase (Sharpe et al. 2013), or papers examining the effects of 
applying topical treatments with particular levels of pH on wound outcomes but failing 
to address primary the primary objectives and outcome measures of this review by 
failing to measure the pH levels of the actual wounds (Leveen et al. 1973, Wilson et al. 
1979). Table 2 presents the author(s), year and study titles of each of the excluded 
research papers along with the rationales for exclusion.  
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Table 2. Excluded studies for pH 
Author(s) (Publication Year) Reason for Study Exclusion 
Leveen H. H., Falk G., Borek B., Diaz C., 
Lynfield Y., Wynkoop B. J., Mabunda G. 
A., Rubricius J. L. & Christoudias G. C. 
(1973) 
This study does not report the pH 
measurements of wounds in relation to 
wound outcomes. 
Sharpe J. R., Booth S., Jubin K., Jordan N. 
R., Lawrence-Watt D. J. & Dheansa B. S. 
(2013)  
This article is both unavailable both through 
the college library and to purchase, and 
therefore is excluded from the review. 
Wilson IA, Henry M, Quill RD, Byrne PJ 
(1979)  
This study does not measure the pH of the 
wound in relation to wound outcomes. 
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4.2.2 Exudate Composition 
The search strategy conducted to retrieve studies involving exudate composition 
measurement in wounds yielded an initial 5657 records, which was subsequently 
reduced to 3911 once duplicate articles were removed (see Figure 3 and Appendix 13). 
Of the 3911 articles screened for eligibility by means of a thorough review of the titles 
and, where further confirmation of eligibility required, review of the abstracts, 3890 
were excluded and 21 that met the criteria and were of potential relevance to the 
outcomes of interest of this review. Following in-depth reading and examination of the 
full-text versions of these 21 articles, 12 were deemed suitable for inclusion in this 
systematic review and 9 were excluded on the grounds of not meeting the eligibility 
criteria. 
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Figure 3. Exudate composition search strategy using the PRISMA 2009 Flow Diagram 
 
Sc
re
en
in
g 
Id
en
ti
fi
ca
ti
o
n
 
Records 
excluded 
(n = 3890) 
Full-text articles 
excluded, with 
reasons 
(n = 9) 
Full-text articles assessed 
for eligibility 
(n = 21) 
Records identified through 
database searching 
(n = 5657) 
Additional records identified 
through other sources 
(n = 0) 
Records after duplicates removed 
(n = 3911) 
Records screened  
(n = 3911) 
El
ig
ib
ili
ty
 
Studies included in 
qualitative synthesis 
(n = 0) 
In
cl
u
d
ed
 
Studies included in 
quantitative synthesis     
(n = 12) 
 
133 
 
4.2.2.1. Included Studies for Exudate Composition 
Of the 21 full-text articles assessed for eligibility, 12 primary research articles were 
selected for inclusion in this review (see Table 3). 
 
Table 3. Included studies for exudate composition 
Author(s) (Publication Year) Study Title 
Bernatchez S. F., Menon V., Stoffel J., 
Walters S.-A. H., Lindroos W. E., 
Crossland M. C., Shawler L. G., 
Crossland S. P. & Boykin J. V. (2013) 
Nitric oxide levels in wound fluid may reflect 
the healing trajectory 
Edsberg L. E., Wyffels J. T., Brogan M. S. 
& Fries K. M. (2012)  
Analysis of the proteomic profile of chronic 
pressure ulcers  
Hoffman R., Noble J. & Eagle M. (1999) The use of proteases as prognostic markers 
for the healing of venous leg ulcers 
James T. J., Hughes M. A., Cherry G. W. 
& Taylor R. P. (2000)  
Simple biochemical markers to assess 
chronic wounds 
Ladwig G. P., Robson M. C., Liu R., Kuhn 
M. A., Muir D. F. & Schultz G. S. (2002)  
 
Ratios of activated matrix 
metalloproteinase-9 to tissue inhibitor of 
matrix metalloproteinase-1 in wound fluids 
are inversely correlated with healing of 
pressure ulcers 
Liu Y., Min D., Bolton T., Nubé V., Twigg 
S. M., Yue D. K. & McLennan S. V. (2009) 
Increased matrix metalloproteinase-9 
predicts poor wound healing in diabetic foot 
ulcers 
Muller M., Trocme C., Lardy B., Morel F., 
Halimi S. & Benhamou P. Y. (2008)  
 
Matrix metalloproteinases and diabetic foot 
ulcers: the ratio of MMP-1 to TIMP-1 is a 
predictor of wound healing 
Tarlton, J. F., Vickery, C. J., Leaper, D. J. 
& Bailey, A. J. (1997) 
Postsurgical wound progression monitored 
by temporal changes in the expression of 
matrix metalloproteinase-9  
Tarlton J. F., Bailey A. J., Crawford E., 
Jones D., Moore K. & Harding K. D. 
(1999)  
Prognostic value of markers of collagen 
remodeling in venous ulcers 
Trengove N. J., Langton S. R. & Stacey M. 
C. (1996)  
Biochemical analysis of wound fluid from 
nonhealing and healing chronic leg ulcers 
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Trengove N. J., Stacey M. C., MacAuley 
S., Bennett N., Gibson J., Burslem F., 
Murphy G. & Schultz G. (1999)  
Analysis of the acute and chronic wound 
environments: the role of proteases and 
their inhibitors 
Wyffels J. T., Fries K. M., Randall J. S., Ha 
D. S., Lodwig C. A., Brogan M. S., Shero 
M. & Edsberg L. E. (2010)  
Analysis of pressure ulcer wound fluid using 
two-dimensional electrophoresis 
 
4.2.2.2. Excluded Studies for Exudate Composition 
Following a thorough examination of the full-text of the 21 remaining articles, 9 
primary research articles were excluded on the grounds of failure to meet eligibility 
criteria. Author(s), year and study titles of each of the excluded research papers along 
with the rationale for exclusion are presented in Table 4. One study was excluded as it 
was unavailable both through accessible libraries and to purchase (Jaynes et al. 2003), 
another study measured the quantity as opposed to the composition of wound 
exudate (Dealey et al. 2006), other studies examined the composition of wound 
exudate but did not analyse these measurements in respect of wound outcomes 
(Prager et al. 1994, Schmidtchen 1999, Jones et al. 2001, Ambrosch et al. 2008, Moor 
et al. 2009, Iizaka et al. 2010a, Iizaka et al. 2010b, Schmohl et al. 2012), and other 
studies explored methodologies for the measurement wound exudate composition but 
did not report examining the reliability and validity of the methodologies nor 
addressed the primary objectives and outcome measures of this review by reporting 
the measurements of wound exudate composition obtained in relation to wound 
outcomes (Schmidtchen 1999, Schmohl et al. 2012). 
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Table 4. Excluded studies for exudate composition 
Author(s) (Publication Year) Reason for Study Exclusion 
Ambrosch A., Lobmann R., Pott A. & 
Preissler J. (2008) 
This pilot study examines the significance, 
specificity and sensitivity, of levels of 
interleukin-6 (IL-6) and tumour necrosis 
factor alpha (TNFα) in wound washout 
fluids for indicating bacterial bioburden, 
specific pathogens and polymicrobial 
infections associated with ulcer 
inflammation, and compares local cytokine 
analyses to serological parameters typically 
used to confirm suspected chronic wound 
infections, however, does not evaluate 
these measurements in relation to wound 
healing. 
Dealey C., Cameron J. & Arrowsmith M. 
(2006) 
This study measures exudate in relation to 
quantity and not exudate composition. 
Iizaka S., Sanada H., Minematsu T., Oba 
M., Nakagami G., Koyanagi H., Nagase 
T., Konya C. & Sugama J. (2010)  
This study examines nutritional components 
albumin, total protein, glucose, and zinc in 
wound fluid as potential biomarkers of 
pressure ulcer status but does not examine 
these biomarkers as indicators of wound 
healing. This study does not test the 
reliability and validity of the methods used 
to measure wound exudate components. 
Iizaka S., Sanada H., Nakagami G., 
Sekine R., Koyanagi H., Konya C. & 
Sugama J. (2010)  
This study quantifies the protein loss owing 
to pressure ulcers and correlates protein loss 
with wound severity, however it does not 
examine protein as an indicator of wound 
healing nor does it examine the validity and 
reliability of the methods of exudate 
component measurement. 
Jaynes C. D., Fries K., Brogan M., Karch 
J. E., Baird K. & Edsberg L. E. (2003)  
This article is both unavailable both through 
the college library and to purchase, and 
therefore is excluded from the review. 
Jones P. W., Taylor D. M., Williams D. R., 
Finney M., Iorwerth A., Webster D. & 
Harding K. G. (2001)  
This study does not examine the clinical 
significance of the measurement wound 
exudate composition as an indicator of 
wound condition or to predict wound 
outcomes. 
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Moor A. N., Vachon D. J. & Gould L. J. 
(2009)  
This study does not examine the 
measurement of exudate composition to 
predict wound outcomes. 
Prager M. D., Baxter C. R. & Hartline B. 
(1994)  
This study does not examine the 
measurement of exudate composition in 
relation to predicting wound outcomes. 
Schmidtchen A. (1999)  The main aim of this study was to develop a 
methodology for the study of the major 
plasma-derived proteins of wound fluid but 
it did not examine the reliability and validity 
of the methodologies described. This study 
did not examine the composition of exudate 
in relation to aspects of wound healing. 
Schmohl M., Beckert S., Joos T. O., 
Königsrainer A., Schneiderhan-Marra N. 
& Löffler M. W. (2012)  
This study examines the technique of 
superficial wound swabbing for harvesting 
wound fluid and the quality of the collected 
fluid for immunoassay analysis of 
inflammatory mediators, however it does 
not test the reliability and validity of the 
wound swabbing sampling methods. 
137 
 
4.2.3. Temperature 
The search strategy conducted to retrieve studies involving temperature measurement 
in wounds yielded an initial 2450 records, of which was reduced to 2054 when 
duplicate articles were removed (see Figure 4 and Appendix 14). Of the 2054 articles 
screened for eligibility by a thorough review of the titles and, where required further 
confirmation of eligibility, review of the abstracts, 2033 were excluded and 21 that met 
the criteria and were of relevance to the outcomes of interest of this review were 
included. Following in-depth reading and examination of the full-text versions of these 
articles, 8 were deemed suitable for inclusion in this systematic review and 13 were 
excluded on the grounds of not meeting the eligibility criteria. 
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Figure 4. Temperature search strategy using the PRISMA 2009 Flow Diagram 
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4.2.3.1. Included Studies 
Of the 21 full-text articles assessed for eligibility, 9 primary research articles were 
selected for inclusion in this review involving data extraction, data analysis and quality 
appraisal (see Table 5). 
 
Table 5. Included studies for temperature 
Author(s) (Publication Year) Study Title 
Armstrong D. G. & Lavery L. A. (1996) Monitoring neuropathic ulcer healing with 
infrared dermal thermometry 
Armstrong D. G., Lipsky B. A., Polis A. B. 
& Abramson M. A. (2006) 
Does dermal thermometry predict clinical 
outcome in diabetic foot infection? Analysis 
of data from the SIDESTEP* trial 
Dini V., Salvo P., Janowska A., Di 
Francesco F., Barbini A. & Romanelli M. 
(2015) 
Correlation between wound temperature 
obtained with an infrared camera and 
clinical wound bed score in venous leg ulcers 
Horzic M., Bunoza D. & Maric K. (1996)  Contact thermography in a study of primary 
healing of surgical wounds 
Horzic M., Bunoza D. & Maric K. (1996)  Three-dimensional observation of wound 
temperature in primary healing 
Nakagami G., Sanada H., Iizaka S., 
Kadono T., Koyanagi H. & Haga N. (2010)  
Predicting delayed pressure ulcer healing 
using thermography: a prospective cohort 
study 
Robicsek F., Masters T. N. & Daugherty 
H. K. (1984)  
The value of thermography in the early 
diagnosis of postoperative sternal wound 
infections 
Siah C. J. R. & Childs C. (2015)  Thermographic mapping of the abdomen in 
healthy subjects and patients after 
enterostoma 
 
4.2.3.2. Excluded Studies  
Following a thorough examination of the full-text of the 21 remaining articles, 12 
primary research articles were excluded on the grounds of failure to meet eligibility 
criteria. Author(s), year and study titles of each of the excluded research papers along 
with the rationale for exclusion are presented in Table 6. All studies that did not 
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address primary outcome measures and objectives were excluded however some of 
the studies remaining at this point were found to address neither the primary or 
secondary objectives and outcome measures (Armstrong 1998, Zhu & Xin 1999, 
Fierheller & Sibbald 2010, Severens et al. 2010, Oe et al. 2013, Lee & Lu 2014). Some 
studies that appeared to address the primary outcomes and objectives of this review 
were excluded due to a failure to report the relevant data (Armstrong et al. 1997, 
Foltynski et al. 2011). Although some studies analysed the validity and/or reliability of 
temperature measurement techniques, the research methods were performed on 
non-wounded as opposed to wounded subjects (Zhu & Xin 1999, Fierheller & Sibbald 
2010). Similarly, studies were excluded that examined surface temperature 
measurements but failed to adequately report the presence of active or open wounds 
(Nishide et al. 2009, Foltynski et al. 2011, van Netten et al. 2014). On the same note, 
one study that included subjects with as well as without open wounds failed to report 
separate temperature measurement results for the two subject types and therefore 
was excluded on these grounds (Nakagami et al. 2011). Although some of the studies 
examined the reliability and/or validity of temperature measurements methods in 
wounds, a failure to address the primary outcome of this review by not relating the 
clinical significance of temperature measurement to wound outcomes resulted in the 
studies being excluded (Andersen & Karlsmark 2008, Mufti et al. 2015). 
 
Table 6. Excluded studies for temperature 
Author(s) (Publication Year) Reason for Study Exclusion  
Andersen E. S. & Karlsmark T. (2008)  This study does not examine both reliability 
and validity of the temperature 
measurement tool employed nor does it 
examine feasibility of the tool. 
Armstrong D. G. (1998)  This study does not explore the clinical 
significance of temperature measurement in 
relation to wound outcomes nor does it 
assess the validity and reliability of the 
temperature measurement technique. 
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Armstrong D. G., Lavery L. A., Liswood P. 
J., Todd W. F. & Tredwell J. A. (1997)  
This study does not assess the reliability of 
the implemented temperature 
measurement device. Temperatures of feet 
affected with diabetic neuropathic ulcers 
were measured and compared to their 
contralateral limb sites over a period of time 
encompassing wound healing, however, no 
data regarding these temperature 
measurements during the course of ulcer 
healing were reported. 
Fierheller M. & Sibbald R. G. (2010)  
 
This study only tests the validity and 
reliability of the measurement tool, an 
infrared thermometer, on non-wounded 
patients (intact skin).  
This study also examines the use of infrared 
thermometer readings to identify the 
presence of wound infection at one point in 
time, however the clinical significance of 
these results are not explored over time so 
as to identify their value in predicting wound 
outcomes. 
Foltynski P., Tarwacka J., Ladyzynski P., 
Wojcicki J. M., Brandl M., Grabner J., 
Rosinski G., Mlynarczuk M., Krzymien J., 
Falkenhagen D. & Karnafel, W. (2011) 
This study monitors the foot temperatures 
of diabetic patients and compares them to 
healthy subjects, however it does not report 
the presence of any wounds. 
Lee S. L. & Lu Y. H. (2014) This study focuses on a three-dimensional 
bioheat equation to simulate the method of 
active dynamic thermography for grade 
assessment of skin burn wounds. No direct 
measurement of skin surface temperature 
or wound temperature is completed or 
reported. 
Nakagami  G., Sanada, H., Higashino, T., 
Kadono, T., Uchida, G., Fujita, H., 
Ogawa, Y., Yamamoto, Y., Iizaka, S., 
Koyanagi, H., Sasaki, S. & Haga, N. 
(2011)  
This study includes both Stage 1 and Stage 2 
pressure sores however does not report the 
results separately for the two different 
stages. As a Stage 1 pressure sore does not 
involve a break in the skin integrity the 
results reported are not exclusive to 
wounds. 
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Nishide K., Nagase T., Oba M., Oe M., 
Ohashi Y., Iizaka S., Nakagami G., 
Kadowaki T. & Sanada H. (2009)  
This study examines patients with 
asymptomatic foot callus and excludes those 
with visible inflammation, pain around the 
calli, foot ulcers, autoimmune diseases or 
other acute inflammatory diseases and, 
therefore, the study sample does not include 
patients with wounds. 
Mufti A., Coutts P. & Sibbald R. G. (2015)  This study compares the reliability of 
commercially available less expensive infrared 
thermometers to a scientifically accepted more 
expensive infrared thermometer, however, 
does not address the primary outcome of this 
review as it does not explore the clinical 
significance of temperature measurement in 
relation to predicting wound outcomes. 
Oe M., Yotsu R. R., Sanada H., Nagase T. 
& Tamaki, T. (2013) 
This study focuses on the use of 
thermography to detect of osteomyelitis and 
does not examine temperature as an indicator 
of wound condition. 
Severens N. M. W., Van Marken 
Lichtenbelt W. D., Frijns A. J. H., Van Ooij 
A., Marcus M. A. E., De Mol B. A. J. M. & 
Van Steenhoven A. A. (2010)  
This study examines a model to predict 
patient temperatures and surgical wound 
heat loss during orthopaedic back surgery. 
No comparison is made with actual wound 
condition. 
van Netten J. J., Prijs M., van Baal J. G., 
Liu C., van der Heijden F. & Bus S. A. 
(2014) 
This study reports on temperatures in 
relation to the presence or absence of 
diabetes-related foot complication but does 
not detail specifically the presence or 
absence of a wound/ ulcer. 
Zhu W. P. & Xin X. R. (1999) The first part of this study does not measure 
temperature of wounds (skin only) and, 
although the second part measures burn 
wound temperature, it does not explore the 
clinical significance of this measurement in 
relation to predicting wound outcomes. 
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4.3. Description of Studies  
For the final papers chosen for inclusion in this review, a description of the studies’ 
designs, geographical locations, settings, populations and sample sizes will be 
collectively presented in relation to subject, pH, exudate composition and 
temperature, followed by a narrative summary of each individual study. With the aid 
of a data table (see Table 7), details will be presented of the techniques of pH 
measurement and the statistical analyses as reported in each of the studies.  
 
4.3.1. pH 
4.3.1.1. Publication Year 
The publication of the chosen articles span a period eight year dating from the years 
2007 (Shukla et al. 2007), 2008 (Gethin et al. 2008) and 2015 (Ono et al. 2015). 
 
4.3.1.2. Study Design  
All three studies employed a quantitative methodology, two of which are prospective 
observational cohort study designs (Shukla et al. 2007, Ono et al. 2015) and the 
remaining one is a prospective, single arm pre-post-test study design (Gethin et al. 
2008). 
 
4.3.1.3. Geographical Location  
A wide geographical spread is noted across the studies as one study was conducted in 
Ireland (Gethin et al. 2008), one in Japan (Ono et al. 2015) and one in India (Shukla et 
al. 2007). 
 
4.3.1.4. Study Settings  
The settings from which participants were recruited comprised of both inpatient and 
outpatient settings. Gethin et al. (2008) recruited a sample of patients from both a 
specialist wound clinic as well as inpatients from community hospitals, whilst both Ono 
et al. (2015) and Shukla et al. (2007) recruited patients from clinics of university 
hospitals. 
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4.3.1.5. Populations  
Participants included were all human subjects, males and females, paediatrics and 
adults, (ranging in age from 7 to 74 years, where reported) with wounds that varied in 
aetiology across the three research studies. Gethin et al. (2008) examined leg ulcers of 
various aetiologies, Ono et al. (2015) examined burn wounds of less than 2% total body 
surface area (TBSA) and Shukla et al. (2007) examined both acute and chronic wounds 
from a broad array of aetiologies. Each study described the population demographics 
in further detail, which are presented in Appendix 18. 
 
4.3.1.6. Sample Size  
The total participants for all three studies was 93 (mean 31; SD 17). Gethin et al. (2008) 
measured wound pH in 20 wounds (3 patients with two wounds each and the 
remainder with only one wound each) from 17 subjects, Ono et al. (2015) examined 26 
patients with burn wound sizes of less than 2% TBSA however did not report the 
number of wounds per patient, and Shukla et al. (2007) examined one wound from 
each of 50 patients. 
 
4.3.1.7. Description of pH Studies’ and Methods 
4.3.1.6.1. Gethin et al. (2008) The impact of Manuka honey dressings on the surface pH of 
chronic wounds 
In Ireland, Gethin et al. (2008) conducted an open label, non-randomised single arm 
pre-test, post-test study to analyse the effect of a 2 week intervention involving a 
topical wound treatment of Apinate (Comvita) on the changes in surface pH and 
wound size reduction of non-healing ulcers. Apinate is a Manuka honey dressing that is 
blended with calcium alginate fibres (Gethin et al. 2008). Following screening for 
eligibility, Gethin et al. (2008) recruited 17 consecutive patients who were attending a 
specialist wound clinic and inpatients in community hospitals providing a total wound 
sample of 20 non-healing ulcers (10 venous, 7 mixed aetiology, 2 arterial, 1 pressure 
aetiology; 10 of which had slough of ≥20% of wound area).  
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Dressing changes, performed once or twice weekly depending on clinical need, 
involved applying the Manuka honey dressing directly onto the wound bed along with 
secondary dressings limited to either a hydrofiber, Aquacel (Convatec, Uxbridge, UK), 
and/or a hydrocellular, Allevyn hydrocellular (Smith & Nephew), with compression 
therapy continued where appropriate and as tolerated (Gethin et al. 2008). At each 
stage of the study, wounds were photographed using a digital still camera (Sony 
Mavica mvc-FD-90 digital still camera; Sony, Tokyo, Japan) and wound size was 
determined using digital planimetry (Visitrak; Smith & Nephew) (Gethin et al. 2008). 
 
4.3.1.6.2. Ono et al. (2015) Increased wound pH as an indicator of local wound infection 
in second degree burns 
From September 2013 to February 2014, Ono et al. (2015) recruited 26 burns patients 
(mean age 46 years) from a hospital outpatient clinic to participate in a prospective 
study to document the temporal changes in pH levels of wound exudate. All included 
patients had second degree burns of less than 2% total body surface area (TBSA) and 
preserved blister films, however, eligibility criteria excluded patients who were under 
the age of 12 years or patients with wounds that were infected at the time of the initial 
assessment (Ono et al. 2015). 
 
4.3.1.6.3. Shukla et al. (2007) Evaluation of pH measurement as a method of wound 
assessment 
To examine variations in wound pH levels and to explore the relationship between 
wound pH and wound healing as measured using litmus paper strips, Shukla et al. 
(2007) recruited fifty patients (mean age of 48 years; range 7-74 years) from a wound 
clinic at a university hospital, each of whom had one acute (n=26, 52%) or one chronic 
wound (n=24, 48%). Wounds were of various aetiology, ranging in size from less than 
4cm2 (n=15, 30%), 4 to 10 cm2 (n=25, 50%), or greater than 10 cm2 (n=10, 20%), and 
had been treated previously with an array of topical agents such as neomycin, 
povidone-iodine, mupirocin, silver sulphadiazine and herbal preparations (Shukla et al. 
2007). Sharp debridement of the wound was performed during the initial visit only 
(Shukla et al. 2007). Wounds were irrigated with normal saline and redressed with 
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saline-impregnated gauze on a daily basis for the remainder of the study (Shukla et al. 
2007). Furthermore, wound exudate was collected on a weekly basis for culture and 
sensitivity (Shukla et al. 2007).  
 
For data analysis purposes, wounds were categorised based on certain characteristics, 
in which acute wounds with slough, pus, or copious discharge present were labelled as 
‘unhealthy’, chronic wounds with slough present were labelled as ‘unhealthy’, and any 
wound type with pink granulation tissue was labelled as ‘granulating’ and with sloping 
edges showing epithelial ingrowth was labelled as ‘healing’ (Shukla et al. 2007).
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Table 7. Summary of pH measurement methods 
Gethin et al. (2008) 
Measurement Technique  Distilled water was dropped onto the top of the glass top electrode (calibrated in pH 4 and 7 solutions prior to 
each clinical assessment), the probe pressed gently onto the wound following dressing removal and prior to 
wound cleansing, and single readings were recorded.  
Statistical Methods  A priori calculation using the resource equation determined the sample size.  
 All data were analysed using Stata release 9.2 with the unit of analysis being wound numbers.  
 Paired samples t-test and linear regression were used for statistical analysis. 
Ono et al. (2015) 
Measurement Technique   During the initial visit, the pH of the blister fluid was measured using pH indicator strips, MColorpHast™ (Merck 
KGaA, Darmstadt, Germany), that could be measured to one decimal point accuracy.  
 After initial measurement, the blister film was taken away, the wound rinsed with saline solution (pH 4.5–8.5), 
and a transparent hydrogel dressing, Viewgel1 (Taiho Pharmaceutical Co., Ltd., Japan) (pH 4.0–7.0), composed 
of polyethylene liner and hydrogel absorbent applied.  
 At each dressing change, the exudate accumulated under the dressing was measured using pH indicator strips, 
the wound was rinsed with saline solution and the hydrogel dressing was reapplied.  
 Wound swabs were obtained at least once weekly.  
Statistical Methods  Statistical analysis was performed using the Student t-test.  
 A p-value <0.05 was considered to indicate a statistically significant difference. 
Shukla et al. (2007) 
Measurement Technique  Each wound was cleansed with normal saline, a litmus paper strip is applied onto the wound bed for five 
seconds, removed and, following 30 seconds, compared to the colour code. 
Statistical Methods  Paired samples t-tests were used to analyse differences in wound condition, discharge and pH between days 1 
and 7, and days 7 and 15.  
 Observations were analysed using the Student’s t-test.  
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4.3.2. Exudate Composition 
4.3.2.1. Publication Year 
Dating from the year 1996 to 2013, the publication of the chosen articles extends over 
a seventeen year period, with half of the articles (n=6) published from the year 1996 to 
2000 (Trengove et al. 1996, Tarlton et al. 1997, Hoffman et al. 1999, Tarlton et al. 
1999, Trengove et al. 1999, James et al. 2000) and the other half (n=6) published from 
the year 2000 to 2013 (Ladwig et al. 2002, Muller et al. 2008, Liu et al. 2009, Wyffels et 
al. 2010, Edsberg et al. 2012, Bernatchez et al. 2013).  
 
4.3.2.2. Study Design  
Twelve eligible quantitative studies were included, most of which were prospective, 
descriptive, observational, cohort design (Trengove et al. 1996, Tarlton et al. 1997, 
Hoffman et al. 1999, Tarlton et al. 1999, Trengove et al. 1999, James et al. 2000, 
Ladwig et al. 2002, Muller et al. 2008, Liu et al. 2009, Wyffels et al. 2010, Edsberg et al. 
2012, Bernatchez et al. 2013), with two of these conducted as pilot studies (Hoffman 
et al. 1999, Muller et al. 2008). In addition, one article was a retrospective, 
multicentre, descriptive cohort pilot study (Bernatchez et al. 2013). 
 
4.3.2.3. Geographical Location 
All of the research papers originate from developed countries, with the majority of 
studies, 75%, emanating from either the United States of America (5 studies) 
(Trengove et al. 1999, Ladwig et al. 2002, Wyffels et al. 2010, Edsberg et al. 2012, 
Bernatchez et al. 2013) or the United Kingdom (4 studies) (Tarlton et al. 1997, Hoffman 
et al. 1999, Tarlton et al. 1999, James et al. 2000), and the remainder from Australia (3 
studies)(Trengove et al. 1996, Trengove et al. 1999, Liu et al. 2009) and France (1 
study) (Muller et al. 2008).  
 
4.3.2.4. Study Settings  
Many of the articles do not specify the exact study setting (Tarlton et al. 1997, Ladwig 
et al. 2002, Liu et al. 2009, Wyffels et al. 2010), however, where reported, settings 
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range from wound clinics (Hoffman et al. 1999, Tarlton et al. 1999, James et al. 2000) 
to hospitals (Trengove et al. 1996, Trengove et al. 1999, Muller et al. 2008, Bernatchez 
et al. 2013) to long-term skilled nursing facilities (Edsberg et al. 2012).  
 
4.3.2.5. Populations  
Participants included were all human subjects, males and females, and of these 
studies, two-thirds involved patients with either leg ulcers (Trengove et al. 1996, 
Hoffman et al. 1999, James et al. 2000), pressure ulcers (Ladwig et al. 2002, Wyffels et 
al. 2010, Edsberg et al. 2012) or diabetic foot ulcers (Muller et al. 2008, Liu et al. 2009), 
and the remaining third of studies involved subject samples that comprised of both 
chronic and acute wound types (Tarlton et al. 1997, Tarlton et al. 1999, Trengove et al. 
1999, Bernatchez et al. 2013). Each study described the population demographics in 
further detail as outlined in Appendix 19. 
 
4.3.2.6. Sample Size  
The total number of participants was 399, with a mean sample size for all twelve 
studies of 29 subjects (SD 23). The largest sample size was 81 subjects in a 
retrospective cohort study (Bernatchez et al. 2013) and the smallest was 7 subjects in a 
preliminary prospective cohort study (Hoffman et al. 1999).  
 
4.3.2.7. Description of Exudate Composition Studies’ and Measurement Methods 
4.3.2.6.1. Bernatchez et al. (2013) ‘Nitric oxide levels in wound fluid may reflect the 
healing trajectory’ 
In Virginia, United States of America, a multicentre, pilot study was conducted to 
develop a nitric oxide and protease measurement method that would be sensitive for 
use with minute amounts of human wound fluid, such as those typically obtained in a 
point-of-care manner, and to determine the diagnostic value of these analytes of 
wound fluid in relation to wound outcomes (Bernatchez et al. 2013). With standard 
wound care continuing in accordance with the subject’s clinician, 81 subjects were 
recruited from a medical centre and a hospital to participate in the study (Bernatchez 
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et al. 2013). A total of one hundred wound fluid samples from wounds ranging in size 
from 0.05 to 259 cm2 were collected from 26 patients with venous leg ulcers, 16 with 
diabetic foot ulcers, and the 39 patients with wounds of various aetiologies such as 
pressure ulcers, burns, surgical wounds, donor site wounds, traumatic wounds and 
drainage tube wounds (Bernatchez et al. 2013). Thirteen of these subjects provided 
two or three collections of wound fluid from the same wound at different time points 
throughout the study (Bernatchez et al. 2013). On commencing the study, wound 
characteristics were recorded that entailed measuring wound dimensions in respect to 
length, width, and depth, and assigning a wound status namely, progressing, 
stagnating, or worsening, as based on the patient’s documented medical history 
(Bernatchez et al. 2013). Wounds presenting with a healthy appearance, robust 
granulation tissue and documented reductions in wound area were considered 
progressing wounds, those without a documented change in wound area were 
considered stagnating, and those with documented poor granulation tissue deposition 
and increasing wound areas were considered worsening wounds (Bernatchez et al. 
2013). 
 
Wound fluid collection for NOx measurement was performed before and after wound 
cleansing using sterile water by pressing a sterile, nitrate-free pad (3M Nexcare First 
Aid dressing, 3M, St. Paul, MN) on the wound bed to absorb as much wound fluid as 
possible, repositioning the pad if required, and then placing the pad into a capped tube 
to be stored at -79 °C until analysis (Bernatchez et al. 2013). Similarly, wound fluids for 
protease measurements were collected before and after wound cleansing however, 
the wound was swabbed using small polyester swabs (polyester tipped applicator Pur-
Wraps, Puritan Medical Products Company, Guilford, ME) and then also placed into a 
capped tube and stored at -79 °C until analysis (Bernatchez et al. 2013). This process 
was repeated with up to two additional swabs in wounds with superfluous wound fluid 
(Bernatchez et al. 2013). 
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4.3.2.6.2. Edsberg et al. (2012) ‘Analysis of the proteomic profile of chronic pressure 
ulcers’ 
Edsberg et al. (2012) conducted a prospective temporal study examining the wound 
fluid from 32 inpatients with 42 pressure ulcers to characterise the protein profile of 
these wounds over a six-week period using a variety of proteomic techniques. With an 
average age of 72.8 years, 10 men and 22 women with ulcers of four weeks or greater 
duration were enrolled from long-term skilled nursing facilities (Edsberg et al. 2012). 
Seven subjects exhibited more than one ulcer and all these ulcers were included in the 
study (Edsberg et al. 2012). At day Zero of the study, pressure ulcers included in 
protein analyses were categorised as stage 2 (2%), stage 3 (74%), and stage 4 (24%), 
where hypertension, diabetes, and coronary artery disease were associated with 
54.8%, 54.8%, and 28.6% of these ulcers, respectively (Edsberg et al. 2012). Wounds 
were evaluated at fifteen time points (day 0, 1, 2, 3, 4, 7, 8, 9, 10, 11, 14, 21, 28, 35, 
and 42) and samples specific to both the interior and the periphery of the wound bed 
were collected (Edsberg et al. 2012). Wound measurement was performed at each one 
of the fifteen time points in which the wounds were digitally photographed with a 
3cm2 calibration target and analysed using VeV MD (Version 1.1.14 ©VERG Inc., Vista 
Medical Ltd, Winnipeg, Canada), and the change in wound surface area was then 
expressed as a percentage of area on day 0 to categorise patients according to wound 
outcome, chronic or not healed (decrease in area of less than 40%), moderate healing 
(40–80% decrease in area), or healed (decrease in wound area of 81–100%) (Edsberg 
et al. 2012).  
 
Collection and isolation of wound fluid proteins involved swabbing the surface of the 
wound interior and periphery independently using polyester-tipped applicators until 
saturated, removing the tip of the swab and placing it tip-down in a 2-mL vial prefilled 
with 150 µL phosphate buffered saline (10 mM, pH 7.4) (Edsberg et al. 2012). The 
wound fluid samples were placed into chilled coolers and transferred immediately for 
lab analysis. Next, 350 µL dH2O was added to the vials which were then vortexed for 
30 seconds (Edsberg et al. 2012). The swabs were inverted, all liquid removed from the 
polyester tip via centrifugation for 10 minutes at 6,000 g, the swabs removed from the 
vial, cellular debris pelleted by repeating the centrifugation, supernatants filtered and 
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concentrated using spin columns with 3 kDa-cutoff membranes and the samples 
removed to 1.5 mL microcentrifuge tubes for storage (Edsberg et al. 2012). In the case 
of wounds where multiple wound fluid swabs had been collected, samples were 
combined prior to protein quantification using the method of Bradford in a microplate 
format with Bovine IgG as the protein standard. The mean and standard error of 
protein concentration replicates were calculated and finally the sample vials were 
stored at -80°C (Edsberg et al. 2012). 
 
4.3.2.6.3. Hoffman et al. (1999) ‘The use of proteases as prognostic markers for the 
healing of venous leg ulcers’ 
In the UK, Hoffman et al. (1999) conducted a preliminary prospective study involving 
two experiments, firstly, to identify whether the level of elastase activity in wound 
fluid correlates with wound healing rate and, secondly, to determine the validity of the 
collection method used. Spanning a period of up to six weeks, the first experiment 
involved weekly collection of wound fluid from the bandages of seven patients with 
venous leg ulcers of 13 months or greater duration that were attending a wound clinic. 
Wound fluid was collected from the dressings by immersing each bandage in 
approximately 25mL of ice-cold phosphate-buffered saline (PBS) containing 0.02% 
sodium azide. The fluid was expressed, the sample volume measured, centrifuged at 
15,000g for ten minutes and then frozen at -70°C. To determine the stability of 
neutrophil elastase in the bandages until the weekly wound fluid collection time 
points, the second experiment entailed adding 20µL of wound fluid specimen to 4mg 
sample of different bandage types used in the study, incubating these specimens at 
37°C in sealed plastic microcentrifuge tubes, and then adding 200µL of PBS either 
immediately, or at three day or seven day intervals. Following this, the specimens were 
incubated at 4°C for 30 minutes, the fluid expressed from the bandage, centrifuged at 
15,000g for ten minutes and finally frozen at -70°C prior to analysis.  
 
4.3.2.6.4. James et al. (2000) ‘Simple biochemical markers to assess chronic wounds’ 
In order to investigate the potential for the biochemical analysis of chronic wound fluid 
to predict healing using simple and commonly available analytes in an out-patient 
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clinic setting, James et al. (2000) recruited patients with chronic lower leg wounds who 
were receiving a range of wound treatments such as compression, grafting and larval 
therapy at a leg ulcer clinic. Of these twelve patients (6 females, 6 males; median age 
74 years; range 65-88 years) with wounds of at least 8 weeks duration, ten had venous 
disease, one had venous disease and diabetes mellitus, and one had mixed venous-
arterial disease (ankle/ brachial pressure index = 0.6) (James et al. 2000).  
 
At the initial assessment, wounds were swabbed for qualitative bacterial evaluation, 
photographed and wound edges traced around onto clear plastic to record wound size 
and appearance, and exudate was collected by covering the wound with a transparent 
occlusive dressing (Opsite, Smith and Nephew Medical Limited), keeping the leg 
dependant for 30–40 minutes, and aspirating the accumulated fluid from under the 
dressing using a syringe and needle. Within 30 minutes, the wound fluid samples were 
centrifuged to remove cell debris (8000 × g for 5 minutes) and either analysed 
immediately or stored at −70 °C. Four patients (three defined as non-healing and one 
as healing) had a second specimen collected at a median time of 8 weeks after the first 
collection (range 4–10 weeks). At twelve weeks, wounds were classified as either 
healing (complete wound closure or wound area reduction of more than 50%) or non-
healing using photography and wound tracings.  
 
4.3.2.6.5. Ladwig et al. (2002) ‘Ratios of activated matrix metalloproteinase-9 to tissue 
inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with 
healing of pressure ulcers’ 
To test the hypothesis that chronic inflammation of acute wounds produces elevated 
levels of proteases that disturb the normal wound healing process by destruction of 
essential growth factors, receptors, and extracellular matrix proteins, Ladwig et al. 
(2002) examined the pro- and activated matrix metalloproteinases (MMP-2 and MMP-
9), tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2), and the ratios of 
MMPs/TIMPs in wound fluids and biopsies and correlated the quantitative assay data 
with the rates of wound healing. Specimens were collected from 56 of 61 patients with 
chronic pressure ulcers who were enrolled in a four-arm, blinded, prospective, 
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randomised placebo-controlled pressure ulcer clinical trial to compare topical 
application of granulocyte macrophage-colony stimulating factor (GM-CSF), basic 
fibroblast growth factor (bFGF), and successive therapy with GM-CSF followed by bFGF 
for a period of 35 days (Robson et al. 2000). Aged from 28 to 70 years, all patients had 
pressure ulcers due to acquired spinal cord pathologies, which were located on the 
truncal region of the body, present for at least 8 weeks’ duration, measured between 
10 and 200 cm3  and involved tissue from a bony prominence which extended to at 
least the subcutaneous tissue (Robson et al. 2000). Wound biopsies and fluid samples 
were taken from the ulcers, treated for 0, 10, and 36 days with conventional therapy 
or with exogenous cytokine therapies, at day 0 (pre-treatment), day 10, and day 36, 
and measurements of the pressure ulcer volume were performed on day 0 and weekly 
for 5 weeks using planimetry and alginate moulds (Robson et al. 2000). Wounds were 
classified according to percentage decrease in wound volume over the 35 days in 
which a reduction of at least 85% defined good healers, between 50 and 85% defined 
intermediate healers and less than 50% defined poor healers (Robson et al. 2000).  
 
Using porous, inert hydrophilic dextranomer beads, the wound fluid collection 
procedure was performed by placing beads into each pressure ulcer to create a layer 
approximately ¼ inch thick, applying an occlusive wound dressing covered by an 
adherent elastic wrap and then, 24 hours later, collecting the beads, mixing 1gm 
weight of saturated beads with 1ml of 100mM sodium phosphate (pH 7.4) for 12 hours 
in a vertical shaker at 4 °C, centrifuging at 1000g for 5 minutes at 4 °C and finally 
storing the supernatant solution at -80 °C until the time of analysis (Robson et al. 
2000). 
 
4.3.2.6.6. Liu et al. (2009) ‘Increased matrix metalloproteinase-9 predicts poor wound 
healing in diabetic foot ulcers’ 
To measure MMP-9, MMP-2, TIMP-1, and TGF-β1 in wound fluid obtained from 
diabetic foot ulcers and to examine their relationships with wound healing, Liu et al. 
(2009) conducted a prospective study collecting wound fluid samples from ulcer sites 
at the time of enrolment and following a four-week period of wound treatment from 
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62 subjects, 49 males and 13 females. The majority of the patients had type 2 diabetes 
(n=56) and the foot ulcers, from 2 to 10 weeks duration, were classified as neuropathic 
(n=48), postsurgical (n=9), or neuro-ischemic (n=5) and graded according to the Texas 
Grading System (Oyibo et al. 2001, Liu et al. 2009). The initial four weeks of wound 
treatment involved weekly debridement, offloading, and other treatments (not 
reported) and, for 83% of subjects, antibiotics were prescribed (Liu et al. 2009). 
Patients were followed-up approximately once a month thereafter. Wound 
measurement was performed by tracing the ulcer borders onto a sterile transparent 
film, digitally scanning the tracings and calculating the area using the National 
Institutes of Health image software (Liu et al. 2009). Wound healing rate over the first 
28 days calculated as; daily change in wound area (%) = [(area at visit 1 - area at visit 
4)/(area visit 1)/28] ×100 (Liu et al. 2009). Wound fluid samples were stored at -20°C 
until analysis (Liu et al. 2009). 
 
4.3.2.6.7. Muller et al. (2008) ‘Matrix metalloproteinases and diabetic foot ulcers: the 
ratio of MMP-1 to TIMP-1 is a predictor of wound healing’ 
From May 2005 to June 2006, sixteen consecutive Type 2 diabetic patients, fifteen 
males and one female, were recruited from the diabetes department in a French 
hospital to partake in a prospective pilot study to explore the correlation between 
levels of MMP and TIMP and ulcer healing, so as to identify potential biomarkers to 
predict wound healing (Muller et al. 2008). Subjects with a mean age of 64 years 
(range 47-84 years) were included if they had a diabetic foot ulcer rated 1 to 3, stage A 
according to the University of Texas Wound Classification (not infected and no severe 
arteriopathy), of at least 30 days’ duration and an area greater than 0.5 cm2 and were 
excluded if they had an infected wound (based on the International Consensus on The 
Diabetic Foot criteria 2003 (Schaper et al. 2003)), soft tissue infection or an 
arteriopathy of the lower limbs (Muller et al. 2008). At each visit (week 0 (W0), W1, 
W2, W4, W8 and W12), the wound area was measured using photography and 
measurement software (Mouseyes®, Salford, UK), and two wound fluid specimens 
were collected by placing sterile absorbent paper strips (Shirmer strips) on the ulcer 
edges for five minutes (Muller et al. 2008). Throughout the duration of the study, the 
wound treatment remained the same for all wounds as provided by a nurse every 2 
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days with dressings known to interfere with MMP levels excluded and the dressing 
selection based the protocol of a wet dressing for dry wounds and an absorbent 
dressing for exudative wounds (Muller et al. 2008). To produce wound fluid samples 
for biological analysis, protein elution from was performed by stirring the Shirmer 
strips in 1ml of buffer (50 mM Tris, 50mM NaCl, 0.05% Brij 35, pH 7.6) for at least 2 
hours at a temperature of +4°C (Muller et al. 2008). At four weeks, wounds showing a 
reduction of at least 82% in the initial wound surface were defined as ‘good healers’ 
whereas wounds a reduction of less than 82% in wound surface were defined as ‘poor 
healers’ (Muller et al. 2008). 
 
4.3.2.6.8. Tarlton et al (1997) ‘Postsurgical wound progression monitored by temporal 
changes in the expression of matrix metalloproteinase-9’  
Tarlton et al. (1997) conducted a prospective comparative study to investigate the 
potential of expression of MMP-2 and MMP-9 in wound fluids to indicate wound 
healing. Acute wound fluids and sera were collected from post-operative patients 
following mastectomy for primary breast carcinoma (n=9) and colectomy for primary 
colorectal carcinoma (n=9) from 0 to 96 hours (at 3, 6, 24, 48, 72 and 96 hours) and 
from 24 to 120 hours (at 24, 48, 72, 96 and 120 hours) post-operatively, respectively. 
None of these patients had any other noted disease and a single dose of prophylactic 
antibiotics had been administered to only the colectomy patients. Collections of 
wound fluids were obtained from sterile wound drainage systems that had been 
inserted at the time of surgery and blood samples were obtained by simultaneous 
venesections. In addition to acute wounds, chronic wound fluids were also collected 
from beneath occlusive wound dressings from the venous leg ulcers of six patients at 
intervals of greater than 24 hours.  Samples were centrifuged and aliquots were stored 
at -80°C until analysed. 
 
4.3.2.6.9. Tarlton et al. (1999) ‘Prognostic value of markers of collagen remodeling in 
venous ulcers’ 
In a prospective study to evaluate the use of markers of matrix degradation and 
collagen synthesis in wound fluids in determining healing status and predicting healing 
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progress of defined sites within ulcers, Tarlton et al. (1999) collected exudate from the 
surface of wounds from 26 patients attending leg ulcer treatment clinics. Over a one-
year period, exudate was collected on at least five occasions with collection intervals 
and the wound treatment determined by clinical need and the number of samples 
taken at each interval determined by the extent of the ulcer. Ulcer healing 
performance was also recorded at each assessment by tracing each wound on clear 
acetate, scanning the wound maps, and then quantitated using image processing 
software.  Three blinded independent assessors categorised the ulcers as improving, 
static or deteriorating, based on changes in wound margins recorded at subsequent 
clinic assessments. In cases where the assessment interval exceeded 8 weeks, the data 
were discounted. The collection procedure involved placing a sterile mesh on the 
wound bed, allowing wound fluid to be absorbed through to a sterile absorptive filter 
prepared from Whatman 54 paper, and then transferring the filter to a tube to be 
stored at -20 °C until analysis. An extraction buffer, comprising 0.1% Brij 35 (BDH, 
Poole, UK) in 20 mM triethanolamine was added at 50: 1 (v/w) and, following 4 hours 
of agitated extraction, the fluid was removed for analysis. The acute wound fluid data 
incorporated in this investigation had been collected in previous research (Tarlton et 
al. 1997) (collection methods not stated in this study report).  
 
4.3.2.6.10. Trengove et al. (1996) ‘Biochemical analysis of wound fluid from nonhealing 
and healing chronic leg ulcers’ 
In a prospective study conducted to determine the biochemical composition of fluid 
taken from chronic wounds at non-healing and healing phases and the differences of 
these results in comparison to their corresponding serum values, Trengove et al. 
(1999) recruited a sample of eight patients (6 males, 2 females; median age 73 years; 
range 69-89 years) all of whom had leg ulcers that had been recorded as having no 
reduction in wound size for more than 3 months. Half of the patients had mixed 
arterial and venous disease ulcers and half had venous disease ulcers ranging in size 
from 50cm2 to 198cm2 (median 68cm2) (Trengove et al. 1999). Patients were admitted 
to hospital for bed rest, 6 hourly saline solution compresses and subsequent skin 
grafting (Trengove et al. 1996). Within 24 hours of admission (non-healing phase) and 
after 2 weeks in hospital (healing phase), wound fluid and blood samples were 
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collected (Trengove et al. 1996).The wound fluid collection procedure required fasting 
the patients from midnight, applying a transparent film (Opsite, Smith & Nephew) over 
the wound at 08:00 hours, placing the limb in a dependant position, encouraging an 
oral fluid intake of one litre of water and, following a period of one hour, aspirating 
accumulated fluid from underneath the dressing and transferring the specimen into a 
vacuum serum collection tube or fluoride oxalate tube (lactate only) (Trengove et al. 
1996). In addition, serum samples were also collected into the same type of vacuum 
collection tubes. On admission and at 2 weeks, ulcer surface area and appearance was 
recorded by tracing around the edges of the ulcer and by photographing the ulcers 
(Trengove et al. 1996). Furthermore, swabs of the ulcer and samples of wound fluid 
were obtained to allow for bacterial analysis (Trengove et al. 1996). 
 
4.3.2.6.11. Trengove et al. (1999) ‘Analysis of the acute and chronic wound environments: 
the role of proteases and their inhibitors’ 
The first of two studies reported by Trengove et al. (1999) examines the levels of 
MMPs, neutrophil elastase, and TIMPs in fluids of acute and chronic wounds, and the 
second study measures the changes in proteases levels in the wound fluids of non-
healing venous ulcers as they progress into a healing phase.  
 
Conducted in the USA, the first study collected wound fluid from 8 mastectomy 
patients (median age 49 years (range 31- 67 years) with acute post-operative wounds 
as well as 12 female and 13 male patients (median age 63 years (range 23–83 years) 
with chronic wounds (17 decubiti, 5 mixed vessel disease ulcers, 3 diabetic foot ulcers) 
of greater than 4 weeks’ duration (Trengove et al. 1999). Acute wound fluid 
accumulated in a vacuum drain from the patient’s chest wall in the initial 8 post-
operative hours was discarded due to blood contamination and subsequent 8 hourly 
wound fluid accumulations were drained, stored at −80 °C and collected for up to 7 
days (Trengove et al. 1999). Chronic wound fluid collection was performed by covering 
the wound with a transparent occlusive dressing (Opsite, Smith & Nephew) for 
approximately one hour, aspirating the fluid accumulated beneath the dressing and 
then storing the specimen at −80 °C (Trengove et al. 1999).  
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In the second study conducted in Western Australia, 15 patients (median age 77 years 
(range 55–91 years) with chronic leg ulcers that had failed to respond to outpatient 
treatment with compression therapy (no reduction in ulcer size for more than 3 
months or a continued increase in the size of the ulcer) were admitted to hospital for 
bed rest, 6 hourly saline compresses and eventual skin grafting (Trengove et al. 1999). 
On admission to hospital and following two weeks, ulcers were photographed and 
ulcer area calculated using tracing measurements and digital planimetry (Kent digital 
planimeter; Jayco) to provide an indication of wound healing (Trengove et al. 1999). 
The method for collecting wound fluid and recording ulcer characteristics reported are 
similar to that by Trengove et al. (1996), whereby, fluid was aspirated from beneath a 
wound dressing (Opsite, Smith & Nephew), placed in a plain collection tube, 
centrifuged at 14,000 ×g for 5 minutes, and stored in aliquots at −80 °C (Trengove et al. 
1999).  
 
4.3.2.6.12. Wyffels et al. (2010) Analysis of pressure ulcer wound fluid using two-
dimensional electrophoresis 
Wyffels et al. (2010) conducted a prospective temporal study to analyse protein 
expression of wound fluid samples from the interior and periphery of 19 chronic 
pressure ulcers of stage 2 (42%), stage 3 (21%), stage 4 (37%) from 17 subjects (6 
males, 11 females; mean age 73·5 years) using two-dimensional polyacrylamide gel 
electrophoresis (2D-PAGE). At each wound assessment performed at fifteen time 
points over 42 days (day 0, 1, 2, 3, 4, 7, 8, 9, 10, 11, 14, 21, 28, 35 and 42) wounds 
were swabbed, digitally photographed and wound size was analysed using 
measurement software (VeV MD). Change in wound area from day 0 placed patients in 
categories according to wound outcome namely, not healed, healing or healed. Wound 
fluid collection involved gently rolling a sterile polyester tipped applicator over the 
wound surface until saturated, breaking off the swab tip and placing in a 2ml vial 
prefilled with 150μl phosphate buffered saline (PBS) (10 mM, pH 7·4). These vials were 
transported immediately in chilled coolers to the lab where proteins were re-
suspended from the polyester tip by adding of 350 μl dH2O, vortexing for 30 seconds, 
inverting the swabs and centrifuging for 10 minutes at 6000g to remove all the fluid 
from the swab tip. The swabs were then removed from the vials, centrifugation 
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repeated, supernatant filtered using spin columns with 3-kDa cut-off membranes 
centrifuged for 99 minutes at 14,000g, 50 μl dH2O added to the column membranes, 
the columns vortexed briefly, incubated at room temperature for 5 minutes, inverted 
into 1·5 ml plastic microcentrifuge tubes, spun at 1000g for 3 minutes and replicates 
combined prior to protein quantification. Bovine IgG was used as a standard and the 
data collected by a BioRad Model 550 microplate reader at 595 nm controlled by Bio-
RadMicroplate Manager Software. Following protein quantisation, the samples were 
finally stored at −80°C. 
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Table 8. Summary of exudate composition measurement methods 
Bernatchez et al. (2013) 
Measurement 
Technique 
Nitric Oxide (NOx) Assay: 
 Potassium nitrate, prepared at a concentration of 4 mM in ultrapure water and stored at 4 °C, was used to make fresh 
standards on the days the assay was performed (0, 5, 10, 20, 30, 50, 75, 100, and 200 mM in saline). Zinc sulfate (ZnSO4) 
was prepared at a concentration of 1.5% in ultrapure water and stored at 4 °C, and the reducing reagent mix, vanadium 
chloride III (VCl3 0.8%), 4-aminophenyl sulfone (Dapsone 0.25%), and N-(2-diethylaminoethyl)-1-naphthylamine oxalate 
(Tsuda reagent 0.05% in 1 N HCl) was prepared and stored as frozen aliquots at -20 °C. Each day an assay was performed a 
fresh aliquot was thawed. 
 On the day each assay was performed, the wound fluid samples were thawed and the nitrate-free pads were centrifuged 
10 min at 8,000 g to obtain the sample. All supplies were prewashed three times in ultrapure water to ensure they were 
nitrate-free.  
 10 mL of each standard or sample was pipetted into a clean tube, 10 mL ZnSO4 was added, vortexed and then 70 mL water 
was added. The tube was then centrifuged for 3 minutes at 8,000g and 75mL of supernatant was removed to separate new 
clean tube. 10mL of VCl3 reagent mix was added, the tube vortexed, centrifuged for 2 minutes at 2,050g, and heated in a 
heating block at 70°C for 10 minutes with agitation (700 rpm). The tube was cooled for two to three minutes and vortexed 
to recover the condensation on the tube walls. The tube was then centrifuged for 2 minutes at 2,050g and 75 mL was 
transferred to a 384 well plate for reading in a spectrophotometer at 545 nm and at 450 nm.  
Matrix metalloproteinase 9 Assay: 
 Matrix metalloproteinase 9 [MMP-9] activity was determined using the Fluorokine E Enzyme Activity Assay for human 
active 
 MMP-9 (R&D Systems, Minneapolis, MN). Frozen swab samples were thawed, centrifuged to obtain a measurable quantity 
(0–16 ng/mL) and then diluted to achieve a concentration in the range of the standard curve.  
Human Neutrophil Elastase Assay: 
 Human neutrophil elastase (HNE) was determined using the InnoZyme Human Neutrophil Elastase Immunocapture Activity 
Assay (Calbiochem, Rockland, MA). Frozen swab samples were thawed, centrifuged to obtain a measurable quantity and 
diluted to achieve a concentration in the range of the standard curve (0.625-20 ng/mL).  
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Statistical 
Methods 
 Wound area was computed assuming an elliptical area.  
 Stepwise discriminant analysis and logistic regression analysis were used to determine the analytical or baseline factors 
significantly associated with wound status.  
Sample concentration determination:  
 Nitric Oxide (NOx) Assay: Spectrophotometer readings at 450 nm were deducted from that at 545 nm, data were analysed 
using a linear regression curve fit for the standard curve, and the equation of the curve was used to determine the 
concentration in the samples. 
 Matrix metalloproteinase 9 Assay: The data were plotted as relative fluorescence units (RFUs) versus active MMP-9 
concentration using a four parameter logistic curve fit for the standard curve and the equation of the curve was used to 
identify the concentration in the samples. 
 Human Neutrophil Elastase Assay: The data were plotted as RFUs versus active HNE concentration using a linear regression 
curve fit for the standard curve and the equation of the curve was used to identify the concentration in the samples. 
 Analyses involved the natural log transform of the average values of the metabolites (NOx, HNE and MMP-9) and the 
natural log transformed value of the wound area. 
 Optimal diagnostic levels of NOx (cut points): determined using the receiver operating characteristic (ROC) curve. The 
natural logarithmic transformation of NOx was carried out to normalise the data before performing the ROC analysis. 
Exploratory analysis of the data provided evidence that two cut points produced a superior diagnostic tool based on the 
area under the ROC curve (AUC). The two cut points were identified in an iterative manner using the transformation: 
|ln(NOx)- X|, where the X value used ranged from 3.0 to 3.5, values close to the overall computed mean and median of the 
ln(NOx). 
Edsberg et al. (2012) 
Measurement 
Technique 
Differential protein expression in wound fluid was analysed by a mass spectroscopy-based system using isotopically tagged peptides 
(iTRAQ): 
 Each specimen was analysed for protein content with bovine plasma gamma globulin as a standard.  
 An aliquot containing 100mg of protein was diluted with six volumes of -20 °C acetone, kept at -20 °C overnight, the 
precipitate centrifuged and taken up in dissolution buffer, denatured, and disulphides reduced by incubation in the 
presence of 0.1% sodium dodecyl sulphate and 5mM tris-(2-carboxyethyl) phosphine.  
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 Cysteine residues were blocked with methyl methanethiosulphonate, trypsin was added to the mixture at a ratio of 10:1 
protein:trypsin and the mixture was incubated overnight at 37 °C.  
 Protein digests of each specimen were labelled by mixing with the appropriate iTRAQ reagent and then the individual 
reaction mixtures were combined.  
 The labelled peptide mixture was fractionated by stepwise elution from the cation exchange column into five fractions, 
desalted on a C18 reverse phase column, and then identified and quantified by nano-LC/MS/MS on a mass spectrometer 
operating in positive ion mode.  
 Peptides were loaded on a 75 mm x 10 cm, 3-mm fused silica C18 capillary column, followed by mobile phase elution, and 
the LC eluent was directed to a NanoES source for electrospray ionization (ESI)/MS/MS analysis.  
Antibody screening array:  
 Wound fluid proteins were surveyed using a biotin label-based microarray of 507 proteins printed on either a glass or 
membrane substrate. Wound samples were biotinylated and incubated with the antibody array.  
 For the glass array substrate: biotin labelled wound proteins bound to the array were secondarily labelled with fluorescent 
dye-conjugated streptavidin and arrays were visualized with an Axon Genepix 4000B Microarray Scanner using the Cy3 
channel.  
 For the membrane array substrate: biotin-labelled wound proteins bound to the array were secondarily labelled with 
horseradish peroxidase- conjugated streptavidin and arrays were visualized using a chemiluminescene imaging system.  
Cytokines quantitatively measured using planar antibody arrays:  
 100 mL of wound fluid (50–500 mg/mL) was incubated with the antibody array printed on a glass slide in quadruplicate and 
bound wound proteins were secondarily labelled with a biotinylated antibody, incubated with fluorescently conjugated 
streptavidin, and arrays visualized with a laser scanner.  
 Cytokine standard curves were generated from an eight-point concentration gradient.  
 Baseline signal derived from the control standard was subtracted when determining concentrations of unknowns using 
Quantibody® Q-Analyzer software.  
 Analyte concentrations were standardised using the wound fluid total protein. 
 A microsphere-based suspension microarray was used to measure the concentration of 10 analytes simultaneously in 69 
wound fluid samples.  
 Wound fluid samples were diluted to 0.2–0.8 mg/mL before quantification in duplicate.  
164 
 
 Multiple analytes in a single aliquot of wound fluid were determined quantitatively and simultaneously with a Bio-Plex™ 
200 Bead Reader System.  
 Analyte concentrations were standardized using the wound fluid total protein and expressed as pg or ng analyte/mg total 
protein.  
Statistical 
Methods 
 Differential protein expression in wound fluid: The accumulated MS/MS spectra were analysed using ProteinPilot III software 
(Applied Biosystems) using the SwissProt fasta database for protein identification. The Pro-Group reports were generated 
with a 95% confidence level for protein identification. 
 Antibody screening array: Background was subtracted and arrays normalized with reference to the positive control using 
RayBio® Analysis Tool software. 
 A generalized linear model (GLM) was employed to determine variables with a significant effect on wound fluid total 
protein concentration. 
 Paired t-tests were employed to evaluate the effect of blood contamination in sequentially matched wound fluid samples 
for differences in total protein concentration. 
 Discriminant function analysis (DFA) was employed to test the predictive ability of total protein concentration to assign 
outcome with up to 5 weeks of data, with potential predictors including protein concentration at weeks 1, 2, 3, 4, and 5 and 
initial wound area. Prior to combination in DFA analysis, predictors were tested individually and in additive temporal 
sequence for collinearity. 
Hoffman et al. (1999) 
Measurement 
Technique 
Neutrophil elastase determined using the selective substrate N-methoxysuccinyl-ala-ala-pro-val-p-nitroanilide (modified method of 
Redini et al. (1988).  
 5-10µL aliquots of wound fluid were incubated with 100 µL reaction mixture (0.2mM substrate in 50mM Tris buffer, pH 8.0, 
50mM NaCl, 0.01% Brij 35, 0.02% NaN3) at 37°C and change in optical density at 405nm was monitored using a Mulitskan 
RC plate reader.  
 
Statistical 
Methods 
 Elastase activity: Determined by a standard curve generated with pure human neutrophil elastase.  
 Total elastase activities: Measured by correcting for the total volume of wound fluid and PBS recovered from the bandage.  
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 Stability of elastase in the dressings: measured by comparing the levels of elastase recovery achieved immediately, with that 
recovered after three days or after seven days following the addition of aliquot to the bandage.  
James et al. (2000) 
Measurement 
Technique 
 Total protein (using Biuret method), albumin (using BCG), creatinine (using Jaffé), urea (using urease), lactate 
dehydrogenase (using LDH; pyruvate to lactate, Tris buffer) and glucose (using hexokinase) were analysed by means of a 
clinical chemistry analyser (Bayer Axon clinical chemistry analyser; Bayer Diagnostics). An aliquot of wound fluid for lactate 
determination was prepared with perchloric acid precipitation, and analysed enzymatically on a clinical chemistry analyser 
(Cobas Fara clinical chemistry analyser; Roche Diagnostics). 
 Limited specimen volumes (approximately 0.5 ml, range 0.2–1.0 ml) resulted in an inability to complete a full set of 
analyses on all fluids.  
Statistical 
Methods 
 The significance of differences between healing and non-healing groups was determined using the Mann–Whitney 
nonparametric U-test. 
Ladwig et al. (2002) 
Measurement 
Technique 
 MMP-2 and MMP-9 in wound fluids and homogenized biopsies measured using quantitative gelatin zymography: 15 µl diluted 
wound fluid or biopsy homogenate supernatant were mixed with an equal volume of sample buffer (63 mM Tris-HCl, pH 
6.8,10% glycerol, 2% sodium dodecyl sulfate and 0.0025% bromophenol blue; Novex, San Diego, CA), incubated at room 
temperature for 10 minutes, following which, 20µl of the equilibrated sample were placed into a well of a 15-well precast 
gelatin zymogram gel (Novex, San Diego, CA).  
 To measure levels of pro and activated MMP-9: Samples were electrophoresed at 4°C at 95 V until the bromophenol blue 
tracking dye had migrated through the stacking gel and then at 125 V until the tracking dye reached the bottom of the gel 
(approximately 2.5 hours).  
 To measure levels of pro and activated MMP-2: Gels were run for an additional hour after the tracking dye reached the 
bottom of the gel (approximately 3.5 hours), immersed in renaturing buffer (2.7% Triton X-100, w/v), placed on a rotary 
shaker at 30 rpm for 30 minutes at 37°C, immersed in developing buffer (50 mM Tris-HCl, 200 mM NaCl, 5 mM CaCl2, 0.2% 
Brij 35, w/v), placed on a rotary shaker at 37°C for 24 hours, stained with Coomassie Rapid Stain (Diversified Biotech, 
Boston, MA), destained with 12.5% trichloroacetic acid, photographed with a Kodak KD120 digital camera (Eastman, NY) 
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and the relative pixel density of each band measured using Kodak Digital Science image analysis software. Pre-stained 
molecular weight standards (Novex, San Diego, CA) and one sample of pro and activated MMP-9 and MMP-2 were run on 
each gel. 
Statistical 
Methods 
 Multivariate analysis of variance (MANOVA) with Statistica software (StatSoft Inc., Tulsa, OK) was used to statistically 
analyse zymogram and ELISA data to determine significant differences between treatment groups and clinical response 
groups. 
 Spearman Rank Order Correlation was used to evaluate for possible correlations for all sequential data on gelatinase 
activity, TIMP-1 activity, and ulcer measurements.  
 Statistical significance was accepted at p < 0.05. 
Liu et al. (2009) 
Measurement 
Technique 
 MMP-2 and MMP-9: Measured using zymography. 
 TIMP-1 and TGF-β1: Measured by enzyme-linked immunosorbent assay (ELISA).  
Statistical 
Methods 
 Students t test or one-way ANOVA was used for comparisons.  
 Multiple regression analysis was used to identify the relationships between wound healing rate at four weeks, age, duration 
of diabetes and ulceration, wound fluid pro– and active–MMP-9 and -2, TIMP-1, and TGF-β1.  
 Receiver operating characteristic analysis was used to determine thresholds for pro–MMP-9 in predicting healing within 12 
weeks. 
Muller et al. (2008) 
Measurement 
Technique 
 MMP-2 and -9 measured by zymography: Proteins were separated on an SDS-PAGE gel copolymerized with 0.5 mg/ml 
gelatine, which, after incubation in a buffer to activate the enzyme, was stained with Coomassie Blue and proteins with 
gelatinolytic activity detected as unstained bands.  
 MMP-1, MMP-8 and TIMP-1 measured by an ELISA technique: Protein concentration was assayed using the Pierce method 
and the concentrations of MMPs and TIMP-1 were expressed as pg/μg protein. 
Statistical 
Methods 
 The statistical software program SSPS® 11.0 was used for statistical analyses with a threshold of α = 0.05% for all statistical 
tests.  
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 Quantitative parameters were expressed as the median and 25th and 75th percentiles and qualitative parameters in 
effectives and percentages.  
 The Mann–Whitney or the Wilcoxon test and the Chi-squared or Fisher test were adopted.  
 The Spearman test was employed to detect correlations between percentage decrease in wound area and changes in the 
MMPs or TIMPs levels.  
 ROC analysis was used to determine whether the parameters had any predictive value with respect to wound healing.  
 (Correlations between MMPs and ulcer healing were established using only fifteen patients as one patient was excluded 
due to an amputation surgery at week eight (W8)). 
Tarlton et al. (1999) 
Measurement 
Technique 
 MMPs -2 and MMP-9 analysed by gelatin substrate gel electrophoresis (zymography): 
 Acute wound fluid samples and venous ulcer fluid extracts were combined with sample buffer to produce a final dilution of 
1/500 in each case, and loaded onto 10% sodium dodecyl sulfate-polyacrylamide gels (SDS-PAGE) that contained 0.75 
mg/ml bovine skin gelatin. Following electrophoresis, gels were rinsed in 2.5% Triton X-100, and incubated for 16 hours at 
37 °C in MMP proteolysis buffer (50 mM tris/HCl pH 7.8, 50 mM CaCl2, 0.5 M NaCl and 0.1 mM amino phenyl mercuric 
acetate (APMA)). 0.1% Coomassie blue was used to stain the gels, which were then de-stained until the zones of proteolysis 
or the stacking gel had cleared. Pro-and activated gelatinases identification was confirmed by loading standards of MMP-2 
and MMP-9, by using inhibitors selective for MMPs, by molecular weight shift brought about by APMA pre-activation, and 
by showing selective affinity for gelatin. Zymographic measurements related to gel clearance achieved with the proMMP-2 
band of the standard loaded at 1.25 ng/lane so as to allow comparisons between separate gels. Specimens that were 
collected from a particular patient were analysed in parallel. 
 Neutrophil elastase (NE) analysed by casein zymography:  
 12.5% polyacrylamide gels were cast and run as described previously for gelatin zymography, with casein replacing gelatin 
as the copolymerized substrate and human neutrophil elastase (NE), prepared from rheumatoid lung lavage, as the enzyme 
standard. Proteolytic clarification of the electrophoresed gels was performed for serine proteinases in 100 mM phosphate 
buffer (pH 6.8) supplemented with 8 mM ethylenediaminetetraacetic acid (EDTA) and 0.2% (v/v) Triton X-100. Identification 
of NE was corroborated using the serine protease inhibitors, PMSF, leupeptin, and soybean trypsin inhibitor, and the NE 
inhibitor, elastatinal. 
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 Quantitation by scanning densitometry 
 A colour flatbed scanner in transmittance mode was used to scan the gels, utilizing Fotolook scanning software with a 
correction curve applied to maintain linearity of the scanner response. The image was analysed in NIH Image 1.5, and the 
proteolytically clarified zones were quantitated according to area and intensity.  
 Analysis of type I collagen C propeptide (CICP) was quantitated using a sandwich enzyme linked immunosorbant microtiter 
assay (Sandwich ELISA). A CICP dilution series of 0, 2, 5, 20 and 80 ng/ml generated a standard curve fitted with a 
polynomial curve fit, the formula for which was used to calculate the concentration of test samples from their absorbance 
readings at 405nm. 
 Acute wound fluids were diluted 1/50 in 20 mM triethanolamine with 0.1% Brij 35, and diluted 1/2 in assay buffer provided. 
Chronic wound fluids were diluted 1/2 in assay buffer.  
 Native acute wound fluid and acute wound fluid with CICP added was incubated at 4 °C or 37 °C for 16 hours, and the 
difference in measured CICP determined as described.  
Statistical 
Methods 
 Two-tailed Student’s t-tests were performed and probabilities were given as p-values, with p < 0.05 regarded as significant. 
 Normality of the data was evaluated using Statworks software. 
Tarlton et al. (1997) 
Measurement 
Technique 
 Analysis of MMPs -2 and -9 by gelatin substrate gel electrophoresis (zymography): Process as described by Tarlton et al. 
(1999) 
 Quantitation by scanning densitometry:  Process as described by Tarlton et al. (1999) 
Statistical 
Methods 
 Statistical comparisons were performed using Student’s t-tests with p < 0.05 regarded as significant. 
Trengove et al. (1996) 
Measurement 
Technique 
 Sodium, potassium, chloride, bicarbonate, calcium, magnesium, phosphate, glucose, lactate, LDH, AST, GGT, Tbil, CK, urea, 
creatinine, uric acid, total protein, albumin, cholesterol, triglycerides measured using Ektachem 700 automated 
biochemical analyser (automated analyser).  
 CRP, C3, C4 measured using Behringwerke Turbitimer (Immunoturbidimetry). 
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 Alpha-1-globulin, alpha-2-globulin, beta-globulin, gamma-globulin measured using Helena Electrophoresis System 
(Electrophoresis). 
Statistical 
Methods 
 The Wilcoxon sign-rank test with the Statistical Package for Social Sciences (SPSS) was employed to statically compare 
paired samples. 
Trengove et al. (1999 
Measurement 
Technique 
 Azocoll assay used to measure MMP activity. 
 Azocasein assay used to measure non-specific protease activity. 
 Specificity of the protease activity tested using the specific MMP inhibitor Illomostat (Galardin) 
 Gelatin and casein measured using zymography 
 Neutrophil elastase activity assay: Wound fluid samples (5–10 μl) or 5–5000 ng purified human neutrophil elastase 
(Calbiochem-Novabiochem Corporation, San Diego, CA) were incubated for 1 hour at 37° C in a final volume of 100 μl of 0.1 
M HEPES buffer, pH 7.4, containing 0.5 M NaCl, 10% DMSO and 1 mM elastase substrate (methoxysuccinyl-ala-ala-pro-val-
p-nitroanilide, Sigma Chemical Co.). Substrate degradation was continuously monitored by measuring OD405. The maximum 
linear rate obtained for each sample was determined and a standard curve prepared from the elastase data. Wound fluid 
activity was converted to μg of elastase per ml of fluid. 
 Cathepsin G activity determination: Wound fluid samples (5–10 μl) or 5–5000 ng purified human neutrophil cathepsin G 
(Calbiochem-Novabiochem) were incubated for 1 hours at 37° C in a final volume of 100 μl of 0.1 M HEPES buffer, pH 7.4, 
containing 0.5 M NaCl, 10% DMSO and 3 mM cathepsin G substrate (succinyl-ala-ala-pro-phe-p-nitroanilide, Sigma 
Chemical Co.), substrate degradation was continuously monitored by measuring OD405 and the maximum linear rate 
obtained for each sample was determined and a standard curve prepared from the human neutrophil cathepsin G data. 
Wound fluid activity was converted to μg of cathepsin G per ml of fluid. 
 TIMP-1 determination by ELISA. 
 Degradation of cytokines in wound fluid measured using I-epidermal growth factor (Chiron Corp., CA) 
Statistical 
Methods 
 Mann Whitney U-test. 
 Wilcoxon matched pairs signed ranks test. 
 Spearman correlation. 
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Wyffels et al. (2010) 
Measurement 
Technique 
 Protein samples thawed to 4°C, vortexed, and an aliquot removed for isoelectric focusing (IEF).  
 Linear gradient IPG ReadyStrips (BioRad) were run in second dimension SDS-PAGE (electrophoresis).  
 Gel images were acquired using a GelDoc XR Gel Imaging System (BioRad) and PD Quest 2D analysis software, version 7.4.0, 
build 036 (BioRad). PD Quest and Proteomeweaver 4.0 (BioRad) software packages used to analyse gel images.  
 Wound fluid samples were partitioned using either a ProteomeLab™ IgY-12 High Capacity SC Spin Column kit (Beckman 
Coulter) or Multiple Affinity Removal Spin Cartridges (Agilent Technologies). 
 The number of occurrences of a super-spot (spots that matched to at least one other 2D-PAGE gel spot) within a wound 
area across days was tabulated.  
 The %TIC total ion current was used as a coarse estimate of protein abundance. 
Statistical 
Methods 
 Proteomeweaver settings were tested by comparing the number of spots recognised in a gel after digital imaging by the 
software and comparing it with the number that could actually be cut by hand. 
 On 9 occasions, protein identification of excised spots was performed using mass spectrometry. 
 Super-spot numbers within patients were tested for internal versus peripheral differences with paired t-tests. 
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4.3.3. Temperature 
4.3.3.1. Publication Year 
The publication dates span a period of 31 years, as one article was published in 1984 
(Robicsek et al. 1984), three in 1996 (Armstrong & Lavery 1996, Horzic et al. 1996a, 
Horzic et al. 1996b), two from 2006 to 2010 (Armstrong et al. 2006, Nakagami et al. 
2010), and the remaining two articles were published in the year 2015 (Dini et al. 2015, 
Mufti et al. 2015, Siah & Childs 2015). 
 
4.3.3.2. Study Design  
Eight quantitative studies were identified, most of which were prospective, descriptive, 
observational, cohort study designs (Robicsek et al. 1984, Armstrong & Lavery 1996, 
Horzic et al. 1996a, Horzic et al. 1996b, Armstrong et al. 2006, Nakagami et al. 2010), 
and, of the remaining articles, one study was a clinical trial (Dini et al. 2015) and one 
was a prospective exploratory cohort study (Siah & Childs 2015). 
 
4.3.3.3. Geographical Location   
The largest proportion of the research was based in the USA which yielded three 
studies (Robicsek et al. 1984, Armstrong & Lavery 1996, Armstrong et al. 2006), 
followed by two studies based in Croatia (Horzic et al. 1996a, Horzic et al. 1996b), and 
with the remaining studies based in Japan (Nakagami et al. 2010), Singapore (Siah & 
Childs 2015), Italy (Dini et al. 2015).  
 
4.3.3.4. Study Settings  
The majority of the studies were set in hospitals examining the wounds from samples 
of inpatients (Robicsek et al. 1984, Horzic et al. 1996a, Horzic et al. 1996b, Nakagami et 
al. 2010, Siah & Childs 2015). The remainder of the studies did not report the study 
setting (Armstrong & Lavery 1996, Armstrong et al. 2006, Dini et al. 2015). 
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4.3.3.5. Populations  
Participants included were all human subjects, males and females with wound types 
that varied across the eight research studies namely, diabetic foot wounds (Armstrong 
& Lavery 1996, Armstrong et al. 2006), leg ulcers (Dini et al. 2015), surgical wounds 
(Robicsek et al. 1984, Horzic et al. 1996a, Horzic et al. 1996b, Siah & Childs 2015), and 
pressure ulcers (Nakagami et al. 2010). Each study described the population 
demographics in further detail, of which are presented in this systematic review in 
Appendix 20. 
 
4.3.3.6. Sample Size  
The total population across the studies was 678 (mean 85 subjects). The largest sample 
size was 362 subjects (Armstrong et al. 2006) and the smallest was 18 subjects (Dini et 
al. 2015).  
 
4.3.3.7. Description of Temperature Studies and Methods 
4.3.3.6.1. Armstrong & Lavery (1996) Monitoring neuropathic ulcer healing with infrared 
dermal thermometry 
A group of 25 diabetic patients with plantar neuropathic ulceration previously treated 
by a primary care physician were recruited to a prospective study. The purpose was to 
monitor skin temperatures using a hand-held infrared skin temperature probe at the 
site of neuropathic ulceration before, during, and after wound healing with the 
contralateral extremity as a physiological control and to concurrently evaluate 
variables that may affect skin temperature (Armstrong & Lavery 1996). The recruited 
sample comprised of 17 male and 8 female diabetic subjects, aged 52.4 ± 11.6 years, 
presenting with ulcers of grade I, Meggitt-Wagner grading system (full thickness skin 
loss not involving tendon, bone or capsule), a mean ulcer duration of 88.5 ± 98.4 days, 
and a mean surface area of 7.7 ± 4cm2 (Armstrong & Lavery 1996). Until ulcer healing, 
all patients were treated with total contact casts (TCCs) that were changed weekly 
allowing for temperature measurement and debridement if necessary (Armstrong & 
Lavery 1996). Once ulcer healing was achieved, patients were provided with prescribed 
shoe gear and were followed for 2, 4, and 8 week intervals (Armstrong & Lavery 1996). 
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4.3.3.6.2. Armstrong et al. (2006) Does dermal thermometry predict clinical outcome in 
diabetic foot infection? Analysis of data from the SIDESTEP* trial 
As part of a large 89-centre, randomised, double-blinded study to compare two 
different intravenous antibiotics for treating moderate to severe diabetic foot 
infections, Armstrong et al. (2006) conducted a quantitative study to assess whether 
differences in skin temperature of the affected foot compared to the corresponding 
site on the contralateral foot correlates with infection severity, certain laboratory 
markers for inflammation or clinical response to antimicrobial therapy.  
 
Before enrolling any patients, all investigators/ research coordinators attended 
training sessions about diabetic foot infections and the study protocol. Using an 
infrared thermometer (Thermo TraceTM; Deltatrak, Pleasanton, CA, USA), baseline 
dermal thermometry readings were recorded for a total of 362 patients and, a mean of 
11.7 ± 7.5 days later, follow up readings were recorded for the 332 participants (92%) 
(64% male, 36% female; mean age 59 years) who were available at the time of 
discontinuation of intravenous therapy (DCIV) (Armstrong et al. 2006).  
 
4.3.3.6.3. Dini et al. (2015) Correlation between wound temperature obtained with an 
infrared camera and clinical wound bed score in venous leg ulcers 
Dini et al. (2015) conducted a clinical trial to correlate wound temperatures measured 
using a handheld infrared camera with wound bed condition measured using validated 
measurement tool (Falanga et al. 2006) that scored wounds in terms of healing edges, 
black eschar, greatest wound depth/ granulation tissue and pink wound bed and 
perilesional skin in terms of exudate, oedema, peri-wound dermatitis and callus. A 
sample of 18 adult patients with total of 24 chronic venous leg ulcers (wound surface 
area range 5 to 51.5 cm2; mean 34.6cm2) of greater than 6 months’ duration included 
in the study all received the same wound management protocol that involved a 
compression multilayer system and moist wound healing. Subjects were excluded if 
their wounds showed clinical signs of infection, they had ankle brachial pressure 
indices of less than 0.8 or an active acute inflammatory disorder. Using the wound bed 
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scoring tool by Falanga et al. (2006), clinical evaluations of the ulcers were determined 
by an operator blinded to the thermal image readings. 
 
4.3.3.6.4. Horzic et al. (1996) Contact thermography in a study of primary healing of 
surgical wounds 
To determine whether temperature changes in wounds healing by primary intention 
follow an orderly sequence, Horzic et al. (1996a) used a semi-quantitative, contact 
thermography method of liquid crystal strips to observe the surface temperature of a 
sample of thirty patients (27 females, 3 males; average age 38 ± 4.1 years) who were 
undergoing gallstone surgery. Tricoire’s liquid crystal strips used in this study are 
resistant to mechanical damage and humidity, 20cm long and 5cm wide, and accurate 
to 0.1°C temperature difference. These strips provide a response within seconds 
following application to the subject presenting with warm colours, such as reds and 
browns, corresponding to lower temperatures, and cool colours, such as deep blues, 
corresponding to higher temperatures. Inclusion criteria meant that only patients with 
wounds healing by primary intention and those without presenting intercurrent 
diseases were included in the study. As patients with post-operative wound 
haemorrhaging and those that subsequently decided not to participate in the study 
were excluded, the original sample size of 40, from whom data collection had 
commenced, were reduced to 30 patients. In the same room with the air temperature 
kept at a consistent 22 ± 1°C, thermographic readings were recorded pre-operatively 
at the presumed site of incision, and at a fixed time each day (13 hours) for eight days 
post-operatively at the actual incision site and its immediate surroundings.  
 
4.3.3.6.5. Horzic et al. (1996) Three-dimensional observation of wound temperature in 
primary healing 
In Croatia, Horzic et al. (1996b) conducted a prospective study to identify changes in 
wound temperature during healing and determine the effect of fatty tissue thickness 
on skin temperature. Using the AGA 780 thermovision system, a non-contact three-
dimensional thermography system, the epigastric region temperatures of a group of 30 
patients (average age 40.5 ± 12.92 years) admitted to hospital for upper medial 
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laparoscopic cholelithiasis were monitored daily for a total of twelve days. This system 
of thermography, with a measurement range of 1000K, measures infrared 
temperature in real-time and can digitalise recorded data to facilitate data analyses. 
The AGA 780 thermovision system can represent temperature distribution in both grey 
scale or colour however, for the purpose of this study, only grey-scale was used. 
Temperature was measured four times for four days pre-operatively at the presumed 
site of incision, and then post-operatively for eight days at a fixed time each day (13 
hours) at the actual incision site and its immediate surroundings, meaning that each 
subject became their own control. In addition, the thickness of fatty tissue in the 
epigastric region of all patients was established by means of ultrasound.  
 
4.3.3.6.7. Nakagami et al. (2010) Predicting delayed pressure ulcer healing using 
thermography: a prospective cohort study 
Between August 2006 and September 2008, Nakagami et al. (2010) recruited 35 
consecutive patients from one university hospital presenting with stage II–IV pressure 
ulcers, as per the National Pressure Ulcer Advisory Panel (NPUAP), to a three-week 
cohort study aimed to investigate the value of thermography in a clinical setting to 
detect latent inflammation in pressure ulcers and predict pressure ulcer prognosis. On 
initial ulcer presentation, temperature measurements of the wound bed and 
periwound skin were captured using infrared thermography (Thermotracer TH5108ME, 
NEC Avio Infrared Technology Co. Ltd., Tokyo, Japan, measurable range: 0–70°C, error 
range: ± 0.7°C, accuracy: 0.1°C) immediately following dressing removal by a Wound, 
Ostomy and Continence (WOC) nurse (Nakagami et al. 2010). Although not listed in 
this article as an exclusion criterion, two patients that developed wound infection were 
excluded on these grounds.  The remaining 33 patients were divided into two groups 
based on wound site temperature, namely the low temperature group (n=21) and the 
high temperature group (n=12), of which the differences in baseline patient and 
wound characteristics were not statistically significant (Nakagami et al. 2010). 
Following thermographic measurement, the pressure ulcer was cleansed, assessed 
visually using the DESIGN tool, wound area measured by a researcher uninvolved in 
the thermographic assessment and lastly treated according to conventional 
assessment (Nakagami et al. 2010). 
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4.3.3.6.8. Robicsek et al. (1984) ‘The value of thermography in the early diagnosis of 
postoperative sternal wound infections’ 
Between February and June 1983, Robicsek et al. (1984) conducted an observational 
cohort study to identify temperature changes associated with normal wound healing 
and patterns indicative of deep-seated wound infections. Using the infrared 
thermography system AGA Thermovision-680 (thermal dissolution power up to 0.1°C 
accuracy), the peri-sternal skin temperatures of 150 patients undergoing open-heart 
surgery, all of whom received prophylactic antibiotics pre-operatively and post-
operatively until all chest tubes were removed, typically from day 2 to day 4 
postoperatively, were recorded the day before surgery, and following surgery at day 7, 
day 14 and until discontinuation of treatment for patients with suspected wound 
infection (Robicsek et al. 1984). From a retrospective analysis of pre- and post-
operative wound temperatures, the patient sample was divided into two groups, 
subgroup A (n=125), those in whom wound temperatures returned to pre-operative 
peri-sternal skin temperature values within a 2 week period, and subgroup B (n= 25), 
those in whom the peri-sternal skin temperatures remained elevated (Robicsek et al. 
1984). 
 
4.3.3.6.9. Siah & Childs (2015) Thermographic mapping of the abdomen in healthy 
subjects and patients after enterostoma 
Over a six month period, Siah & Childs (2015) conducted a prospective, exploratory 
pilot study to chart the temperature of healing surgical wounds and to produce data to 
confirm the optimum IR imaging distance from skin temperature target field of view 
(FOV), the effects of body composition on abdominal skin surface temperature 
readings and the post-operative thermal characteristics of wounds with infection 
compared to those without infection. A sample of 30 afebrile “healthy” volunteers 
(aged 19-52 years; median 29 years) without evidence of concurrent inflammatory 
disease or significant co-morbidities were recruited to the study. A second sample of 
ten pre-operative patients of Chinese (n=7) and Malay race (n=3) admitted to hospital 
for surgical closure of enterostoma (ileostomy n=9, colostomy n=1) were also recruited 
to the study. Of the healthy participants, 3 were a body mass index (BMI) of less than 
18.5 (lean), 7 were greater than 25 (overweight), the remaining 20 were ranges within 
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normal ranges of 18.6 to 24.9, and, of the surgical patients, 8 were between 18.5 to 
24.9 (normal) and 2 were greater than 25. 
 
For a minimum of four hours prior to study commencement, all subjects were 
requested to refrain from smoking, ingesting caffeine, performing active exercise and 
applying topical agents to the abdomen. A clinical room was prepared for 
thermographic imaging by eliminating any potential sources of reflected infrared 
radiant heat sources and conditions were monitored using a Hot-Wire Anemometer 
(model TES-1341, TES Pte, Taipei) (healthy subjects: ambient temperature 24°C (range: 
24.0–24.3°C), relative humidity approximately 60% (range: 60–62%), still air <0.01m/s; 
patient sample: ambient temperatures 24–29°C (median: 26.5°C), relative humidity 
50–90% (median 70%), still air <0.01m/s). Temperature measurement was performed 
one day preoperatively, two hours following surgery and then daily for the remaining 7 
days, where possible, using a long-wave infrared camera FLIR T640 25° (ALX Pte, 
Singapore) (image resolution 640 x 480 pixels, spatial resolution 0.68mrad, calibrated 
and certified using a radiation source blackbody (FLIR Systems AB, Sweden)) with skin 
emissivity set to 0.98 and an operational temperature range span set to a range of 30-
38°C. A ‘rainbow’ high contrast (HC) palette was used for colour rendering so that the 
‘hottest’ temperatures would appear as white in colour and the ‘coolest’ temperatures 
as the darkest colours. Before closure of ileostomy and colostomy, the surrounding 
skin surface was mapped to an area of 4cm and, postoperatively, this area was 
typically reduced a rectangular region of interest of approximately 2cm of skin 
surrounding the closure site.  
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Table 9. Summary of temperature measurement methods 
Armstrong et al. (1996) 
Measurement 
Technique 
 For 15 minutes, patients rested in the examination room and then temperature measurements were made with a 
hand-held infrared skin temperature probe (Exergen DT 1001). Ambient air temperature was thermostatically 
controlled between 70°F ± 2°F during the test period.  
 To produce patient-specific control readings, the temperature was recorded on the matched anatomical site of 
ulceration on the contralateral extremity of each patient. 
Statistical Methods  The Mann-Whitney test used to compare sex, maximum pressure, haemoglobin A1C, and initial temperature gradient 
(99N/cm2 cut-off point for maximum pressure, 9% cut-off point for glycosylated haemoglobin). 
 Pearson’s test was used to compare the potential associations of ulcer duration prior to treatment and duration of 
treatment with skin temperature gradient. 
 Student’s t-test was used for matched samples to compare temperature differences between limbs. 
Armstrong et al. (2006) 
Measurement 
Technique  
 Subjects removed their shoes and rested in a supine position for 3 to 5 minutes.  
 The infrared thermometer was held approximately 1 inch above the skin and the temperature recorded.  
 Temperature measurements on the affected foot were taken as close as possible to the area of the diabetic foot 
infection.  
 Temperature measurements were taken in the corresponding area of the unaffected contralateral foot.  
 For patients with an amputation on the contralateral limb, temperature was measured on the distal aspect of the 
residual limb. 
Statistical Methods  Difference in surface skin temperatures was calculated by subtracting the temperature measurement of the 
unaffected foot from that of the affected. 
 Mean temperature changes from baseline to discontinuation of intravenous therapy (DCIV) were measured using 
paired t-test and 95% confidence intervals calculated. 
 To compare treatment groups with regard to the mean change in skin temperature difference from baseline to DCIV, 
analysis of covariance model with a factor for treatment group and covariate for baseline severity. 
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Dini et al. (2015) 
Measurement 
Technique 
 In an air-conditioned facility at a mean room temperature of 22°C, wound dressings were removed and patients were 
rested immediately for a period of 15 minutes.  
 Temperature measurements were then recorded using an infrared camera, FLIR T620 Thermal Imager (FLIR Systems, 
Boston, MA). 
Statistical Methods  Statistical analysis performed in MATLAB (Mathworks, Natick, MA) 
 The least- square algorithm was used to obtain a linear regression model of the temperatures of the wound bed or 
perilesional skin versus the wound bed score. 
 To determine if the variables were bivariate normal distributed, the validity of assuming a linear correlation, 
expressed by the Pearson’s coefficient analysis, was checked by the Kolmogorov- Smirnov test at a 95% confidence 
level. 
 The monotonicity of data was benchmarked by the Spearman’s rank-order coefficient. 
Horzic et al. (1996)    
Measurement 
Technique 
 Skin was dried of sweat before each measurement.  
 Two separate liquid crystal strips with temperature ranges of 34-35°C (lower strip) and 35-36°C (upper strip), 
corresponding to the different skin temperatures in the upper and lower areas of the wound, were placed in the 
centre of the incision site perpendicular to the direction of the wound.  
Statistical Methods  Each patient acted as their own control. 
 Photographs of the thermographic findings in each examinee were compared for temporal changes.  
 Data presented using a time series line graph. 
Horzic et al. (1996)  
Measurement 
Technique 
 In a separate room with a temperature of 18-20°C, patients rested for 10 to 15 minutes prior to temperature 
measurement using the AGA 780 thermovision system.  
 Pre-operative thermograms were recorded at the presumed incision site.  
 On the first post-operative day, thermograms were taken of the wound and its' surroundings with the patient in a 
supine position and, for the remainder of the study, thermograms were taken with patients in the upright position.  
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 Taking a maximum duration of 60 seconds, the thermovision measurement procedure also involved compiling a 
detailed register of each patient which included the conditions during the recording and the that were results 
obtained.  
 The thermovision image for every patient was recorded on a standard video recorder and all relevant data were 
logged on the audio channel. 
Statistical Methods  Each patient acted as their own control. Thermogram analysis involved conversion from grey-scale to thermal scale to 
temperature. 
 For each pre-operative day, thermographic measurements were quantitatively presented in degrees Celsius.  
 For post-operative temperature readings, quantitative analysis of thermogram readings was created using the 
measurement of the highest and the lowest temperature of each thermogram from the day of surgery to the eighth 
post-operative day, of which was reported graphically. 
 The absolute values of difference in the temperature between the wound and its’ surroundings were established and 
also reported graphically. 
Nakagami et al. (2010) 
Measurement 
Technique 
 Procedure conducted in a normal patient room without rigorous air conditioning.  
 Measurement temperature range was automatically adjusted according to the environmental temperature which 
ranged from 22.3°C to 39.4°C. Thermography was performed immediately after the removal of dressings.  
Statistical Methods  Kappa coefficients were used to evaluate the intra- and inter-rater reliability for temperature assessment. 
 The Wilcoxon rank sum test or chi-square test was used to compare demographic and baseline PU variables, including 
the DESIGN sub-scores and the wound areas between the high and low temperature groups. 
 To assess the predictive usefulness of a high temperature, sensitivity, specificity, and positive predictive values were 
calculated. All statistical analyses performed using Statistical Analysis System Version 9.1 (SAS Institute Inc., USA). 
Robicsek et al. (1984) 
Measurement 
Technique 
 Air currents in the room was set to a minimum, the patient removed all clothing from the chest area and, after 15 
minutes, infrared thermography was recorded using the AGA Thermovision-680 system. 
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Statistical Methods  To quantitate the thermal polaroid picture, a grid was placed over the image which permitted temperature 
measurements at 8 positions along the sternum.  
 Temperatures were determined by comparing with the reference colour to the average colour in each portion of the 
grid which increased or decrease by 0.5°C per colour change.  
 The 8 temperatures thus derived were averaged for a total sternal temperature at each designated time period. 
Siah & Childs (2015) 
Measurement 
Technique 
 Prior to the recording of thermal images, the infrared camera was stabilised on a tripod stand, connected to a power 
supply, switched on, allowed to stabilise and calibrate in the clinical room for 15 minutes. 
 Using the umbilicus as the central marker and the abdomen, the infrared camera was adjusted at an angle of 20° from 
the perpendicular to the abdominal surface.  
 The IR camera was set to automatic mode and the focus checked before the image was saved.  
 Subjects rested for ten minutes in the prepared clinical room.  
 With subjects in standing positions, thermographic images of abdominal skin surface were recorded at distances of 
30cm, 60cm and 100cm for healthy subjects and, based on these results, thermographic images were recorded at a 
distance of 100cm only for all the surgical patients. Measurements took approximately 25 minutes for each subject. 
Statistical Methods  Thermal images along with skin emissivity values, atmospheric temperature, relative humidity and distance between 
the abdomen and the camera lens detector were inputted and saved in Research IRTM software (FLIR Systems Inc., 
Sweden). 
 Statistical Package for the Social Sciences version 18 (SPSS, v18) was used for data analyses. 
 Descriptive statistics were used for quantitative data. 
 One-way repeated measures ANOVA was used to measure the effect of distance on IR temperature readings 
produced from the thermal maps. Statistical significance was set at the level of p<0.05.  
 One-way between-group analysis of variance was performed to explore for the effect of BMI on abdominal skin 
surface temperature. The interpretation of thermal images was described qualitatively. 
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4.4. Quality Appraisal of Included Studies  
No randomised controlled trials were identified as meeting the inclusion criteria for 
this systematic review however, a collection of studies with a variety of quantitative 
research designs assessed as suitable for inclusion. Employing the EBL Critical Appraisal 
check list (Glynn 2006), these studies were quality appraised. The EBL Critical Appraisal 
check list (Glynn 2006) generates quality scores to determine the validity of particular 
domains of a study, namely population, data collection, study design and results, 
where scores for Yes/Total (Y/T) of less than 75% or No + Unclear/Total (N+U/T) of less 
than 25% identify the presence of significant omissions. In addition, the checklist 
determines the total validity of a study where scores for Yes/Total (Y/T) of 75% or 
higher or No + Unclear/Total (N+U/T) of 25% or less indicate the validity of the study is 
of sound quality (Glynn 2006). With the aid of a hierarchy of evidence pyramid 
adapted specifically for this review (see Appendix 2), the quality of studies included is 
acknowledged in relation to study design.  
 
4.4.1. pH 
4.4.1.1. Quality appraisal for pH studies 
Using the EBL Critical Appraisal check list (Glynn 2006), quality scores of the studies 
included for pH measurement in wounds were generated, as presented in Table 10. 
The mean quality appraisal score for these studies was 54.48%. None of the studies 
yielded quality appraisal scores of Y/T ≥ 75% N+U/T ≤ 25%, meaning that the studies’ 
overall validities are questionable and thus the generalisability of the conclusions 
drawn from these studies is limited.  
  
Table 10. EBL Critical Appraisal Checklist scores for pH studies 
Study Reference Quality Score % 
Gethin et al. 2008 Y/T= 57.89%; N+U/T = 42.11% 
Ono et al. (2015) Y/T = 44.44%; N+U/T = 66.66% 
Shukla et al. (2007) Y/T = 61.11%; N+U/T = 38.89% 
 
183 
 
4.4.1.2. Research design appraisal for pH studies 
In respect to research design, all three studies addressing pH measurement in wounds 
were quantitative, two were prospective observational cohort design (Shukla et al. 
2007, Ono et al. 2015) and one was a prospective, single arm pre-post-test design 
(Gethin et al. 2008). As part of quality appraisal, the studies were compared by design 
to hierarchy of evidence pyramid. As evident in Figure 5, the studies correspond to 
level IV of the pyramid. 
 
 
Figure 5. Hierarchy of evidence pyramid for pH 
 
4.4.2. Exudate Composition 
4.4.2.1. Quality appraisal for exudate composition studies 
Using the EBL Critical Appraisal check list (Glynn 2006), quality scores of the studies 
included for measurement of exudate composition in wounds were generated, as 
presented in Table 11. The mean quality appraisal score for the studies involving 
exudate composition measurement in wounds was 46.54%. None of the studies 
yielded quality appraisal scores of Y/T ≥ 75% N+U/T ≤ 25%, meaning that the studies’ 
overall validities are questionable and thus there is limited generalisability to the 
conclusions drawn from the findings of these studies.  
 
LEVEL IV 
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Table 11. EBL Critical Appraisal Checklist scores for exudate composition studies 
Study Reference Quality Score % 
Bernatchez et al. (2013) Y/T = 50%; N+U/T = 50% 
Edsberg et al. (2012) Y/T = 44.44%; N+U/T = 66.66% 
Hoffman et al. (1999) Y/T = 44.44%; N+U/T = 66.66% 
James et al. (2000) Y/T = 50%; N+U/T = 50% 
Ladwig et al. (2002) Y/T = 42.11%; N+U/T = 57.89% 
Liu et al. (2009) Y/T = 27.78%; N+U/T = 72.22% 
Muller et al. (2008) Y/T = 61.11%; N+U/T = 38.89% 
Tarlton et al. (1997) Y/T = 44.44%; N+U/T = 55.56% 
Tarlton et al. (1999) Y/T = 50%; N+U/T = 50% 
Trengove et al. (1996) Y/T = 52.63%; N+U/T = 47.37% 
Trengove et al. (1999) Y/T = 52.63%; N+U/T = 47.37% 
Wyffels et al. (2010) Y/T = 38.89%; N+U/T = 61.11% 
 
4.4.2.2. Research design appraisal for exudate composition studies 
In respect to research design, all twelve studies were quantitative, with the majority 
prospective, descriptive, observational, cohort designs (Trengove et al. 1996, Tarlton et 
al. 1997, Hoffman et al. 1999, Tarlton et al. 1999, Trengove et al. 1999, James et al. 
2000, Ladwig et al. 2002, Muller et al. 2008, Liu et al. 2009, Wyffels et al. 2010, Edsberg 
et al. 2012, Bernatchez et al. 2013), two of which were pilot studies (Hoffman et al. 
1999, Muller et al. 2008), and one study, also a pilot, was retrospective, multicentre, 
descriptive cohort design  (Bernatchez et al. 2013). As part of quality appraisal, the 
studies were compared by design to hierarchy of evidence pyramid. As evident in 
Figure 6, the studies correspond to level IV of the pyramid. 
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Figure 6. Hierarchy of evidence pyramid for exudate composition 
 
4.4.3. Temperature 
4.4.3.1. Quality appraisal for temperature studies 
Using the EBL Critical Appraisal check list (Glynn 2006), quality scores of the studies 
included for temperature measurement in wounds were generated, as presented in 
Table 12. The mean quality appraisal score for the studies involving temperature 
measurement in wounds was 36.66%. None of the studies yielded quality appraisal 
scores of Y/T ≥ 75% N+U/T ≤ 25%, meaning that the studies’ overall validities are 
questionable and thus there is limited generalisability to the conclusions that are 
drawn from the findings of these studies. 
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Table 12. EBL Critical Appraisal Checklist scores for temperature studies 
Study Title  Quality Score % 
Armstrong & Lavery (1996) Y/T = 33.33%; N+U/T = 66.67% 
Armstrong et al. (2006) Y/T = 44.44%; N+U/T = 55.56% 
Dini et al. (2015) Y/T = 33.33%; N+U/T = 66.67% 
Horzic et al. (1996a) Y/T = 38.89%; N+U/T = 61.11% 
Horzic et al. (1996b) Y/T = 27.78%; N+U/T = 72.22% 
Nakagami et al. (2010) Y/T = 44.44%; N+U/T = 55.56% 
Robicsek et al. (1984) Y/T = 21.05%; N+U/T = 78.95% 
Siah & Childs (2015) Y/T = 50%; N+U/T = 50% 
 
4.4.3.2. Research design appraisal for temperature studies 
In respect to research design, all nine studies were quantitative, with the majority 
prospective, descriptive, observational, cohort designs (Robicsek et al. 1984, 
Armstrong & Lavery 1996, Horzic et al. 1996a, Horzic et al. 1996b, Armstrong et al. 
2006, Nakagami et al. 2010), and, of the remaining articles, one study was a clinical 
trial (Dini et al. 2015) and one was a prospective exploratory cohort design (Siah & 
Childs 2015). As part of quality appraisal, the studies were compared by design to 
hierarchy of evidence pyramid. As evident in Figure 7, the studies correspond to level 
IV of the pyramid. 
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Figure 7. Hierarchy of evidence pyramid for temperature 
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4.5. Results of Outcomes of Interest for this Review  
Given that the search strategy did not yield any eligible randomised controlled trials 
for inclusion in this systematic review, conducting a meta-analysis of the chosen 
research studies was not possible. The results of the studies are therefore presented in 
a narrative format with respect to the outcomes of interest for this review. These 
outcomes are, primarily, an objective measure of pH, exudate composition and 
temperature as predictors of wound healing outcomes and, secondarily, an objective 
measure of the reliability and validity of current methods used for the measurement of 
wound pH, wound exudate composition, wound temperature. The reporting of study 
results is arranged by concept, pH, exudate composition and temperature, in the form 
of data tables to outline the principle findings followed by narrative summaries to 
describe and develop meaning from these findings. 
 
4.5.1 pH 
In respect to the outcomes of interest for this review, this section reports the results of 
the included studies relating to pH measurement in wounds. A table is presented that 
outlines the principle results of each of the three studies and is followed by a narrative 
summary to acknowledge and develop meaning from the findings (see Table 13). 
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Table 13. Summary of results for pH studies 
Study Reference Results 
Gethin et al. (2008) 
 
Start-of-study: 
 Mean wound pH:  
7.72 (SD 0.339)  
 Mean wound size:  
10.1 cm2 (SD 13.98) 
End-of-study:  
 Mean wound pH:  
7.26 (SD 0.53) (decrease in wound pH (p<0.001)). 
 Mean wound size:  
9.1 cm2 (SD 16.25) (decrease in wound size (p=0.274)). 
Ono et al. (2015) 
 
Start-of-study mean wound pH:  
 Non-infected wounds:  
pH 8.6 (range 7.7–9.0) 
 
 
 
 
 Infected wounds: 
pH 8.0 (range 6.5–9.0) 
 
During study mean wound pH:  
 Non-infected wounds: 
range pH 5.0-9.0 
 
 
 
 
 Infected wounds: 
range pH 6.5-10.0 
 
End-of-study mean wound pH: 
 Non-infected wounds:  
Not reported (Statistically 
significant decrease between 
initial and final pH measurement 
just prior to epithelialization 
(p<0.05)). 
 Infected wounds: 
Not reported (Statistically 
significant increases in pH 
compared to previous 
measurement (p<0.01). 
Shukla et al. (2007) 
 
Start-of-study (day 1): 
 Wound pH: 
>9: 54% 
8.5-9.0: 40% 
8.0-8.5: 6% 
7.5-8.0: 0% 
 Wound condition: 
During study (day 7):  
 Wound pH: 
>9: 10% 
8.5-9.0: 48% 
8.0-8.5: 40% 
7.5-8.0: 2% 
 Wound condition: 
End-of-study (day 15): 
 Wound pH: 
8.5-9.0: 26% 
8.0-8.5: 26% 
7.5-8.0: 34% 
<7.5: 14% 
 Wound condition: 
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Unhealthy: 94% 
Granulating: 4% 
Healing: 2% 
Unhealthy: 12% 
Granulating: 68% 
Healing: 20% 
Unhealthy: 2%  
Granulating: 42% 
Healing: 56% 
191 
 
4.5.1.1. Summary of Results for pH Studies 
Of the three studies included for the measurement of pH in wounds, the general findings 
appear to suggest that reducing levels of pH are associated with improvements in wound 
condition.  
 
In the study by Gethin et al. (2008), a corresponding correlation appears to exist 
between measurements of pH and wound healing as the mean pH levels and mean 
wound size reduce from start-of-study to end-of-study from pH 7.72 to pH 7.26 
(p<0.001) and 10.1 cm2 to 9.1 cm2 (p=0.274), respectively. Although the reduction in 
wound size fails to reach statistical significance, the relationship of these two variables 
is potentially of clinical significance. 
 
In relation to wound infection, the study by Ono et al. (2015) found that wounds that 
healed without the occurrence of infection had statistically significant decreases in 
wound pH measurements taken at the start of the study to measurements taken just 
prior to epithelialization on completion of the study (p<0.05). In contrast, wounds that 
developed infection showed statistically significant increases from previous 
measurements to those recorded on completion of the study (p<0.01). 
 
Exploring temporal changes in pH levels with those of wound condition, Shukla et al. 
(2007) revealed a general association between reducing pH levels and improved wound 
condition. At the start of the study the majority of wounds had pH measurements of 
above pH 9 (54%), with 94% of all wounds in the sample measuring a pH of 8.5 or greater, 
and 94% of wounds documented as unhealthy in terms of wound condition. Conversely, 
by the end of the study the majority of wounds (34%) had pH levels between 8.0 and 
8.5, with no wounds measuring above a pH level of 9, and 56% of wounds documented 
as having exhibiting healing conditions (Shukla et al. 2007). Notably, the reduction of 
wound pH levels reached statistical significance from both day 1 to day 7 (p=0.001) and 
day 7 to day 15 (p=0.001).  
 
In summary, these findings appear to suggest that as the pH level reduces in alkalinity 
towards an increasingly neutral pH, wound conditions are more indicative of progressing 
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wound healing in terms of wound size, wound infection and wound bed tissue. As the 
studies vary in respect to study design, outcome measures and reporting, it was not 
possible to accurately illustrate a specific pattern of the changes measured in pH levels 
in relation to those of wound condition.  
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4.5.2. Exudate Composition 
In respect to the outcomes of interest for this review, this section reports the results of 
the included studies relating to exudate composition measurement in wounds. A table 
is presented that outlines the principle results of each of the twelve studies and is 
followed by a narrative summary to acknowledge and develop meaning from the 
findings (see Table 14). 
 
. 
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Table 14. Summary of data extraction table for exudate composition studies 
Study Reference Results 
Bernatchez et al. 
(2013)  
 MMP-9, HNE, and baseline wound area did not significantly discriminate between progressing and worsening 
wounds. 
 NOx represented the only significant covariate to discriminate between progressing and worsening wounds. The 
midpoint of 3.25 yielded the same AUC as 3.2 and 3.3 of 0.8121 (95% CI: 0.6716, 0.9526).  
 Approximate NOx values of >57mM and <12mM appeared to represent worsening wounds; Approximate values 
between 13.5 and 49mM tend to be progressing wounds. 
 NOx analytical results did not separate stagnating wounds from the progressing wounds. 
Edsberg et al. (2012)   515 internal and 467 peripheral wound fluid swabs collected in total. 
 Wound fluid samples from interior wound location showed higher protein concentrations than from the wound 
periphery for all outcomes (p < 0.0001).  
 Periphery samples compared to interior samples (chronic wounds only): 19 proteins differentially expressed 
between the interior and periphery of wounds;  
 4 proteins (pyruvate kinase isozymes M1/M2, profilin-1, Ig lambda-1 chain C regions, and Ig gamma-1 chain C 
region) present in lower levels, 
 6 proteins (keratin, type II cytoskeletal 6A (KRT6A), keratin, type I cytoskeletal 14, S100 calcium binding proteins 
A7, alpha- 1-antitrypsin precursor, haemoglobin subunit alpha, and haemoglobin subunit beta) present in higher 
levels. 
 Mixed linear model for each protein to compare temporal trends in concentration between healed and chronic 
samples: only one of 58 proteins had significant values for all four parameters in the model, monokine induced by 
gamma interferon (MIG), synonymous with chemokine (C-X-C motif) ligand 9 (CXCL9). CXCL9 increased as wounds 
healed and remained almost constant or decreased slightly for ulcers that were not approaching closure. (specific 
data not numerically reported). 
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 Discriminant function analysis to test the ability of total protein concentration to be used as an indicator of 
wound status or outcome: no significant models resulted; no statistically significant correlation between wound 
fluid total protein concentration and clinical outcome (Specific data not numerically reported). 
Hoffman et al. (1999)  During 6 week study period: 
 NE activity varied widely. 
 NE activity levels: no correlation with wound healing. 
 NE activity levels recoverable one-week after adding wound fluid to bandages varied. 
 
9 month follow-up: 
 NE activity levels: no correlation with wound healing. 
 (All data not reported; some data described and/or graphically displayed). 
James et al. (2000)  Median (range); SD 
 Total protein (g/l): 
 Albumin (g/l):  
Non-healing (n=8) 
30 (20-42); 7.6 (p < 0.05) 
17.0 (14-27); 4.3 (p < 
0.05) 
vs  
vs 
vs 
healed wounds (n=4) 
44.3 (30-49); 8.8  
25 (25-29); 2.3. 
 Glucose: Unable to analyse reliably by routinely available methods due to low levels, typically <1 mmol/l. 
 Lactate, urea, creatinine, LDH: No statistically significant difference. 
 
Subset analysis: (Initial wound fluid collection sample compared to a second sample collected during the 12 week study 
period) 
Non-healing wounds (n=3) 
 Total protein (g/l): 2 wounds: >30 vs <30   
                                                1 wound:  <30 vs <30 
 
 Albumin (g/l):         1 wounds: <30 >20 vs <20   
                                                2 wound:  <20 vs <20 
Healing wound (n=1) 
 Total protein (g/l): 41 vs 72  
 
 
 Albumin (g/l):         25 vs 38 
 
Ladwig et al. (2002)  MMP-9:  
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 Day 0: Activated MMP-9 levels higher in poor healers compared with good healers (p < 0.05).  
 Day 10: Pro MMP-9 and activated MMP-9 exhibited inverse relationship with percent wound closure (p < 0.05).  
 Day 36: Only activated MMP-9 exhibited an inverse relationship with percent wound closure (p < 0.05).  
MMP-2: 
 Day 0: Pro-MMP-2 difference between good healers and poor healers (p=0.077).  
 Days 10 and 36: MMP-2 levels did not progressively decrease as healing proceeded on but remained almost 
constant. 
TIMP-1: 
 Day 0: TIMP-1 levels lower in poor healers compared to good healers (p=0.05).  
 Day 10: TIMP-1 levels increased in poor or intermediate healers  
 Day 36: TIMP-1 levels in poor or intermediate healers similar to good healers. 
Total MMP-9/TIMP-1 ratio:  
 Day 0: Greatest difference in ratios of MMP-9/TIMP-1 between the groups recorded; ratio approximately four-fold 
higher in poorly healed ulcers and, approximately twofold higher in ulcers healed intermediately, compared to 
patients who healed well (p < 0.05).  
 Days 0, 10, and 36: Total MMP-9/TIMP-1 ratio significantly lower in good healers compared to poor healers or 
wounds that healed intermediately. 
 Days 10 and 36: MMP-9/TIMP-1 ratio decreased compared with day 0 values of poor healers (p≤0.05) A similar 
trend seen in ulcers that healed intermediately. 
Liu et al. (2009)  Week 4 assessment: (No ulcers completely healed) 
 Pro-MMP-9: correlation with wound healing rate (r = 0.4538, p < 0.001). 
 Pro-MMP-9-to-TIMP-1 ratio: correlation with wound healing rate (r = 0.4959, p < 0.0001).  
 MMP-2:  correlation with wound healing rate not significant. 
 TIMP-1: correlation with wound healing rate not significant. 
 
End of study assessment (week 12): 23 ulcers healed at 12-weeks (no differences in age, duration of diabetes, or initial 
size of the ulcer between the healed and unhealed groups). 
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Unhealed vs healed wounds:  
 Pro-MMP-9 µg/ml:  
 Active–MMP-9 µg/ml:  
 TIMP-1 pg/ml:  
 TGF-β1 pg/ml:  
 Pro-MMP-9-to-TIMP-1 ratio:  
 Active-MMP-9-to-TIMP-1 ratio:  
 
8.19 ± 2.75 
2.90 ± 1.64 
531.2 ± 377.6 
142.4 ± 119.7 
18.88 ± 6.87 
6.01 ± 1.08 
 
vs 4.47 ± 2.75 
vs 1.18 ± 1.21 
vs 732.5 ± 270 
vs 231.9 ± 141.9 
vs 7.2 ± 5.24 
vs 2.03 ± 2.47 
 
p<0.01 
p<0.05 
p<0.05 
p<0.01 
p<0.05 
p<0.05 
 Measurement of pro–MMP-9 with addition of cut-offs for TIMP-1 at >480 pg/ml and TGF-β1 at >115 pg/ml was 
the best predictor of wound healing (area under the curve 0.94; P < 0.00001). Sensitivity and specificity were 87% 
and 91%, respectively, and predicted outcome in 94% of cases. 
 
Muller et al. (2008)  
 
Initial Assessment: 
Good Healers (n = 7) vs Poor healers (n = 9): 
 MMP-1: 4.88 (2.43-10.32) vs 2.66 (9–2.69) (p = 0.1)  
 Total MMP-2: 22.89 (12.4–37.78) vs 42.22 (23.63–57.46) 
 Activated MMP-2: 5.41 (0–9.82) vs 5.75 (4.95–7.88) 
 MMP-8: 140.44 (70.8–342.2) vs 279.63 (109.5–350) 
 Total MMP-9: 461.6 (282–524) vs 479.4 (246.4–876.6) 
 Activated MMP-9: 0 (0–7.16) vs 20.85 (0–81.2) (p= 0.068) 
 TIMP-1: 3.25 (2.93–5.01) vs 4.26 (3.47–4.96) 
 
During the 12 weeks of follow-up:  
Good healers:  
 Between W0 and W2; MMP-8 and MMP-9 levels remained stable.  
 Between W0 and W4; difference in MMP-9 levels did not reach significance (P=0.14).  
Poor healers: 
 MMP-8 and MMP-9 levels remained constant.  
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 MMP-1: significantly higher at W0 in good healers compared to poor healers at week 2 [4.78 pg/μg of protein (CI 
1.9–7.65) vs. 2.27 pg/μg (CI 1.24–0.29); P=0.039]. MMP-1 level in good healers appeared to diminish during the 
study whereas it remained stable in poor healers. 
 TIMP-1: No significant difference in the TIMP-1 level between the two groups. 
 MMP-2: level did not differ between the groups during the study. 
 MMP-1/TIMP-1 ratio: not significantly different at W0 in good healers compared to poor healers (P=0.064).  
 Initial (W0) MMP-1/TIMP-1 ratio correlates positively with reduction in wound area at week 4 (r=0.65; P=0.008) 
and week2 (r=0.69, P=0.009).  
 Initial (W0) MMP-1/TIMP-1 ratio of 0.39 has a sensitivity of 71% and a specificity of 87.5% to predict a reduction 
in wound area of ≥82% by week 4. 
Tarlton et al. (1997)  ProMMP-9: 
Acute surgical wounds;  
 At 24 hours proMMP-9 levels peaked from baseline levels (mastectomy wound group (M) 4-fold increase; 
colectomy wound group (C), 10-fold increase) 
 Between 3 and 24 hours post-surgery: a sharp increase in proMMP-9 activity in mastectomy wounds (colectomy 
wound fluid collection did not commence until 24 hours).  
 Between 24 and 48 hours post-surgery: MMP-9 levels significantly decreased (M: P = 0.015, C: P<0.001).  
 Between 24 and 72 hours: MMP-9 levels significantly decreased (M: P = 0.003, C: P<0.001). 
 
Mastectomy wound fluids subsequently found to be infected;  
 Between 24 and 48 hours post-surgery: no drop in proMMP-9 levels. 
 At 72 hours post-surgery: further elevation (clinical signs of an infection were not noted until 96 hours). 
 Maximum expression of pro-MMP-9 2.2 times that of the mean maximal of non-acute fluids. 
 
Chronic wounds fluids (n=6) compared with mastectomy (n=2) and colectomy (n=3) wound fluid samples; 
 ProMMP-9 elevated in chronic samples above the average maximal (24 hours) acute wound fluids by a factor of 3 
(P< 0.01).  
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ProMMP-2: 
Acute surgical wounds;  
 MMP-2 levels increased in both groups. Greater in colectomy group with increase from 24 to 72 hours by a factor 
of 1.2 (P = 0.003).  
 
Chronic wounds fluids (n=6) compared with mastectomy (n=2) and colectomy (n=3) wound fluid samples;  
 1.8-fold increase in ProMMP-2 of chronic wound fluid samples compared to the mean maximal levels of acute fluids 
(not statistically significant).  
 
Acute wound fluids subsequently found to be infected;  
 ProMMP-2 levels of infected surgical wound fluids reached a maximum of 2.8 times that of the mean maximal acute 
fluids. 
 
Fluid serum ratio of MMP-9: 
Acute surgical wounds;  
 At 24 hours post-surgery: Maximal MMP-9 from baseline levels in wound fluid to serum ratio (7-fold increase in 
the mastectomy group, 5-fold increase in colectomy group).  
 Between 24 and 48 hours post-surgery: MMP-9 levels in both groups (M: 0.78, P=0.35, C: 0.5, P=0.08).  
 Between 24 and 72 hours post-surgery: ratios remained lower in both groups (M: 0.65, P = 0.14; C: 0.35, P<0.02). 
 (All results data not reported; data reported descriptively and/or using line graphs and images). 
Tarlton et al. (1999)   ProMMP-9, proMMP-2, activated MMP-2, type I collagen C propeptide (CICP), and neutrophil elastase (NE): 
greater expression in more severe wounds (only pro-MMP-9 statistically significant).   
 Activated MMP-9: no apparent trend. 
 Pro-MMP-9: significant difference between improving and deteriorating wounds (p = 0.006). 
 
Subset analysis (paired samples): 
 Pro-MMP-9: statistically significant difference between improving and deteriorating wound sites (p<0.001). 
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 NE: statistically significant difference between improving and deteriorating wound sites (p<0.005). 
 (All results data not reported; data reported descriptively and/or using line graphs and images). 
Trengove et al. (1996)  
 
 
 
 
 
 
 
Median wound size reduction: 12% (range 1-23%) (statistical significance not reported). All ulcers showed granulation 
tissue formation and epithelialisation at 2 weeks.  
 
Non-healing versus healing phase (range): 
Bicarbonate (mmol/L):  
Glucose (mmol/L):  
Total protein (gm/L):  
Albumin (gm/L):  
CRP (gm/L):  
Gamma-Globulin (gm/L):  
Cholesterol (mmol/L):  
  
17.5 (14-20) 
1.2 (0.6-3.7) 
34 (26-46) 
19 (14-24) 
13 (5-25) 
4.5 (3.9-6.6) 
1.6 (1.2-3.2) 
 
vs 19 (16-22)  
vs 2 (1.1-5.9) 
vs 41 (36-51) 
vs 23 (18-28) 
vs 5 (2.5-21) 
vs 6 (4.4-9.0) 
vs 1.8 (1.3-3.2) 
 
(p=0.02) 
(p=0.02) 
(p=0.01) 
(p=0.01) 
(p=0.02) 
(p=0.01) 
(p=0.05) 
Trengove et al. (1999)  Phase 1 Study: 
Mean protease level (μg MMP Eq/ml):  
 Acute wounds: 0.75 ± 0.3 (median 0.76). 
 Chronic wounds: 59.9 ± 70.9 (median 22.8). (difference p < 0.001). 
Median neutrophil elastase activity (μg/ml) (Acute wound fluid samples (14), Chronic wound fluid samples (13): 
 Acute wounds: < 1 (below the level of detection) in all samples.  
 Chronic wounds: 7 samples < 1.  
     6 samples with elevated levels (median 99.5 (range: 5.9–344 μg/ml). 
Cathepsin G activity (μg/ml) (Acute wound fluid samples (14), Chronic wound fluid samples (13): 
 Acute wounds: < 1 in all samples.  
 Chronic wounds: < 1 in 9 samples,  
 4 samples with elevated levels (range 5.2 - 49 μg/ml).  
Median TIMP-1 levels (μg/ml): 
 Acute wounds: 44 
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 Chronic wounds: 0.8 
 (In same samples) Elevated TIMP-1 levels correlated with low MMP levels and elevated MMP levels correlated with 
low TIMP-1 levels (p = 0.02, r = – 0.78, Spearman correlation). 
Median percentage degradation of Epidermal Growth Factor (EGF) 
 Acute wound fluid: 0.6% (range 0.2-1.2%, mean 0.6%)  
 Chronic wound fluid: 8.5% (range 1.2-100%, mean 28.1%) (difference p < 0.001).  
 Percentage degradation of EGF in acute and chronic wound fluid samples correlated with MMP activity measured 
with the azocoll assay (p < 0.001). 
 EGF degradation by wound fluid samples was completely inhibited by MMP inhibitor Illomostat (data not reported). 
 
Phase 2 Study: 
Mean protease level (μg MMP Eq/ml):  
Initial sample: 
 Non-healing wounds (n=15): 38 ± 10 (median 23.3, range 1.3–140.4).  
Sample at 2 weeks: 
 Healing wounds (n=12): (11 ±4; mean reduction 49%) (median 4.8, range 0.3–64.9). (difference p < 0.01). 
 All wounds (15):  
 MMP inhibitor Illomostat (Galardin) test: reduction of 0.31 ± 0.04 (median 0.26, range 0.06–1.01) (overall reduction 
approx. 90%). 
 Mean trypsin levels (Eq/ml): 
 Reduction in Azocasein protease levels from 322 ± 94 to 190 ± 35 (medians 226.7 to 189.5) (p > 0.05) (overall 
reduction approx. 66%). 
 Median neutrophil elastase activity (μg/ml) (not detectable in 4 patients) 
 Non-healing wounds: 1.4 (range, < 1–11.9)  
 Healing wounds: 0.6 (range, < 1–8.6) (difference p > 0.05). 
Wyffels et al. (2010)   (Temporal comparisons available for 19 wounds): 
 Healed wounds: temporal trend showing increased number of protein spots coincident with wound closure. 
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 Unhealed wounds: no temporal trend.  
 (Temporal effects showed statistically significant difference between healed and unhealed wounds). 
 Interaction between stain and location (peripheral (P) vs internal (I)): 12 of 19 wounds showed statistically 
significant differences for super-spot abundance.  
 Protein S100A9 identified as a potential biomarker of wound healing. 
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4.5.2.1. Summary of Results for Exudate Composition Studies 
As distinctly evident from the descriptions of the studies examining exudate 
composition, a vast array of components of exudate have been measured for their 
significance in relation to wounds and wound healing. Consequently, data tables were 
formulated in order to clearly depict the analytes of exudate that were measured in 
each study (see Appendices 18 to 20 and Table 15) and to illustrate the most 
frequently measured analytes within the collection of included studies (see Table 16).  
 
As demonstrated in tables 15 and 16, MMP-9, MMP-2, tissue inhibitor of 
metalloproteinase, neutrophil elastase and albumin, in successive order, were the 
most frequently measured analytes in wound exudate. To a lesser extent, bicarbonate, 
glucose, total protein, albumin, CRP, gamma-globulin, cholesterol (Trengove et al. 
1996), TGF-β1 (Liu et al. 2009) and MMP-1 (Muller et al. 2008), were also found to be 
components of wound exudate measured and studied for their role in wound healing. 
Due to the quantity of various components researched, only a selected number are 
discussed in individual detail and these are those explored most commonly, namely, 
MMP-9, MMP-2, nitric oxide, albumin, neutrophil elastase, total protein, tissue 
inhibitor of metalloproteinase and MMP/TIMP ratio. As two of the included papers 
described performing proteomic research that entailed measuring vast numbers of 
various components in wound exudate to determine the ones most significant in 
relation to wound outcomes, the results of these studies are also discussed further. 
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Figure 8. Quantity of different exudate composites in decending order of frequency 
measured: The 6 most frequently measured composites illustrated in red and the 
remaining 23 composites in blue; shades becoming lighter with descending order of 
measurement frequency. [MMP-9 (Matrix Metalloproteinase-9), MMP-2 (Matrix 
Metalloproteinase-2), TIMP (Tissue Inhibitor of Metalloproteinase), NE (Neutrophil 
Elastase), Albumin, MMP/TIMP ratio (Matrix Metalloproteinase/ Tissue Inhibitor of 
Metalloproteinase ratio), Creatinine, Glucose, Lactate, LDH (Lactate Dehydrogenase), 
MMP-1 Matrix Metalloproteinase, MMP-8 (Matrix Metalloproteinase), Total Protein, 
Proteomics, Urea, ALP (Alkaline Phosphatase), ALT (Alanine Aminotransferase), AST 
(Aspartate Aminotransferase), Αlpha-1-Globulin, Αlpha-2-Globulin, Βeta-Globulin 
Bicarbonate, Bilirubin, Calcium, Cathepsin G, Chloride, Cholesterol, CICP (Type I Collagen 
C-Propetide), C3 (Complement Factor 3), C4 (Complement Factor 4), CK (Creatinine 
Kinase), CRP (C-reactive Protein), EGF (Epidermal Growth Factor), Gamma-Globulin, GGT 
(Gamma Glutamyltranspeptidase), Magnesium, MMP-3 (Matrix Metalloproteinase-3), 
MMP-10 (Matrix Metalloproteinase-10), MMP-13 (Matrix Metalloproteinase-13), NOx 
(Nitric Oxide), Phosphate, Potassium, Sodium, TGF-β1 (Transforming Growth Factor Beta 
1), Triglycerides, Trypsin, Uric Acid]. 
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Figure 9. Most frequently measured exudate composites 
 
4.5.2.1.1. Matrix Metalloproteinase-9 (MMP-9) 
As the most commonly measured component of wound exudate in the included 
studies, MMP-9 levels were measured in eight studies in the form of pro-MMP-9 and 
activated MMP-9, (Tarlton et al. 1997, Tarlton et al. 1999, Trengove et al. 1999, Ladwig 
et al. 2002, Muller et al. 2008, Liu et al. 2009, Edsberg et al. 2012, Bernatchez et al. 
2013). Measurement methods included fluorometric assays, SDS-PAGE and 2D-PAGE, 
however, gelatin zymography was the most frequently performed technique used to 
identify MMP-9.  
 
On initial assessment, Ladwig et al. (2002) found activated MMP-9 levels were higher 
in the wounds of poor healers compared with good healers (p < 0.05). However, as the 
study progressed (day 10), both activated MMP-9 and pro MMP-9 exhibited inverse 
relationships with percentage wound closure (p < 0.05). Furthermore, on completion 
of the study (day 36), activated MMP-9 remained the only wound exudate component 
to exhibit an inverse relationship with percentage wound closure (p < 0.05). In a similar 
way, Liu et al. (2009) discovered statistically significant higher levels of both pro MMP-
9 and activated MMP-9 in the initial exudate composition measurements of wounds 
that failed to heal compared to those that healed following a period of twelve weeks 
0 1 2 3 4 5 6 7 8 9
Albumin
MMP/TIMP ratio
NE
TIMP
MMP-2
MMP-9
Number of Studies Measuring Each Composite
Ex
u
d
at
e
 C
o
m
p
o
si
te
s
206 
 
(pro MMP-9: 8.19µg/ml ±2.75 versus 4.47 ±2.75, p<0.01; activated MMP-9: 2.90µg/ml 
± 1.64 versus 1.18 µg/ml ± 1.21, p<0.05).  
In the temporal study by Tarlton et al. (1999) that categorised wounds by severity as 
improving, static or deteriorating according to wound progression between 
assessments, the expression of pro MMP-9 appeared to be highly statistically 
significant with increasing wound severity (p = 0.006). Whilst activated MMP-9 showed 
no statistically significant association with wound progression. In the same study, 
Tarlton et al. (1999) explored further a subset of paired exudate samples collected 
simultaneously from improving and deteriorating regions of the same wound and 
found statistically significant differences in levels of both activated MMP-9 (p < 0.05) 
and pro MMP-9 (p < 0.001) between the wound sites. The combined results of this 
study by Tarlton et al. (1999) establish MMP-9 as a significant component of exudate in 
relation to wound progression and thus suggest it as a potential indicator of 
subsequent wound healing. Trengove et al. (1999) also supported these findings in 
their study that compared wound exudate samples that were initially obtained from 
leg ulcers when they were in a phase of non-healing and then when they were in a 
phase of healing in demonstrating that the elevated levels of MMP activity decreased 
significantly as the wounds progressed into the healing phase (p < 0.01).  
 
Comparing the characteristic temporal reductions in levels of MMP-9 in the exudate of 
normally healing acute surgical wounds to that of chronic non-healing wounds, Tarlton 
et al. (1997) found no reductions in MMP-9 levels in the exudate of the chronic 
wounds. In contrast, Tarlton et al. (1997) found MMP-9 levels in acute normally 
healing wounds to rise in the initial 24 hour postoperative period and then sharply 
decrease over the subsequent two days. Although exudate composition measurements 
performed by Muller et al. (2008) at the start of the study showed no statistically 
significant differences in total MMP-9 levels between wounds that, at four weeks, had 
surface size reductions of at least 82%, ‘good healers’, and wounds that had a surface 
size reductions of less than 82%, ‘poor healers’, activated MMP-9 levels in isolation 
were found to be approaching statistical significance (p = 0.068) (Muller et al. 2008). 
Findings by Muller et al. (2008) showed that measurements of MMP-9 levels in good 
healers remained stable until two weeks into the study before beginning to decrease 
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and, even though the reduction in the level of MMP-9 in good healers following four 
weeks did not reach statistical significance (p = 0.14), it is of note to acknowledge the 
fact that the level of MMP-9 in poor healers did not reduce but remained constant 
throughout the entire follow up period of twelve weeks (Muller et al. 2008). 
 
Focusing on levels of pro MMP-9 in relation to acute wound healing and infection 
development, Tarlton et al. (1997) described initial rises in levels of pro MMP-9 from 3 
to 24 hours postoperatively which were followed by a statistically significant decreases 
MMP-9 levels between 24 and 48 hours (p < 0.015), and between 24 and 72 hours (p < 
0.003). In contrast, wound exudate samples from post-operative wounds subsequently 
found to be infected showed no drop in pro MMP-9 levels between the first and 
second postoperative day with further elevations in levels on the third postoperative 
day. When acute surgical wounds that healed normally (wounds not developing 
infection) were compared to chronic wound exudate specimens, pro MMP-9 levels 
were statistically significantly elevated above the average maximal levels that had 
been recorded at 24 hours in acute wound fluids by a factor of 3 (p < 0.01), and 
remained elevated for extended periods. Conversely, the maximum expression of pro 
MMP-9 was 2.2 times higher in acute surgical wounds that developed infection than 
chronic wound exudate specimens.  
 
In contrast to the results of these studies, research by Bernatchez et al. (2013) found 
that levels of MMP-9 in wound exudate did not significantly discriminate between 
progressing and worsening wounds. Furthermore, the study by Edsberg et al. (2012) 
failed to report a statistically significant correlation between MMP-9 levels and clinical 
wound outcome.  
 
4.5.2.1.2. Matrix Metalloproteinase-2 (MMP-2) 
The second most frequently measured component of wound exudate of the included 
studies, MMP-2 was measured in seven of the studies in the form of pro MMP-2 and 
activated MMP-2 (Tarlton et al. 1997, Tarlton et al. 1999, Trengove et al. 1999, Ladwig 
et al. 2002, Muller et al. 2008, Liu et al. 2009, Edsberg et al. 2012). Similar to the 
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measurement of MMP-9, methods to identify MMP-9 in wound exudate included 
fluorometric assays, SDS-PAGE and 2D-PAGE, however, gelatin zymography was the 
most frequently performed technique. 
 
Muller et al. (2008) found no statistically significant difference between the levels of 
MMP-2 in the exudate of wounds that, at four weeks, had surface size reductions of at 
least 82%, ‘good healers’, and wounds that had surface size reductions of less than 
82%, ‘poor healers’, 5.41 pg/μg and 5.75 pg/μg, respectively. Similarly, Tarlton et al. 
(1999) reported that neither pro MMP-2 nor activated MMP-2 levels in wound exudate 
showed statistically significant differences between venous leg ulcers that were 
categorised as improving, static or deteriorating. Supporting the findings of these two 
studies, Liu et al. (2009) also found no statistically significant correlation between 
MMP-2 levels and wound healing rate. Yet again, Ladwig et al. (2002) likewise found 
no difference between initial MMP-2 levels in wounds classified as good healers and 
poor healers (p = 0.077) and, as healing progressed at 10 and 36 days into the study, 
MMP-2 levels did not appear to decrease but remained almost constant. 
 
In acute surgical wounds, Tarlton et al. (1997) reported levels of pro MMP-2 increased 
by a factor of 1.2 from baseline levels at twenty-four hours to maximal levels at 
seventy-two hours in post-colectomy subjects (p = 0.003). When compared to chronic 
wound exudate composition, a 1.8-fold elevation was reported in the chronic exudate 
relative to the mean maximal of the acute wound exudate, however this was not 
statistically significant (Tarlton et al. 1997). In respect to acute surgical wounds that 
later went on to develop infection, pro MMP-2 levels reached a maximum of 2.8 times 
that of the mean maximal of acute wounds without infection development (Tarlton et 
al. 1997). 
 
4.5.2.1.3. Neutrophil Elastase 
Another exudate composite found to be frequently measured and analysed in relation 
to wound healing was neutrophil elastase. Of the included papers, the four studies 
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encompassing measurement of this component were conducted by Hoffman et al. 
(1999), Tarlton et al. (1999), Trengove et al. (1999), Bernatchez et al. (2013). 
 
Two experiments performed by Hoffman et al. (1999) to examine neutrophil elastase 
in the wound exudate of leg ulcers found wide variations in the amount of elastase 
measured from the bandages with no consistent correlation between the activity of 
elastase and wound healing, as determined by a nine months follow up period. 
Furthermore, the stability of neutrophil elastase in the wound bandages examined by 
measurements at different time points varied significantly from approximately 50% to 
100%, depending on the type of bandage used (Hoffman et al. 1999). 
When neutrophil elastase activity was compared between acute and chronic wound 
exudate samples in the study by Trengove et al. (1999), levels of neutrophil elastase 
were elevated in almost half of the chronic wounds whereas levels were below the 
level of detection (< 1 μg/ml) in the acute wounds. Analysing sequential wound fluid 
samples from non-healing and healing venous leg ulcers, levels of neutrophil elastase 
were found to vary considerably and, despite a decrease in the median neutrophil 
elastase levels from 1.4 μg/ml (range, < 1–11.9 μg/ml) in the exudate from non-healing 
wounds to 0.6 μg/ml (range, < 1–8.6 μg/ml) from healing wounds, this decrease failed 
to achieve statistical significance (p > 0.05). Similarly, in the study by Bernatchez et al. 
(2013) measurements of neutrophil elastase levels in wound exudate showed no 
potential to significantly discriminate between progressing and worsening wounds. 
 
In contrast, for samples simultaneously collected from improving and deteriorating 
regions of the same wound, Tarlton et al. (1999) found from paired data analysis 
statistically significant differences in levels of neutrophil elastase (p < 0.005), with the 
greatest levels in wound regions exhibiting the poorest healing performance. 
 
4.5.2.1.4. Tissue Inhibitor of Metalloproteinase (TIMP) 
Five of the studies included in this review reported measuring TIMP levels (Trengove et 
al. 1999, Ladwig et al. 2002, Muller et al. 2008, Liu et al. 2009, Edsberg et al. 2012).  
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Analysing measurements of TIMP-1 taken at the beginning of the study, Liu et al. 
(2009) found statistically significant lower levels of TIMP-1 in wounds that failed to 
heal compared to wounds that healed following the twelve-week study period, 531.2 
pg/ml ±377.6 compared to 732.5 ± 270.0 (p<0.05), respectively. Similarly, examining 
measurements of wound exudate composition recorded at three time points at the 
beginning, during (day 10), and at the end (day 36) of the study, Ladwig et al. (2002) 
found initial TIMP-1 levels lower in wounds that had less 50% reductions in volume by 
the end of the study (poor healers) compared to wounds that had at least 85% 
reductions in volume by the end of the study (good healers) (p = 0.05). Ten days into 
the study, TIMP-1 levels increased in poor or intermediate healers (a 50–85% decrease 
in wound volume) and, by the thirty-sixth day, TIMP-1 levels in poor or intermediate 
healers were similar to good healers. The statistically significant findings from both of 
these studies by Ladwig et al. (2002) and Liu et al. (2009) thus demonstrate the 
potential of initial TIMP measurements of wound exudate composition to predict 
wound healing outcomes. On the other hand, the study by Muller et al. (2008) 
reported finding no significant differences between either initial TIMP-1 levels in 
wounds defined as good healers (a reduction of at least 82% in initial wound surface at 
4 weeks) and those defined as poor healers (reduction of less than 82% in wound 
surface at 4 weeks) or in TIMP-1 levels measured at various intervals over the twelve 
week follow-up period. 
 
4.5.2.1.5. Matrix Metalloproteinase/ Tissue Inhibitor of Metalloproteinase (MMP/TIMP) 
ratio  
Given the complex nature of wound healing and the delicate balance between activating 
and inhibiting factors, some of the studies that measured both levels MMPs and TIMPs 
in wound exudate went further by analysing MMP/TIMP ratios in relation to wound 
healing outcomes (Ladwig et al. 2002, Muller et al. 2008, Liu et al. 2009). 
 
In the study by Ladwig et al. (2002), the average MMP-9/TIMP-1 ratio appeared to 
decrease as wounds progressed to healing. Measurements taken at the commencement 
of the study showed the greatest difference in MMP-9/TIMP-1 ratios between the 
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groups where ratios were approximately four-fold greater in wounds that healed poorly 
(less than 50% wound volume reduction) and approximately two-fold greater in ulcers 
healed intermediately when compared to patients who healed well (85% or more 
reduction in initial wound volume) (p < 0.05). Furthermore, measurements taken on the 
tenth and the thirty-sixth day of the study also showed significantly lower MMP-9/TIMP-
1 ratios in the wound exudate of good healers compared to poor healers and in exudate 
of wounds that healed intermediately. Compared with the initial MMP-9/TIMP-1 ratios 
of poor healers, values recorded on the tenth and thirty-sixth day appeared statistically 
significantly decreased (p ≤ 0.05). Similarly, Liu et al. (2009) found statistically significant 
greater MMP-9/TIMP-1 ratios in wounds that remained non-healed following a twelve-
week period (p<0.05). In the study by Muller et al. (2008), although MMP-1/TIMP-1 ratio 
in the initial wound exudate composition measurements was not statistically 
significantly different in good healers compared to poor healers (p = 0.064), initial MMP-
1/TIMP-1 ratio correlated positively with reduction in wound area at week 4 (r=0.65; 
P=0.008) and week 12 (r=0.69, P=0.009).  Implementing a receiver operating 
characteristic curve, Muller et al. (2008) showed an initial MMP-1/TIMP-1 ratio of 0.39 
best predicts a reduction in wound area of at least 82% at four weeks and, with a 
sensitivity of 71% and a specificity of 87.5%, therefore has potential to act as a predictor 
of total wound healing at twelve weeks.  
 
Considering the results of these studies together, it is evident that MMP-9/TIMP-1 ratio 
holds potential to act as an indicator of wound healing outcomes. 
 
4.5.2.1.6. Albumin  
Using clinical chemistry analysers, two studies included in this review reported 
measuring albumin in wound exudate (Trengove et al. 1996, James et al. 2000). From 
initial exudate composition measurements, both studies similarly found statistically 
significantly lower albumin levels from wounds defined as non-healing compared to 
those defined as healing, reporting mean albumin levels in the non-healing groups of 
less than 20 g/l and in the healing groups as 23 g/l or greater (Trengove et al. 1996, 
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James et al. 2000). As a matter of interest, in the study by James et al. (2000) no 
wound with an exudate albumin of less than 20 g/l was reported to have healed. 
 
4.5.2.1.7. Nitric Oxide 
Of the included studies in this review, one study measured nitric oxide as a component 
of wound exudate and, employing a nitric oxide assay based on a previously published 
work by Doane & Horwáth (2003), reported promising results for the use of this 
analyte as a potential indicator of wound healing (Bernatchez et al. 2013). 
Approximate threshold levels of greater than 57mM and less than 12mM nitric oxide 
indicated deteriorating wounds and levels between 13.5mM and 49mM indicated 
wounds progressing in healing. From these results, a two cut point diagnostic test for 
measuring nitric oxide in wound exudate as opposed to a single cut point test appears 
a superior method to utilise this wound exudate composition measurement to 
determine between progressing and worsening wounds. 
 
4.5.2.1.8. Proteomics 
In respect to wound exudate collection, Edsberg et al. (2012) found protein 
concentration levels differed between interior and peripheral wound locations 
wherein samples collected from interior of the wound showed higher protein 
concentrations than from the periphery (p < 0.0001). Examining chronic wounds only, 
19 proteins were found to be differentially expressed between the interior and 
periphery of wounds (Edsberg et al. 2012). Similarly, Wyffels et al. (2010) found the 
interior and periphery of individual wounds to have different protein signatures.  
 
Edsberg et al. (2012) reported that chemokine ligand 9 (CXCL9) in wound exudate 
appears to increase as wounds heal and remains almost constant or decreases slightly 
for ulcers that are not healing. However, using discriminant function analysis to test 
the ability of total protein concentration to be used as an indicator of wound status or 
outcome, no statistically significant correlation was found between wound fluid total 
protein concentration and clinical outcome (statistical data not reported). In a 
different study using electrophoresis, the protein S100A9 was identified in wound 
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exudate (Wyffels et al. 2010). In this particular study, Wyffels et al. (2010) recognised 
that due to the balance between degrading proteins and their inhibitors in wounds, 
using a set of proteins that represent multiple stages of healing would make more 
sense rather than relying on a single protein as a biomarker for wound healing (Wyffels 
et al. 2010).  
 
4.5.2.1.9. Total Protein 
In the study by Wyffels et al. (2010), a temporal trend of increased numbers of 
proteins fragments was seen in exudate of wounds that healed with the effect of day 
statistically significant. Similarly, using wound exudate composition measurements 
taken at the beginning of the study, James et al. (2000) found statistically significant 
lower levels of total protein concentrations in wounds classified as non-healing 
compared to healing at twelve weeks, 30 g/l (range 20-42; SD: 7.6) and 44.3 g/l (range 
30-49; SD: 8.8), respectively (p < 0.05). Examining a small subset of wounded subjects 
(healing, n=1, and non-healing, n=3) from which a second wound exudate sample was 
obtained during the study period, James et al. (2000) confirmed these findings in that 
total protein levels increased from 41 g/l to 72 g/l in the healing wound compared to 
levels that remained below 30 in one non-healing wound and dropped from above 30 
to less than 30 in the two remaining non-healing wounds. Trengove et al. (1996) 
supported the reports by James et al. (2000) finding statistically significant lower levels 
of total protein concentration in wounds defined as being in a non-healing phase 
compared to those in a healing phase, 34 g/l (range 26-46 g/l) and 41 g/l (range 36-51 
g/l), respectively (p=0.01). 
 
In summary of the findings described for the measurement of wound exudate 
composition, MMP-9, TIMP and MMP-9/TIMP ratio appear to offer the most potential 
to act as indicators of wound healing outcomes. This is due to both the quantity of 
research that has been conducted in relation to these biomarkers as well as the 
significance of the findings produced. Despite the potential of each of the numerous 
exudate composites to act as biomarkers in wound healing, clear limitations are 
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evident by the conflicting study findings and the scarcity of research in respect to 
particular composites.        
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4.5.3. Temperature 
In respect to the outcomes of interest for this review, this section will report the 
results of the included studies relating to temperature measurement in wounds. A 
table will be presented that will outline the principle results of each of the eight 
studies followed by a narrative summary to acknowledge and develop meaning from 
the findings (see Table 15). 
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Table 15. Summary of data extraction table for temperature studies 
Study Reference Results 
Armstrong et al. 
(1996)  
Mean initial surface temperature (wound site vs unwounded contralateral site): 
91.1 vs 84.2°F, difference 6.9°F (t=8.9, p<0.0001, 95% CI: 5.3 to 8.5). 
Skin temperature following ulcer healing (wound site vs unwounded contralateral site): 
83.4 vs. 85.3°F, difference 1.9 °F (t= -1.35, not significant (NS), 95% CI: -7.5 to 3.9). 
 
Greatest temperature gradient and absolute temperature: site of ulceration in all patients. 
 
Patients with toe-brachial indices <0.60 had greater skin temperature gradients at the site of the ulcer than those with 
higher indices (9.4 ± 4.0°F vs. 5.8 ± 3.4°F, p= 0.01). 
Armstrong et al. (2006)  Mean temperature differential between the limbs: 
Baseline: 2.81 ± 5.75°F 
DCIV: 2.43 ± 4.84°F  
(difference -0.37; 95% CI: -0.98, 0.23; p=0.225).  
≥10°F: 81.4% favourable clinical response (improvement or cure) 
<10°F: 94.3% favourable clinical response  
(difference 12.9% (95% CI: 3.5%, 27.3%; p=0.007). 
Dini et al. (2015)  Temperature ranges: Wound bed: 31-35°C 
                                        Perilesional skin: 31°C-34°C.  
Wound bed score range: 5-14 (> 10, n=14; ≤ 10, n=11). 
Wound bed score and wound bed temperatures: Monotonic increasing relationship; ρ=0.805, P = 0.000002, CI 95%.  
Wound bed score and perilesional skin temperature: ρ = 0.55, P = 0.005, CI 95%), scatter plot: (R2 = 0.35) (not linear). 
Horzic et al. (1996)    Post-operative days 1-3: temperatures rose, with few differences between the temperatures of the wounds and their wider 
surroundings.  
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Post-operative days 4-8: temperatures of the wounds and surroundings fell gradually, zones of warmer skin around the 
wounds became narrower and wound zones became increasingly pronounced with sharply separated nuances.   
Post-operative day 8: (stitches removed on day 7) only narrow zones of the incision sites measured higher temperatures 
than the surroundings. 
Line graph of average wound temperatures post-surgery:  
Day 1 to 3: temperatures appear increasing. 
From day 3 until day 8: temperatures appear gradually decreasing.   
Horzic et al. (1996)  4 day preoperative temperature averages:  
32.67 ±1.07 °C to 32.8 ±1.11°C. 
8 day postoperative temperature averages: 
Graph curves show a rise in temperature up to day 3 followed by a gradual temperature decline until day 8. 
(presented visually using a 3D image, a post-operative wound at day 5, and relative co-ordinate graphs, day 1 to 8). 
Nakagami et al. (2010)  Thermographic assessment:  
Kappa coefficients for temperature classification:  
Intra-rater reliability: 0.93  
Inter-rater reliability: 0.94 
 
Healing wounds:  
High temperature (n = 3) (25%) 
Low temperature (n=14) (66.7%) 
Delayed healing wounds:  
High temperature (n=9) (75%) 
Low temperature (n=7) (33.3%) 
Robicsek et al. (1984)  Pre-operative sternal skin temperatures (n=150):  
33.7 ±0.1 °C. 
Day 7 post-operative temperatures (pre- vs post-operative statistical significance difference): 
*Subgroup A (n=125): 35 ± 0.1 °C (p<0.001); 
^Subgroup B (n=25): 35.4 ± 0.1 °C (p<0.001). 
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Day 14 post-operative temperatures: 
Subgroup A: returned to pre-operative readings; 
Subgroup B: 35.1 ± 0.1 °C (reported as remaining significantly elevated). 
3-month follow-up period:  
Subgroup A: No infections developed  
Subgroup B: 20% developed wound infections, of whom peristernal temperatures remained elevated post-operatively 
beyond week 4.  
*Subgroup A = patients whose sternal temperatures returned to preoperative levels within 2 weeks postoperatively. 
^Subgroup B = patients whose sternal temperatures did not return to preoperative levels within 2 weeks postoperatively (i.e. remained elevated). 
Siah & Childs (2015)  Pre-surgery: stoma site lowest temperature within the field of view (FOV).  
 
Non-infected wounds  
Immediately post-surgery: a ‘cold’ linear scar site is identifiable within the region of interest (ROI). 
Days 1-2; scar site emerges as a ‘cold spot’ within hotter surrounding abdominal skin. 
Days 3 or day 4; the area of skin ‘warming’ surrounding the post-operative scar continues to increase in size and is little 
more than a few ‘dots’ of yellow amidst a ‘red’ thermal map. 
Patients with a high BMI (>24.9) and no infection: 
Surgical scar remained as cool, warming by day 6 only and blending to the surrounding skin temperature by day 7. 
 
Infected wounds 
Immediately post-surgery:  
Similar thermal imaging maps as non-infected wounds.  
Day 2: Thermal image along the incisions revealed ‘cold’ spots along the incision.  
Day 3: remaining in-patients (4 of 5) had either an increased ‘cold’ spot size along the surgical site or failed to show the 
warming of the skin. 
For the one other patient, purulent exudate was drained from a ‘cold spot’ area on day 7, and confirmed the diagnosis of 
surgical wound infection. 
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4.5.3.1. Summary of Results for Temperature Studies 
Overall, the results of the studies chosen for inclusion in this systematic review appear 
to suggest that temperature measurements are highest in non-healing, worsening or 
acute wounds and decrease as wounds progress into phases of healing. Of the eight 
studies chosen for inclusion in this review, six studies examined wound temperature 
using infrared thermography (Robicsek et al. 1984, Horzic et al. 1996a, Horzic et al. 
1996b, Nakagami et al. 2010, Dini et al. 2015, Siah & Childs 2015) and the remaining 
two used infrared thermometers (Armstrong & Lavery 1996, Armstrong et al. 2006). 
The majority of the thermography studies employed non-contact methods of 
thermography, however, one study used a contact method of thermography that 
involved the application of liquid crystal strips to the body surface of the study subjects 
(Horzic et al. 1996a). Due to the nature of the methods used to measure temperature, 
namely infrared thermometers and infrared thermography, in addition to numerous 
other potentially influencing factors, the results of the studies included were reported 
in a variety of forms, such as by thermographic images, line graphs, 3D graphical 
images, relative co-ordinate graphs, narrative descriptions, and quantified as degrees 
of Fahrenheit or degrees Celsius. 
 
4.5.3.1.1. Summary of Results for Studies using Thermometers in Wounds 
Despite using similar wound sample types, diabetic foot wounds, the two studies 
included that examined wound temperatures using infrared thermometers yielded 
contrasting findings. Both studies, however, presented positive findings for the use of 
infrared thermometry measurements to indicate clinical wound outcomes.        
 
In the earlier study by Armstrong & Lavery (1996), the start-of-study mean surface 
temperature differential between wound site and unwounded contralateral site of 
6.9°F was statistically significant (t = 8.9; p < 0.0001; 95% CI: 5.3 - 8.5) whereas the 
temperature differential following ulcer healing that reduced to 1.9 °F was not 
statistically significant (t = -1.35, not significant, 95% CI: -7.5 - 3.9). These results 
therefore suggest that higher temperature gradients indicate active wounds and lower 
gradients indicate healed wounds. In addition, considering a temporal line graph 
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presented in the paper displaying mean surface temperature differences, the mean 
temperature differential between wounds and their contralateral unwounded sites 
appears to gradually decrease with small fluctuations as the wounds progress towards 
healing. Of interest, Armstrong & Lavery (1996) found the greatest temperature 
gradient and greatest absolute temperature was at the site of ulceration in all subjects 
and, furthermore, found the greatest surface temperature differentials in subjects with 
severe degrees of peripheral neuropathy or reduced peripheral vascular perfusion.  
 
In the later study by Armstrong et al. (2006) examining wound outcome in terms of 
markers of wound inflammation and infection, no statistically significant difference 
was found from the start-of-study mean temperature gradient (2.81 ± 5.75°F) between 
the wound site and unwounded contralateral site to the end-of-study temperature 
gradient (2.43 ± 4.84°F; difference -0.37; 95% CI: -0.98 - 0.23; p = 0.225), no correlation 
was found between the start-of-study mean temperature gradient with the 
inflammatory markers of white blood cell count (WBC), C-reactive protein (CRP) or 
erythrocyte sedimentation rate (ESR), or with the ulcer infection severity score (r = 
0.058, 0.148, -0.002, 0.067, respectively) and no overall trend was seen between the 
start-of-study mean surface temperature differential and end-of-study clinical wound 
outcome. On the other hand, Armstrong et al. (2006) discovered a statistically 
significant difference in the rate of favourable clinical wound outcomes (improvement 
or cure) in wounds that exhibited temperature differentials of 10°F or greater between 
the wound site and unwounded contralateral site when compared to wounds with 
differentials of less than 10°F, 81.4% compared to 94.3%, respectively (difference 
12.9%; 95% CI: 3.5 - 27.3; p = 0.007). Even though the findings of this study showed no 
overall relationship between skin temperatures recorded using an infrared 
thermometer and clinical wound outcomes, applying a threshold effect of baseline 
differential temperature measurements of above or below 10°F between wounded 
and unwounded sites appears to offer itself as a potential indicator of wound healing 
outcomes.  
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4.5.3.1.2. Summary of Results for Studies using Thermography in Wounds 
Of the six included studies that measured wound temperatures using infrared 
thermography, a variety of reporting styles were adopted to present the study 
findings. Although all the papers displayed thermographic images and narrative 
descriptions of results, the format of the narrative descriptions and the reporting of 
numerical data relating to temperature measurements varied. For this reason, the 
literature is presented according to the style of reporting adopted by each paper so as 
to facilitate the emergence of contrasting and comparative findings from the data.  
 
Using non-contact thermography, Horzic et al. (1996b) found temperature differences 
between the surgical wound and its surroundings rose steadily until the third and 
fourth day post-operatively and then gradually declined until day 8 returning to pre-
operative measurements. In the same year, the same authors, Horzic et al. (1996a), 
published comparable findings using contact thermography with acute surgical 
wounds reporting temperature rises from day one to day three post-operatively, with 
few differences between the temperatures of the wounds and their wider 
surroundings, and temperature reductions from day four to eight postoperatively, with 
zones of warmer skin around the wounds becoming narrower and increasingly more 
pronounced.  
 
In relation wound healing and the development of post-operative wound infection, 
Siah & Childs (2015) reported temperatures in wounds healing without developing 
infection showed an initial increase in temperature on the first post-operative day 
followed by a general ‘warming’ until day six, whereas temperatures in wounds that 
subsequently developed infection, ‘cold spots’ typically increased and warming failed 
to show.  
 
Independent of infection development, Siah & Childs (2015) further documented the 
effect of body mass index (BMI) on the thermal wound pattern finding that for subjects 
with elevated BMIs of greater than approximately 25 the surgical scar remained as cool 
and only began warming on the sixth post-operative day. Supporting this finding by 
Siah & Childs (2015), Horzic et al. (1996b) also found a statistically significant 
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connection between the thickness of adipose tissue in the wounded area and the 
thermographic measurement with lower temperatures associated with thicker layers 
of adipose tissue.   
 
Using retrospective analysis to form two groups of subjects depending on whether 
their post-operative thermographic wound measurements returned to their pre-
operative skin measurements within two weeks post-operatively, Robicsek et al. 
(1984) found that wounds with temperatures that remained elevated beyond fourteen 
days were associated with an increased likelihood of developing infection. In general, 
Robicsek et al. (1984) found the thermal pattern of post-operative wound healing 
increased to statistically significant values on the seventh post-operative day (p<0.001) 
and reduced to pre-operative measurements by the fourteenth post-operative day. 
 
In relation to non-surgical wounds, non-contact thermography was used to examine 
wound temperatures of a sample of 35 patients with stage II to IV pressure ulcers in 
order to detect latent inflammation and to predict wound outcomes (Nakagami et al. 
2010). As part of this study, Nakagami et al. (2010) reported kappa coefficient values 
for the thermographic assessment which indicated high reliability of the temperature 
measurement method. Using a classification tool for measuring gross wound status, 
Nakagami et al. (2010) discovered a greater proportion of pressure ulcers that 
exhibited relatively low wound bed temperatures demonstrated signs of normal 
healing (66.7%) compared to those exhibiting high temperatures (25%). Nakagami et 
al. (2010) associated a statistically significant relative risk of 2.25 (95% CI: 1.13–4.47, p 
= 0.021) for delayed healing in ulcers with higher temperature measurements.  
 
Using an infrared thermographic camera and a wound bed scoring tool validated by 
Falanga et al. (2006) similar to that described in the study by Nakagami et al. (2010), 
Dini et al. (2015) found a monotonic increasing relationship between wound bed 
temperatures and improved wound conditions in terms of healing edges, black eschar, 
wound depth, and granulation and pink tissue (ρ=0.805, P value = 0.000002, CI 95%). 
Overall, the findings from this study indicate that temperatures in the higher ranges of 
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33 to 35°C correlated with wound bed scores which are conducive to wound healing 
(Dini et al. 2015).    
 
Acknowledging the results produced using both methods of temperature 
measurement in wounds, thermometry and thermography, some general agreements 
as well as some conflicting findings appear to exist between the studies. A multitude of 
reasons for these conflicting findings potentially stem from the variances in the 
research designs across the studies. For example, differences appear to exist between 
the thermal dynamics of wounds with longer duration (chronic or non-healing) 
compared to those of acute healing wounds. Looking at only the study results of 
temperature measurements recorded using infrared thermometers, it would appear 
that lower or decreasing temperature gradients between the subject’s wound site and 
unwounded site indicate improved wound conditions and progression towards wound 
healing. In relation to measurements recorded using infrared thermography, 
conflicting reports exist in relation to post-operative wound healing and the 
development of wound infection with one study suggesting colder temperatures at the 
wound site signify the development of infection (Siah & Childs 2015) whereas another 
study suggests persistently elevated temperatures at the wound site signify the 
development of infection (Robicsek et al. 1984). There does however exist a general 
agreement in relation to temperatures associated with normal post-incisional acute 
wound healing which appear to increase over the first few days and subsequently 
return to baseline measurements within a two-week period. In terms of wounds of 
greater duration, one of the studies associated wound temperature measurements in 
a higher range of between 33 to 35°C with improved wound bed healing conditions 
(Dini et al. 2015), whereas another of the studies associated elevated wound 
temperature measurements with an increased risk of delayed healing (Nakagami et al. 
2010).  
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4.6. Summary  
With the aid of flow charts and tables, this chapter outlined the process of the search 
strategy that yielded the final 23 primary research papers included in this review and, 
following data extraction, described the methods of each these studies arranged in 
order of subject, pH, exudate composition and temperature. Using the EBL Critical 
Appraisal Checklist devised by Glynn (2006), the studies were individually quality 
appraised and, using a hierarchy of evidence pyramid, the studies were presented in 
respect of design so as to reflect the ranking and the relative authority of the research 
included. Lastly, a summary of the findings of each study was reported with regard to 
the outcomes of interest for this systematic review. 
 
Search strategies performed in 8 different databases yielded an initial 4707 articles 
relating to pH in wounds, 5657 articles relating to exudate composition in wounds and 
2450 articles relating to temperature in wounds. By removal of duplicate studies and 
applying eligibility criteria, a final number of 3 studies were included for pH, 12 studies 
for exudate composition and 8 studies for temperature. As there was no restriction 
placed on date of research publication, differences were evident between the topics in 
relation to publication years, in which the pH research extended from the year 2007 to 
2015 whereas research for temperature dated back as far as 1984, spanning a period 
of 31 years, with the most recent publication date in the year 2015. Although there 
appeared to be a broad geographical spread of study locations, it would seem that the 
majority of the studies were located in developed countries, with the largest 
proportion in the United States of America. Where reported, samples were mainly 
recruited from hospitals or clinics, subject demographics varied widely and sample 
sizes ranged from 7 to 362 participants with an approximated mean sum of 51 
participants over all the 23 studies. The types of wounds varied both within and across 
the reviews’ subjects of interest, pH, exudate composition and temperature, to include 
diabetic foot (n=4), surgical (n=5) and burn wounds (n=1), leg (n=5) and pressure ulcers 
(n=4), as well as a variety of wound types included within single studies (n=4).     
 
225 
 
Methods involved in the measurement of pH, exudate composition and temperature 
varied greatly within each subject, however, some similar features and techniques 
became evident. In respect of exudate composition, the wide variation in collection 
techniques would appear to reflect the types of wounds in each sample which required 
collecting exudate from beneath occlusive wound dressings, from surgical wound drains 
or wound bandages, or by using pads, hydrophilic beads, filter papers, applicator swabs 
or mesh and collection filter systems. It was also noted that one study for exudate 
composition did not report the method of wound fluid collection employed (Liu et al. 
2009). In relation to the actual measurement of pH, exudate composition and 
temperature, each study for pH employed different methods of measurement which 
involved using either a glass surface electrode and pH meter set, pH indicator strips, or 
litmus paper strips. Although studies for exudate composition also varied in relation to 
assays, techniques and equipment used, zymography and enzyme-linked 
immunosorbent assay appeared as the most commonly performed measurement 
methods. The diversity among the studies in respect to the measurement of exudate 
composites is possibly due to the vast array of exudate composites that were examined. 
In contrast, only two main methods for measuring temperature in wounds emerged 
namely, infrared thermometry and thermography.   
 
Across the three subjects, quality appraisal demonstrated issues of validity for all studies 
with overall scores ranging between 27.78% and 61.11%. Studies measuring 
temperature in wounds yielded the lowest mean validity score of 36.66%, studies 
measuring exudate composition yielded a mean score of 46.54% and studies measuring 
pH produced the highest mean validity score of 54.48%. None of the studies yielded 
quality appraisal scores of Y/T ≥ 75% N+U/T ≤ 25%, meaning that all of the studies’ 
overall validities are questionable and the generalisability of the conclusions drawn from 
the findings of these studies are limited. In addition, no randomised controlled trials 
were found as eligible for inclusion in this review and, when compared to the hierarchy 
of evidence pyramid, the designs of the studies included were at level IV. It is of note 
that these issues limit the generalisability of the conclusions drawn based on the findings 
of these studies.  
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Reflecting on the findings of all 23 reviewed studies, pH, exudate composition and 
temperature measurements offer a beneficial role in aiding wound management and 
appear as potential predictors of healing outcomes in wounds. 
 
4.7. Conclusion 
The main objective of this systematic review was to develop a greater understanding 
of the clinical significance of the measurement of pH, exudate composition and 
temperature in wounds. As stated, this chapter reported the results of this systematic 
review in relation to three aspects of measurement in wounds, pH, exudate 
composition and temperature. The findings of these studies provide the central data 
on which the overall conclusions and recommendations of this review will be based. 
Nevertheless, whilst acknowledging the significance of the findings, the 
methodological issues of the studies that were identified in this chapter must be 
considered and will impact the final conclusions.   
 
As stated by Reeves et al. (2011), before informed debate can be performed about the 
meaning and importance of any non-randomised study, and decisions can be made in 
respect to the certainty of its’ findings, the evidence must first be ‘exposed’ on the 
particular topic. This chapter has exposed the data in respect to the measurement of 
pH, exudate composition and temperature in wounds to facilitate the exploration of 
meaning of these data in the next chapter. 
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Chapter 5. Discussion 
5.1. Introduction 
In relation to the outcomes of interest, this chapter will discuss the core findings as 
well as the methodological issues that emerged from the included articles within this 
systematic review. Placed in context with the current knowledge of this subject field, 
the findings of the included studies will be analysed to reveal the possible 
contributions of this systematic review to both clinical practice and future research. 
Following this, the strengths and limitations of this review which came to light during 
the review process will be discussed in order to determine the significance of the 
findings and, consequently, their contribution to advances in research and clinical 
practices in this area.     
 
5.2. Summary of the Key Findings of this Systematic Review 
The key findings that emerged from the systematic review of the included studies on 
pH, exudate composition and temperature in wounds are: 
 Although the true impact of wounds remains unknown, wounds pose 
significant challenges worldwide, particularly those that are considered to be 
non-healing. 
 In relation to wound healing measurement, the majority of the research on pH, 
exudate composition and temperature has been conducted in developed 
countries, with the largest proportion in the United States of America. 
 In this systematic review, the types of wounds researched varied among the 
studies addressing pH, exudate composition and temperature measurement.     
 The methods of measuring wound pH in the studies comprised of a glass 
surface electrode and pH meter set, pH indicator strips, and litmus paper strips.  
 All studies measuring wound exudate composition collected exudate samples 
prior to analysis by retrieving exudate from beneath occlusive wound dressings, 
from surgical wound drains or wound bandages, or by using pads, hydrophilic 
beads, filter papers, applicator swabs or mesh and collection filter systems. 
 All methods used to measure exudate composition were laboratory-based 
techniques. 
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 The methods used to measure wound temperatures were contact 
thermography, infrared thermometry and infrared thermography. 
 Reducing or low pH levels appear to correspond with wound healing and 
healthier wound conditions whereas increasing or high pH levels appear to 
correspond with the development of wound infection and non-healing wounds. 
 The composition of exudate is seen to differ depending on the wound location 
from where the sample is collected (interior versus periphery). 
 In relation to wound healing outcomes, the most frequently measured wound 
exudate composites are metalloproteinase-9 (MMP-9), metalloproteinase-2 
(MMP-2), tissue inhibitor of metalloproteinase (TIMP), neutrophil elastase (NE) 
and albumin.  
 Of all the components of exudate measured, MMP-9, TIMP and MMP-9/TIMP 
ratio measurements appear to offer the most potential as indicators of wound 
healing outcomes. 
 Measurements of MMP-9 appear to show prolonged elevation in exudate of 
wounds in a non-healing phase and appear to reduce as wounds progress into a 
phase of healing. 
 MMP-9/TIMP-1 ratios decrease as wounds progress into a phase of healing. 
 Temperature measurements are seen as highest in non-healing, worsening or 
acute wounds and decrease as wounds progress to healing.  
 
5.3. Methodological issues within the included studies  
Measurement is the allocation of numerical values to observations with the aim of 
quantifying phenomena (Kimberlin & Winterstein 2008). In healthcare, measurement 
involves the operationalisation of certain concepts in defined variables and the 
creation and application of methods or tools to quantify these variables (Kimberlin & 
Winterstein 2008). For example, the efficacy of wound treatment with a particular 
dressing may be operationalized as the rate of wound healing and the related 
measurement instrument may ascertain data on the occurrence of changes in the size 
of wound area from the prospective examination of wounds during a particular study 
period. Measurement of outcomes is of key interest in healthcare related research 
particularly where changes are as a result of certain interventions and, as such, the 
reliability and validity of a measure is of central importance to ensure the accuracy of 
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the findings (Kimberlin & Winterstein 2008). In addition to measurement methods, 
assessing the reliability and validity of the research studies supporting this data is 
fundamental.   
 
As healthcare professionals are required to practice at the highest level of 
effectiveness and efficiency, based on the most up-to-date valid, reliable and 
applicable research, critical appraisal is essential to ensure the quality of the research 
as well as to assess the applicability and practicability of incorporating the evidence in 
to clinical practice (Gerrish & Lathlean 2015). Validity and reliability are the two key 
concepts concerned with the quality of research (Gerrish & Lathlean 2015). Reliability 
and validity are not independent qualities, such that a measure which is unreliable 
cannot be valid (Polit & Beck 2013). Reliability refers to the repeatability and 
consistency of a measure and can be demonstrated by test-retest, inter-rater and 
internal consistency (Gerrish & Lathlean 2015). Validity is typically defined as the 
extent to which an instrument or a study measures what it purports to measure 
(Kimberlin & Winterstein 2008, Polit & Beck 2013) and has several aspects referred to 
as face validity, content validity, criterion-related validity and construct validity (Polit & 
Beck 2013), concurrent validity and predictive validity (Gerrish & Lathlean 2015). 
Furthermore, the value of findings is dependent on the internal and external validity of 
the study, internal validity being the extent to which changes in the dependent 
variable, if occurring, can be said to be as a sole result of the independent variable, and 
external validity being the extent to which the study’s findings can be applied or 
generalised to other similar populations (Parahoo 2014).   
 
In this systematic review, the EBL Critical Appraisal Checklist designed by Glynn (2006) 
was employed to appraise the methodological issues of the research studies chosen 
for inclusion. Discussion in this section will be structured according to the four domains 
of study validity of the checklist, population, data collection, study designs, and results. 
Following this, the studies will be discussed in relation to heterogeneity and hierarchy 
of study design. 
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5.3.1. Population  
A population can be defined as all the constituents that are considered to have one or 
more shared features and consequently constitute a group (Cronin et al. 2014). The 
characteristics of a study’s population, of which in health science research typically 
consists of people, are predetermined by the researcher dependent on the focus of 
the research (Cronin et al. 2014). In conducting research, the researcher must set 
criteria to identify the subjects that will provide the focus of the study to create a 
group known as the target or theoretical population (Cronin et al. 2014). A study’s 
included population, the sample, should be representative and relevant to the 
population to which the review findings are to be applied, and the study should specify 
both the inclusion and exclusion criteria, with eligibility limitations that are clinically 
justifiable and appropriate (Centre for Reviews and Dissemination 2008).  
 
In order of subject, this section will discuss the quality appraisal outcomes of the 
studies resulting from the first domain of the EBL Quality Appraisal Checklist 
addressing the validity of the population in relation to population representativeness, 
inclusion and exclusion criteria, sample size, response rate, selection bias, 
randomisation and informed consent (Glynn 2006). 
 
The studies involving the measurement of pH in wounds produced a mean validity of 
approximately 33.33%, with the study reported by Ono et al. (2015) (see Appendix 22) 
significantly influencing this mean total due to its failure to achieve any of the 
requirements for scoring in this section. The studies by Gethin et al. (2008) and Shukla 
et al. (2007) produced validity scores of 60% and 40%, respectively, which were due to 
poor reporting in areas relating to population representativeness (Shukla et al. 2007, 
Gethin et al. 2008), sample size (Shukla et al. 2007) and selection bias (Gethin et al. 
2008) (see Appendices 21 and 23). In addition, the study by Ono et al. (2015) also 
neglected to definitively outline inclusion and exclusion criteria and report the 
attainment of informed consent. 
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In relation to the studies measuring exudate composition in wounds, six of the studies 
failed to reach any of the requirements for scoring in this section (Hoffman et al. 1999, 
James et al. 2000, Ladwig et al. 2002, Liu et al. 2009, Wyffels et al. 2010, Edsberg et al. 
2012), five studies achieved a validity score of just 20% (Trengove et al. 1996, Tarlton 
et al. 1997, Tarlton et al. 1999, Trengove et al. 1999, Bernatchez et al. 2013), and, as 
the highest validity score produced from the studies, the study by Muller et al. (2008) 
was the only report to reach a validity score of 40% (see Appendices 24 to 35). Similar 
to the studies measuring pH, failure to score was a consequence of absent or unclear 
reporting in areas relating to population representativeness, sample size, selection 
bias, inclusion and exclusion criteria and informed consent. 50% of the studies failed to 
describe whether informed consent had been obtained and every one of the studies 
failed to clearly report whether the population was representative, the sample was of 
sufficient size and the choice of population was free of bias. 
 
Appraising the research papers measuring temperature in wounds, five of the eight 
studies failed to achieve any of the quality requirements to score positively in relation 
to population validity (Robicsek et al. 1984, Horzic et al. 1996a, Horzic et al. 1996b, 
Nakagami et al. 2010, Siah & Childs 2015), with the remaining three studies producing 
validity scores of just 20% (Armstrong & Lavery 1996, Armstrong et al. 2006, Dini et al. 
2015) (see Appendices 36 to 43). Like the studies measuring pH and exudate 
composition, failure to score was typically as a consequence of absent or unclear 
reporting in areas addressing population representativeness, sample size, selection 
bias, inclusion and exclusion criteria and informed consent. Only one study clearly 
documented whether informed consent had been obtained (Armstrong et al. 2006) 
and all of the studies failed to achieve validity in relation to population 
representativeness, sample size and population selection bias.  Furthermore, only the 
studies reported by Horzic et al. (1996a) and Dini et al. (2015) definitively outlined the 
population inclusion and exclusion criteria. As two of the studies included for 
temperature measurement in wounds were pilot projects, issues inherent to the 
nature of this type of research resulted in the failure to achieve validity requirements.  
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Unlike internal validity that can be determined intuitively and based on specific 
principles, determining the external validity of a study often requires more clinical 
rather than statistical expertise that is specific to the particular subject being 
researched (Rothwell 2006). Therefore, sufficient reporting of population information 
is required so that clinical experts can make reliable judgments about the external 
validity of a study’s findings and implement practices correctly and accurately in 
clinical practice. 
 
As the matters identified affect the attempts to determine the validity, applicability 
and appropriateness of a study (Glynn 2006), and thus ensure the strength of evidence 
on which the conclusions of the systematic review are based (Centre for Reviews and 
Dissemination 2008, Gerrish & Lacey 2010), the quality appraisal of the studies in 
relation to inclusion and exclusion criteria, sample size, selection bias and informed 
consent will be discussed in further detail. 
 
5.3.1.1. Inclusion and Exclusion Criteria 
Inclusion and exclusion criteria, together termed as eligibility criteria, are the key 
standards that subjects must meet or the characteristics they must have in order to 
participate in a clinical study (U.S. National Institutes of Health 2016). These key 
standards are determined by the researcher at the beginning of the study when 
identifying the target population and should be justified (Gerrish & Lathlean 2015). As 
unreported data cannot be assumed to exist nor can it be appraised, failure of an 
article to describe these inclusion and exclusion criteria of a study will inevitably 
impact negatively on the validity of the research. Definitive reporting of exclusion and 
inclusion criteria appears as an issue of significant concern across all three research 
topics. This concern is particularly evident of the papers addressing the measurement 
of exudate composition as none achieved validity in this area (see Appendices 24 to 
35). To a lesser extent, 80% of the studies measuring wound temperature failed to 
definitively report inclusion and exclusion criteria, with only the studies by Dini et al. 
(2015) and Horzic et al. (1996a) achieving this quality standard (see Appendices 36 to 
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43), and, in relation to the studies measuring wound pH, only one study failed to meet 
this reporting standard (Ono et al. 2015) (see Appendix 22).  
 
Although all the studies described their samples as subjects that exhibited wounds, 
describing inclusion and exclusion criteria in adequate detail is essential. An example 
of this is apparent when one considers the recognised differences between the 
features of the chronic, non-healing wound and the acute wound or the influences of 
population demographics on wound healing. It is therefore understandable to 
acknowledge that such deficits in the quality of reporting of primary research studies, 
such as failure of a study to adequately report inclusion and exclusion criteria, have 
been suggested to affect the research consumers’ interpretation of the results (Centre 
for Reviews and Dissemination 2008).  
 
An example of the way in which inclusion and exclusion criteria can affect the accuracy 
of a study’s findings was demonstrated in a review that examined 214 drug trials in 
acute myocardial infarction (Gurwitz et al. 1992). This review found over 60% of 
excluded patients were greater than 75 years of age despite the fact that over 50% of 
myocardial infarctions are reported to occur in this older age group (Gurwitz et al. 
1992). From this review it is evident that certain exclusions can limit the 
generalisability of the studies’ findings to the patient population whom experience the 
most morbidity and mortality from a particular disease. Similarly, a review of forty-one 
randomised controlled trials found a comparably large average exclusion rate of 73% 
of potential research subjects (Charlson & Horwitz 1984). Although screening sizeable 
numbers of patients appears to be a logical requirement to achieve successful 
recruitment targets, trials should not be criticised as lacking generalisability on this 
basis alone (Charlson & Horwitz 1984). On the other hand, the failure of a study to 
report the details of the exclusion and inclusion process is considered a significant 
weakness as this information is essential for the research consumer to assess the 
generalisability of the research findings (Charlson & Horwitz 1984).  
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5.3.1.2. Sample Size  
As including the entire population in a study is generally neither practical nor feasible, 
a smaller but adequately representative group of subjects, referred to as a sample, is 
selected to produce results which can be used to make inferences about the 
population from which it was drawn (Kadam & Bhalerao 2010), a process known as 
generalising (Cronin et al. 2014). As quantitative and qualitative research differ in their 
research focus, so do their approaches to sampling, namely probability and non-
probability sampling (Cronin et al. 2014). Generally, the sample size for any study 
depends on the acceptable level of significance, the power of the study, the expected 
effect size, the underlying event rate and standard deviation in the population, the 
expected drop-out rate, an unequal allocation ratio, and the study objective and 
design (Kadam & Bhalerao 2010). In the case of quantitative studies, a power 
calculation is typically performed to estimate the minimum sample size needed for the 
study (Gerrish & Lathlean 2015). Despite the fact that all 23 studies reported the size 
of their study samples, only one study, namely the paper reported by Gethin et al. 
(2008), referred to the process of sample size calculation. Reporting sample size 
calculation is important in order that the representativeness of the population can be 
determined.  
 
Overall, the sample sizes were typically small but ranged widely from 7 to 362 subjects 
(approximated mean of 51 subjects). Considering that a sample containing too few 
subjects may fail to produce findings that can be generalised to the population and, 
due to a potential inability to detect differences between test groups, may result in a 
study that is unethical (Kadam & Bhalerao 2010), the neglect of the studies examined 
in this review to substantiate reasons for their sample size is therefore deemed a 
considerable failing.  
 
Inadequate and inaccurate reporting of sample size calculation is reported to persist as 
a frequently occurring issue in research articles (Charles et al. 2009). In a review of 215 
randomised controlled trials conducted to assess the quality of reporting of sample 
size calculation, ascertain accuracy of sample size calculations and determine the 
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relevance of assumptions made of calculations for sample size, Charles et al. (2009) 
found that 5% of studies failed to report any calculation for sample size and 43% did 
not report all the necessary parameters to perform sample size calculation. Following a 
systematic replication of the sample size calculations and quantification of 
discrepancies between a priori hypothesised parameters for sample size calculations 
and a posteriori estimates, Charles et al. (2009) discovered that the differences 
between the sample sizes reported in the research articles and the replicated sample 
size calculation were more than 10% in 47 (30%) of the 157 studies of which had 
provided sufficient information to allow sample size calculation replication. This review 
highlights the importance of accurate and sufficiently detailed reporting of sample size 
calculation in research studies. 
 
5.3.1.3. Selection Bias  
Selection bias refers to ‘bias in the estimated association or effect of an exposure on an 
outcome that arises from the procedures used to select individuals into the study or the 
analysis’ (Porta 2014)(p.258). This type of bias is a common and frequently ignored 
issue in clinical and microbiological or preclinical research (Porta 2014). Although 
selection bias is difficult to determine analytically (Porta 2014), it can assessed by 
examining quality of the particular selection methods performed for the study such as 
sequence generation and concealment (Sambunjak & Franic 2012). Considering the 
majority of the studies included in this review were descriptive, observational designs 
and none were randomised controlled trials, the importance is clear for sufficient 
reporting of the methods employed to avoid selection bias. As selection bias can result 
in invalid and inaccurate results, the quality appraisal checklist by Glynn (2006) 
addresses this issue by prompting the research reviewer to consider whether the 
choice of population bias-free. Across all of the subjects of wound measurement, none 
of the studies provided sufficient information to determine whether the choice of 
population was bias-free. Due to potential differences between the studies’ subjects 
and the target populations, the research results may present with low external validity 
or lack generalisability (Porta 2014). 
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5.3.1.4. Informed Consent  
The concept of informed consent refers to where research subjects are provided with 
sufficient accurate information about the relevant study, the information provided is 
understood, and the right to self-determination is acknowledged, which enables the 
subjects to voluntarily consent to or refuse to participate in the study (Polit & Beck 
2013). Although it is generally an ethics committee imperative, informed consent is not 
necessary for all types of studies. Despite this, it is vital that any published study report 
whether or not informed consent was required, and where relevant, provide a 
description of the measures taken to obtain the informed consent (Glynn 2006).  
 
Using the EBL Quality Appraisal Checklist, weaknesses in the validity of the included 
studies were discovered which revealed that almost half of the twenty-three research 
papers failed to clearly report whether informed consent had been obtained. In the 
study by Ono et al. (2015) relating to pH in wounds, the acquisition of informed 
consent was not reported and, although the study reported that it was conducted with 
approval of the institutional review board, it cannot be assumed that informed consent 
was obtained. Similarly, studies relating to exudate composition (Hoffman et al. 1999, 
James et al. 2000, Ladwig et al. 2002, Wyffels et al. 2010, Edsberg et al. 2012) and 
temperature (Nakagami et al. 2010, Siah & Childs 2015) in wounds reported that 
ethical approval was achieved however failed to report whether informed consent had 
been attained from the sample participants. In addition to failing to report on aspects 
of informed consent, some studies relating to exudate composition (Liu et al. 2009) 
and temperature (Robicsek et al. 1984, Armstrong & Lavery 1996, Horzic et al. 1996a, 
Horzic et al. 1996b, Dini et al. 2015) also failed to state whether ethical approval had 
been granted.     
 
5.3.2. Data Collection  
Although data collection methods vary depending on the type of research being 
conducted, each method possesses its own set of problems (Glynn 2006). 
Consequently, research methods must be described to a level sufficient for study 
replication, as this allows for thorough examination of the study for risk of bias and 
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threats to validity (Glynn 2006). Glynn (2006) describe inadequate reporting of 
methods of data collection in research articles as a ‘serious omission’. 
 
Following application of the EBL Quality Appraisal Checklist to the studies included in 
this review it became apparent that many of the questions in the data collection 
domain were not applicable. Reasons for the high proportion of irrelevant questions 
are related to the methods of the studies as none of the studies were comparative in 
design, none involved regularly collected statistics and none employed data collection 
instruments or questionnaires suitable for publication. In addition, only a small 
number of studies included an intervention, such as was seen in the study by Gethin et 
al. (2008) with the intervention of a Manuka honey dressing. As the stated by the 
author of the quality appraisal tool implemented in this review advised, some of the 
tool’s questions may not apply to certain studies and the appraisal of particular papers 
may raise questions which are not addressed by the appraisal tool (Glynn 2006). 
Despite the apparent limitations of the tool, such cases should prompt the reviewer to 
use the questions and calculations of the appraisal tool to equate the significance of 
the emerging questions and to determine their importance (Glynn 2006).  
 
Validity issues in this domain were evident in every study across all the subjects of 
wound measurement. Studies measuring pH in wounds produced a mean validity of 
approximately 31% (range 25% to 33.33%), studies measuring exudate composition 
produced a mean validity of approximately 32% (range 0% to 50%), and studies 
measuring temperature produced a mean validity of approximately 25% (range 0% to 
66%). Of the questions that were applicable to the included studies, the main areas for 
concern related to the persons involved in collection of the data, the descriptions of 
the data collection methods and the validity of the data collection instruments. 
 
In all studies, validity concerns were identified from the question addressing whether 
the persons who were involved in data collection were also involved in delivering a 
service to the target population. Due to the risk of introducing bias, it is important that 
this criterion is met and adequately reported so as to ensure the reliability of the 
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results (Glynn 2006). As none of the papers in this systematic review reported 
sufficient information to ascertain that the risk of bias associated with non-blinding of 
assessors was appropriately managed, this oversight is considered as a significant 
weakness in the quality of the studies. 
 
Demonstrating that the risk of bias can increase in research studies due to non-
blinding of outcome assessors, a review of 24 randomised clinical trials with outcomes 
involving subjective measurement scales found estimated treatment effects were 
more beneficial in studies employing non-blinded assessors (pooled difference in 
effect size -0.23, CI: 95%; 0.40 to -0.06) and, in relative terms, showed exaggerated 
pooled effect in size of 68% (CI: 95%, 14% to 230%). This review concluded by affirming 
that studies which neglect to blind assessors of outcomes put research at a high risk of 
substantial bias. 
 
In relation to the instruments used for data collection, only one study addressed the 
validity of the employed measurement tool (Nakagami et al. 2010). As all of the 
measurement tools employed are widely known and accepted methods for collecting 
readings of either pH, exudate composition or temperature, the studies appear to 
assume their quality as opposed to providing definitive evidence of their validity and 
reliability.  
 
Another area identified with issues of validity related to the descriptive reporting of 
the methods of data collection. Overall, this criterion appeared well accomplished with 
failure to achieve the validity score seen only three of the studies measuring 
temperature (Robicsek et al. 1984, Armstrong & Lavery 1996, Dini et al. 2015) and only 
one of the studies measuring exudate composition (Liu et al. 2009). Given the process 
of data collection can be described as the assembly of information in a meaningful and 
reliable way (Porta 2014), it is clear that failure to describe this process adequately 
could significantly affect the reader’s ability to determine the validity of the methods 
of a research study. 
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5.3.3. Study Designs and the Evidence-Based Research Pyramid 
Although study designs can be arranged into hierarchical systems based broadly on 
their susceptibility to bias (Centre for Reviews and Dissemination 2008), which 
consider some study designs to be more robust than others, this viewpoint should not 
be the only factor to determine the types of studies eligible for inclusion in a 
systematic review (Sackett & Wennberg 1997). On the other hand, the type of study 
will inevitably influence the reliability of the results and the design will influence the 
validity of the estimates of effect (Centre for Reviews and Dissemination 2008). In 
respect to the research included in this systematic review, all twenty-three studies 
were quantitative in methodology and were situated at level IV on the hierarchy of 
evidence pyramid in terms of study design (see Figures 5 to 7 and Appendix 1). This 
domain of the EBL Quality Appraisal Checklist which addresses aspects of study design 
(Glynn 2006) appeared highly applicable to the research papers included in this 
systematic review. Every question was of relevance to all three of the studies 
measuring pH in wounds, all of which achieved perfect validity scores of 100%. Equally, 
all questions were relevant to the research measuring exudate composition however, 
the validity of three of these studies was suboptimal in terms of providing a clear 
description the methodology to a standard that would facilitate replication (Ladwig et 
al. 2002, Liu et al. 2009) and reporting the attainment of ethics approval (Trengove et 
al. 1999, Ladwig et al. 2002, Liu et al. 2009). Similar to the studies of pH, this domain 
achieved high validity scores with an overall approximated mean of 87% validity (range 
60% to 100%). Out of the three research topics, the studies measuring temperature in 
wounds produced the poorest validity scores with an approximated mean validity of 
72% (range 40% to 100%). Similar to the studies of exudate composition, the two main 
areas where suboptimal validity was detected were in the descriptions of the research 
methodology (Robicsek et al. 1984, Armstrong & Lavery 1996, Horzic et al. 1996b, 
Nakagami et al. 2010, Dini et al. 2015) and ethics approval (Robicsek et al. 1984, 
Armstrong & Lavery 1996, Horzic et al. 1996a, Horzic et al. 1996b, Dini et al. 2015). In 
addition, a third area of concern was noted of the studies measuring wound 
temperature which related to the reporting of the study outcomes (Robicsek et al. 
1984). As a consequence of these omissions, the checklist found that only half of the 
studies measuring temperature in wounds produced validity scores of greater than 
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75% (Horzic et al. 1996a, Armstrong et al. 2006, Nakagami et al. 2010, Siah & Childs 
2015).  
 
Due to the validity issues detected in the studies, this following section will discuss the 
results from this domain of the EBL Quality Appraisal Checklist in relation to the 
particular areas where the omissions were observed, namely outcome description, 
ethical approval and study design. 
 
5.3.3.1. Outcome Description  
Gethin et al. (2015) describes outcomes as measurable variables within an outcome 
domain which can be assessed at a range of time points. Study outcomes are what the 
research intends to measure and therefore, where outcomes are not clearly stated, 
difficulties can arise in determining the appropriateness of data collection methods, 
the fulfillment of the intended measures (Glynn 2006) and the existence of within-
study selective reporting (Higgins et al. 2011b). Of all the studies across all three 
research subjects of pH, exudate composition and temperature measurement, only 
one study did not describe the study outcomes in satisfactory clarity and with 
sufficient discussion in relation to the methods of data collection. It is worth noting the 
publication year of this particular study by Robicsek et al. (1984) which is dated beyond 
thirty years prior to conducting this systematic review. The year of publication is 
significant considering the developments in research reporting in more recent years 
due to the great efforts made to improve the quality of reporting (Des Jarlais et al. 
2004, Guyatt et al. 2008, Liberati et al. 2009, Moher et al. 2010, von Elm et al. 2014).  
 
5.3.3.2. Ethical Approval  
Although not all research is subject to ethical approval, academic research involving 
humans generally requires approval from a research ethics committee and, where 
applicable, the published research study must report this clearly (Glynn 2006). In 
relation to medical research, ethical standards must be adhered to that uphold respect 
for all human beings and safeguard their health and rights (World Medical Association 
General Assembly 2008). Results of any research conducted without the required 
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ethical approval are potentially invalid as there exists no assurance of subjects’ 
confidentiality, autonomy, justice and non-maleficence (Watson et al. 2008). Both the 
researcher and the publishing bodies are responsible for upholding ethical standards, 
by ensuring negative as well as positive results are published or are elsewhere publicly 
available. Furthermore, there is an expectation that sources of funding, institutional 
affiliations and any potential conflicts of interest are professed, and reports of 
research not in accordance with the current legal ethical principles are not be accepted 
publication (World Medical Association General Assembly 2008).  
 
Eight out of the twenty-three studies included in this systematic review did not clearly 
report whether ethical approval had been obtained (Robicsek et al. 1984, Armstrong & 
Lavery 1996, Horzic et al. 1996a, Horzic et al. 1996b, Trengove et al. 1999, Ladwig et al. 
2002, Liu et al. 2009, Dini et al. 2015) and, of these, six studies also failed to report 
whether informed consent had been obtained (Robicsek et al. 1984, Armstrong & 
Lavery 1996, Horzic et al. 1996a, Horzic et al. 1996b, Liu et al. 2009, Dini et al. 2015). 
Most of these studies were published more fifteen years prior to conducting this 
systematic review, and therefore this omission may be related to differences in 
reporting formats which have become more structured and controlled in recent years 
(Guyatt et al. 2008, Liberati et al. 2009, Moher et al. 2010, von Elm et al. 2014). 
Irrespective of possible explanations, this shortcoming weakens the validity of these 
studies and their findings.  
 
5.3.3.3. Study Design  
An ideal study design reduces risk of bias and anticipates confounding in research 
(Gerrish & Lathlean 2015). As mentioned, different types of research can be arranged 
by hierarchy relating to the particular designs’ susceptibility to bias (Centre for Reviews 
and Dissemination 2008). While quality appraisal of the studies in this review included 
comparing the research designs against the hierarchy of evidence pyramid, it is 
important that consideration is also given to the individual aspects of the study’s 
design which may result in bias rather than solely focusing on the descriptive design 
terminology employed (Centre for Reviews and Dissemination 2008). Furthermore, it is 
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important to consider the suitability and the appropriateness of the design in relation 
to the research being conducted such as where a quasi-experimental or observational 
study design is chosen over the typically considered superior randomised controlled 
trial design (Centre for Reviews and Dissemination 2008).  
 
In critical appraisal of research reports, the results and conclusion are not weighted as 
heavily as the research methodology which is viewed as an essential element to 
determining the relevance, accuracy and validity of the study (Glynn 2006). 
Consequently, research papers that fail to present a detailed description of their 
methodologies prevent the possibility of the study being thoroughly evaluated or 
replicated and, hence, produce poorer validity scores (Glynn 2006). Applying the EBL 
Quality Appraisal Checklist, seven of the studies failed to achieve the requirements to 
score positively in this area (Robicsek et al. 1984, Armstrong & Lavery 1996, Horzic et 
al. 1996b, Ladwig et al. 2002, Liu et al. 2009, Nakagami et al. 2010, Dini et al. 2015) 
and, as a result, their validities were deemed questionable.  
 
Reflecting on the selection of research designs employed, the majority of the studies 
chose prospective cohort study designs. The remainder of the designs were clinical 
trials, pre-post-test studies and pilot studies. Although randomized controlled trials are 
generally considered the ‘gold standard’ in terms of study design for evaluating the 
efficacy and safety of a treatment intervention (Silverman 2009), the application of 
such an experimental design may be unnecessary, inappropriate, impossible, or 
inadequate (Black 1996). Due to the nature of randomised controlled trials, their 
results may have limited applicability in clinical settings (Silverman 2009). In contrast, 
observational design studies can offer results that complement and expand on those 
produced from randomized controlled trials by involving more diverse populations 
with common comorbidities and encompassing lengthier follow-up periods. In 
addition, well-conducted observational design studies also offer the potential to detect 
clinically important variances among different health-related therapies (Silverman 
2009). Despite the qualities of the observational design, studies conducted using this 
type of design are usually more at risk of bias than experimental studies (Centre for 
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Reviews and Dissemination 2008). As a consequence, conclusions made on the 
grounds of these studies must be created with due caution and are frequently 
hypothesis generating, highlighting areas for future research (Centre for Reviews and 
Dissemination 2008). The majority of the observational studies included in this review 
are prospective cohorts with only one study using a retrospective cohort design. 
Prospective cohort designs are considered to be less susceptible to bias than 
retrospective cohort studies (Centre for Reviews and Dissemination 2008) and hence 
can be acknowledged as superior in terms of research quality.  
 
5.3.3.4. Evidence based practice  
Since its introduction in the latter part of the twentieth century, the concept of 
evidence-based practice has evoked interest, developed, and has resulted in the 
concurrent existence of numerous definitions. One of the most widely accepted 
definitions is contained within the Sicily Statement on evidence based practice (Leen et 
al. 2014) which describes evidence based practice as decision-making in healthcare 
that is established on the best available, current, valid and relevant evidence, by those 
in receipt of the care who have been educated by the tacit and explicit knowledge of 
the healthcare provider, of whom has a comprehensive understanding of the principles 
and multi-faceted requirements involved in providing evidence based practice (Dawes 
et al. 2005). To exercise evidence based practice, systematic reviews are therefore vital 
to promote the availability of the most recent, valid and reliable evidence (Victor 
2008). Considering systematic reviews typically critique studies with reference to 
research design hierarchy systems (Dijkers & NCDDR Task Force on Systematic Review 
and Guidelines 2009), a hierarchy of evidence pyramid was created for this systematic 
review based on the common principles of previously published hierarchy systems 
(Sackett 1989, Glover et al. 2006, Melnyk & Fineout-Overholt 2011, Lo Biondo-Wood & 
Haber 2013, University of New Hampshire 2015) in order to make explicit the levels of 
evidence of the included research in relation to subject (see Appendix 1 and Figures 5 
to 8). In identifying the research designs of the studies included in this review and 
making a comparison to the evidence pyramid, all studies were seen as situated at 
level IV in the hierarchy of research evidence (see Figures 5 to 8). 
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Figure 10. Hierarchy of evidence pyramid 
 
5.3.4. Results 
Critical aspects involved in quality appraising the results of the articles included in this 
systematic review concerned the description of results, accounting for confounding 
variables, development of conclusions based on the data analysis, reporting of subsets 
analysis, where applicable, external validity and identifying areas for future research. It 
is imperative that a study clearly and comprehensively outline its results without bias 
as full disclosure, including reporting of both negative and positive results, facilitates 
the reader to more accurately reflect on all the data produced from the research 
(Glynn 2006). Following application of the EBL Quality Appraisal Checklist, substantial 
omissions became evident in the results section of all the included studies measuring  
pH, exudate composition and temperature in wounds and, as a result, the validity of 
this domain as well as the study as a whole was deemed questionable (Glynn 2006).  
 
In respect to the studies measuring pH in wounds, the quality appraisal tool found a 
mean validity score of 54.48% (range 44.44% to 61.11%). Similarly, the mean validity 
score for studies measuring exudate composition in wounds was 46.54% (range 
27.78% to 61.11%) and, for studies measuring temperature in wounds, the mean 
validity score was 36.66% (range 27.78% to 50%). The main areas the studies failed to 
LEVEL IV 
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meet the validity requirements related to confirming external validity, accounting for 
confounding variables and clear reporting of results, in successive order. To a lesser 
extent, suggesting future research was also identified in the included studies as an 
area of concern for validity. 
 
Across all three subject topics, none of the twenty-three studies achieved external 
validity. External validity, or generalisability (Gerrish & Lacey 2010), is the extent to 
which a study’s findings are relevant, applicable, or can be generalised to populations 
or groups that were not part of the actual research study (Porta 2014). The failure of 
the studies in this review to achieve external validity relates to a combination of 
identified factors such as those due to inadequate reporting of inclusion and exclusion 
criteria and sample size calculation. As sample representativeness increases the 
generalisability of the research findings beyond that of those included in the specific 
study (Watt & van den Berg 2002, Kukull & Ganguli 2012), inadequate reporting of this 
aspect of a study will impede performing a comprehensive assessment of the sample 
and, hence, will reduce the external validity of the findings. However, despite the 
significant limitations identified in the generalisability of these research findings, when 
considered with due caution, these studies can contribute to the existing knowledge in 
this field and may most beneficially highlight areas for future research.  
 
Another issue of quality identified in almost all of the studies resulted from the failure 
of the studies to report whether confounding variables had been accounted for. A 
confounding variable is a factor related to both the intervention, or exposure, and the 
outcome of interest, and is a factor of major concern in non-randomised studies (The 
Cochrane Collaboration). Confounding is considered to exist where it is not possible to 
determine whether an effect is as a result of the variable of interest or due to another 
variable (Gerrish & Lacey 2010). Unless definitively reported, it cannot be assumed 
that a study accounted for confounding variables, and, as a result, this omission 
significantly impacts the validity of the studies’ findings.   
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The third area of concern in the studies was the degree of clarity by which the results 
were reported. Deficiencies in the reporting of results can appear in various forms such 
as, preferential publication of positive results, non-publication or biased reporting of 
research findings, or insufficient or misleading reporting of adverse events (Simera et 
al. 2010). Such weaknesses in the reporting of the study’s findings can cause an 
overestimation of the benefits of new interventions, potentially leading to increased 
expenses that are not reflected by improved patient outcomes, and can also cause 
indirect harm to patients as well as to subjects of future research (Song et al. 2010). In 
this review, the main issues causing reduced clarity in the reporting of results were 
related to imprecise, vague or inconsistent presentations of results as well as 
insufficient provision of results data. These concerns are consistent with common 
shortcomings in health care research which are caused by confusing or misleading 
presentations of results, data and graphs (Gigerenzer et al. 2008, Boutron et al. 2010). 
Acknowledging the negative impact caused by indistinctly reported research findings, 
it is inevitable that the validity of the study will be reduced.   
 
Suggesting future research and accurately reporting conclusions are important aspects 
of a study report which were found to be unsatisfactory in seven of the included 
studies. Identifying gaps, concepts and inadequacies in the research not only presents 
evidence to show that the author has a thorough knowledge of the subject of interest 
but also provides important information to inspire future research which is 
appropriate, relevant and necessary (Glynn 2006).  
 
As evident from the discussion of the quality appraisal process, weaknesses in the 
validity of the studies are considerably owed to inadequate standards of reporting. 
This is of significant importance as research reports need to be of sufficient detail to 
allow for research replication, evidence synthesis, and wider implementation (Craig et 
al. 2008, Glasziou et al. 2008).  
5.3.5. Heterogeneity of Studies  
Heterogeneity is related to the variability among studies included in a systematic 
review which can relate to the study’s participants, interventions and outcomes, 
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referred to as clinical diversity or clinical heterogeneity. Heterogeneity can also relate 
to the study’s design and risk of bias, referred to as methodological diversity or 
methodological heterogeneity (Deeks et al. 2011). Furthermore, statistical 
heterogeneity is as a consequence of clinical or methodological diversity, or both, and 
is evident where the difference between observed intervention effects is greater than 
would be expected due to random error alone (Deeks et al. 2011). Although, it is 
important to acknowledge that eligible studies retrieved for inclusion in a systematic 
review will inevitably differ (Deeks et al. 2011), the level of variability must be assessed 
as meta-analysis should not be performed for a groups of studies that are relatively 
heterogeneous as these will most likely yield meaningless results (Deeks et al. 2011, 
Moore 2012).  In this systematic review, the included studies varied significantly in 
relation to both clinical and methodological heterogeneity and therefore, as 
recommended by Sambunjak & Franic (2012), a thorough narrative summary was 
performed and a discussion of studies’ results will now be carried out with the aim of 
producing more meaningful review outcomes. 
 
5.4. Discussion on Findings of the Systematic Review  
The outcomes of interest for this review were, primarily, an objective measure of pH, 
exudate composition and temperature as predictors of wound healing outcomes and, 
secondarily, an objective measure of the reliability and validity of current methods 
used for the measurement of wound pH, wound exudate composition, wound 
temperature. The search strategy yielded eligible primary research for each of the 
measurement subjects, pH, exudate composition and temperature, all of which 
contributed noteworthy findings in relation to the outcomes of interest for this review.  
 
As evident from the thorough literature review conducted a priori to this systematic 
review, measuring various characteristics of wounds has sparked great interest and is 
suggested to offer significant potential as a means of determining wound outcomes. A 
consensus document published in 2008, ‘Diagnostics and Wounds’ (World Union of 
Wound Healing Societies 2008), reflects this interest outlining various aspects relating 
to the use of diagnostics in wounds. Of the various measurable characteristics of 
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wounds, pH, exudate composition and temperature are acknowledged for their key 
roles in wound healing and, consequently, have been identified as possible biomarkers 
to indicate wound healing outcomes. This information substantiated the rationale for 
conducting this systematic review which examined the measurement of pH, exudate 
composition and temperature in wounds.  
 
Across every topic of wound measurement, a substantial level of heterogeneity existed 
among the studies that meant a narrative summary and discussion was chosen as the 
most appropriate approach to produce meaningful findings for this review. As 
identified by Sambunjak & Franic (2012), conducting a meta-analysis with considerable 
diversity among studies would produce meaningless and obscured results (Deeks et al. 
2011). Hence, the next section will discuss the findings of the studies presented in 
chapter 4 of this review with the aim of creating meaning and developing new 
understanding of this topic of interest. 
    
5.4.1. pH  
From the search strategy performed for this systematic review, the measurement of 
pH in wounds yielded the least amount of primary research articles. The methods of 
pH measurement differed between each of three included articles, and were a glass 
surface electrode and pH meter set (Gethin et al. 2008), pH indicator strips (Ono et al. 
2015), and litmus paper strips (Shukla et al. 2007). Furthermore, the characteristics of 
the wounds in each sample also differed, namely, leg ulcers (Gethin et al. 2008), burn 
wounds (Ono et al. 2015) and wounds of various aetiology (Shukla et al. 2007). Despite 
these variances, the overall results of the studies suggest that as pH levels reduce in 
alkalinity towards an increasingly neutral pH, wound conditions are more indicative of 
wound healing progression in terms of wound size, wound infection resolution and 
wound bed tissue improvement. One of the major explanations for the connection 
between wound environment of lower pH levels and wound healing is the potential for 
increased tissue oxygen availability through oxygen dissociation. Furthermore, there is 
a potential for reduced histotoxicity of the waste particles produced by bacteria 
(Romanelli et al. 2002b).  
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In the two-week study involving a Manuka honey dressing intervention, Gethin et al. 
(2008) used a glass surface electrode and pH meter set to produce results which 
appeared to show a corresponding relationship between reducing levels of pH and 
wound size. Due to their increased accuracy, potentiometric methods, such as the flat 
glass surface electrode used by Gethin et al. (2008), have been recognised as the 
preferential method for measuring the extractable water-soluble components of the 
skin surface, as opposed to colorimetric methods (Ehlers et al. 2001, Vanýsek 2004, 
Schmid-Wendtner & Korting 2006). This would suggest that using a glass surface 
electrode for measuring pH in wounds would also be more accurate than using 
colorimetric methods such as litmus paper. This non-invasive method of pH 
measurement requires moistening the tip of the electrode with distilled water prior to 
application to the skin or wound (Romanelli et al. 2002b, Gethin et al. 2008).  
 
Glass pH measuring electrodes consist of a glass bulb membrane and an electrically 
insulating tubular body that separates an internal solution and a silver/silver chloride 
(Ag/AgCl) electrode from the solution of measurement (Vanýsek 2004), such as wound 
substances. The Ag/AgCl electrode is connected to a lead cable that can connect to a 
voltmeter, namely a pH meter (Vanýsek 2004). Once the pH sensing electrode is 
applied to the sample, pH is measured from the potential that develops across the 
sensing membrane surface which varies according to pH, with a reference electrode 
providing a second, unvarying potential to quantitatively compare the deviations of 
the sensing membrane potential (Thermo Fisher Scientific 2013). The pH meter 
calculates the variance between the reference electrode and sensing electrode 
potentials in millivolts, converts units of millivolts to units of pH and finally presents 
the measurement readings on the meter display (Thermo Fisher Scientific 2013).  
An alternative technique of measuring pH was employed in the study by Ono et al. 
(2015) in the form of pH indicator strips that could measure to one decimal point 
accuracy. Constructed of natural or synthetic organic compounds, pH indicator strips 
change colour depending the on pKa and pH values of a solution with the greatest 
colour change occurring when the pH attained is closest to its pKa value (Nigam & 
Ayyagari 2007). The mechanism of pH indicator strips is based on the understanding 
that a pH value represents the amount of hydrogen ion dissociation from molecules 
within a solution, with lower pH values indicating higher hydrogen ion concentrations 
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in the solution and stronger acidity and, likewise, higher pH values indicating lower 
hydrogen ion concentrations and weaker acidity (Kotyk & Slavik 1989). pH indicators 
are weak acids as well as natural dyes which means the change in colour of a pH 
indicator is caused by the dissociation of the hydrogen ion from the indicator (Nigam & 
Ayyagari 2007). Universal pH indicators can adjust colour over the entire pH scale due 
to their combination of several different indicators which each have specific colour 
changes at particular pH values, with alkaline substances ranging from blue to dark 
purple, acidic substances ranging from yellow to red and neutral substances appearing 
as green (Walker 2007). Using this colorimetric method, Ono et al. (2015) discovered 
statistically significant decreases in pH measurements of burn wounds that healed and 
statistically significant increases in burn wounds that developed infection.  
 
Using another type of colorimetric method to determine the pH levels in wounds, 
Shukla et al. (2007) revealed with litmus paper a general association between reducing 
pH levels and improving wound conditions. The litmus paper strips had gradations of 
0.5, ranging from 6.5 to 9, the accuracy of which was confirmed through testing 
against standard solutions of known pH levels. Litmus is a dye made from species of 
lichens (fungi) and paper dyed with this substance is called litmus paper. Litmus paper 
comes in the form of either red paper which detects basicity by turning to blue under 
basic conditions and blue paper which detects acidity by changing to red in the 
presence of acids (Booth et al. 1999, Chapman et al. 2001). This method of measuring 
pH is considered less precise than universal indicator strips or electrode probe and pH 
meter sets as litmus paper can only indicate whether a substance is acidic or basic and 
does not determine exact numerical pH value (Taylor 2000). 
 
In considering the methods of pH measurement in wounds, it is important to 
acknowledge that a shift of only one unit in the pH value represents a hydrogen ion 
concentration change of a factor of ten (Springer 2014) and that even a slight change 
in pH levels can affect the delicate balance of processes occurring in wound healing 
(Percival et al. 2014b). In this regard, pH measurement methods that produce values to 
a tenth of a unit or even a hundredth of a unit are clearly superior for use in 
determining wound pH levels (Springer 2014). Although litmus paper is a quick, 
inexpensive and effective method of indicating whether a substance is acidic or basic, 
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it is unable to report an exact numerical pH value (Booth et al. 1999, Chapman et al. 
2001). Albeit, both Ono et al. (2015) and Shukla et al. (2007) documented that the pH 
indicator papers used in conducting their research were accurate to at least 0.5 pH 
unit. On the other hand, pH meters are reported to offer a more precise quantification 
of pH by using electricity to determine a numerical pH value which, when great care is 
taken with the measurement procedure, can achieve an accuracy of ± 0.05 pH units 
(Mettler-Toledo 2007). Although the glass microelectrode is said to remain the gold-
standard for clinical measurements of the skin surface and wound pH (Schreml et al. 
2010a), a major problem of this and the other mentioned techniques is that they only 
measure pH at a specific point rendering this process time-consuming to evaluate the 
spatial pH distribution of an entire and often very heterogeneous wound (Schreml et 
al. 2010a).  
 
The significance of pH levels in wound healing is well established in the literature 
(Gethin 2007, Percival et al. 2014a, Percival et al. 2014b, Jones et al. 2015, Nagoba et 
al. 2015). The pH environment affects numerous activities and features of the wound 
in a variety of manners. In this review, a positive relationship appeared between pH 
levels and wound healing which suggested that decreasing pH levels from alkaline 
towards neutral indicate progression towards wound healing. This finding is in keeping 
with existing literature stating the benefits of a more acidic environment for the 
process of wound healing. This acidic environment is considered favourable for 
inducing proliferation of fibroblasts (Liu et al. 2002, Schneider et al. 2007), promoting 
epithelization and angiogenesis (Nagoba et al. 2008), controlling bacterial colonization 
(Jones et al. 2015) and facilitating the release of oxygen from oxyhaemoglobin (Leveen 
et al. 1973). In addition, considering that the surface of intact skin has a naturally acidic 
pH ranging from 4 to 6 (Zlotogorski 1987, Lambers et al. 2006, Schmid-Wendtner & 
Korting 2006), it would seem consistent that pH levels of the wound decrease as the 
wound progresses towards epithelialisation. In contrast, alkalinity is believed to have 
an adverse effect on the wound tissue by depriving the wounds of oxygen (Leveen et 
al. 1973) and providing an environment more favourable for bacterial growth (Nagoba 
et al. 2015). Furthermore, bacterial growth will produce ammonia liberated from urea 
by the enzyme urease which is also detrimental to wound healing due to its toxicity to 
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wound tissue (Leveen et al, 1973; Thomas, 1990). Despite the wealth of literature 
acknowledging the influence of wound pH on cellular and subcellular events, enzyme 
activity, protein conformation and expression, bacterial colonisation and skin barrier 
performance, the precise function and impact of varying levels of pH in the wound 
remains uncertain (Schreml et al. 2010a).  
 
The measurement of pH in wounds emerges from the literature as a relatively simple 
and clear technique that has the potential to act as indicator of wound healing 
outcomes. Applying the eligibility criteria of this systematic review, only three studies 
were identified that measure this characteristic in wounds and, applying a quality 
appraisal tool, all three studies failed to achieve scores that would indicate research 
validity. In addition, the studies were heterogeneous in relation to aspects such as 
design, measurement techniques and subject demographics. For these main reasons, 
further research is recommended to elucidate the role of measuring wound pH in 
predicting wound healing outcomes. 
 
5.4.2. Exudate Composition 
From the search strategy performed for this systematic review, the measurement of 
exudate composition in wounds retrieved both the largest amount of initial journal 
article papers and the greatest quantity of primary research articles for final inclusion 
in the review. The methods involved in the study of exudate composition differed 
across the twelve papers in relation to the collection of the wound exudate and the 
measurement of the wound exudate composites. The variances in measurement 
methods employed between the studies are owed to the varying components of 
exudate measured in the studies as well as acknowledging the influence of researcher 
preference. Wound exudate collection included methods that involved retrieving fluids 
from beneath occlusive wound dressings, from surgical wound drains or from wound 
bandages, or by using pads, hydrophilic beads, filter papers, applicator swabs or mesh 
and collection filter systems. Exudate composition measurement involved various 
laboratory-based techniques, with the majority beginning with electrophoresis. In 
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addition to differing collection and measurement techniques, the characteristics of the 
samples varied across the studies in terms of general demographics and wound types.  
 
Of the studies included in this review, matrix metalloproteases, specifically MMP-9 and 
MMP-2, were found to be the most frequently measured components of wound 
exudate. In normal wound healing, specific proteases are produced for precise 
durations, at distinct locations, and at controlled levels (Ziegler et al. 1997, Bryant & 
Nix 2016). For example, proteases are required for removal of matrix proteins that 
become denatured during tissue injury, for degradation of the basement membrane 
and facilitation of new capillary loops to develop for epidermal regeneration 
(angiogenesis), and for remodeling of the initial wound scar matrix to produce a 
functional mature scar (Ziegler et al. 1997, Bryant & Nix 2016). Furthermore, proteases 
are necessary for activation of latent growth factors and for conversion of procollagen 
molecules to tropocollagen molecules that can associate into collagen fibers (Ladwig et 
al. 2002).  
 
Despite the essential role of proteases in wound healing, prolonged, elevated levels 
are reported to have detrimental effects on wound healing (Gibson et al. 2009, 
Harding et al. 2011b). Part of the protease family, matrix metalloproteinases are a 
group of highly homologous calcium- and zinc-dependent endopeptidases that have 
the potential to degrade extracellular matrix proteins, including collagen, fibronectin, 
laminin, elastin, and proteoglycans (Tarlton et al. 1997, Sang 1998, Sternlicht & Werb 
2001, Gibson et al. 2009). MMPs are initially created as a zymogen, which is a latent 
pro-MMP devoid of enzymatic activity (Hawkins et al. 2013). The pro-MMP contains a 
cysteine residue that performs as a zinc-coordinating ligand covering the catalytic 
domain of the protease, referred to as the ‘cysteine switch’, and prevents the zinc 
atom in the catalytic domain from being available for enzymatic function (Van Wart & 
Birkedal-Hansen 1990). MMPs are normally tightly regulated at several levels including 
activation, the presence of specific inhibitors (TIMPs) and at the transcriptional level 
(Baker & Leaper 2000). On activation, MMPs can influence numerous central 
physiological as well as pathological events (Hawkins et al. 2013). 
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Among other methods including fluorometric assays, SDS-PAGE and 2D-PAGE, the 
measurement of MMP-9 and MMP-2 was most frequently performed using 
zymography. Described in the research literature for over 50 years, the technique of 
zymography has been employed to detect the activity of a variety of different enzymes 
in biological samples (Wilkesman & Kurz 2009, Hawkins et al. 2013). An electrophoretic 
method, zymography, has been used extensively used for the detection of MMP 
activity due to its advantages which includes simplicity and high sensitivity permitting 
the identification of specific enzymes of interest from within a complex mixture of 
proteases, and the estimation of the molecular weight of latent and active forms of the 
enzyme due to the process of denaturation and renaturation that takes place within 
the gel (Quesada et al. 1997). A type of substrate zymography, gelatin zymography, is a 
simple process of detecting proteolytic enzymes capable of degrading gelatin from 
various biological sources and is often used for the assessment of the particular matrix 
metalloproteinases MMP-2 (gelatinase A) and MMP-9 (gelatinase B) due to their 
potent gelatin-degrading activity (Toth et al. 2012). This polyacrylamide gel 
electrophoresis-based method can identify the type of gelatinase, relative amount, 
and activation status (latent, compared with active enzyme forms) in cultured cells, 
tissues, and biological fluids, and can be used to explore factors that control gelatinase 
expression and modulate zymogen activation in experimental systems (Toth et al. 
2012). On the other hand, zymography can be laborious when testing a large number 
of samples, is not appropriate for determining MMP inhibitors and may not always 
detect active forms of these proteases in the gels due to low levels of expression. This, 
therefore, hinders efforts to accurately quantify net levels of activity for each 
gelatinase (Hawkins et al. 2013). Furthermore, as pro-MMPs may become activated by 
oxidative stress without proteolytic cleavage, gelatin zymography by quantifying active 
bands migrating at lower molecular weight, could potentially underestimate MMP 
activity (Hawkins et al. 2013). 
 
Focusing on the results of the studies, the measurements of MMP-9, in general, show 
prolonged elevation in wound exudate when wounds are in a non-healing phase and 
appear to reduce as wounds progress into a phase of healing (Tarlton et al. 1997, 
Tarlton et al. 1999, Trengove et al. 1999, Ladwig et al. 2002, Muller et al. 2008, Liu et 
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al. 2009). In contrast, when wounds develop infection the characteristic pattern of 
reducing levels of MMP-9 is not observed (Tarlton et al. 1997). This finding is 
consistent in results presented by Liu et al. (2009) and Moor et al. (2009) which 
demonstrate an association between high bacterial levels and elevated MMP-9 in non-
healing wounds. Of particular relevance to the outcomes of interest of this review is 
the finding that differences between MMP-9 measurements in the exudate of normally 
healing wounds and wounds that develop infection are evident 24 hours before the 
traditional clinical signs of wound infection appear (Tarlton et al. 1997). Given that 
wound infection is known to interrupt and delay the process of normal wound healing 
(Swanson et al. 2014), the measurement of MMP-9 levels may aid early detection of 
infection development and thus have a role in predicting healing outcomes. In 
opposition to the majority of the studies’ findings, two of the included papers reported 
finding no statistically significant relationship between levels of MMP-9 and wound 
outcomes (Edsberg et al. 2012, Bernatchez et al. 2013). Nonetheless, the 
measurement of MMP-9 levels, in general, appears to correspond with wound healing 
and therefore is considered as a potential biomarker of wound healing outcomes. 
 
The findings of studies measuring levels of MMP-2 in relation to wound outcomes 
report no statistically significant differences between measurements in wounds 
described as healing and described as non-healing (Tarlton et al. 1999, Ladwig et al. 
2002, Muller et al. 2008, Liu et al. 2009). Congruent with these findings, an animal 
study exploring the role of MMP-2 in wound healing in mice found the activity of 
MMP-2 unnecessary for wound healing (Frøssing et al. 2010). In this study by Frøssing 
et al. (2010), incisional skin wounds were generated in mice with deficiencies in MMP-
2 as well as in mice with deficiencies in both MMP-2 and plasminogen. Analysing the 
data collected until the wounds were healed, no differences were found from the time 
of wounding to overt gross restoration of the epidermal surface between the mice 
with MMP-2 deficiency and the control mice (Frøssing et al. 2010). On the other hand, 
measurements of MMP-2 levels in acute wounds may be of value for indicating 
developing wound infection. In the study by Tarlton et al. (1997), levels of MMP-2 in 
acute wounds that developed infection reached 2.8 times that of the mean maximal of 
acute wounds that did not develop infection (Tarlton et al. 1997).  
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As stated, the activities of metalloproteinases are strictly regulated under physiological 
conditions at the stages of transcription, zymogen activation and inhibition by 
endogenous inhibitors, such as tissue inhibitors of metalloproteinases (TIMPs) (Baker 
& Leaper 2000). Four types of TIMPs exist, TIMP-1, TIMP -2, TIMP -3, and TIMP -4 (Gill 
& Parks 2008), which act in a one to one inhibitor to enzyme ratio through interaction 
of the N-terminal domain of the TIMP molecule with the active site of the enzyme (Gill 
& Parks 2008). TIMPs are important regulators of extracellular matrix formation, tissue 
remodelling and cellular behaviour and consequently, disruption of the delicate 
balance between the production of active enzymes and their inhibition may lead to 
pathologies associated with unregulated extracellular matrix turnover, inflammation, 
cell growth and cell migration (Brew & Nagase 2010). Five of the studies included in 
this review reported measuring TIMP levels (Trengove et al. 1999, Ladwig et al. 2002, 
Muller et al. 2008, Liu et al. 2009, Edsberg et al. 2012), however the studies reported 
conflicting findings in relation to the significance of this component of exudate as a 
potential indicator of wound healing outcome. Both Ladwig et al. (2002) and Liu et al. 
(2009) reported positive findings of the beneficial use of TIMP measurements to 
predict wound healing whereas the findings reported by Muller et al. (2008) showed 
no potential value of TIMP measurements to indicate wound healing outcomes. 
Likewise, findings from other research studies fail to reach a consensus to determine 
the exact role of TIMPs in the regulation of wound healing, particularly cell migration. 
For example, Mirastschijski et al. (2004) used the synthetic metalloproteinase 
inhibitor, GM6001, to treat cutaneous wounds in rat subjects and found impaired re-
epithelialization in wounds treated with the inhibitor of metalloproteinase when 
compared to wounds of the untreated control animals. Mirastschijski et al. (2004) 
concluded that this result was most likely due to altered cell migration as epithelial cell 
proliferation was unaffected by the synthetic inhibitor of metalloproteinase. 
Conversely, a separate study by Terasaki et al. (2003) found TIMP-2 to accelerate 
keratinocyte migration in vitro, from the study of the effects of recombinant human 
tissue inhibitor of metalloproteinases-2 (rh-TIMP-2) on the migration of normal human 
epidermal keratinocytes, and in vivo, from the study of daily applications of rh-TIMP-2 
solution to induced full-thickness wounds in healthy and diabetic rodents. Although 
the existing research acknowledges the crucial role of TIMPs in wound healing, it is 
evident that further evidence is required to comprehensively elucidate their specific 
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mechanisms of activity before the measurement of TIMP levels can be considered as 
an indicator of wound healing outcomes. 
 
In relation to the measurement of neutrophil elastase in wound exudate, the majority 
of studies reported that this component had no association with the condition of the 
wound (Hoffman et al. 1999, Trengove et al. 1999, Bernatchez et al. 2013) and, based 
on these findings, neutrophil elastase is ruled out as an exudate composite worth 
measuring for indicating wound healing outcomes. Accepting the findings of the 
studies included in this review which are presented in relation to the outcomes of 
interest of this review, neutrophil elastase remains a clinically significant component in 
the biomechanics of wounds (Wilgus et al. 2013). Neutrophil elastase is a neutrophil-
derived serine protease which is able to degrade a variety of structural and functional 
proteins deposited in wounds such as collagen, fibronectin and essential growth 
factors such as tumor necrosis factor α (TNF-α) (McDonald & Kelley 1980, Kafienah et 
al. 1998, Serhan et al. 2008). Since neutrophil elastase is capable of degrading 
basement membrane proteins, this exudate composite has potential to interfere with 
re-epithelialization and the formation of a new basement membrane in the dermo–
epidermal junction by keratinocytes in wound healing (Briggaman et al. 1984). 
Neutrophil elastase is secreted in high levels during an infection and has a potent 
ability to destroy bacteria and host tissue (Belaaouaj et al. 2000). Supporting this 
statement, research by (Hasmann et al. 2011) concluded that the activity of neutrophil 
elastase could be used as an early biomarker to detect wound infection. It is also of 
interest to note that research examining non-healing wounds has found significantly 
elevated mean neutrophil elastase activity levels in wounds such as pressure ulcers 
and leg ulcers (Grinnell & Zhu 1994, Rao et al. 1995, Yager et al. 1996). In addition, an 
important point to consider is the indirect impact of neutrophil elastase in wound 
healing resulting from its influence on other wound exudate composites such as 
growth factors (Wilgus et al. 2013). 
 
Both albumin and total protein concentrations were reported as displaying potential as 
predictive markers of wound healing. In general, lower albumin levels of less than 20 
g/l appear to indicate wounds that are not healing and levels above 23 g/l indicate 
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healing wounds (Trengove et al. 1996, James et al. 2000). Similarly, lower levels of total 
protein concentrations in wound exudate appeared to indicate wounds that were 
failing to heal and higher levels indicated wound healing. In addition, total protein 
levels were seen to increase as wounds healed whereas levels remained lower in 
wounds failing to heal. In the study by Trengove et al. (1996), all subjects were 
admitted to hospital and treated with bed rest and regular wound care. As a 
consequence, Trengove et al. (1996) concluded that it was not possible to determine 
whether findings showing higher concentrations of total protein and albumin in wound 
fluids collected from healing wounds were a direct indication of wound healing or 
were due to a potentially improved nutritional status acquired in the hospital setting. 
Likewise, James et al. (2000) acknowledged the possible influence of improved 
nutritional status to cause observed higher protein measurements in wound exudate 
however, as their study included both in-patients and out-patients, nutritional status 
was not considered directly related to protein levels in wound exudate and, 
alternatively, capillary collapse that can occur in leg ulceration and causes decreased 
protein delivery to the wound was suggested as a reason for lower protein 
concentration measurements. Similarly, in a study conducted to examine protein loss 
from pressure ulcers in association with wound-related factors and nutritional status, 
Iizaka et al. (2010b) concluded that levels of protein in wound exudate could be 
affected by numerous variables and thus could not be related directly to nutritional 
status (Iizaka et al. 2010b). In contrast to the studies included in this review, this study 
reported opposing findings in relation to protein concentrations and wound healing 
conditions as the levels of protein were found to statistically significantly increase as 
wounds increased in severity in terms of area, depth, the wound severity score, and 
infectious markers Iizaka et al. (2010b). In a study conducted to assess the differences 
between exudate composites of wounds treated with topical negative therapy and 
conventional gauze therapy, Moues et al. (2008) found albumin levels increased by 
0.10 g/L per day in acute healing wounds while levels decreased by 0.12 g/L per day in 
chronic, non-healing wounds (p<0.01). Due to inconsistencies in the literature and the 
insufficient understandings of the influence of variables on protein and albumin levels 
in wound exudate, further research is required before the measurement of albumin 
and protein levels in wound exudate can be recommended as a potential indicator of 
wound healing outcomes. 
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From the single study included in this review that reported measuring nitric oxide 
levels in wound exudate, threshold measurements of nitric oxide were suggested to 
have potential to indicate wound healing outcomes (Bernatchez et al. 2013). 
Considering the results of this study with regard to existing related literature, strong 
correlations have been reported between reduced cutaneous nitric oxide levels and 
impaired wound healing under disease conditions such as diabetes (Schaffer et al. 
1996, Stallmeyer et al. 2002, Luo et al. 2004) and malnutrition (Schaffer et al. 1997). 
Although these findings are consistent with those of the study by Bernatchez et al. 
(2013) that found levels of nitric oxide of less than 12mM nitric oxide to indicate 
deteriorating wounds, Bernatchez et al. (2013) conversely found that levels greater 
than 57mM nitic oxide also to indicate deteriorating wounds. Only one study 
measuring nitro oxide met the eligibility criteria of this review and the majority of 
existing research of this subject appears to have involved animal as opposed to human 
subjects. The use of nitric oxide measurements in wound exudate requires further 
research to establish the potential of this component as a predictor of wound healing 
outcomes.  
 
Three studies included in this review further examined MMP and TIMP measurements 
by analysing MMP/TIMP ratios in relation to wound healing outcomes (Ladwig et al. 
2002, Muller et al. 2008, Liu et al. 2009). All three studies found MMP-9/TIMP-1 ratios 
decreased as wounds progressed to healing. These findings are supported in the study 
by Lobmann et al. (2006) which examined the effects of a protease inhibitory 
modulating matrix wound dressing on patients with chronic diabetic foot lesions. This 
study found significantly reduced levels of MMP-9/TIMP-2 ratio in the group of 
diabetic patients treated with the protease inhibitory modulating matrix wound 
dressing who exhibited faster rates of healing compared to the diabetic patients in the 
control group who received only standard wound care (Lobmann et al. 2006). Similarly, 
in a study investigating the exudate composition of healing and non-healing wounds, 
exudate from acute surgical wounds collected one hour to ten days post-operatively 
found tissue inhibitor of metalloproteinases-1 increased rapidly to significantly higher 
levels within two days whilst MMP-2 and MMP-9 levels decreased an average of 
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twofold within four days (Bullen et al. 1995). Bullen et al. (1995) compared these 
results to exudate of chronic, non-healing wounds and noted significantly higher levels 
of MMP activity and lower levels of tissue inhibitor of metalloproteinases-1 levels. 
Furthermore, in animal research statistically significant differences have been found in 
the ratio of MMP-9 to TIMP-1 in the wounds of diabetic rats that exhibited slower 
wound healing compared to non-diabetic control rodents (Yang et al. 2009). Over the 
two-week course of the study, Yang et al. (2009) discovered the ratio of MMP-9 to 
TIMP-1 remained stable in the control subjects but increased significantly in the 
diabetic skin wounds. Reflecting on the findings of the studies included in this review 
in addition to other existing literature, these data appear to indicate that an imbalance 
of proteases and their inhibitors causes excess proteolysis which can result in impaired 
healing. Furthermore, the ratio between MMPs and TIMPs appears to correspond with 
wound healing outcomes and is therefore considered a potential indicator for wound 
healing outcomes.  
 
As evident from these findings, numerous analytes have been examined and 
considered for their potential as indicators of wound healing. Acknowledging the 
complex nature of wound healing and reflecting on these findings, using a combination 
of analytes as opposed to a single analyte may contribute greater indications of wound 
healing outcomes. For example, Wyffels et al. (2010) suggested using a set of proteins 
rather than relying on a single protein and Liu et al. (2009) found the measurement of 
pro MMP-9 in combination with cut-offs for TIMP-1 of above 480 pg/ml and TGF-β1 of 
above 115 pg/ml (AUC 0.94; p < 0.00001; sensitivity 87%; specificity 91%) the best 
measure which predicted wound outcomes in 94% of cases. Similarly, measuring the 
balance between proteases and protease inhibitors offers potential to predict wound 
healing rates. Evident from the research included in this review and other related 
literature, further research is essential in order to improve understandings of the 
dynamics of wound healing and to determine the potential of measurements of certain 
components in wound exudate to predict wound healing outcomes.
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5.4.3. Temperature 
Due to the nature of the methods used to measure temperature, namely infrared 
thermometry, infrared thermography and contact thermography, the results of the 
studies included were reported in a variety of forms, such as using thermographic 
images, line graphs, narrative descriptions, and quantified as degrees of Fahrenheit or 
degrees Celsius. Overall, it appears that temperature measurements are highest in 
non-healing, worsening or acute wounds and decrease as wounds progress to healing.  
 
As far back as the fifth century BC, an association has been known to exist between 
human body temperature and health with Hippocrates reported to have used the 
sense of touch to detect skin surface temperature to indicate of wellbeing or to detect 
anomalies in health (Meola & Carlomagno 2004). Temperature regulation plays a 
significant role in the physiology and functioning of every biological system in the 
human body (Smeltzer et al. 2008). In a healthy human, body temperature is kept 
constant within a small range, despite potentially large variances of temperature in the 
surrounding environment (Romanovsky 2014). Strict regulation of body temperature, 
necessary for optimal functioning of enzymatic reactions, is a characteristic of all 
homoeothermic animals including humans (Romanovsky 2014). The surface 
temperature of human skin is owed to the thermal balance between energy supplied 
from the core and perfusion and energy lost to the environment (Charkoudian 2003, 
Fierheller & Sibbald 2010). Breaks in the integrity of the skin trigger activities to occur 
within and surrounding the area of wounding, such as immune responses, 
inflammatory cytokine-induced vasodilation and increased tissue metabolism, which 
can result in alterations in surface temperatures (Petricevich 2004). As these internal 
activities which effect surface temperature change throughout the course of wound 
healing, measuring wound site temperature has been suggested as a potential 
mechanism to indicate wound healing outcomes. 
 
Contact thermography was among the methods used to measure temperature in the 
studies included in this review. Contact thermography has been used extensively in 
various fields of medical research to explore different pathologies such as deep vein 
thrombosis (Kjaer et al. 1988, Kohler et al. 1998), breast cancer (Davison et al. 1972), 
262 
 
skin damage due to chemical irritants (Agner & Serup 1988), diabetic foot ulcer (Chan 
et al. 1991, Houghton et al. 2013) and in orthopaedic surgery (Romano et al. 2011). In 
the study included in this review that measured surface temperature by means of 
contact thermography, Horzic et al. (1996a) used thermochromic liquid crystal strips. 
Liquid crystal is a unique organic cholesteric material which exists between the solid 
and the isotropic liquid phase (Rao & Zang 2010). Under different temperatures and 
viewing angles, the liquid crystals reflect definite colours, with red at the low end, to 
blue at the high end of the active temperature scale (Rao & Zang 2010). In other 
words, warm colours, such as browns and reds, correspond to lower temperatures 
whereas cooler colours, such as deep blues, correspond to higher temperatures 
(Horzic et al. 1996a). Such optical characteristics of liquid crystal thermography, which 
are dependent on its temperature, are repeatable and reversible (Rao & Xu 2012). The 
accurate relations between the thermographic liquid crystal colours and temperatures 
can be built through careful calibration experiments, which can then be used for 
precise temperature measurements of any surface (Rao & Zang 2010). For example, in 
the study by Horzic et al. (1996a) it was possible to measure a temperature change of 
0.1°C on the basis of liquid crystal colour change. It is worth noting that only one study 
included in this systematic review employed contact thermography and used liquid 
crystal bearing strips (Horzic et al. 1996a). This may be due to recognised 
disadvantages of contact thermography devices which are associated with low thermal 
sensitivity, poor spatial resolution of the liquid crystal display and the sensitivity of the 
measurement results by the process which requires precisely timed skin contact in 
order to provide reproducible temperature distributions (Sikdar et al. 2010). In 
addition, since the skin surface has a considerably low heat capacity its temperature 
can be easily altered by contact with external objects and, as such, measurement 
devices that need to make contact with the skin cannot produce reliable recordings of 
surface temperature (Sikdar et al. 2010).  
 
The other seven studies included in this review employed methods of temperature 
measurement that exploited infrared radiation (Robicsek et al. 1984, Armstrong & 
Lavery 1996, Horzic et al. 1996b, Armstrong et al. 2006, Nakagami et al. 2010, Dini et 
al. 2015, Siah & Childs 2015). These methods are based on the principle that all objects 
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at a temperature above absolute zero (−273 ◦C) emit rays of electromagnetic radiation 
within the infrared (below red) section of the electromagnetic spectrum from 1 to 
1000 μm (Meola & Carlomagno 2004). Although undetectable by the unaided human 
eye (Meola & Carlomagno 2004), these rays of electromagnetic radiation can be 
measured using infrared detecting devices (Usamentiaga et al. 2014, Paul et al. 2015).  
 
The majority of advanced infrared radiation measurement devices consist of a range of 
sensors that produce a detailed infrared image of the target object (Usamentiaga et al. 
2014). In contrast to an image observed by the naked human eye, which is a 
representation of the reflected light on an object, an infrared image is formulated by 
an infrared camera which designates different colours to each infrared energy to 
produce a false-colour image referred to as a thermogram (Usamentiaga et al. 2014). 
Five of the studies included in this systematic review measured wound temperatures 
by means of infrared thermography (Robicsek et al. 1984, Horzic et al. 1996b, 
Nakagami et al. 2010, Dini et al. 2015, Siah & Childs 2015). The advantages of infrared 
thermography are related to it being a non-contact, non-invasive technology that 
provides reproducible, two-dimensional thermal images over large or small areas of a 
target object (Romanò et al. 2012) allowing assessment of the relative skin 
temperature over the defined surface area (Renkielska et al. 2005, Roback 2010). This 
feature may be of particular benefit in measuring temperatures of chronic or non-
healing wounds which are typically extremely heterogeneous in structure (Mercer et 
al. 2008). Furthermore, infrared thermography does not cause harmful effects such as 
those associated with X-ray imaging and, therefore, is suitable for prolonged and 
repeated use (Usamentiaga et al. 2014). There are however some disadvantages that 
limit the use of infrared thermometry in routine clinical assessments such as, 
difficulties in patient and camera positioning, visual and thermal image registration, 
controlling environmental conditions as well as a lack of quantitative tools (Paul et al. 
2015). An example of the challenges experienced when using infrared thermography 
to measure wound temperature was demonstrated in a study exploring the potential 
of thermographic assessments of burn wounds to determine wound depth and to 
predict healing outcomes (Cole et al. 1990, Renkielska et al. 2005). The main challenge 
associated with the use of infrared thermography in evaluating burn wounds related to 
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the distortion of the results caused by evaporative water loss in the wound bed. 
Despite the identified disadvantages of infrared thermography, it is evident that efforts 
can be made to accommodate for some of the limitations associated with this modality 
Such an example is described in the measurement of burn wound injuries where 
wounds are allowed to dry completely or non-permeable coverings are applied to the 
wound bed prior to performing thermographic measurements (Cole et al. 1991). 
 
Another method of temperature measurement is infrared thermometry. This method 
is similar to infrared thermography in that it is based on the simple premise that all 
objects above the temperature of absolute zero release infrared radiation (Blundell & 
Blundell 2010). Measurement of temperature by infrared thermometry occurs when 
infrared radiation is detected by a sensor in the thermometer, such as heat released by 
inflammation in the form of infrared radiation, the sensor translates this energy into a 
precise electrical signal which represents a specified temperature (Mufti et al. 2015). 
As such, higher temperatures in wounds and cutaneous surfaces cause greater levels 
infrared radiation to be received by the examining sensor which, in turn, produces 
elevated temperature measurement readings (Mufti et al. 2015). It is important to 
note that infrared thermometers provide information regarding skin surface 
temperatures and do not measure internal temperatures (Mufti et al. 2015). All the 
same, surface temperatures can be influenced by internal conditions such as vascular 
supply, inflammation and infection (Mufti et al. 2015).  
 
Focusing on the studies included in this review that measured wound temperature, 
two studies used infrared thermometry devices (Armstrong & Lavery 1996, Armstrong 
et al. 2006). Overall, the findings from these studies reported lower and decreasing 
wound temperature gradients corresponded with improved wound conditions and 
progression towards wound healing, respectively. Both studies examined the wound 
temperatures of subjects with diabetic foot ulcers and used the subject’s contralateral 
limb as the control measurement. Bilateral symmetry is a characteristic of the human 
body’s surface heat distribution and any significant asymmetry of greater than 0.7 °C 
has been defined as abnormal and suggested to indicate physiological or anatomical 
variance (Zhu & Xin 1999, Szentkuti et al. 2011). This statement has been supported by 
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studies in which the abnormality under examination is a wound, such as in studies 
involving subjects with diabetic foot ulcers (Armstrong & Lavery 1997, van Netten et al. 
2014) or burns (Zhu & Xin 1999). An example of such research is the retrospective 
study conducted by Armstrong & Lavery (1997) that examined the foot temperatures 
of subjects with diabetic neuropathic ulcers using a portable hand-held infrared skin 
temperature probe. (Armstrong & Lavery 1997) found differences in skin temperatures 
of 5.6 °F between the ulcerated foot and the contralateral foot. Twelve months after 
the foot ulcers healed, bilateral skin temperatures recorded showed no differences 
between the site of previous ulceration and the contralateral site (Armstrong & Lavery 
1997). These findings support the measurement techniques employed by the two 
studies in this review by Armstrong & Lavery (1996) and Armstrong et al. (2006) that 
recorded contralateral temperatures using infrared thermometers. Furthermore, 
findings from the study by Armstrong & Lavery (1997) showed no temperature 
differential existed between bilateral skin temperatures following wound healing. This 
result, which is suggestive of reducing temperature differentials as wounds heal, 
supports the findings reported from the studies included in this review by Armstrong & 
Lavery (1996) and Armstrong et al. (2006).       
 
In relation to assessing the value of infrared thermometers for measuring wound 
temperatures, a study conducted to evaluate four non-invasive methods for 
characterising pressure ulcers concluded that infrared thermometers were of little 
diagnostic value due to the various factors that were considered to influence skin 
surface temperature readings, such as distance from body joints and the body truncus 
(Andersen & Karlsmark 2008). In contrast, a cross-sectional pilot study examining 
chronic leg ulcers found a statistically significant relationship between increased peri-
wound skin temperature and wound infection, and determined infrared thermometry 
to be a reliable method of temperature measurement in the relatively ‘‘healthy’’ non-
wounded population when examined under consistent environmental conditions (r = 
0.939; p = 0.000, CI: 95%) (Fierheller & Sibbald 2010). In light of their findings, 
Fierheller & Sibbald (2010) recommended the use of infrared thermometry as a wound 
assessment aid to quantify the temperature associated with deep and surrounding skin 
infection and to monitor wound healing. The results of the studies included in this 
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review similarly demonstrate the potential of infrared thermometers to provide 
objective quantitative temperature measurements which may aid the identification of 
wound healing outcomes.      
 
Five studies included in this review measured wound temperature using infrared 
thermography devices (Robicsek et al. 1984, Horzic et al. 1996b, Nakagami et al. 2010, 
Dini et al. 2015, Siah & Childs 2015). Overall, the studies that examined acute incisional 
wounds found temperatures in normally healing post-operative wounds increased 
over the first few days and returned to baseline within a two-week period (Robicsek et 
al. 1984, Horzic et al. 1996b, Siah & Childs 2015). In support of these findings, a 
prospective, observational, nonrandomized cohort study which examined the 
thermographic patterns of surgical site healing over the course of uncomplicated 
orthopaedic surgery found no thermographic differences between the affected side 
and the contralateral side preoperatively, a steep increase in the mean differential 
temperature of the operated joint immediately following surgery that peaked at three 
days postoperatively, and then a gradual decline in temperatures to preoperative 
values (Romano et al. 2011). 
 
In relation to post-operative wound healing and the development of wound infection, 
the included studies using infrared thermography devices reported incongruent 
findings. For example, the study published by Siah & Childs (2015) concluded that 
colder temperatures at the wound site indicate developing infection, whereas the 
study published by Robicsek et al. (1984) described that persistently elevated 
temperatures at the wound site indicate developing infection. Many physiological and 
pathological activities may have contributed to the varying temperature patterns 
noted in these two studies. In the study by Siah & Childs (2015) the initial post-
operative cold area that appeared in the area surrounding the wound site was owed to 
the increased permeability of the vascular membranes in response to tissue injury. In 
the uncomplicated healing wound, this cold area began ‘warming’ following the first 
postoperative day (Siah & Childs 2015). In contrast, this cold area was seen to continue 
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or increase in wounds that developed infection and was suggested to be as a result of 
excess fluid within the tissues which was preventing angiogenesis (Siah & Childs 2015).  
 
Two studies included in this review used infrared thermography to examine wound 
temperatures of abnormally healing wounds, namely venous leg ulcers (Dini et al. 
2015) and pressure ulcers (Nakagami et al. 2010). Monitoring the thermographic 
healing patterns of leg ulcers, Dini et al. (2015) found an increasing relationship 
between improved wound conditions and wound bed temperatures rising to within 
the range of 33 to 35°C (Dini et al. 2015). These findings are consistent with animal 
research that suggests wound temperatures which are below core body temperatures 
experience delayed healing due to inadequate collagen deposition and reduced late-
phase inflammatory cells and fibroblasts (Esclamado et al. 1990), as well as, in vitro 
studies which have shown decreased neutrophil, fibroblast, and epithelial cell activity 
in temperatures below 33°C (Xia et al. 2000). Results from this study which associated 
lower wound temperatures with wound bed conditions indicative of abnormal healing 
concur with suggestions that the base of non-healing ulcers is typically severely 
hypoxic and subsequently, low in energy, metabolism and temperature (Kivisaari et al. 
1975, Mercer et al. 2008, Schreml et al. 2010b). This local wound tissue hypoxia has 
been attributed to pathological alterations of the vascular bed that typically exist in 
non-healing wounds, such as arteriosclerosis, micro- or macro-angiopathy and venous 
hypertension, and peri-wound fibrosis (Schreml et al. 2010b). These alterations lead to 
local reduction of tissue perfusion or oedema and cause increased distance between 
capillaries (Schreml et al. 2010b). Given that local tissue hypoxia is widely accepted to 
impair wound healing profoundly (Schreml et al. 2010b) and that low wound bed 
temperatures are an indication hypoxia in the tissues of the wound bed (Mercer et al. 
2008), the potential value of measuring wound bed temperatures as an indicator of 
wound healing outcomes is apparent.  
 
In the other study that examined subjects with abnormally healing wounds, Nakagami 
et al. (2010) compared thermographic images of stage II to IV pressure ulcers which 
were recorded at the start of the study with the rate of wound healing following a 
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three week period. Pressure ulcers exhibiting lower wound bed temperatures than the 
peri-wound skin were associated with normal healing whereas pressure ulcers that had 
higher wound bed temperatures than the peri-wound skin were linked with delayed 
healing (Nakagami et al. 2010). Based on the findings of this study, Nakagami et al. 
(2010) deduced that pressure ulcers with higher wound temperature gradients had 
more than two times greater risk of delayed healing. Some potential reasons for these 
findings are the presence of bacterial colonisation which is below the threshold for an 
acute inflammatory response or excessive mechanical loading which can produce 
inflammation or cause the release of nitric oxide due to cell deformation leading 
vasodilation in the wound bed (Nakagami et al. 2010).  
 
Acknowledging the inconsistencies in the evidence and the limitations that exist for 
the use of temperature measurement as an indicator of wound healing outcomes, 
combining wound temperature measurements with additional wound assessment 
measurements may reveal value of this characteristic as an aid in predicting wound 
healing outcomes. In a study conducted by Hazenberg et al. (2014), diagnosis of wound 
infection based on a combination of temperature measurements and photographic 
assessments was found to be both sensitive (>60%) as well as specific (>79%). In 
contrast, when temperature measurements were used in isolation, although sensitivity 
was above 90%, specificity was less than 25% for diagnosis of infection (Hazenberg et 
al. 2014). Acknowledging that this study only demonstrated the potential of the 
combined use of these assessments to diagnose wound infection at one point in time, 
a similar formula may offer potential to increase the value of temperature 
measurements in wounds to predict healing outcomes.    
 
With over thirty years of clinical use and the publication of more than eight thousand 
peer-reviewed studies in the medical literature, thermography has been established as 
a safe and effective means to measure temperatures of the human body (Mercer et al. 
2008). Due to advances in technology, infrared thermal imaging has increased in 
efficiency for the study of skin temperature in clinical practice and in research as 
devices now are available that are lightweight, portable, easy to use and relatively 
inexpensive (Mercer et al. 2008, Paul et al. 2015). Similarly, infrared thermometers are 
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devices that are well accepted in both clinical practice and research for the 
measurement of wound temperature (Romanelli et al. 2002b, Mufti et al. 2015). The 
infrared thermometer is a device that is fast, stable, and relatively insensitive to user 
technique (Romanelli et al. 2002b) which can produce objective quantitative 
temperature measurements that may aid the identification of wound healing 
outcomes. Contact thermography is another alternative measurement technique that 
has been employed throughout various fields of biomedical research and shows 
advantages for application in measuring wound temperatures. One particular benefit 
of this technique is as it allows assessment of relative skin temperature over the 
defined surface area. 
 
Due to the inconsistencies which emerged from the current research, the value of 
measuring wound temperature to indicate wound healing outcomes remains unclear. 
The disparities among the papers included in this review are possibly due to 
heterogeneity among the studies as well as numerous diverse factors that can affect 
wound temperature, of which the exact mechanisms and extent of influence remain 
undetermined. Nevertheless, as temperature measurement appears to offer much 
potential as an indicator of wound healing outcomes, further research is 
recommended in this field.   
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5.5. Summary and Conclusion  
From the studies included in this review it is clear that there are methodological issues 
relating to the population, data collection methods, study design, reporting and 
presentation of results. Moreover, based on the hierarchy of evidence pyramid the 
majority of the studies included are at a relatively low level of evidence. With further 
research which increases homogeneity across the studies, improves the quality of the 
research and ensures comprehensiveness in the reporting of fundamental 
methodological aspects, it should be possible to accurately compare the studies and 
conduct meta-analyses which would consequently enhance the validity of the review’s 
conclusions and increase the generalisability of the review’s findings and 
recommendations.   
 
Due to the small quantity and diverse nature of primary research studies obtained that 
involved the measurement of pH in wounds, it was not possible to come to any solid 
conclusion regarding the implementation of pH as an indicator of wound healing. 
Nonetheless, some promising findings were apparent in the studies which were 
included in this review. pH has been acknowledged as having a considerable influence 
on cellular and subcellular functions, enzymatic activities, protein conformation and 
expression, bacterial colonisation and skin barrier function. As noted in this systematic 
review, a deficit of knowledge renders uncertain the precise role of pH in wounds as 
well as the value of this characteristic of measurement as an indicator of wound 
healing outcomes. Further research is therefore essential in order to develop a greater 
understanding of the impact of pH in wounds as well as to clarify the patterns of 
changing wound pH values throughout the different stages of physiological wound 
healing. 
 
Similar to the way in which pH values are intertwined with the various stages of wound 
healing, so too are the levels of the various composites of exudate. Normal wound 
healing requires specific proteases to be produced at particular wound locations for 
distinct periods of time and at precise levels. As such, measuring exudate composition 
and interpreting the results in relation to wound outcomes requires a comprehensive 
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knowledge of these particular details. From this review, it is evident that such a level of 
understanding does not currently exist and, therefore, further research in this subject 
field is required. Despite obvious gaps in the existing literature, some particular wound 
exudate components showed prominence for their potential to act as biomarkers of 
wound healing outcomes with further supporting research, specifically matrix 
metalloprotease-9 and tissue inhibitor of metalloprotease. Although, the potential of a 
single component of exudate to indicate wound healing outcomes in isolation is 
currently not substantiated by sufficient evidence, research findings have suggested 
combining the measurements of different exudate components as a potential means 
of indicating wound healing outcomes, such as MMP/TIMP ratio.  
 
Similar to the measurement of pH and exudate composition in wounds, measuring the 
thermal characteristics of wounds as a method of predicting wound healing outcomes 
requires further research before its potential can be clearly defined. Although some 
general consensus existed across the studies, conflicting findings were also reported. A 
significant issue impeding the comparison of these results was owed to the substantial 
heterogeneity among the studies which appeared in various aspects of the studies’ 
methodology. Although the literature suggested the potential of this characteristic to 
indicate wound healing outcomes, further research is necessary in order to clarify 
conflicting reports and to build on the existing evidence. 
 
In conclusion, the measures of pH, exudate composition and temperature in wounds 
each show promise as potential predictors of healing outcomes. However, further 
research is required to increase reduce heterogeneity and increase quality among the 
research studies, and to develop a greater understanding of the complex dynamics of 
wound healing. With this knowledge, the value of measuring pH, exudate composition 
and temperature in wounds will become more apparent and potentially reveal valid 
biomarkers to predict wound healing outcomes.      
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5.6. Strengths and Limitations of the Systematic Review 
With the aid of the PRISMA systematic review checklist (Moher et al. 2009), this 
systematic review was assessed as fulfilling the applicable requirements (see Appendix 
45). This is considered a strength of this review as the PRISMA checklist supports 
transparency and complete reporting of systematic reviews (Liberati et al. 2009). In 
addition, the enhanced quality of reporting in this review promoted through the 
application of this checklist ensured that essential data were presented which would 
also facilitate the replication of this piece of work. Another strength of this systematic 
review is the literature review that was performed at the beginning of this project 
which provided an overview of relevant information pertaining to this field of research 
and substantiated the rationale for performing this systematic review.   
  
Despite these strengths, there are also limitations to this systematic review. Some of 
these limitations are owed to the methodological weaknesses and inconsistencies in 
the research studies that were included in the review. An example of this is the 
significant heterogeneity that became apparent among the studies across all three 
characteristics of measurement such as relating to sample demographics, study 
methods, and reporting style. In addition, the poor validity scores noted in the 
included studies are also considered a significant weakness for this review as no 
research article achieved the required score that would indicate the findings of the 
study could be confidently regarded as valid.   
 
A further limitation of this review is owed to the inadequate or absent description in 
the majority of the research reports regarding the wound treatments or interventions 
that had been implemented during the study period. Different wound treatments 
influence healing conditions and, based on this premise, various wound dressings have 
been specifically devised to alter the wound environment and functioning, such as 
hydrocolloid dressings (Fletcher et al. 2011 ), collagen/oxidised regenerated cellulose 
dressings (Cullen & Ivins 2010), and certain superabsorbent dressings containing 
polyacrylate which are reported to have the ability to bind to and reduce the activity of 
MMPs in vitro (Wiegand & Hipler 2013) and to inhibit the activity of bacterial 
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proteases (McCarty et al. 2015). Considering this information, the importance of 
comprehensive reporting of all aspects of research methodology is considered as 
essential for all research studies and, as specifically demonstrated, is of fundamental 
importance in studies measuring microscopic variances in wound biochemistry.  
 
Further limitations are due to the eligibility criteria that was applied for studies to be 
included in this review. For example, only studies published in the English language 
were included because of time and financial restrictions. These such limitations must 
be acknowledged by the review consumer when analysing the findings and conclusions 
of this systematic review.  
 
In relation to the research designs that were employed, all the included studies 
appeared at a sub-optimal level when measured against the hierarchy of evidence 
pyramid. No randomised controlled trials were identified from the search strategy as 
eligible for inclusion in this review, of which exist at top of this hierarchy of evidence 
pyramid in relation to primary research study design. Although randomised controlled 
designs are considered as the ‘gold standard’ in many aspects of scientific research, 
when poorly conducted the randomised controlled trial will produce poor results and 
have no relevance in clinical practice (Pocock 1983). Considering this, a well conducted 
study of lower ranking in terms of design on the hierarchy of evidence pyramid could 
essentially provide superior quality findings.  
 
The quantity of comparable research studies retrieved was also a significant limitation 
which will impact on the potential of this review to draw solid conclusions. This 
limitation was most apparent from the search for studies encompassing pH 
measurement which yielded only three heterogeneous research papers.     
 
Although the significant limitations of this review can be considered to negatively 
impact the conclusions of this review, identification of particular weaknesses and 
deficits in the existing literature can be viewed as a major strength as it allows for 
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specific recommendations to be made for future research. Research bodies have 
recognised that an important role of systematic reviews is to not only synthesise the 
relevant existing literature, but also to uncover gaps in the evidence that obstruct 
achieving the outcomes of interest of the systematic review (Agency for Healthcare 
Research and Quality 2010). In this way, systematic reviews can produce 
recommendations to enhance the ability of future research to achieve growing 
demands for improvements in healthcare technology, cost-effectiveness, clinical care, 
and to reduce the burden of ill-health.      
 
5.7. Contributions of the Systematic Review  
From a comprehensive search strategy, this systematic review retrieved the existing 
literature that addressed the primary outcome of this review which was to attain an 
objective measure of pH, exudate composition and temperature as predictors of 
wound healing outcomes. From examination of the literature, measurements of pH, 
exudate composition and temperature in wounds each displayed promise as potential 
indicators of wound healing outcomes, however, insufficient research was a common 
restricting feature across all three subjects. pH level emerged as the measure that 
appeared to offer the most potential as an indicator of wound healing outcomes. In 
spite of having the least amount of literature available, only three primary research 
studies, all three reports presented similar or complementary findings. Moreover, the 
mechanisms of pH measurement appeared to be relatively simple for use in clinical 
practice and research studies and produced quantitative data that could be easily 
recorded and analysed. Although particular components of exudate also showed 
promise as indicators of wound healing outcomes, it was not possible to confidently 
recommend any exudate composite as a biomarker to predict healing. This was due to 
a lack of sufficient knowledge regarding both the balance between proteolytic 
enzymes and their inhibitors as well as various potentially influential factors such as 
temperature, pH and oxygen. Another limitation of the measurement of exudate 
composition in routine clinical practice related to the extensive processes required to 
collect, measure and analyse the data. In relation to the measurement of temperature 
in wounds, this technique was limited due to methodological issues across the studies 
in addition to conflicting results. Nonetheless, it is worth noting that some similar 
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findings did emerge from the studies, the majority of which could be supported by 
existing evidence. Due to advances in temperature measurement devices that are 
considered practical, efficient and suitable for use in clinical practice and research, 
with further research to clarify the patterns and dynamics of temperature in wound 
healing, this characteristic may offer potential as a biomarker of wound healing 
outcomes. As such, the potential of exudate composition and temperature 
measurement in wounds to predict abnormal healing or efficient healing remains 
uncertain. Although much research is required, the measure of pH emerges from the 
findings of this review as the characteristic offering the most promise to act as a 
predictor of wound healing outcomes. 
 
5.8. Recommendations for Clinical Practice and for Future Research 
Wound healing is an intricate physiological process which can be interrupted and lead 
to impaired wound healing. Despite the strong acknowledgement in the literature of 
the influential and multifaceted role of pH in wound healing (Leveen et al. 1973, 
Wilson et al. 1979, Liu et al. 2002, Gethin 2007, Schneider et al. 2007, Nagoba et al. 
2008, Sharpe et al. 2009, Percival et al. 2014a, Jones et al. 2015), only a small number 
of primary research studies were found which examined the measurement of pH in the 
wounds of humans. Clearly, there is need for further research in this area in order to 
strengthen the information already known about this concept and to develop and 
examine its potential as an indicator of wound healing outcomes. In contrast, a large 
number of eligible articles were retrieved relating to the measurement of exudate 
composition in wound healing. Despite this, these studies varied in relation to the 
specific components of exudate that were measured and therefore the strength of the 
evidence in terms of the quantity of published literature was reduced. This review 
identified MMP-9, TIMP and MMP/TIMP ratio as the most frequently researched and 
most suggestive components in exudate for predicting wound healing outcomes. 
Based on this finding, further research is recommended which examines these 
components in relation to their ability to accurately predict wound healing outcomes.  
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Based on the discoveries of this systematic review, the main recommendation for 
future study for all three features of wound measurement relates to the need to 
improve the quality of the research evidence produced. Existing systematic reviews 
have similarly highlighted the considerable deficiencies in the quality of clinical 
research and it has been advised that wounds research should follow guidelines for 
conducting and reporting clinical studies (Gottrup et al. 2010). A significant limitation 
in this review was owed to the heterogeneity among the studies which prevented 
meta-analyses and even impaired comparing the results narratively. Adhering to 
guidelines to increase homogeneity in wound care research would enhance the 
strength of evidence and the conclusions produced from systematic reviews. 
Furthermore, the poor validity scores of the research articles included in this review 
generated the need to recommend future research that is of higher quality both in 
terms of methodology as well as reporting. Interestingly, the validity issues identified 
in this systematic review have been suggested as a common feature in wounds 
research with studies exhibiting issues such as inadequate sample sizes, insufficient 
follow-up periods, lack of randomised allocation to intervention and control groups, 
failure to implement blinded assessment of outcomes, and inadequate descriptions of 
all study subjects and concurrent interventions (Gottrup et al. 2010). Many challenges 
are acknowledged to exist for achieving such homogeneity and high quality in wounds 
research and, therefore, combined efforts are required by all researchers and research 
agencies to bring about these improvements.  
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Chapter 6  
6.1. Introduction  
This chapter will provide an overall summary and conclusion of this paper which 
systematically reviewed the existing literature relating to the measurement of pH, 
exudate composition and temperature in wounds with the aim of determining the 
potential role of these characteristics as predictors of wound healing outcomes. 
 
6.2. Summary and Conclusion 
All types of wounds have the potential to impact significantly on patients’ lives, 
healthcare systems and government arrangements (Bowler et al. 2001, Dow 2003, 
Herber et al. 2007, Gorecki et al. 2009), with wounds displaying impaired or stalled 
healing, in particular, presenting the most substantial challenges worldwide (Sen et al. 
2009, World Health Organisation 2010). Efficient wound healing can become impaired 
by numerous factors which can relate to the local wound environment or the 
conditions of the host subject. An example of this is surgical site infection which is 
reported to be the most expensive post-surgical complication (Sen et al. 2009). 
Although much research has been conducted in an attempt to quantify the prevalence, 
incidence and finances implicated in wounds, the exact statistics remain unknown. This 
is as a result of specific barriers in existence which hinder the ability of researchers to 
accurately collect data in this subject field as well as impede the capacity of reviewers 
to compare and contrasting study findings. For instance, in the case of non-healing 
wounds which seldom appear in individuals that are otherwise healthy, these wounds 
are more typically viewed as a co-morbidity and, consequently, the true impact of non-
healing wounds is reduced (Sen et al. 2009). Wounds with impaired healing are 
present in both the industrialised and developing worlds. The incidence of wounds 
with impaired healing is expected to increase due to the rising number of elderly 
individuals (Government of Ireland 2012), the increase in concurrent comorbidities, 
such as diabetes, obesity, venous hypertension, and peripheral vascular disease 
(Whelton et al. 2007, World Health Organisation 2008, Gist et al. 2009, Morgan et al. 
2009, Zhang et al. 2010, Carter 2014, Dee et al. 2015) and deficits in healthcare 
services particularly related to countries with lower socioeconomic standing and 
experiencing social unrest (MacDonald & Ryan 2010). 
278 
 
A cutaneous wound is a disruption in the integrity of the skin caused by pathologic 
processes originating internally or externally the skin surface (Lazarus et al. 1994, 
Schultz et al. 2003). Cutaneous wound healing is a process that aims to restore the 
skin’s anatomic continuity and function (Thamm et al. 2013) and requires synchronised 
efforts from numerous different cell types to progress through the typical phases of 
haemostasis, inflammation, proliferation, and remodelling (Lorenz & Longaker 2008). 
 
Factors that influence healing include the wound’s pH, exudate composition and 
temperature. As a result, research has been conducted in these areas in an attempt to 
determine the potential of these measureable characteristics of wounds to act as 
biomarkers of wound healing. Considering the numerous benefits which would arise 
from the ability to predict wound healing outcomes for both patients as well as 
healthcare providers and systems, this systematic review was performed to determine 
the potential of pH, exudate composition and temperature measurements in wounds 
to predict healing outcomes. In terms of study design, systematic reviews are 
positioned at the top of the hierarchy of evidence pyramid as findings from a well 
conducted systematic review are considered to be of great strength and value (Egger 
et al. 2003, Sambunjak & Franic 2012). This type of review design was deemed most 
beneficial to achieve the objectives of this research project due to its multitude of 
advantages, such as decreasing the effects of possible errors in single studies, 
exploring and resolving diverse findings from similar studies, developing deeper 
understandings of subjects, identifying gaps or sufficiency in the evidence (Egger et al. 
2003, Sambunjak & Franic 2012).  
 
In relation to the studies of wound pH, the measurement methods included the use of 
a glass surface electrode and pH meter set (Gethin et al. 2008), pH indicator strips 
(Ono et al. 2015), and litmus paper strips (Shukla et al. 2007). The overall results from 
these studies suggest that as pH levels reduce in alkalinity towards an increasingly 
neutral pH, wound conditions are more indicative of wound healing progression in 
terms of wound size, wound infection and wound bed tissue. The advantages of this 
relatively quick and simple measurement is that it can be performed at the point-of-
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care and produces numerical results that can facilitate clear and concise data 
collection and analysis. Considering the research addressing wound pH included in this 
systematic review, pH measurement appears to offer much promise as a biomarker of 
wound healing outcomes.  
 
On the subject of wound exudate composition, the exudate collection procedures 
conducted in the studies involved the retrieval of fluids from beneath occlusive wound 
dressings, from surgical wound drains or from wound bandages, or by using pads, 
hydrophilic beads, filter papers, applicator swabs or mesh and collection filter systems, 
and the measurement methods were all conducted in a laboratory setting employing 
various techniques such as zymography, Western blot, SDS-PAGE, and label-based 
microarrays. In the included studies, MMP-9 and MMP-2 were the most frequently 
measured wound exudate components and MMP-9, TIMP and MMP-9/TIMP ratio 
measurements were the components that appeared to offer the most potential as 
indicators of wound healing outcomes. MMP-9 levels were seen to be elevated in 
exudate of wounds in a non-healing phase and reduced as wounds progress into a 
phase of healing and, similarly, MMP-9/TIMP-1 ratios appeared to decrease in wounds 
that progressed into a phase of healing. Although matrix metalloproteinase activity is 
acknowledged as being necessary for the many of the crucial cellular responses of 
early wound healing, such as inflammatory infiltration, angiogenesis and re-
epithelialization (Tarlton et al. 1997), the findings of the studies suggest persistently 
high levels of protease activity can be detrimental to the wound. Furthermore, the 
results of these studies would suggest the ratios of different proteolytic enzymes and 
their inhibitors are also critical to successful wound healing to ensure the correct 
balance between matrix deposition and tissue turnover. Considering the studies which 
address wound exudate composition eligible for inclusion in this review, particular 
composites of exudate appear to show promise for identifying wound healing. 
However, following close examination and appraisal of these studies it is evident that 
disadvantages for the measurement of components in wound exudate exist in relation 
to factors such as the time, skills and equipment that are required to perform the 
collection and measurement procedures. Furthermore, due to the intricate 
interactions of the numerous exudate components with each other as well as the 
280 
 
influence of external elements, which are as yet not fully understood, there appears to 
be insufficient evidence at present to confidently propose the measurement of 
exudate composition as a predictor of wound healing outcomes.  
 
Using the measurement methods of infrared thermometry, infrared thermography and 
contact thermography, the studies of wound temperature overall found temperatures 
were the highest in non-healing, worsening or acute wounds and decreased as wounds 
progressed to healing. As increased temperature in wounds can be related to 
hyperaemia, inflammation or infection (Sussman & Bates-Jensen 2012), it is 
acknowledged that temperature measurements will vary and fluctuate as a result of 
the processes involved in wound healing. Although there are advantages to the 
measurement methods used for wound temperature compared to other wound 
characteristics and there appears to be promising findings for temperature to indicate 
changes occurring in the wound, this systematic review failed to find sufficient 
evidence to adequately support the use of temperature measurement as an indicator 
of wound healing outcomes. 
 
Assessing a wound for healing potential requires considering all aspects of the patient 
as well as examining the wound itself. The ability to indicate the potential of a wound 
to heal is of great significance for medical, legal and financial reasons as it facilitates 
the earlier detection of complications in healing and therefore promotes the 
implementation of more efficient and suitable interventions. As traditional methods of 
wound measurement such as scaling systems, simple linear measurements, and wound 
tracings are often based on subjective interpretation of the wound which can lead to 
bias in measurement results, this systematic review explored the potential of pH, 
exudate composition and temperature measurement in wounds to act as objective and 
valid indicators of wound healing outcomes. Overall, there appears to be promising 
findings for all three characteristics of measurement, most particularly pH, as aids to 
predict wound healing outcomes. Due to the significant deficits and weaknesses in 
current research, it is not possible at present to conclude by proposing any of these 
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measures for use in clinical practice, however, this systematic review has highlighted 
and recommended areas that would be of value for further research.  
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Appendix 1: Hierarchy of Evidence Pyramids and Tables  
 
 
Source: Glover, J., Izzo, D., Odato, K. & Wang, L. (2006) Evidence Pyramid & Resources 
[Online]. Chicago: Trustees of Dartmouth College and Yale University. Available: 
http://guides.lib.uchicago.edu/c.php?g=297292&p=1984444 [Accessed 1st February 
2016]. 
 
 
Source: Lo Biondo-Wood, G. & Haber, J. (2013) Nursing Research: Methods and Critical 
Appraisal for Evidence-Based Practice, Missouri, Elsevier Mosby. 
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Source: Melnyk, B. M. & Fineout-Overholt, E. (2011) Evidence-based Practice in Nursing 
& Healthcare: A Guide to Best Practice, Philadelphia, Wolters Kluwer/Lippincott 
Williams & Wilkins. 
 
 
 
Source: University of New Hampshire. (2015) Health Literacy: Evidence Pyramid 
[Online]. Available: http://libraryguides.unh.edu/c.php?g=326606&p=2191225 
[Accessed 1st February 2016]. 
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Appendix 2: Adapted Hierarchy of Evidence Pyramid 
 
 
Adapted Hierarchy of Evidence Pyramid based on work by:  
Glover, J., Izzo, D., Odato, K. & Wang, L. (2006) Evidence Pyramid & Resources [Online]. 
Chicago: Trustees of Dartmouth College and Yale University. Available: 
http://guides.lib.uchicago.edu/c.php?g=297292&p=1984444 [Accessed 1st February 
2016]; 
Lo Biondo-Wood, G. & Haber, J. (2013) Nursing Research: Methods and Critical 
Appraisal for Evidence-Based Practice, Missouri, Elsevier Mosby; 
Melnyk, B. M. & Fineout-Overholt, E. (2011) Evidence-based Practice in Nursing & 
Healthcare: A Guide to Best Practice, Philadelphia, Wolters Kluwer/Lippincott Williams 
& Wilkins; 
University of New Hampshire. (2015) Health Literacy: Evidence Pyramid [Online]. 
Available: http://libraryguides.unh.edu/c.php?g=326606&p=2191225 [Accessed 1st 
February 2016]. 
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Appendix 3: CONSORT 2010 checklist (http://www.consort-statement.org/consort-2010) 
     CONSORT 2010 checklist of information to include when reporting a randomised trial* 
Section/Topic 
Item 
No Checklist item 
Reported on 
page No 
Title and abstract 
 1a Identification as a randomised trial in the title  
1b Structured summary of trial design, methods, results, and conclusions (for specific guidance see CONSORT for abstracts)  
Introduction 
Background and 
objectives 
2a Scientific background and explanation of rationale  
2b Specific objectives or hypotheses  
Methods 
Trial design 3a Description of trial design (such as parallel, factorial) including allocation ratio  
3b Important changes to methods after trial commencement (such as eligibility criteria), with reasons  
Participants 4a Eligibility criteria for participants  
4b Settings and locations where the data were collected  
Interventions 5 The interventions for each group with sufficient details to allow replication, including how and when they were actually 
administered 
 
Outcomes 6a Completely defined pre-specified primary and secondary outcome measures, including how and when they were assessed  
6b Any changes to trial outcomes after the trial commenced, with reasons  
Sample size 7a How sample size was determined  
7b When applicable, explanation of any interim analyses and stopping guidelines  
Randomisation:    
 Sequence generation 8a Method used to generate the random allocation sequence  
8b Type of randomisation; details of any restriction (such as blocking and block size)  
 Allocation 
concealment 
mechanism 
9 Mechanism used to implement the random allocation sequence (such as sequentially numbered containers), describing any 
steps taken to conceal the sequence until interventions were assigned 
 
 Implementation 10 Who generated the random allocation sequence, who enrolled participants, and who assigned participants to interventions  
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Blinding 11a If done, who was blinded after assignment to interventions (for example, participants, care providers, those assessing 
outcomes) and how 
 
11b If relevant, description of the similarity of interventions  
Statistical methods 12a Statistical methods used to compare groups for primary and secondary outcomes  
12b Methods for additional analyses, such as subgroup analyses and adjusted analyses  
Results 
Participant flow (a 
diagram is strongly 
recommended) 
13a For each group, the numbers of participants who were randomly assigned, received intended treatment, and were analysed 
for the primary outcome 
 
13b For each group, losses and exclusions after randomisation, together with reasons  
Recruitment 14a Dates defining the periods of recruitment and follow-up  
14b Why the trial ended or was stopped  
Baseline data 15 A table showing baseline demographic and clinical characteristics for each group  
Numbers analysed 16 For each group, number of participants (denominator) included in each analysis and whether the analysis was by original 
assigned groups 
 
Outcomes and 
estimation 
17a For each primary and secondary outcome, results for each group, and the estimated effect size and its precision (such as 95% 
confidence interval) 
 
17b For binary outcomes, presentation of both absolute and relative effect sizes is recommended  
Ancillary analyses 18 Results of any other analyses performed, including subgroup analyses and adjusted analyses, distinguishing pre-specified 
from exploratory 
 
Harms 19 All important harms or unintended effects in each group (for specific guidance see CONSORT for harms)  
Discussion 
Limitations 20 Trial limitations, addressing sources of potential bias, imprecision, and, if relevant, multiplicity of analyses  
Generalisability 21 Generalisability (external validity, applicability) of the trial findings  
Interpretation 22 Interpretation consistent with results, balancing benefits and harms, and considering other relevant evidence  
Other information 
 
Registration 23 Registration number and name of trial registry  
Protocol 24 Where the full trial protocol can be accessed, if available  
Funding 25 Sources of funding and other support (such as supply of drugs), role of funders  
 
*We strongly recommend reading this statement in conjunction with the CONSORT 2010 Explanation and Elaboration for important clarifications on all the items. If relevant, we also 
recommend reading CONSORT extensions for cluster randomised trials, non-inferiority and equivalence trials, non-pharmacological treatments, herbal interventions, and pragmatic trials. 
Additional extensions are forthcoming: for those and for up to date references relevant to this checklist, see www.consort-statement.org. 
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Appendix 4: STROBE Statement 
STROBE Statement — Checklist of items that should be included in reports of observational studies 
 Item 
No 
 
Recommendation 
Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or the 
abstract 
(b) Provide in the abstract an informative and balanced summary of what was 
done and what was found 
Introduction 
Background/rationale 2 Explain the scientific background and rationale for the investigation being 
reported 
Objectives 3 State specific objectives, including any prespecified hypotheses 
Methods 
Study design 4 Present key elements of study design early in the paper 
Setting 5 Describe the setting, locations, and relevant dates, including periods of 
recruitment, exposure, follow-up, and data collection 
Participants 6 (a) Cohort study—Give the eligibility criteria, and the sources and methods of 
selection of participants. Describe methods of follow-up 
Case-control study—Give the eligibility criteria, and the sources and methods 
of case ascertainment and control selection. Give the rationale for the choice 
of cases and controls 
Cross-sectional study—Give the eligibility criteria, and the sources and 
methods of selection of participants 
(b) Cohort study—For matched studies, give matching criteria and number of 
exposed and unexposed 
Case-control study—For matched studies, give matching criteria and the 
number of controls per case 
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and 
effect modifiers. Give diagnostic criteria, if applicable 
Data sources/ 
measurement 
8*  For each variable of interest, give sources of data and details of methods of 
assessment (measurement). Describe comparability of assessment methods if 
there is more than one group 
Bias 9 Describe any efforts to address potential sources of bias 
Study size 10 Explain how the study size was arrived at 
Quantitative variables 11 Explain how quantitative variables were handled in the analyses. If applicable, 
describe which groupings were chosen and why 
Statistical methods 12 (a) Describe all statistical methods, including those used to control for 
confounding 
(b) Describe any methods used to examine subgroups and interactions 
(c) Explain how missing data were addressed 
(d) Cohort study—If applicable, explain how loss to follow-up was addressed 
Case-control study—If applicable, explain how matching of cases and 
controls was addressed 
Cross-sectional study—If applicable, describe analytical methods taking 
account of sampling strategy 
(e) Describe any sensitivity analyses 
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Results 
Participants 13* (a) Report numbers of individuals at each stage of study—eg numbers potentially 
eligible, examined for eligibility, confirmed eligible, included in the study, completing 
follow-up, and analysed 
(b) Give reasons for non-participation at each stage 
(c) Consider use of a flow diagram 
Descriptive 
data 
14* (a) Give characteristics of study participants (eg demographic, clinical, social) and 
information on exposures and potential confounders 
(b) Indicate number of participants with missing data for each variable of interest 
(c) Cohort study—Summarise follow-up time (eg, average and total amount) 
Outcome data 15* Cohort study—Report numbers of outcome events or summary measures over time 
Case-control study—Report numbers in each exposure category, or summary measures 
of exposure 
Cross-sectional study—Report numbers of outcome events or summary measures 
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their 
precision (eg, 95% confidence interval). Make clear which confounders were adjusted 
for and why they were included 
(b) Report category boundaries when continuous variables were categorized 
(c) If relevant, consider translating estimates of relative risk into absolute risk for a 
meaningful time period 
Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and sensitivity 
analyses 
Discussion 
Key results 18 Summarise key results with reference to study objectives 
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or 
imprecision. Discuss both direction and magnitude of any potential bias 
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, 
multiplicity of analyses, results from similar studies, and other relevant evidence 
Generalisability 21 Discuss the generalisability (external validity) of the study results 
Other information 
Funding 22 Give the source of funding and the role of the funders for the present study and, if 
applicable, for the original study on which the present article is based 
 
*Give information separately for cases and controls in case-control studies and, if applicable, for exposed and 
unexposed groups in cohort and cross-sectional studies. 
 
Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background 
and published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article 
(freely available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at 
http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is 
available at www.strobe-statement.org. 
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Appendix 5: PRISMA 2009 checklist 
Section/topic  # Checklist item  
Reported 
on page 
#  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.   
ABSTRACT   
Structured 
summary  
2 Provide a structured summary including, as applicable: background; 
objectives; data sources; study eligibility criteria, participants, and 
interventions; study appraisal and synthesis methods; results; 
limitations; conclusions and implications of key findings; systematic 
review registration number.  
 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already 
known.  
 
Objectives  4 Provide an explicit statement of questions being addressed with 
reference to participants, interventions, comparisons, outcomes, and 
study design (PICOS).  
 
METHODS   
Protocol and 
registration  
5 Indicate if a review protocol exists, if and where it can be accessed (e.g., 
Web address), and, if available, provide registration information 
including registration number.  
 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and 
report characteristics (e.g., years considered, language, publication 
status) used as criteria for eligibility, giving rationale.  
 
Information 
sources  
7 Describe all information sources (e.g., databases with dates of coverage, 
contact with study authors to identify additional studies) in the search 
and date last searched.  
 
Search  8 Present full electronic search strategy for at least one database, 
including any limits used, such that it could be repeated.  
 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, 
included in systematic review, and, if applicable, included in the meta-
analysis).  
 
Data collection 
process  
10 Describe method of data extraction from reports (e.g., piloted forms, 
independently, in duplicate) and any processes for obtaining and 
confirming data from investigators.  
 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, 
funding sources) and any assumptions and simplifications made.  
 
Risk of bias in 
individual studies  
12 Describe methods used for assessing risk of bias of individual studies 
(including specification of whether this was done at the study or 
outcome level), and how this information is to be used in any data 
synthesis.  
 
Summary 
measures  
13 State the principal summary measures (e.g., risk ratio, difference in 
means).  
 
Synthesis of 
results  
14 Describe the methods of handling data and combining results of studies, 
if done, including measures of consistency (e.g., I2) for each meta-
analysis.  
 
Risk of bias across 
studies  
15 Specify any assessment of risk of bias that may affect the cumulative 
evidence (e.g., publication bias, selective reporting within studies).  
 
Additional 
analyses  
16 Describe methods of additional analyses (e.g., sensitivity or subgroup 
analyses, meta-regression), if done, indicating which were pre-specified.  
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Section/topic  # Checklist item  
Reported 
on page 
#  
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included 
in the review, with reasons for exclusions at each stage, ideally with a 
flow diagram.  
 
Study 
characteristics  
18 For each study, present characteristics for which data were extracted 
(e.g., study size, PICOS, follow-up period) and provide the citations.  
 
Risk of bias within 
studies  
19 Present data on risk of bias of each study and, if available, any outcome 
level assessment (see item 12).  
 
Results of 
individual studies  
20 For all outcomes considered (benefits or harms), present, for each 
study: (a) simple summary data for each intervention group (b) effect 
estimates and confidence intervals, ideally with a forest plot.  
 
Synthesis of 
results  
21 Present results of each meta-analysis done, including confidence 
intervals and measures of consistency.  
 
Risk of bias across 
studies  
22 Present results of any assessment of risk of bias across studies (see Item 
15).  
 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup 
analyses, meta-regression [see Item 16]).  
 
DISCUSSION   
Summary of 
evidence  
24 Summarize the main findings including the strength of evidence for each 
main outcome; consider their relevance to key groups (e.g., healthcare 
providers, users, and policy makers).  
 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at 
review-level (e.g., incomplete retrieval of identified research, reporting 
bias).  
 
Conclusions  26 Provide a general interpretation of the results in the context of other 
evidence, and implications for future research.  
 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support 
(e.g., supply of data); role of funders for the systematic review.  
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Appendix 6: PRISMA 2009 Flow Diagram 
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Appendix 7: GRADE Classification System of Quality of Evidence 
 
 
 
 
 
 
 
 
 
 
 
  
Quality of evidence and definitions 
High quality— Further research is very unlikely to change 
our confidence in the estimate of effect 
Moderate quality— Further research is likely to have an 
important impact on our confidence in the estimate of effect 
and may change the estimate 
Low quality— Further research is very likely to have an 
important impact on our confidence in the estimate of effect 
and is likely to change the estimate 
Very low quality— Any estimate of effect is very uncertain 
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Appendix 8: AMSTAR tool 
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Appendix 9: Gantt Chart 
Systematic Review  September October    November  December  January  February  March  April  May June 
Research Question  
& Project Proposal 
          
Databases Search & 
Literature Review 
          
Chapter on Systematic 
Review 
          
Chapter on 
Methodologies for this 
Systematic Review 
          
Data Extraction           
Data analysis           
Chapter on Results           
Chapter on Discussion 
of Results 
          
Finalise Thesis           
Thesis submission           
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Appendix 10: MEDLINE Pubmed Search 
# Search Query Result 
#51 #35 AND #49 Filters: English" 7266 
#50 #35 AND #49 8660 
#49 #39 OR #42 OR #48 533298 
#48 #43 OR #44 OR #45 OR #46 OR #47 12997 
#47 Skin Temperature [Mesh] 8975 
#46 ulcer temperature* [Title/Abstract] 743 
#45 wound temperature* [Title/Abstract] 36 
#44 skin temperature* [Title/Abstract] 7090 
#43 cutaneous temperature* [Title/Abstract] 235 
#42 #40 OR #41 484610 
#41 Hydrogen-Ion Concentration [Mesh] 274052 
#40 pH [Title/Abstract] 361975 
#39 #36 OR #37 OR #38 36912 
#38 wound fluid*[Title/Abstract] 707 
#37 exudat* [Title/Abstract] 27191 
#36 Exudates and Transudates [Mesh] 13531 
#35 #29 OR #30 OR #31 OR #32 OR #33 OR #34 900710 
#34 #1 OR #2 872710 
#33 #27 OR #28 10104 
#32 #22 OR #23 OR #24 OR #25 OR #26 10701 
#31 #20 OR #21 90 
#30 #15 OR #16 OR #17 OR #18 OR #19 12018 
#29 #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14  20809 
#28 burn wound* [Title/Abstract] 3717 
#27 burn injur* [Title/Abstract] 6984 
#26 feet ulcer* [Title/Abstract] 8350 
#25 diabetic foot [Title/Abstract] 5460 
#24 diabetic feet [Title/Abstract] 160 
#23 plantar ulcer* [Title/Abstract] 461 
#22 foot ulcer* [Title/Abstract] 3900 
#21 laceration injur* [Title/Abstract] 71 
#20 laceration wound* [Title/Abstract] 19 
#19 pressure area* [Title/Abstract] 1142 
#18 bed sore* [Title/Abstract] 187 
#17 bedsore* [Title/Abstract] 413 
#16 decubitus ulcer* [Title/Abstract] 1832 
#15 Pressure Ulcer [Mesh] 10262 
#14 arterial insufficiency wound* [Title/Abstract] 276 
#13 arterial insufficiency ulcer* [Title/Abstract] 6 
#12 ischaemic wound* [Title/Abstract] 26 
#11 ischemic ulcer* [Title/Abstract] 479 
#10 ischemic wound* [Title/Abstract] 165 
#9 ischaemic ulcer* [Title/Abstract] 144 
#8 stasis ulcer* [Title/Abstract] 399 
#7 venous hypertension ulcer* [Title/Abstract] 2 
#6 venous stasis ulcer* [Title/Abstract] 222 
#5 varicose ulcer* [Title/Abstract] 665 
#4 leg ulcer* [Title/Abstract] 6098 
#3 Leg Ulcer [Mesh] 18621 
#2 wound* [Title/Abstract] 167607 
#1 Wounds and Injuries [Mesh] 762988 
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Appendix 11: EBSCO Cinahl Search 
# Search Query Limiters/Expanders Result 
S53 S36 AND S51 
Narrow by Language: - english  
Search modes - Boolean/Phrase 1,619 
S52 S36 AND S51 Search modes - Boolean/Phrase 1,688 
S51 S42 OR S46 OR S50 Search modes - Boolean/Phrase 13,934 
S50 S47 OR S48 OR S49 Search modes - Boolean/Phrase 9,256 
S49 
TI Hydrogen-Ion Concentration* OR AB Hydrogen-
Ion Concentration* Search modes - Boolean/Phrase 24 
S48 TI pH OR AB pH Search modes - Boolean/Phrase 6,459 
S47 (MH "Hydrogen-Ion Concentration") Search modes - Boolean/Phrase 4,756 
S46 S43 OR S44 OR S45 Search modes - Boolean/Phrase 2,868 
S45 (MH "Exudates and Transudates") Search modes - Boolean/Phrase 1,698 
S44 TI wound fluid* OR AB wound fluid* Search modes - Boolean/Phrase 271 
S43 TI exudat* OR AB exudat* Search modes - Boolean/Phrase 1,377 
S42 S37 OR S38 OR S39 OR S40 OR S41 Search modes - Boolean/Phrase 1,865 
S41 TI skin temperature* OR AB skin temperature* Search modes - Boolean/Phrase 1,043 
S40 
TI cutaneous temperature* OR AB cutaneous 
temperature* Search modes - Boolean/Phrase 46 
S39 TI ulcer temperature* OR AB ulcer temperature* Search modes - Boolean/Phrase 21 
S38 
TI wound temperature* OR AB wound 
temperature* Search modes - Boolean/Phrase 62 
S37 (MH "Skin Temperature") Search modes - Boolean/Phrase 1,280 
S36 S3 OR S29 OR S30 OR S32 OR S33 OR S35 Search modes - Boolean/Phrase 61,773 
S35 
S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 
OR S25 OR S26 OR S27 OR S28 OR S34 Search modes - Boolean/Phrase 4,623 
S34 TI ischemic wound* OR AB ischemic wound* Search modes - Boolean/Phrase 84 
S33 S12 OR S13 OR S14 OR S15 OR S16 OR S17 Search modes - Boolean/Phrase 12,173 
S32 S11 OR S31 Search modes - Boolean/Phrase 319 
S31 TI laceration wound* OR AB laceration wound* Search modes - Boolean/Phrase 78 
S30 S6 OR S7 OR S8 OR S9 OR S10 Search modes - Boolean/Phrase 4,316 
S29 S4 OR S5 Search modes - Boolean/Phrase 4,150 
S28 (MH "Leg Ulcer") Search modes - Boolean/Phrase 2,780 
# Search Query Limiters/Expanders Result 
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S27 TI leg ulcer* OR AB leg ulcer* Search modes - Boolean/Phrase 2,433 
S26 TI varicose ulcer* OR AB varicose ulcer* Search modes - Boolean/Phrase 57 
S25 TI venous stasis ulcer* OR AB venous stasis ulcer* Search modes - Boolean/Phrase 115 
S24 
TI venous hypertension ulcer* OR AB venous 
hypertension ulcer* Search modes - Boolean/Phrase 32 
S23 
TI arterial insufficiency ulcer* OR AB arterial 
insufficiency ulcer* Search modes - Boolean/Phrase 27 
S22 TI ischaemic wound* OR AB ischaemic wound* Search modes - Boolean/Phrase 71 
S21 TI stasis ulcer* OR AB stasis ulcer* Search modes - Boolean/Phrase 138 
S20 TI ischaemic ulcer* OR AB ischaemic ulcer* Search modes - Boolean/Phrase 154 
S19 TX ischemic ulcer* OR AB ischemic ulcer* Search modes - Boolean/Phrase 707 
S18 
TI arterial insufficiency wound* OR AB arterial 
insufficiency wound* Search modes - Boolean/Phrase 10 
S17 (MH "Pressure Ulcer") Search modes - Boolean/Phrase 10,333 
S16 TI pressure ulcer* OR AB pressure ulcer* Search modes - Boolean/Phrase 6,029 
S15 TI decubitus ulcer* OR AB decubitus ulcer* Search modes - Boolean/Phrase 361 
S14 TI bedsore* OR AB bedsore* Search modes - Boolean/Phrase 143 
S13 TI bed sore* OR AB bed sore* Search modes - Boolean/Phrase 85 
S12 TI pressure area* OR AB pressure area* Search modes - Boolean/Phrase 1,017 
S11 TI laceration injur* OR AB laceration injur* Search modes - Boolean/Phrase 254 
S10 TI diabetic feet* OR AB diabetic feet* Search modes - Boolean/Phrase 139 
S9 TI diabetic foot* OR AB diabetic foot* Search modes - Boolean/Phrase 3,526 
S8 TI plantar ulcer* OR AB plantar ulcer* Search modes - Boolean/Phrase 261 
S7 TI foot ulcer* OR AB foot ulcer* Search modes - Boolean/Phrase 2,393 
S6 TI feet ulcer OR AB feet ulcer Search modes - Boolean/Phrase 32 
S5 TI burn wound* OR AB burn wound* Search modes - Boolean/Phrase 1,338 
S4 TI burn injur* OR AB burn injur* Search modes - Boolean/Phrase 3,105 
S3 S1 OR S2 Search modes - Boolean/Phrase 43,721 
S2 TI wound* OR AB wound* Search modes - Boolean/Phrase 28,332 
S1 (MH "Wounds and Injuries") Search modes - Boolean/Phrase 17,935 
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Appendix 12: Flow Diagram – pH in Wounds 
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Appendix 13: Flow Diagram – Exudate Composition in Wounds 
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Appendix 14: Flow Diagram – Temperature in Wounds 
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Appendix 15: PRISMA 2009 Flow Diagram Temperature, pH and Exudate Composition in 
Wounds 
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Appendix 16: Data Extraction Table Adapted from the Cochrane Handbook (Higgins & Green 2011) 
Author(s) & 
Publication Year 
Title 
Source/  
Journal & 
Impact Factor 
Geographical Location Objectives 
Study 
Methodology 
& Design 
Outcome Measures 
Care Setting 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
Inclusion/  
Exclusion 
Criteria 
 Sample Size & 
Characteristics 
Study procedure Measurement 
equipment & 
other materials 
Data Analysis Results Conclusions 
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Appendix 17: Evidence Based Literature (EBL) Critical Appraisal Checklist by Glynn (2006) 
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Appendix 18. Data Extraction Table for pH 
Author(s) & 
Publication Year 
Title 
Source/  
Journal  
Geographical Location Objectives 
Study 
Methodology 
& Design 
Outcome Measures 
Care Setting 
 
 
Gethin G. T., 
Cowman S. & 
Conroy R. M. 
(2008) 
  
 
The impact of 
Manuka 
honey 
dressings on 
the surface 
pH of chronic 
wounds 
International 
Wound Journal 
Ireland To evaluate 
the changes in the 
surface pH and 
wound size 
of chronic non 
healing wounds 
over a 2-week 
period when a 
Manuka honey 
dressing is 
applied.  
 
To determine the 
ease of use of a 
diagnostic 
instrument and to 
gain consensus 
among clinical 
nurse specialists 
on its 
contribution in 
wound 
assessment 
 
Quantitative, 
prospective, 
single arm pre-
test post-test 
study design 
1. Wound surface pH. 
2. Wound size. 
3. Diagnostic instrument usability.  
 
 
A specialist wound 
clinic and community 
hospitals. 
 
Inclusion/  
Exclusion 
Criteria 
 Sample Size & 
Characteristics 
Study procedure Measurement 
equipment & 
other materials 
Data Analysis Results Conclusions 
Inclusion 
criteria:  
Non-healing 
superficial 
17 subjects (8 
males, 9 
females). 
3 bilateral lower 
Study duration: 2 weeks. 
Wound specialists trained in 
the technique conducted all 
measurements.  
pH Measurement 
Device:  
Blueline 27 glass 
surface 
All data were 
analysed using 
Stata release 
9.2.  
 
Initial wound pH measurement:  
Overall mean wound pH 7.72 (SD 
0.339) 
 
Although the overall 
wound pH decreased 
following the 2-week 
treatment with honey 
dressings, there was no 
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chronic 
wounds.  
Wounds with 
no size 
reduction 
over the 
previous 
3 weeks. 
Wound 
history of 
poor 
response to 
treatment. 
 
Exclusion 
criteria:  
Malignant 
wounds, 
wounds with 
undermining, 
clinically 
infected 
wounds or a 
known 
sensitivity to 
topical honey 
dressings. 
 
leg wounds & 14 
unilateral leg 
wounds.  
50% venous 
ulcers (n=10), 
35% mixed 
aetiology ulcers 
(n=7), 10% 
arterial ulcers 
(n=2).  
5% pressure 
ulcers (n=1)  
 
10 wounds with 
slough of ≥20% 
of wound area 
On removal of old dressing, pH 
measured by dropping distilled 
water onto the top of the glass 
top electrode and then 
pressing the probe onto the 
wound.  
Wounds cleansed with saline.  
Manuka honey dressing, 
Apinate (Comvita), applied 
direct to the wound.  
Secondary dressings restricted 
to a hydrofiber Aquacel 
hydrofibre (Convatec, 
Uxbridge, UK) and/or 
Allevyn hydrocellular 
(Smith&Nephew).  
Dressings changed once or 
twice weekly depending on 
clinical need.  
Compression therapy 
continued for patients with 
venous ulcers, as tolerated. 
All other aspects of care 
remained unchanged.  
The pH of honey dressing and 
the pH of alginate dressings 
were recorded using the same 
method as for wounds.  
Wounds photographed. 
Electrode, 
calibrated in pH 4 
and 7 solutions 
prior to each 
clinical 
assessment, and 
R 315 pH meter 
set (Reagecon/ 
Alkem, Ireland). 
 
Other materials: 
Wound size 
measured using 
Visitrak (Smith & 
Nephew) digital 
planimetry. 
 
Wounds 
photographed 
using Sony 
Mavica mvc-FD-
90 digital still 
camera (Sony, 
Tokyo, Japan). 
 
Wounds dressed 
using Apinate 
(Comvita) 
dressing (a 
Manuka honey 
dressing 
combined with 
calcium alginate 
fibres), Aquacel 
hydrofibre 
(Convatec, 
Uxbridge, UK) 
and/or Allevyn 
Statistical 
analysis 
conducted 
using paired 
samples t-test 
and linear 
regression. 
End-of-study wound pH 
measurement: 
Overall mean wound pH 
7.26 (SD 0.53)  
(statistically significant decrease in 
mean wound pH, P < 0.001). 
 
Initial wound size measurement:  
Overall mean wound size 10.1 cm2 
(SD13.98) 
 
End of study pH measurement: 
Overall mean wound size 9.1 cm2 
(SD 16.25) (decrease in wound size 
not statistically significant, p=0.274). 
 
Wounds with an initial pH ≤7.60 did 
not increase in size (mean size 
reduction 32%).  
Wounds with an initial pH ≥8.00 
increased in size by 5–122%. 
 
The coefficient for initial wound pH 
shows a 1-unit reduction in pH 
is associated with a decrease of 8.1% 
in wound size, which was statistically 
significant (regression coefficient -
8.13, t= -2.79, P= 0.012). 
 
Wounds with slough area ≥20%: 
wounds with reduced area of slough 
(5 wounds) had an initial mean pH 
7.60 and showed a mean decrease in 
wound size of 29% at 2-weeks 
compared to wounds with no change 
in slough (5 wounds) which had a 
higher mean pH 7.70.and showed a 
mean increase in wound size of 6%.  
statistically significant 
change in wound size. 
   
Initial wound pH 
appears to be 
associated with 
reduction of wound 
slough and wound size 
following two-weeks 
treatment with honey 
dressings. 
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hydrocellular 
(Smith & 
Nephew). 
Author(s) & 
Publication Year 
Title 
Source/  
Journal 
Geographical Location Objectives 
Study 
Methodology 
& Design 
Outcome Measures 
Care Setting 
 
 
Ono S., Imai R., Ida 
Y., Shibata D., 
Komiya T. & 
Matsumura H. 
(2015)  
 
Increased 
wound pH as 
an indicator 
of local 
wound 
infection in 
second 
degree burns. 
Burns Japan To follow the 
changes in pH of 
wound exudate 
over time for 
cases of second 
degree burns 
Quantitative 
prospective 
observational 
cohort 
1. Wound epithelialisation without 
infection.  
2. Development of local wound 
infection. 
 
Outpatient clinic of the 
Department of Plastic 
and Reconstructive 
Surgery, Tokyo Medical 
University Hospital 
 
Inclusion/  
Exclusion 
Criteria 
 Sample Size & 
Characteristics 
Study procedure Measurement 
equipment & 
other materials 
Data Analysis Results Conclusions 
Inclusion 
criteria:  
A second 
degree burn 
and a 
preserved 
blister film  
 
Exclusion 
criteria: 
Paediatric 
cases under 
the age of 12, 
and infected 
cases  
 
Sample size = 26  
Sample recruited 
September 2013 
to February 2014 
 
Mean age: 46 
years (range 20–
72 years) 
 
Male n=16 
(62%),  
Female n=10 
(38%) 
 
All burn wound 
sizes <2% TBSA 
 
Initial assessment: Blister fluid 
pH measured.  
 
After initial measurement: 
Blister film removed and 
wound rinsed with saline 
solution, and a transparent 
hydrogel dressing applied. 
 
Dressing changes 2 or 3 times a 
week depending on clinical 
need. 
 
Wound exudate accumulated 
under hydrogel dressing 
measured for pH at each 
dressing change (Total pH 
measurements taken = 103). 
 
pH Measurement 
Device:  
pH indicator 
strips 
(MColorpHast™; 
Merck KGaA, 
Darmstadt, 
Germany) 
measuring to one 
decimal point 
accuracy (pH 4.0–
7.0 and 6.5–10.0). 
 
Other materials 
used: 
Transparent 
hydrogel dressing 
(Viewgel1; Taiho 
Pharmaceutical 
Statistical 
analysis: 
Student t-test. 
P-value <0.05 
considered to 
indicate 
statistically 
significant 
difference. 
Initial assessment:  
Overall mean pH (range) = 8.55 (6.5-
9.0)  
 
After initial assessment: 
Non-infected wounds (n=20 (77%)): 
-Mean initial pH (range) = 8.6 (7.7–
9.0). 
-During study pH range = 5.0-9.0. 
-End of study pH statistically 
significantly decreased compared to 
initial pH (p-value not reported). 
 
Infected wounds (n= 6 (23%)): 
-Mean initial pH (range) = 8.0 (6.5–
9.0). 
-During study pH range = 6.5-10.0. 
-End of study pH increased compared 
to initial pH (p < 0.01). 
 
All wounds that 
developed local 
infection showed 
statistically significant 
increases in pH at the 
end of the study 
compared to the pH at 
the initial measurement 
(p < 0.01). This study 
reports that the pH 
value was elevated 
before the clinical 
symptoms of infection 
occurred. In non-
infected wounds, this 
study reports a 
statistically significant 
decrease in pH value 
between the initial visit 
and the pH value at the 
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After pH measurement, wound 
rinsed with saline solution and 
dressing reapplied.  
 
Wound swab sampling 
performed minimum once 
weekly.  
Study ceased after detection of 
clinical signs of local wound 
infection. 
Co., Ltd., Japan) 
composed of 
polyethylene 
liner and hydrogel 
absorbent (pH of 
4.0–7.0). 
 
Saline solution pH 
of 4.5–8.5. 
 final measurement just 
before epithelialization.  
 
These findings suggest 
pH measurement is a 
clinically significant 
predictor of wound 
outcomes in terms of 
wound infection and 
wound epithelization. 
Author(s) & 
Publication Year 
Title 
Source/  
Journal  
Geographical Location Objectives 
Study 
Methodology 
& Design 
Outcome Measures 
Care Setting 
 
 
Shukla V. K., 
Shukla D., Tiwary 
S. K., Agrawal S. & 
Rastogi A. (2007)  
  
 
Evaluation of 
pH 
measurement 
as a method 
of wound 
assessment 
Journal of 
Wound Care 
India To assess 
variations in pH 
levels in wounds 
and explore the 
relationship 
between wound 
pH and the state 
of healing.  
 
Quantitative 
prospective 
cohort 
Change in wound bed condition 
(‘unhealthy’, ‘granulating’, or 
‘healing’) and exudate level.  
Wound clinic at a 
university hospital. 
Inclusion/  
Exclusion 
Criteria 
 Sample Size & 
Characteristics 
Study procedure Measurement 
equipment & 
other materials 
Data Analysis Results Conclusions 
Exclusion 
criteria: 
Malignant 
wounds, 
osteomyelitis 
and patient 
unwillingness 
to attend the 
clinic 
regularly for 
treatment 
50 patients (1 
wound each) 
37 males (74%) 
and 13 females 
(26%)  
Mean age 48 +/- 
6 years (range 7-
74 years).  
 
Patients with 
diabetes (n=7, 
14%), leprosy 
At the first visit, sharp 
debridement and cleansing 
with normal saline were 
performed. A litmus paper strip 
was placed on the wound bed 
for five seconds, removed and, 
30 seconds later, compared 
with the colour code. Wound 
dressings (saline-impregnated 
gauze) were changed daily. 
Wounds were irrigated with 
Litmus pH paper 
strips with 
gradations of 0.5, 
ranging from 6.5-
9. 
Accuracy of the 
pH strips was 
confirmed by 
testing against 
standard 
solutions of 
known pH. 
Paired samples 
t-tests were 
used to 
analyse 
differences in 
wound 
condition, 
discharge and 
pH between 
days 1 and 7, 
and 7 and 15. 
Observations 
Day 1:  
Wound condition: 
Unhealthy: 94% 
Granulating: 4% 
Healing: 2% 
 
Wound pH: 
>9: 54% 
8.5-9.0: 40% 
8.0-8.5: 6% 
 
Day 7: 
This study showed 
wound pH to reduce as 
wounds healed and 
therefore measuring 
wound pH may assist in 
predicting wound 
healing outcomes. 
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and follow-up 
assessment. 
 
(n=2, 4%), 
tuberculosis 
(n=1, 2%), 
chronic venous 
insufficiency 
(n=1, 2%). 
 
Acute wounds 
(n=26, 52%) 
caused by 
trauma (22%), 
cellulitis (16%), 
unknown cause 
(14%)  
 
Chronic wounds 
(n=24, 48%) 
caused by 
trauma (26%), 
diabetes (14%), 
leprosy (4%), 
tuberculosis 
(2%), chronic 
venous 
insufficiency 
(2%). 
 
Lower limb 
wounds (78%), 
trunk wounds 
(12%), upper 
limb wounds 
(6%) and facial 
wounds (4%). 
 
Mean wound 
duration 16 +/- 3 
normal saline during the 
dressing change.  
 
Wound condition (‘unhealthy’, 
‘granulating’, or ‘healing’), 
exudate level and pH were 
recorded at day 1, 7 and 15.  
 
Acute wounds classified as 
unhealthy if slough, pus, or 
copious discharge were 
present. 
Chronic wounds classified as 
unhealthy if slough was 
present. 
All wound types with pink 
granulation tissue were 
defined as granulating. 
Wounds with sloping edges 
with epithelial ingrowth were 
defined as healing. 
 
Exudate from all wounds was 
tested for culture and 
sensitivity each week. 
 
  
were analysed 
using the 
Student’s t-
test.  
Wound condition: 
Unhealthy: 12% 
Granulating: 68% 
Healing: 20% 
 
Wound pH: 
>9: 10% 
8.5-9.0: 48% 
8.0-8.5: 40% 
7.5-8.0: 2% 
 
Day 15: 
Wound condition: 
Unhealthy: 2%  
Granulating: 42% 
Healing: 56% 
 
Wound pH: 
8.5-9.0: 26% 
8.0-8.5: 26% 
7.5-8.0: 34% 
<7.5: 14% 
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weeks (range 3-
28 weeks) 
 
Wound sizes: 
<4cm2 (n=15, 
30%), 4-10 cm2 
(n=25, 50%), >10 
cm2 (n=10, 20%). 
 
Previous topical 
wound 
treatments: 
neomycin, 
povidone-iodine, 
mupirocin, silver 
sulphadiazine, 
herbal 
preparations. 
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Appendix 19: Data Extraction Table for Exudate Composition 
Author(s) & 
Publication Year 
Title 
Source/  
Journal 
Geographical Location Objectives 
Study 
Methodology 
& Design 
Outcome Measures 
Care Setting 
 
Bernatchez S.F.,  
Menon V., Stoffel 
J., Walters S.A.H.,  
Lindroos W. E., 
Crossland M.C.,  
Shawler L. G., 
Crossland S. P. & 
Boykin J. V. 
(2013) 
 
  
 
Nitric oxide 
levels in 
wound fluid 
may reflect 
the healing 
trajectory 
Wound Repair 
and 
Regeneration 
United States of America To develop a 
nitric oxide 
measurement 
method sensitive 
using small 
amounts of 
wound fluid and 
to confirm the 
diagnostic value 
of this wound 
fluid marker 
 
Quantitative, 
retrospective,
multicentre, 
descriptive 
cohort 
pilot study 
 
Nitric oxide levels Hospital (Chippenham 
& Johnston-Willis 
Medical Centre and 
Retreat Doctors’ 
Hospital, Richmond, 
Virginia) 
Inclusion/  
Exclusion 
Criteria 
 Sample Size & 
Characteristics 
Study procedure Measurement 
equipment & 
other materials 
Data Analysis Results Conclusions 
Inclusion 
criteria:  
Adult 
patients with 
either a 
chronic or 
acute wound 
with 
sufficient 
exudate for 
sampling  
 
Exclusion 
criteria: Not 
stated 
100 wound 
samples from 
81 
patients 
 
13 patients 
provided more 
than one 
sample (2 or 3)  
 
50 wounds that 
provided 
suitable 
samples for 
nitric oxide 
analysis were 
Initial wound recordings: 
Dimensions measured by 
length, width, depth and the 
wound status (progressing, 
stagnating, or worsening) 
recorded based on patient’s 
medical history by the subject’s 
treating physician. 
 
Wound recordings during 
clinical observation: 
Progressing wounds = healthy 
appearance, robust granulation 
tissue and documented 
reductions in wound area over 
time.  
A sterile, nitrate-
free pad 
(commercially 
available 3M 
Nexcare First Aid 
dressing, 
3M ID Number: 
44-0041-8851-9, 
St. Paul, MN). 
 
Small polyester 
swabs (polyester 
tipped applicator 
Pur-Wraps, REF 
25-800 1PD 50, 
Puritan Medical 
Products 
Wound area 
computed 
assuming an 
elliptical area.  
 
Correlation 
coefficients 
computed 
between pre- 
and post-
cleansing 
samples on a 
subset of 
subjects for 
which data 
were 
available. 
NOx represented the only significant 
covariate to discriminate between 
progressing and worsening wounds. 
The midpoint of 3.25 yielded the 
same AUC as 3.2 and 3.3 of 0.8121 
(95% CI: 0.6716, 0.9526). A 95% 
lower confidence limit of the AUC 
that is greater than 50% shows the 
test’s utility over pure chance. 
 
Exploratory analysis of the data 
provided evidence that two cut 
points rather than a single cut point 
produced a better diagnostic tool 
based on the area under the ROC 
curve (AUC).  
 
MMP-9, HNE, and 
baseline wound area 
were found not to 
significantly help to 
discriminate between 
progressing and 
worsening wounds. 
 
Additional data with 
the NOx assay 
proposed in this study 
could indicate a 
particular utility of this 
measurement in 
specific wound types.  
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included, of 
which;  
26 patients had 
venous leg 
ulcer, 16 had 
diabetic foot 
ulcer, and 39 
had other 
aetiologies i.e. a 
pressure 
ulcer, burn, 
surgical wound, 
donor site, 
trauma or 
drainage 
tube wound.  
 
Wound size 
range= 0.05-259 
cm2 
 
 
Stagnating wounds: no 
documented change in wound 
area over time. 
Worsening wounds: 
documented poor granulation 
tissue deposition and enlarging 
wound areas (with or without 
wound margin deterioration). 
 
All subjects received standard 
wound care as deemed 
appropriate by their clinician. 
Wound fluid was collected 
before wound cleansing (pre-
cleansing) and after wound 
cleansing with sterile water 
(post-cleansing). 
 
Collection  procedure: 
Wound fluid for nitric oxide 
measurement was collected by 
placing a sterile, nitrate-free 
pad on the wound to absorb 
the fluid. The pad was pressed 
firmly against the wound 
surface to saturate it as much 
as possible with wound fluid, 
repositioning it if needed. The 
pad was placed into a capped 
tube, identified, and stored at -
79 °C until analysis. 
 
Wound fluids for protease 
measurements were collected 
utilizing small polyester swabs. 
The wound was swabbed and 
the swab was placed into a 
capped tube, identified, and 
Company, 
Guilford, ME). 
 
Nitrate free gauze 
(3M Nexcare 
Triple Layer 
Gauze). 
 
Fluorokine E 
Enzyme activity 
Assay for human 
active MMP-9 
(R&D Systems, 
Cat. No F9M00, 
Minneapolis, MN) 
 
InnoZyme Human 
Neutrophil 
Elastase 
Immunocapture 
Activity Assay Kit 
(Calbiochem, Cat. 
No CBA016, 
Rockland, MA)  
Average of 
the pre- and 
post-cleansing 
metabolites 
computed 
and plotted 
for each 
subject based 
on the wound 
status 
(progressing, 
stagnating, 
and 
worsening) 
assigned at 
enrolment.  
 
Stepwise 
discriminant 
analysis and 
logistic 
regression 
analysis used 
to determine 
analytical or 
baseline 
factors 
significantly 
associated 
with wound 
status.  
 
Covariates 
used in the 
analyses: the 
natural log 
transform of 
the average 
NOx values roughly >57mM and 
roughly <12mM tend to be 
worsening wounds and values of 
roughly 13.5 and 49mM tend to be 
progressing wounds. 
 
Stagnating wounds did not separate 
from the progressing wounds based 
on NOx analytical results. 
The method developed 
in this study could be 
used to monitor NOx 
levels in wounds 
producing enough 
exudate for its 
prognostic value or to 
monitor the response 
to a therapy, and 
provide a useful tool to 
help guide treatment in 
wound care.  
 
Additional work is 
needed to get 
longitudinal data and a 
larger number of 
wound patients in each 
of the various chronic 
wound categories. 
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stored at -79 °C until analysis. If 
sufficient wound fluid was 
available, this procedure was 
repeated with up to two 
additional swabs. The wound 
was then cleansed with sterile 
water and pat dry with nitrate 
free gauze.  
 
The same sampling procedure 
described previously (pad plus 
swabs) was repeated after 
cleansing. 
 
Measurement procedure: 
Potassium nitrate was prepared 
at a concentration of 4 mM in 
ultrapure water and stored at 4 
°C. This solution was used to 
make fresh standards each day 
an assay was run (0, 5, 10, 20, 
30, 50, 75, 100, and 200 mM in 
saline). Zinc sulfate was 
prepared at a concentration of 
1.5% in ultrapure water and 
stored at 4 °C. The reducing 
reagent mix (VCl3 0.8%, 
Dapsone 0.25%, and Tsuda 
reagent 0.05% in 1 N HCl) was 
prepared and stored as frozen 
aliquots (-20 °C). A fresh aliquot 
was thawed for each day an 
assay was run. On the day of 
analysis, the wound fluid 
samples were thawed and the 
nitrate-free pads were 
centrifuged 10 min at 8,000 g 
to retrieve the sample. 
values of the 
metabolites 
(NOx, HNE 
and MMP-9) 
as well as the 
natural log 
transformed 
value of the 
wound area. 
 
The optimal 
diagnostic 
levels of NOx 
(cut points) 
were 
determined 
using the 
ROC. The 
natural 
logarithmic 
transformatio
n of NOx 
carried out to 
normalise the 
data before 
performing 
the ROC 
analysis.  
 
The two cut 
points for 
diagnostic 
accuracy of 
the tool were 
determined in 
an iterative 
manner using 
the 
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To ensure that that all 
materials in contact with the 
sample be nitrate free, all 
supplies used were prewashed 
three times in ultrapure water. 
 
Nitrate assay: consisted of 
pipetting 10 mL of each 
standard or sample in a clean 
tube, adding 10 mL ZnSO4, 
vortexing and adding 70 mL 
water. The tube was then 
centrifuged 3 minutes at 8,000 
g and 75 mL of supernatant was 
transferred to new clean tube. 
Ten mL of VCl3 reagent mix was 
added. The tube was vortexed 
and centrifuged 2 minutes at 
2,050 g, then heated in a 
heating block (Eppendorf 
Thermomixer R, Hamburg, 
Germany) at 70 °C for 10 
minutes with agitation (700 
rpm). The tube was cooled 2–3 
min and vortexed to recover 
the condensation on the tube 
walls. The tube was then 
centrifuged for 2 minutes at 
2,050 g and 75 mL was 
transferred to a 384 well plate 
for reading in a 
spectrophotometer (BioTek 
Synergy 4, Winooski, VT) at 545 
nm and at 450 nm. 
 
MMP-9 activity assay: 
Fluorokine E Enzyme Activity 
transformatio
n: |ln(NOx)- 
X|, where the 
X value used 
ranged from 
3.0 to 3.5, 
values close 
to the overall 
computed 
mean and 
median of the 
ln(NOx). 
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Assay (R&D Systems) for 
human active MMP-9 (a 
fluorometric assay designed to 
quantitatively measure enzyme 
activity). Frozen swab samples 
were thawed and centrifuged 
to retrieve a measurable 
amount. Samples were diluted 
to reach a concentration in the 
range of the standard curve, 
i.e., 0–16 ng/mL. The data were 
plotted as relative fluorescence 
units (RFUs) vs. active MMP-9 
concentration using a four 
parameter logistic curve fit for 
the standard curve and the 
equation of the curve was used 
to determine the concentration 
in the samples. 
 
HNE activity assay: InnoZyme 
Human Neutrophil Elastase 
Immunocapture Activity Assay 
(Calbiochem) (an assay 
designed to measure HNE 
activity in cell lysates and body 
fluids). Frozen swab samples 
were thawed and centrifuged 
to retrieve a measurable 
amount. Samples were diluted 
to reach a concentration in the 
range of the standard curve, 
i.e., 0.625–20 ng/mL. The data 
were plotted as RFUs vs. active 
HNE concentration using a 
linear regression curve fit for 
the standard curve and the 
equation of the curve was used 
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to determine the concentration 
in the samples. 
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Edsberg L. E., 
Wyffels J. T., 
Brogan M. S. & 
Fries K. M. (2012)  
   
 
  
 
Analysis of 
the 
proteomic 
profile of 
chronic 
pressure 
ulcers 
Wound Repair 
and 
Regeneration 
United States of America To characterize 
the protein profile 
of pressure ulcers 
over 42 days 
using a variety of 
proteomic 
techniques 
Quantitative, 
prospective, 
descriptive, 
observational, 
cohort study 
Wound healing In-patients recruited 
from long-term skilled 
nursing facilities. 
Inclusion/  
Exclusion 
Criteria 
 Sample Size & 
Characteristics 
Study procedure Measurement 
equipment & 
other materials 
Data Analysis Results Conclusions 
Inclusion 
criteria:  
Stage 2, stage 
3, or stage 4 
pressure 
ulcers. 
 
Exclusion 
criteria: 
wounds being 
treated with 
negative 
pressure 
wound 
therapy, 
topical 
growth 
factors, or 
dressings 
containing 
proteins. 
34 subjects with 
46 pressure 
ulcers (PUs) 
 
PUs ≥ 4 weeks 
duration. 
 
PUs: Stage 2 
(32%), stage 3 
(23%), stage 4 
(45%). 
 
10 males, 24 
females 
(average age 
72.3 years) 
Comorbidities: 
hypertension 
52.2%, diabetes 
54.3%, coronary 
artery disease 
30.4%.  
Assessment at days 0, 1, 2, 3, 4, 
7, 8, 9, 10, 11, 14, 21, 28, 35, 
and 42.  
 
At each assessment: wounds 
were digitally photographed 
with a 3 cm2 calibration target 
and analyzed using VeV MD 
(Version 1.1.14 ©VERG Inc., 
Vista Medical Ltd, Winnipeg, 
Canada) to measure the wound 
size. The change in wound 
surface area expressed as a 
percentage of area on day 0 
was used to place patients in 
one of three categories for 
wound outcome, chronic or not 
healed, moderate healing or 
healed.  
 
Collection and isolation of 
wound fluid proteins: 
Wound size 
analysed using 
VeV MD (Version 
1.1.14 
©VERG Inc., Vista 
Medical Ltd, 
Winnipeg, 
Canada). 
 
Two dimensional 
polyacrylamide 
gel 
electrophoresis 
(2D PAGE), label-
based 
microarrays, and 
isobaric tags for 
relative and 
absolute 
quantitation 
(iTRAQ). 
To identify 
variables 
with a 
significant 
effect on 
wound fluid 
total protein 
concentration
: generalized 
linear model. 
 
Discriminant 
function 
analysis: To 
test the 
predictive 
ability of total 
protein 
concentration 
to correctly 
assign 
outcome 
21 proteins found to distinguish 
between healed and chronic wounds.  
 
19 proteins differentially expressed 
between the interior and periphery 
of wounds. 
 
Samples from interior location of the 
wound had higher protein 
concentrations than samples 
collected from the wound periphery 
for all outcomes (p < 0.0001). 
 
High protein concentrations were 
correlated with deeper ulcers (p < 
0.0001). 
Samples contaminated with blood 
had higher protein concentrations 
than those free of blood for both 
internal and peripheral swab samples 
from all outcomes (p < 0.0001). 
 
In respect to predicting 
wound healing 
outcomes, results are 
not presented 
numerically and 
statistical significance is 
not reported. 
 
 
Using DFA, there was 
not a statistically 
significant correlation 
between wound fluid 
total protein 
concentration and 
clinical outcome. 
This study 
demonstrated the 
differences in samples 
of wound fluid 
collected from different 
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Subset 
temporal 
study:  
Total 42 PUs 
from 32 
subjects 
(10 males, 22 
females; 
average age 
72.8 years).  
 
7 subjects had 
more than 1 PU, 
all PUs were 
included in the 
study.  
PUs: stage 2 
(29%), stage 3 
(24%), and 
stage 4 (48%).  
 
PU staging 
documented in 
medical records 
did not reflect 
the breadth of 
tissue damage 
upon enrolment 
in the study. 
Following 
assessment at 
day 0; PUs stage 
2 (2%), stage 3 
(74%), and 
stage 4 (24%).  
 
Polyester-tipped applicators 
rolled over surface of the 
wound interior and periphery 
independently until saturated. 
The tip of the swab was broken 
off and placed tip-down in a 2-
mL vial prefilled with 150 uL 
phosphate buffered saline (10 
mM, pH 7.4). Wound fluid 
samples were placed in chilled 
coolers and transported 
immediately to the lab for 
analysis.  
 
Measurement procedure: 
Wounds surveyed for the total 
proteome using three methods, 
two dimensional 
polyacrylamide gel 
electrophoresis (2D PAGE), 
label-based microarrays, and 
isobaric tags for relative and 
absolute quantitation (iTRAQ). 
Protein targets from the 
surveys were chosen for 
quantitation using multiplexed 
microarrays. Bioinformatic 
analysis annotated protein 
function and mapped 
relationships. 
using up to 5 
weeks of 
data. 
 
Potential 
predictors 
included in 
models were 
protein 
concentration 
at weeks 1, 2, 
3, 4, and 5 
and initial 
wound area. 
Predictors 
were tested 
for 
collinearity 
before 
combination 
in DFA 
analysis. 
Predictors 
were tested 
individually 
and in 
additive 
temporal 
sequence 
(i.e., 1 and 2; 
1, 2, and 3, 
etc.).  
 
Models were 
evaluated 
based on the 
percent of 
correct 
4 proteins, pyruvate kinase isozymes 
M1/M2, profilin-1, Ig lambda-1 chain 
C regions, and Ig gamma-1 chain C 
region, present in lower levels for 
periphery samples compared to 
interior samples and 6 proteins, 
keratin, type II cytoskeletal 6A 
(KRT6A), keratin, type I cytoskeletal 
14, S100 calcium binding proteins A7, 
alpha- 1-antitrypsin precursor, 
haemoglobin subunit alpha, and 
haemoglobin subunit beta, present in 
higher levels in periphery samples  
compared with interior samples.  
 
S100 calcium binding protein A6, 
S100 calcium binding protein A7, and 
soluble receptor for advanced 
glycation end-products had higher 
levels in the periphery of chronic 
wounds vs. the interior in planar 
arrays.  
 
Using a mixed linear model built for 
each protein to compare temporal 
trends in concentration between 
healed and chronic samples, only one 
of 58 proteins had significant values 
for all four parameters in the model, 
MIG, synonomous with chemokine 
(C-X-C motif) ligand 9 (CXCL9). CXCL9 
increased as wounds healed and 
remained nearly constant or 
decreased slightly for ulcers 
that were not approaching closure. 
 
The ability of total protein 
concentration to be used as an 
locations of the wound 
(I vs P). 
  
This study 
demonstrated the 
difficulties in 
identifying specific 
proteins as potential 
biomarkers of wound 
healing due to the high 
individual variation of 
protein levels and 
between group 
variations. However, 
the presence of the 
S100 family proteins 
in multiple wound fluid 
analyses is of note as is 
the significant temporal 
trend of CXCL9 among 
healed wounds (CXCL9 
increased as wounds 
healed and remained 
nearly constant or 
decreased slightly for 
ulcers that were not 
approaching closure). 
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Hypertension 
54.8%, diabetes 
54.8%, and 
coronary artery 
disease 28.6%. 
 
predictions in 
a 
resubstitution 
matrix using 
that model. 
 
indicator of wound status or 
outcome was further tested using a 
DFA but no significant models 
resulted. There was not a statistically 
significant correlation between 
wound fluid total protein 
concentration and clinical outcome. 
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Hoffman R., 
Noble J. & Eagle 
M. (1999) 
  
 
The use of 
proteases as 
prognostic 
markers for 
the healing of 
venous leg 
ulcers 
 
Journal of 
Wound Care 
United Kingdom To identify 
whether the level 
of elastase activity 
in wound fluid 
correlates with 
wound healing 
rate. 
 
To determine the 
validity of the 
collection method 
used in this study. 
 
Preliminary, 
quantitative 
prospective 
descriptive 
observational 
cohort study 
Wound healing Wound clinic 
Inclusion/  
Exclusion 
Criteria 
 Sample Size & 
Characteristics 
Study procedure Measurement 
equipment & 
other materials 
Data Analysis Results Conclusions 
Not stated 7 subjects with 
venous leg 
ulcers ranging in 
duration from 
13 months to 
greater than 7 
years. 
 
(no further 
sample data 
reported) 
Wound fluid collection: 
Over a period of up to six weeks, 
the first experiment involved 
weekly collection of wound fluid 
from the bandages of patients 
with venous leg ulcers. Wound 
fluid was collected from the 
dressings by immersing each 
bandage in approximately 25mL 
of ice-cold phosphate-buffered 
saline (PBS) containing 0.02% 
Neutrophil 
elastase was 
determined by a 
method using the 
selective 
substrate N -
methoxysuccinyl-
ala-ala-pro-val-p-
nitroanilide 
Elastase 
activity 
compared 
with healing 
outcomes at 9 
months post 
wound fluid 
collection.  
 
Total elastase 
activity 
Elastase activity recovered from 
wound fluid in wound bandages 
varied widely. 
 
No correlation between wound 
healing and the amounts of elastase 
recovered from wound bandages. 
 
Elastase activity remaining 
recoverable one-week after adding 
wound fluid to bandages varied. 
The format of reporting 
the results of this study 
limited the evaluation 
of the research data. 
 
As this is a preliminary 
study, the small sample 
size is deemed a 
limitation to the results 
of this study. 
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sodium azide. The fluid was 
expressed, the sample volume 
measured, centrifuged at 
15,000g for ten minutes and 
then frozen at -70°C. 
  
Measurement procedure: 
Neutrophil elastase activity 
measured by a method using 
the selective substrate N -
methoxysuccinyl-ala-ala-pro-
val-p-nitroanilide. 
 
To determine the stability of 
neutrophil elastase in the 
bandages until the weekly 
wound fluid collection time 
points: 20µL of wound fluid 
specimen was added to 4mg 
sample of different bandage 
types used in the study, these 
specimens incubated at 37°C in 
sealed plastic microcentrifuge 
tubes, and then 200µL of PBS 
added either immediately, at 
three days, or seven days 
intervals. Following this, the 
specimens were incubated at 
4°C for 30 minutes, the fluid 
expressed from the bandage, 
centrifuged at 15,000g for ten 
minutes and finally frozen at -
70°C prior to analysis. 
determined 
by correcting 
for the total 
volume of 
wound fluid 
and PBS 
reovered from 
the bandage.  
 
Elastase assay 
conducted in 
duplicate for 
each sample. 
 
Stability of 
elastase in the 
bandages 
estimated by 
comparing the 
amount that 
could be 
recovered 
immediately 
after adding it 
to the 
bandage with 
the amount 
that could be 
recovered 
after it had 
been left on 
the bandage 3 
or 7 days. 
 
This study identifies the 
need to conduct a 
larger study to better 
evaluate elastase as a 
predictor of wound 
healing. 
Author(s) & 
Publication Year 
Title 
Source/  
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James T. J., 
Hughes M. A., 
Cherry G. W. & 
Taylor R. P. (2000)  
  
Simple 
biochemical 
markers to 
assess 
chronic 
wounds 
Wound Repair 
and 
Regeneration 
United Kingdom To investigate the 
potential for the 
biochemical 
analysis of chronic 
wound fluid to 
predict healing 
using simple and 
widely available 
analytes in an 
out-patient clinic 
setting 
 
Quantitative, 
prospective 
descriptive, 
observational, 
cohort study 
Wound healing; complete wound 
healing or greater than 50% 
reduction in wound size or non-
healing. 
Leg ulcer clinic 
Inclusion/  
Exclusion 
Criteria 
 Sample Size & 
Characteristics 
Study procedure Measurement 
equipment & 
other materials 
Data Analysis Results Conclusions 
Not stated 12 patients 
Female n=6, 
Males n=6  
 
Median age: 74 
years (range 65-
88 years) 
 
All subjects had 
chronic wounds 
of the lower leg 
of at least 8-
weeks duration. 
 
Venous disease 
n=10, Venous 
disease and 
diabetes 
mellitus n=1, 
Mixed venous- 
arterial disease 
(ankle/ brachial 
12 weeks after specimen 
collection the wound was 
classified as healing if complete 
wound closure had occurred or 
the wound area had been 
reduced by greater than 50%. 
The initial median wound size 
was 35 cm2 (range 2.5–101.1). 
4 of the patients had a second 
specimen collected at a median 
time of 8 weeks after the first 
collection (range 4–10 weeks). 
 
All wounds were photographed 
when the fluid was collected 
and when the wound was 
assessed for evidence of 
healing. Wound size was 
determined from these 
photographs and by tracing 
around the edge of the ulcer 
onto clear plastic. The 
photographs provided a visual 
Bayer Axon 
clinical chemistry 
analyser (Bayer 
Diagnostics, 
Newbury, UK) 
 
Cobas Fara clinical 
chemistry 
analyser (Roche 
Diagnostics, 
Lewes, UK). 
 
Other materials: 
Transparent 
occlusive dressing 
(Opsite, Smith 
and Nephew 
Medical Limited, 
Hull, UK 
The Mann–
Whitney 
nonparametri
c U-test used 
to assess the 
significance of 
differences 
between 
healing and 
non-healing 
groups using 
Statview 
software 
(Cricket 
Software, 
Malvern, PA). 
Of the 12 patients studied, 4 (2 
males, 2 females) were assessed as 
healed (2 completely, 1 reduced by 
70% and 1 by 85%) and 8 as 
nonhealing (no evidence of size 
reduction or improved wound 
appearance). 
 
Only albumin and total protein 
showed a significant difference 
between healing and non-healing.  
 
Glucose in all of the exudate 
specimens was too low to analyse 
reliably by routinely available 
methods, in most cases being less 
than 1 mmol/l. 
 
The median total protein (44.3 ± 8.8 
g/l) and albumin (25.0 ± 2.3 g/l) 
concentrations in exudate collected 
from 4 healing wounds were 
significantly higher (p < 0.05) than in 
Total protein and 
albumin are stable 
analytes which can be 
easily measured in any 
laboratory and have 
the potential to act as 
indicators of healing. 
 
Due to an identified 
risk of selection bias in 
positive favour of 
wounds with high 
exudate output, 
further research is 
required to confirm 
these results with a 
larger group of 
patients. 
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pressure index 
= 0.6) n=1 
 
Various wound 
dressings used 
record of changes in wound 
appearance. 
 
Collection technique:  
Exudate was collected by 
covering the wound with a 
transparent occlusive dressing 
(Opsite, Smith and Nephew 
Medical Limited, Hull, UK) and 
keeping the leg dependant for 
30–40 minutes. Fluid was 
withdrawn from beneath the 
dressing with a syringe and 
needle. The specimens 
collected were centrifuged 
within 30 minutes to remove 
cell debris (8000 ×g for 5 
minutes) and either analysed 
immediately or stored at −70 
°C.  
 
Measurement procedure: 
On a Bayer Axon clinical 
chemistry analyser (Bayer 
Diagnostics, Newbury, UK): 
Total protein analysis using 
Biuret method, albumin using 
BCG, creatinine using Jaffé, 
urea using urease, lactate 
dehydrogenase using pyruvate 
to lactate, Tris buffer, and 
glucose using hexokinase.  
 
Precision studies showed that 
these methods had coefficients 
of variation less than 3%.  
An aliquot of wound fluid for 
lactate determination was 
exudate from 8 non-healing wounds 
(median total protein 29.7 ± 7.6 g/l, 
median albumin 17.0 ± 4.3 g/l).  
 
No significant difference was 
observed for lactate.  
 
A second specimen of wound fluid 
was collected from 4 of the patients 
(3 non-healing and 1 healing). The 
protein analysis confirmed the 
pattern observed for the first 
collection: non-healing wounds had 
total protein and albumin which 
remained low compared to healing 
wounds.  
 
No wound with an exudate albumin 
of less than 20 g/l healed. 
 
Biochemical analyses with respect to 
the bacterial swab results showed 
the healing rates of wounds 
colonized with different organisms 
did not differ significantly. 
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prepared with perchloric acid 
precipitation, and analysed 
enzymatically on a Cobas Fara 
clinical chemistry analyser 
(Roche Diagnostics, Lewes, UK). 
 
Because of limited specimen 
volumes (approximately 0.5 ml 
was collected, range 0.2–1.0 
ml) it was not possible to 
complete a full set of analyses 
on all fluids.  
The bacteriological 
investigations were carried out 
qualitatively using ulcer swabs 
which were cultured in 
selective media 
Author(s) & 
Publication Year 
Title 
Source/  
Journal 
Geographical Location Objectives 
Study 
Methodology 
& Design 
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Care Setting 
 
 
Ladwig G. P., 
Robson M. C., Liu 
R., Kuhn M. A., 
Muir D. F. & 
Schultz G. S. 
(2002)  
 
Ratios of 
activated 
matrix 
metalloprotei
nase-9 to 
tissue 
inhibitor of 
matrix 
metalloprotei
nase-1 in 
wound fluids 
are inversely 
correlated 
with healing 
of pressure 
ulcers 
Wound Repair 
and 
Regeneration 
United States of America To examine levels 
of MMP-2, MMP-
9 and TIMP-1 in 
sequential wound 
fluids and 
biopsies from 
patients with 
chronic pressure 
ulcers and to 
correlate the 
levels of these 
MMPs and 
inhibitor with the 
extent of ulcer 
healing. 
 
Quantitative, 
prospective, 
descriptive, 
observational, 
cohort study 
Reduction in wound volume 
 
 
Not stated  
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Inclusion/  
Exclusion 
Criteria 
 Sample Size & 
Characteristics 
Study procedure Measurement 
equipment & 
other materials 
Data Analysis Results Conclusions 
Reported 
elsewhere (in 
main study 
(Robson et al. 
2000)): 
Inclusion 
criteria: 
Age 28-
70years 
 
Pressure 
ulcers on the 
truncal area 
involving any 
tissue from a 
bony 
prominence 
to the 
subcutaneous 
tissue (grade 
III/IV). 
 
Pressure 
ulcers 
measuring 
10-200 cm3 of 
at least 8 
weeks’ 
duration 
 
Exclusion 
criteria:  
Significant 
diabetes 
mellitus, 
Samples from 
56 of the 61 
patients 
enrolled in a 
four-arm, 
blinded, 
prospective, 
randomized 
placebo-
controlled 
pressure ulcer 
clinical trial 
comparing 
topical 
administration 
of granulocyte 
macrophage- 
colony 
stimulating 
factor (GM-
CSF), basic 
fibroblast 
growth factor 
(bFGF), and 
sequential 
treatment with 
GM-CSF 
followed by 
bFGF over a 35-
day period, 
were used in 
this study. 
 
All patients 
were 
Wound biopsies and fluid 
samples were taken from the 
ulcers at day 0 (pre-treatment), 
day 10, and day 36. 
Measurements of the pressure 
ulcer volume was performed on 
day 0 and weekly for 5 weeks 
using planimetry of the ulcer 
opening and volume 
determination using alginate 
moulds. 
 
Wound fluid collection: 
Wound fluids were collected 
from the ulcers using porous, 
inert hydrophilic dextranomer 
beads. The beads were placed 
in each pressure ulcer forming 
a layer approximately ¼ inch 
thick. The ulcer was dressed 
with an occlusive dressing and 
covered with an adherent 
elastic wrap. The beads 
remained in the ulcers for 24 
hours. The beads were 
collected, and 1 gram of the 
saturated beads was mixed 
with 1ml of 100mM sodium 
phosphate, pH 7.4 for 12 hours 
in a vertical shaker at 4°C to 
elute the wound fluid protein 
from the dextran beads. The 
beads were then centrifuged at 
1000×g for 5 minutes at 4°C 
and the supernatant solution 
Pro and activated 
forms of MMP-2 
and MMP-9 
measurement: 
quantitative 
gelatin 
zymography and 
electrophoresis 
 
Gels 
photographed 
with Kodak KD120 
digital camera 
(Eastman, NY) and 
the relative pixel 
density of each 
band measured 
using Kodak 
Digital Science 
image analysis 
software. 
 
A modified 
technique of 
Western blotting 
was performed to 
further 
characterize the 
bands observed 
by zymography 
for MMP-2 and 
MMP-9. 
 
TIMP-1 
measurement: 
Levels of pro 
and activated 
MMP-2 and 
MMP-9 in 
samples were 
calculated 
from standard 
curves 
generated 
with 
recombinant 
pro and 
activated 
MMP-2 and 
MMP-9.  
 
Levels of pro 
and activated 
MMP-2 and 
MMP-9 were 
expressed as 
ng of MMP 
per ml of 
wound fluid 
or as ng of 
MMP per gm 
of biopsy. 
 
A response of 
at least an 
85% decrease 
in wound 
volume over 
35 days 
indicated 
Gelatin zymography approximately 8 
times more sensitive in detecting 
MMP-9 than MMP-2 
 
Visual evaluation of the gelatinolytic 
band patterns suggests that samples 
of wound fluids contain abundant 
amounts of proMMP-9 and activated 
MMP-9 and have extremely low or 
undetectable levels of pro MMP-2 and 
activated MMP-2. However, because 
of the greater sensitivity of gelatin 
zymograms for MMP-9 gelatinolytic 
activity, wound fluid samples actually 
contain only about 4 times more 
MMP-9 than MMP-2 when the levels 
of MMPs are calculated using the 
standard curves and appropriate 
dilutions of wound fluids are 
analysed. 
 
None of 10 representative wound 
fluid samples contained detectable 
proMMP-2 or activatedMMP-2 bands 
when 5µl of 500-fold diluted wound 
fluids were assayed. 
 
Only 20 of 125 (16%) wound fluid 
samples had a detectable pro MMP-2 
band, and only 4 of the 20 fluids (3% 
overall) also had a detectable 
activated MMP-2 band. The activated 
MMP-2 band was less than half the 
intensity of the pro MMP-2 band in 
Overall, the general 
impression is that levels 
of activated MMP-9 
tend to decrease as 
healing proceeds on 
days 10 and 36 for 
intermediate and poor 
healers, while they 
remain at a constant 
low level in fluids of 
ulcers that healed well. 
 
Measurements of 
proteins presented 
graphically and 
descriptively, and exact 
numerical data not 
reported.  
 
Because the ratio of 
MMP-9/TIMP-1 in 
wound fluid was 
significantly correlated 
with the eventual 
outcome of healing, 
this data suggests the 
initial MMP-9/TIMP-1 
ratio on day 0 is a 
prognostic indicator of 
eventual clinical healing 
at 36 weeks. 
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renal 
insufficiency, 
vasculitis, or 
hepatic, 
immunologic, 
cardiac, or 
haemorrhagic 
disease. 
Malignant or 
neoplastic 
disease, 
except for 
adequately 
treated skin 
cancers. 
Significant 
malnutrition, 
systemic 
steroidal 
therapy, 
immunothera
py, or 
chemotherap
y. 
Cytokine 
therapy 
within 90 
days or 
investigationa
l drug study 
within 30 
days.  
denervated in 
the area of 
ulceration 
because of 
acquired spinal 
cord pathology. 
 
(reported 
elsewhere, in 
main study). 
 
Ulcers 10-200 
cm3 and 
minimum 8 
weeks’ 
duration. 
 
 
were stored at )80°C until 
analysed. 
 
Wound biopsy collection: 
A 4-mm punch biopsy of tissues 
was collected at either the 
centre or the edge of the 
pressure ulcer from 13 patients 
and stored at -80°C. Frozen 
punch biopsies were weighed, 
cut into small pieces, and then 
homogenized using a 1ml 
frosted glass-on-glass 
homogeniser (Wheaton, 
Milville, NJ) in buffer (20mM 
Tris, 0.1% Triton X-100, pH 7.4) 
at a ratio of 100 mg tissue/ml 
of homogenising buffer. The 
homogenates were centrifuged 
at 14,000×g for 5 minutes to 
remove particulate matter, and 
the supernatant was stored -
80°C until analysed. 
 
Measurement procedure: 
15 µl of appropriately diluted 
wound fluid or biopsy 
homogenate supernatant were 
mixed with an equal volume of 
sample buffer (63 mM Tris-HCl, 
pH 6.8, 10% glycerol, 2% 
sodium dodecyl sulfate and 
0.0025% bromophenol blue; 
Novex, San Diego, CA) and 
incubated at room temperature 
for 10 minutes. 20µl of the 
equilibrated sample were 
loaded into a well of a 15-well 
ELISA (Amersham 
Pharmacia 
Biotech, 
Piscataway, NJ). 
 
Wound fluid 
collection: 
porous, inert 
hydrophilic 
dextranomer 
beads. 
the good 
healers, 50–
85% decrease 
in volume 
indicated 
intermediate 
healers, and a 
decrease in 
wound 
volume of less 
than 50% 
indicated 
poor healers. 
 
Only 
gelatinolytic 
profiles 
between 
wound fluids 
and biopsy 
homogenates 
were 
qualitatively 
compared.  
 
All zymogram 
and ELISA 
data were 
statistically 
analysed 
using a 
MANOVA 
with Statistica 
software 
(StatSoft Inc., 
Tulsa, OK) to 
determine 
significant 
the 4 wound fluid samples that had 
both pro and activated MMP-2 bands. 
 
The intensity of the activated MMP-9 
band was greater than or equal to 
the intensity of the pro MMP-9 band 
in 7 of the 9 wound fluid samples that 
had MMP-9 bands. 
114 (91%) of the wound fluids 
contained a detectable activated 
MMP-9 band, and 89 (71%) contained 
a detectable pro MMP-9 band when 5 
µl of 200-fold dilutions of wound 
fluids were assayed. Also, the relative 
intensity of the activated MMP-9 
band was equal to or greater than the 
intensity of the pro MMP-9 band in 94 
of the 125 (75%) wound fluid samples. 
 
Levels of activated MMP-9 in wound 
fluids were significantly (p < 0.05) 
higher at day 0 (pre-treatment) in 
poor healers compared with good 
healers. On day 10, both pro MMP-9 
and activated MMP-9 exhibited a 
significant (p < 0.05) inverse 
relationship with percent closure of 
the wound. On day 36, only activated 
MMP-9 exhibited an inverse 
relationship with percent wound 
closure (p < 0.05).  
 
Difference in levels of pro-MMP-2 in 
wound fluids at day 0 between good 
healers and poor healers approached 
statistical significance (p=0.077). The 
levels of MMP-2 did not progressively 
decrease as healing proceeded on 
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precast gelatin zymogram gel 
(Novex, San Diego, CA).  
 
To measure levels of pro and 
activated MMP-9, samples 
were electrophoresed at 4°C at 
95 V until the bromophenol 
blue tracking dye had migrated 
through the stacking gel and 
then were electrophoresed at 
125 V until the tracking dye 
reached the bottom of the gel 
(approximately 2.5 hours).  
To measure levels of pro and 
activated MMP-2, gels were 
run an additional hour after the 
tracking dye reached the 
bottom of the gel 
(approximately 3.5 hours). Gels 
were then immersed in 
renaturing buffer (2.7% Triton 
X-100, w/v) and placed on a 
rotary shaker at 30 r.p.m. for 
30 minutes at 37°C. The gels 
were then placed in developing 
buffer (50 mM Tris-HCl, 200 
mM NaCl, 5 mM CaCl2, 0.2% 
Brij 35, w/v) on a rotary shaker 
at 37°C for 24 hours to allow 
the MMPs to digest the gelatin 
substrate. After digestion, the 
gels were stained with 
Coomassie Rapid Stain 
(Diversified Biotech, Boston, 
MA) and destained with 12.5% 
trichloroacetic acid.  
Gels were photographed with a 
Kodak KD120 digital camera 
differences 
between 
treatment 
groups and 
clinical 
response 
groups. 
 
All sequential 
data obtained 
on gelatinase 
activity, TIMP-
1 activity, and 
ulcer 
measurement
s were 
evaluated for 
possible 
correlation 
using the 
Spearman 
Rank Order 
Correlation.  
 
Statistical 
significance 
was accepted 
at p < 0.05. 
days 10 and 36 but remained nearly 
constant. 
 
Levels of TIMP-1 at day 0 were 
significantly lower in patients who 
healed poorly compared with patients 
who healed well (p=0.05).  
Levels of TIMP-1 increased in wound 
fluids on day 10 from patients who 
were poor or intermediate healers, 
and on day 36 were similar to the 
levels of TIMP-1 in patients who 
healed well. 
 
Ratio of total MMP-9/TIMP-1 was 
significantly lower in patients whose 
pressure ulcers healed well at all three 
time points (days 0, 10, and 36) 
compared with patients whose ulcers 
healed poorly or healed 
intermediately. 
 
Furthermore, the ratio of MMP-
9/TIMP-1 decreased significantly 
(p≤0.05) on days 10 and 36 compared 
with initial (day 0) values in the fluid 
samples from patients whose ulcers 
healed poorly. A similar trend seen in 
patients whose ulcers healed 
intermediately. 
 
The largest difference in ratios of 
MMP-9/TIMP-1 between the groups 
of patients occurred on day 0, where 
the ratio was approximately four-fold 
higher in patients whose pressure 
ulcers healed poorly at the end of the 
36 week study, and approximately 
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(Eastman, NY) and the relative 
pixel density of each band was 
measured using Kodak Digital 
Science image analysis 
software.28,29 Pre-stained 
molecular weight standards 
(Novex, San Diego, CA) and one 
sample of pro and activated 
MMP-9 and MMP-2 were run 
on each gel. 
twofold higher in patients whose 
pressure ulcers healed 
intermediately, compared to patients 
who healed well (p < 0.05).  
Author(s) & 
Publication Year 
Title 
Source/  
Journal 
Geographical Location Objectives 
Study 
Methodology 
& Design 
Outcome Measures 
Care Setting 
 
 
Liu Y., Min D., 
Bolton T., Nubé 
V., Twigg S. M., 
Yue D. K. & 
McLennan S. V. 
(2009) 
  
 
Increased 
matrix 
metalloprotei
nase-9 
predicts poor 
wound 
healing in 
diabetic foot 
ulcers 
Diabetes Care Australia To measure 
MMP-9, MMP-2, 
TIMP-1, and TGF-
β1 in wound fluid 
obtained from 
diabetic foot 
ulcers. 
 
To examine the 
relationship 
between MMP-9, 
MMP-2, TIMP-1, 
and TGF-β1 in 
wound fluid 
with wound 
healing. 
Quantitative, 
prospective, 
descriptive, 
observational, 
cohort study 
Wound healing rate Not stated 
Inclusion/  
Exclusion 
Criteria 
 Sample Size & 
Characteristics 
Study procedure Measurement 
equipment & 
other materials 
Data Analysis Results Conclusions 
Not stated 62 subjects 
(male=49, 
female=13) 
 
All patients seen weekly for 
debridement, offloading, and 
other treatments during the 
initial 4 weeks and assessed 
MMP-2 and MMP-
9 measurement: 
zymography. 
 
Wound 
healing rate 
over the 28 
days 
calculated as: 
No ulcers healed at 4-weeks 
 
23 ulcers healed at 12-weeks 
(no differences in age, duration of 
diabetes, or initial size of the ulcer 
Measurement of pro-
MMP-9 with addition of 
cut-offs for TIMP-1 at 
>480 pg/ml and TGF-β1 
at >115 pg/ml appear 
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Patients with 
type 2 diabetes 
(n=56). 
 
Ulcers classified 
as neuropathic 
(n=48), 
postsurgical 
(n=9), or neuro-
ischemic 
(n=5). 
 
Ulcers present 
for 2–10 weeks 
before 
presentation. 
 
 
approximately monthly 
thereafter.  
 
Antibiotics prescribed for 83% 
of subjects. 
 
At each assessment: the ulcer 
was debrided, ulcer borders 
traced onto sterile transparent 
film using an acetate pen, 
tracings digitized by scanning 
and the area calculated using 
National Institutes of Health 
image software.  
 
Wound fluid collection: 
Wound fluids were collected 
from the ulcer site at the first 
clinic visit and after 4 weeks of 
treatment. Samples were stored 
at -20°C No further collection 
details reported. 
 
Measurement procedure: 
Quantitation of MMP-2 and 
MMP-9 by zymography and 
TIMP-1 and TGF-β1 by enzyme-
linked immunosorbent assay. 
 
TIMP-1 and TGF-
β1 measurement: 
enzyme-linked 
immunosorbent 
assay (ELISA). 
 
daily change 
in wound area 
(%) = [(area at 
visit 1 - area at 
visit 4)/(area 
visit 1)/28] 
×100. 
 
Students t test 
or one-way 
ANOVA was 
used for 
comparisons. 
Multiple 
regression 
analysis was 
used to 
determine the 
relationships 
between 
WHR4 weeks, 
age, duration 
of diabetes 
and 
ulceration, 
wound fluid 
pro– and 
active–MMP-
9 and MMP-2, 
TIMP-1, and 
TGF-1. ROC 
analysis was 
used to 
determine 
thresholds for 
pro–MMP-9 in 
predicting 
between the healed and unhealed 
groups). 
 
Wound healing at 4 weeks: 
Pro-MMP-9 and pro-MMP-9/TIMP-1 
ratio at presentation correlated 
significantly with wound healing rate 
(r = 0.4538, P < 0.001, and r = 0.4959, 
P < 0.0001, respectively). Correlation 
not evident for MMP-2 or TIMP-1 at 4-
weeks. 
 
Wound healing at 12-weeks: 
Concentrations of pro– and active–
MMP-9 in unhealed ulcers obtained at 
presentation were significantly higher 
and those of TIMP-1 and TGF-β1 
significantly lower than healed ulcers. 
 
Measurement of pro-MMP-9 with 
addition of cut-offs for TIMP-1 at >480 
pg/ml and TGF-β1 at >115 pg/ml 
(respective median values for healed 
wounds) was the best predictor of 
wound healing (AUC 0.94; P < 
0.00001). The sensitivity and 
specificity were 87% and 91%, 
respectively, and predicted outcome 
in 94% of cases. 
 
Unhealed vs healed wounds:  
Pro-MMP-9 µg/ml: 8.19 ± 2.75 vs 4.47 
± 2.75, p<0.01 
Active–MMP-9 µg/ml: 2.90 ± 1.64 vs 
1.18 ± 1.21, p<0.05  
TIMP-1 pg/ml: 531.2 ± 377.6 vs 732.5 
± 270.0, p<0.05 
as the best predictors 
of wound healing in 
diabetic foot ulcers 
examined in this study. 
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healing within 
12 weeks. 
TGF-β1 pg/ml: 142.4 ± 119.7 vs 231.9 
± 141.9, p<0.01 
Pro-MMP-9-to-TIMP-1 ratio: 18.88 ± 
6.87 vs 7.2 ± 5.24, p<0.05 
Active-MMP-9-to-TIMP-1 ratio: 6.01 ± 
1.08 vs 2.03 ± 2.47, p<0.05. 
Author(s) & 
Publication Year 
Title 
Source/  
Journal 
Geographical Location Objectives 
Study 
Methodology 
& Design 
Outcome Measures 
Care Setting 
 
 
Muller M., 
Trocme C., Lardy 
B., Morel F., 
Halimi S. & 
Benhamou P. Y. 
(2008)  
  
 
Matrix 
metalloprotei
nases and 
diabetic foot 
ulcers: the 
ratio of 
MMP-1 to 
TIMP-1 is a 
predictor of 
wound 
healing 
Diabetic 
Medicine 
France Primary objective: 
to describe 
changes in MMP 
and TIMP levels 
during healing in 
diabetic foot 
ulcers.  
 
Secondary 
objective: to 
search for any 
correlation 
between changes 
in MMP and TIMP 
levels and wound 
healing, in order 
to find possible 
predictors of 
healing. 
Quantitative, 
prospective, 
descriptive, 
observational, 
cohort pilot 
study 
Wound size reduction Diabetology 
Department in a 
University Hospital. 
Inclusion/  
Exclusion 
Criteria 
 Sample Size & 
Characteristics 
Study procedure Measurement 
equipment & 
other materials 
Data Analysis Results Conclusions 
Inclusion 
criteria:  
a diabetic 
foot ulcer 
rated 1 to 3, 
stage A 
16 subjects (15 
male, 1 female) 
 
Mean age 64 
years (range 47-
84 years) 
Local wound treatment same 
for all wounds (local wound care 
given by a nurse every 2 days) 
and choice of the dressing 
according to our local protocol. 
No dressing known to interfere 
Shirmer strips. 
 
MMP-2 and MMP-
9 measurement: 
SDS-PAGE. 
Statistical 
software 
program 
SSPS® 11.0 
(SPSS Inc., 
Chicago, IL, 
Initial Assessment:  
Good Healers (n = 7): 
MMP-1: 4.88 (2.43–10.32) (p = 0.1)  
Total MMP-2: 22.89 (12.4–37.78)  
Activated MMP-2: 5.41 (0–9.82)  
MMP-8: 140.44 (70.8–342.2)  
Week 1 measurement 
of MMP-1/TIMP-1 ratio 
appears as a prognostic 
indicator for complete 
healing at 12-weeks. 
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according to 
the University 
of Texas 
Wound 
Classification 
(not infected 
and no severe 
arteriopathy); 
a chronic 
wound (at 
least 30 days’ 
duration);  a 
wound area 
larger than 
0.5 cm2.  
 
Exclusion 
criteria:  
infected 
wound (based 
on the 
International 
Consensus on 
The Diabetic 
Foot criteria 
2003); 
arteriopathy 
of the lower 
limbs, 
characterized 
either by 
absence of 
posterior 
tibial and 
pedal pulses 
or by an 
ABPI<0.9; soft 
 
Type 2 diabetic 
patients aged 
over 40 years 
 
1 subject had an 
amputation at 
week 8. 
with MMP levels (such as 
Beclapermine or Promogran) 
used. 
 
Wound fluid collection:  
At each visit [week 0 (W0), W1, 
W2, W4, W8 and W12]: wound 
area measured using a numeric 
photograph and appropriate 
software. 2 samples of wound 
fluid collected using sterile 
absorbent paper strips placed 
on the edges of the wound for 5 
min, in order to measure MMP-
1, -2, -8, -9 and TIMP-1 levels.  
 
Measurement procedure: 
Protein elution from the 
Shirmer strips performed by 
stirring the strips in 1 ml of 
buffer (50 mM Tris, 50 mM 
NaCl, 0.05% Brij 35, pH 7.6) for 
at least 2 h at +4°C. 
 
MMP-2 and MMP-9 
measurement: zymography. 
Proteins were separated on an 
SDS-PAGE gel copolymerized 
with 0.5 mg/ml gelatine. After 
incubation in a buffer to 
activate the enzyme, the gel is 
stained with Coomassie Blue 
(Sigma, Saint Quentin Fallavier, 
France): proteins with 
gelatinolytic activity are thus 
detected as unstained bands. 
The quantity of enzyme is 
assessed by densitometry of the 
MMP-1, MMP-8 
and TIMP-1: 
ELISA. 
 
Wound 
measurement 
software: 
Mouseyes®, 
Salford, 
UK;http://www.h
op.man.ac.uk/staf
f/rtaylor. 
USA) used for 
statistical 
analyses. 
 
A decrease in 
wound area of 
at least 82% at 
4 weeks 
defined the 
‘good healers’ 
and a 
decrease in 
wound area of 
less than 82% 
at 4 weeks 
defined the 
‘poor healers’. 
 
Non-
parametric 
tests used: 
Mann-
Whitney or 
Wilcoxon test 
and Chi-
squared or 
Fisher test. 
The Spearman 
test was 
performed to 
detect 
correlations 
between 
percentage 
decrease in 
wound area 
and changes 
in the MMPs 
Total MMP-9: 461.6 (282–524)  
Activated MMP-9: 0 (0–7.16) 
TIMP-1: 3.25 (2.93–5.01) 
 
Poor healers (n = 9):  
MMP-1: 2.66 (9–2.69) 
Total MMP-2: 42.22 (23.63–57.46) 
Activated MMP-2: 5.75 (4.95–7.88) 
MMP-8: 279.63 (109.5–350) 
Total MMP-9: 479.4 (246.4–876.6) 
Activated MMP-9: 20.85 (0–81.2) (p= 
0.068) 
TIMP-1: 4.26 (3.47–4.96) 
 
During the 12 weeks of follow-up: 
MMP-8 and MMP-9: levels in good 
healers remained stable between W0 
and W2, before starting to decrease 
from W2 onwards. The change in 
MMP-9 levels between W0 and W4 
did not reach significance (P=0.14).  
In poor healers, MMP-8 and MMP-9 
levels remained constant throughout 
the follow-up period.  
MMP-1: The level of MMP-1 was 
significantly higher at W0 in good 
healers compared to poor healers at 
week 2 [4.78 pg/μg of protein (CI 1.9–
7.65) vs. 2.27 pg/μg (CI 1.24–0.29); 
P=0.039]. MMP-1 level in good 
healers appeared to diminish during 
the study whereas it remained stable 
in poor healers. 
TIMP-1: No significant difference in 
the TIMP-1 level between the two 
groups. 
Some of the results are 
presented only 
graphically and 
descriptive data are not 
definitively outlined. 
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tissue 
infections. 
lysis bands, the area under the 
curve thus obtained being 
referred to a standard scale of 
purified gelatinase. This method 
quantifies both latent and 
activated forms of MMP-2 and -
9, and, by addition, the total 
concentration of each 
gelatinase. 
 
MMP-1, MMP-8 and TIMP-1 
measurement: ELISA; R&D 
Systems, Lille, France for MMP-
1; Amersham, Orsay, France for 
MMP-8; Oncogene Research, 
VWR International, Fontenay 
sous Bois, France for TIMP-1.  
Protein concentration was 
assayed using the Pierce 
method and the concentrations 
of MMPs and TIMP-1 were 
expressed as pg/μg protein. 
or TIMPs 
levels. The 
retrospective 
division into 
good and poor 
healers was 
not used for 
detecting 
these 
correlations.  
 
ROC analysis 
used to 
determine 
whether 
parameters 
had predictive 
value with 
respect to 
wound 
healing. 
MMP-2: level did not differ between 
the groups during the study. 
 
MMP-1/TIMP-1 ratio: not 
significantly different at W0 in good 
healers compared to poor healers 
(P=0.064).  
The percentage reduction in wound 
area at W4 correlated positively with 
the MMP-1/TIMP-1 ratio at W0 
(r=0.65; P=0.008) and at W2 (r=0.69, 
P=0.009). Hence the MMP-1/TIMP-1 
ratio at W0 is a prognostic indicator of 
complete healing at the end of the 12-
week follow-up period. 
The ROC curve showed that an MMP-
1/TIMP-1 ratio at W0 of 0.39 best 
predicts a reduction in wound area of 
at least 82% at W4—i.e. predicts 
complete wound healing at W12—
with a sensitivity of 71% and a 
specificity of 87.5%. 
 
Author(s) & 
Publication Year 
Title Source/  
Journal 
Geographical Location Objectives Study 
Methodology 
& Design 
Outcome Measures Care Setting 
 
 
Tarlton, J. F., 
Vickery, C. J., 
Leaper, D. J. & 
Bailey, A. J.  
(1997) 
  
Postsurgical 
wound 
progression 
monitored by 
temporal 
changes in 
the 
expression of 
matrix 
metalloprotei
nase-9 
British Journal 
of Dermatology 
United Kingdom To investigate 
whether 
comparative 
measurements of 
MMPs may be 
used to monitor 
the progression of 
early wound 
healing. 
Quantitative, 
prospective, 
descriptive, 
observational, 
cohort study 
Type of wound healing (acute 
surgical wounds versus chronic 
wounds)  
Not stated 
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Inclusion/  
Exclusion 
Criteria 
 Sample Size & 
Characteristics 
Study procedure Measurement 
equipment & 
other materials 
Data Analysis Results Conclusions 
Not stated Post-operative 
patients 
following 
mastectomy for 
primary breast 
carcinoma (n=9) 
and colectomy 
for primary 
colorectal 
carcinoma (n=9) 
None of these 
patients had 
any other noted 
disease and a 
single dose of 
prophylactic 
antibiotics had 
been 
administered to 
only the 
colectomy 
patients. 
Wound fluid collection: 
Collections of wound fluids 
were obtained from sterile 
drainage systems inserted at 
surgery and blood samples by 
simultaneous venesections.  
 
Chronic wound fluids were 
collected from venous leg 
ulcers of six patients, from 
beneath occlusive dressings at 
intervals greater than 24 hours.  
Samples were centrifuged and 
aliquots were stored at -80°C 
until analysed. 
 
Measurement procedure: 
Analysis of MMPs -2 and -9: 
Gelatin substrate gel 
electrophoresis (zymography). 
 
Analysis of caseinolytic serine 
proteases: Casein zymography. 
 
Analysis of type I collagen C 
propeptide (CICP): sandwich 
enzyme linked immunosorbant 
microtiter assay (ELISA). 
Analysis of MMP-
2 and MMP-9: 
Gelatin substrate 
gel 
electrophoresis 
(zymography). 
 
Analysis of 
caseinolytic serine 
proteases: Casein 
zymography. 
 
Analysis of type I 
collagen C 
propeptide (CICP): 
sandwich enzyme 
linked 
immunosorbant 
microtiter assay 
(ELISA). 
 
 
Statistical 
comparisons 
performed 
using 
Student’s t-
tests with p < 
0.05 regarded 
as significant. 
ProMMP-9 
In acute surgical wounds, proMMP-9 
levels peaked at 24 hours, a 4-fold 
increase from baseline levels for the 
mastectomy wound group (M) and 
10-fold for the colectomy wound 
group (C).  
Between 3 and 24 hours post-op: 
Mastectomy group; a sharp initial 
increase in proMMP activity 
(colectomy wound fluid collection did 
not commence until 24 hours).  
 
Between 24 and 48 hours: MMP-9 
levels significantly decreased (M: P = 
0.015, C: P<0.001),  
Between 24 and 72 hours: MMP-9 
levels significantly decreased further 
(M: P = 0.003, C: P<0.001). 
 
Mastectomy wound fluids 
subsequently found to be infected; 
Between 24 and 48 hours: no drop in 
proMMP-9 levels (at which point 
activated MMP-9 became apparent), 
At 72 hours: further elevation was 
masked by the presence of bacterial 
metalloproteinases. (clinical signs of 
an infection were not noted until 96 
hours). 
 
Wound fluids from 6 chronic wounds 
were analysed for comparison with 2 
mastectomy and 3 colectomy wound 
fluid samples.  
These results suggest 
that measurement of 
MMP-9 in post-
operative wound fluids 
provides an early 
indicator of impaired 
healing which may be 
evaluated non-
invasively within 48 
hours of surgical 
wound closure. 
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ProMMP-9 was elevated in the 
chronic specimens over and above 
the average maximal (24 hours) 
acute wound fluids by a factor of 3 
(P< 0.01) and remained so for 
extended periods.  
The infected mastectomy fluids 
reached a maximum expression of 
2.2 times that of the mean maximal 
acute fluids.  
MMP-9 levels were not seen to drop 
from maximum levels over the 
subsequent 24 hours in the chronic 
wound fluids. 
 
ProMMP-2 
An increase in wound fluid MMP-2 
levels was seen in surgical wounds, 
with that in the colectomy group 
being the greater, demonstrating an 
increase from baseline levels at 24 
hours to maximal levels at 72 hours 
by a factor of 1.2 (P = 0.003). A 
comparison of proMMP-2 in chronic 
and acute wound fluids 
demonstrated a 1.8-fold elevation in 
the chronic samples relative to the 
mean maximal acute fluids, although 
this was not statistically significant.  
The infected acute fluids reached a 
maximum of 2.8 times that of the 
mean maximal acute fluids. 
 
Fluid serum ratio of MMP-9: 
Surgical wounds: the maximal MMP-
9 wound fluid to serum ratio was at 
24 hours, representing a 7-fold 
increase in the mastectomy group, 
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and a 5-fold increase in the 
abdominal group in comparison with 
baseline levels.  
When ratios were compared at 48 
and 24 hours they were found to be 
lower in both the mastectomy group 
(0.78, P= 0.35} and the colectomy 
group (0.5, P=0.08). At 72 hours 
ratios were found to be still lower in 
both groups (in comparison with 24 
hours (M: 0.65, P = 0.14; C: 0.35, 
P<0.02). 
Author(s) & 
Publication Year 
Title 
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Journal 
Geographical Location Objectives 
Study 
Methodology 
& Design 
Outcome Measures 
Care Setting 
 
 
Tarlton J. F., 
Bailey A. J., 
Crawford E., 
Jones D., Moore 
K. & Harding K. D. 
(1999)  
  
 
Prognostic 
value of 
markers of 
collagen 
remodeling in 
venous ulcers 
Wound Repair 
and 
Regeneration 
United Kingdom To evaluate the 
use of markers of 
matrix 
degradation 
(MMP-2, MMP-9, 
and NE), and 
collagen synthesis 
(type I collagen C 
propeptide 
[CICP]) collected 
from wound 
exudate, in 
determining the 
healing status and 
predicting the 
progress of repair 
of defined sites 
within venous 
ulcers. 
Quantitative, 
prospective, 
descriptive, 
observational, 
cohort study  
Wound healing Clinics for treatment 
of venous leg ulcers 
Inclusion/  
Exclusion 
Criteria 
 Sample Size & 
Characteristics 
Study procedure Measurement 
equipment & 
other materials 
Data Analysis Results Conclusions 
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Not stated Chronic 
wounds: 26 
patients 
 
Data of acute 
wounds from 
previous study: 
Surgical wound 
from simple 
mastectomies 
for primary 
breast 
carcinoma 
(n=4), and left 
sided colonic 
resection for 
primary 
colorectal 
carcinoma 
(n=6),  
 
Exudate were collected from 
the surface of venous leg ulcer 
wounds on at least 5 occasions 
over a one-year period, with 
collection intervals, and the 
wound treatment, determined 
by clinical need.  
Number of samples taken 
varied according to the extent 
of the ulcer.  
 
Sterile mesh placed on the 
ulcer, and wound fluid absorbed 
through to a collection filter. 
The filter was returned to a tube 
and stored at – 20 °C until 
analysis. Further collections 
were performed at different 
wound sites if warranted by the 
size of the ulcer. These 
procedures were repeated at 
subsequent assessments. 
 
Wound site healing evaluated 
by acetate measurement and 
software. Blinded independent 
assessors defined wounds as 
improving, static, where no net 
change occurred, or 
deteriorating. 
 
Data of acute wound fluid from 
previous study collected at 24, 
48, 72, and 96 hours 
postoperatively included.  
 
Analysis of MMPs 
-2 and MMP-9: 
Gelatin substrate 
gel 
electrophoresis 
(zymography). 
 
Analysis of 
caseinolytic serine 
proteases: Casein 
zymography. 
 
Analysis of type I 
collagen C 
propeptide (CICP): 
sandwich enzyme 
linked 
immunosorbant 
microtiter assay 
(ELISA). 
Other materials: 
Absorptive filters, 
of 1 cm2 
dimensions, 
prepared from 
Whatman 54 
paper, sterilized in 
ethanol, oven 
dried at 60 °C, and 
pre-weighed in 
sterile 2ml Apex 
tubes (Alpha, 
Hants, UK).  
Sterile 
Tegapore™ 
mesh (3M, 
Weatherford, OK.) 
Two-tailed 
Student’s t-
tests (p < 0.05 
regarded as 
significant) 
ProMMP-9, proMMP-2, activated 
MMP-2, type I collagen C propeptide 
(CICP), and neutrophil elastase (NE): 
greater expression in more severe 
wounds (only pro-MMP-9 statistically 
significant).   
 
Activated MMP-9: no apparent trend. 
 
Pro-MMP-9: significant difference 
between improving and deteriorating 
wounds (p = 0.006). 
 
Subset analysis (paired samples): 
Pro-MMP-9: significant difference 
between improving and deteriorating 
wound sites (p<0.001). 
NE: significant difference between 
improving and deteriorating wound 
sites (p<0.005). 
 
The results of this study 
suggest markers of 
collagen biochemistry 
are potential predictors 
of repair in venous 
ulcers, particularly 
MMP-9 and NE which 
were found to be 
accurate prognostic 
indicators of 
subsequent healing. 
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Analysis of MMPs -2 and -9: 
Gelatin substrate gel 
electrophoresis (zymography). 
 
Analysis of caseinolytic serine 
proteases: Casein zymography. 
 
Analysis of type I collagen C 
propeptide (CICP): sandwich 
enzyme linked immunosorbant 
microtiter assay (ELISA). 
 
 
  
cut into 4 cm2 
segments. 
 
Wound 
assessment with 
an Agfa 
Studioscan II and 
Fotolook software 
(Agfa-Gevaert, 
Brentford, UK), 
quantitated using 
NIH Image 1.5.  
 
Author(s) & 
Publication Year 
Title 
Source/  
Journal 
Geographical Location Objectives 
Study 
Methodology 
& Design 
Outcome Measures 
Care Setting 
 
 
Trengove N. J., 
Langton S. R. & 
Stacey M. C. 
(1996)  
  
 
Biochemical 
analysis of 
wound fluid 
from non-
healing and 
healing 
chronic leg 
ulcers 
Wound Repair 
and 
Regeneration 
Western Australia To compare 
wound fluid, 
collected in a 
standardised 
manner, with 
serum in order to 
understand 
whether wound 
fluid represents 
extracellular fluid. 
  
To identify 
changes in the 
biochemical 
composition of 
wound fluid 
collected from 
chronic leg ulcers 
at non-healing 
and healing 
phases. 
Quantitative, 
prospective, 
descriptive, 
observational, 
cohort study 
Reduction in wound size In-patients in a hospital 
373 
 
Inclusion/  
Exclusion 
Criteria 
 Sample Size & 
Characteristics 
Study procedure Measurement 
equipment & 
other materials 
Data Analysis Results Conclusions 
Inclusion 
criteria: Leg 
ulcers with no 
reduction in 
size > 3 
months or a 
continued 
increase in 
ulcer size. 
 
Exclusion 
criteria: Not 
stated 
8 patients (6 
male, 2 female). 
 
Median age 73 
years (range 69-
89 years). 
 
(Mixed arterial 
and venous 
disease ulcers 
n=4) 
(Venous disease 
ulcers n=4) 
 
2 patients with 
venous disease 
alone had 
insulin-
dependant 
diabetes. 
 
Median ulcer 
size 68cm2 
(range 50-
198cm2).  
  
Wound fluid and blood samples 
were collected from patients 
within 24 hours of admission to 
the hospital (non-healing phase) 
and after 2 weeks of regular 
dressings and bed rest (healing 
phase). Wound fluid was 
collected from each patient in a 
standardised manner. The 
patient was fasted beginning at 
midnight, and a transparent film 
(Opsite dressing, Smith & 
Nephew) was placed over the 
wound at 8:00 AM. The 
patient’s leg was placed in a 
dependant position, and the 
patient was encouraged to drink 
one litre of water. The fluid was 
aspirated from beneath the 
dressing following a period of 
one hour and then transferred 
into Greiner Vacuette vacuum 
serum collection tubes 
(Interpath Ltd) for all tests 
except lactate for which fluoride 
oxalate tubes were used.  
 
Serum samples were collected 
directly into the same type of 
vacuum collection tubes used 
for the wound fluid collection.  
 
Wound fluid and serum samples 
were analysed for a wide range 
of general biochemical 
Osmometer- to 
measure 
osmolarity. 
 
Kodak Ektachem 
700 automated 
biochemical 
analyser- 
measured 
sodium, 
potassium, 
chloride, 
bicarbonate, 
calcium, 
magnesium, 
phosphate, 
glucose, lactate, 
LDH, AST, GGT, 
Tbil, CK, urea, 
creatinine, uric 
acid, total protein, 
albumin, 
cholesterol, 
triglycerides.  
 
Behringwerke 
Turbitimer- CRP, 
C3, C4. 
 
Helena 
Electrophoresis 
System- Alpha-1-
globulin, alpha-2-
globulin, beta-
The Wilcoxon 
sign-rank test 
with the 
Statistical 
Package for 
Social 
Sciences 
(SPSS) was 
employed to 
statically 
compare 
paired 
samples. 
Median reduction in wound size: 12% 
(range 1-23%) (statistical significance 
not reported). All ulcers showed 
granulation tissue formation and 
epithelialisation at two weeks.  
 
Wound fluid changes from non-
healing phase to healing phase: 
(range) (decreased analytes in italics) 
Bicarbonate (mmol/L):  
17.5 (14-20) to 19 (16-22) (p=0.02) 
Glucose (mmol/L):  
1.2 (0.6-3.7) to 2 (1.1-5.9) (p=0.02) 
Total protein (gm/L):  
34 (26-46) to 41 (36-51) (p=0.01) 
Albumin (gm/L):  
19 (14-24) to 23 (18-28) (p=0.01) 
CRP (gm/L):  
13 (5-25) to 5 (2.5-21) (p=0.02) 
Gamma-Globulin (gm/L):  
4.5 (3.9-6.6) to 6 (4.4-9.0) (p=0.01) 
Cholesterol (mmol/L): 1.6 (1.2-3.2) to 
1.8 (1.3-3.2) (p=0.05) 
  
Changes in levels of 
bicarbonate, glucose, 
total protein, albumin, 
cholesterol, CRP, and 
gamma-globulin   may 
indicate the status of 
the wound and be 
potential biomarkers in 
predicting wound 
healing. 
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parameters and measured using 
standard automated 
biochemical analysers. 
 
Ulcer surface area was 
measured on admission to 
hospital and at 2 weeks by 
tracing around the edge of the 
ulcer onto clear plastic, 
photocopying the tracing onto 
paper, using a Kent digital 
planimeter (Jayco), and 
calculating the percentage 
reduction in size of the ulcer 
after 2 weeks to indicate 
healing. Ulcers were also 
photographed on admission 
and at 2 weeks to record wound 
appearance. 
 
Qualitative bacterial swabs of 
the ulcer were cultured.  
Quantitative bacterial analysis 
of wound fluid samples: Wound 
fluid mixed thoroughly, 10µl 
aliquot of wound fluid serially 
diluted (1:20, 1:200, 1:2000). 
Dilutions plated onto agar 
plates and the number of 
colonies counted and bacteria 
per milimeter of wound fluid 
calculated. 
globulin, gamma-
globulin. 
Author(s) & 
Publication Year 
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Source/  
Journal 
Geographical Location Objectives 
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& Design 
Outcome Measures 
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Trengove N. J., 
Stacey M. C., 
Analysis of 
the acute and 
chronic 
Wound Repair 
and 
Regeneration 
United States of America & 
Western Australia 
Part 1 phase: 
To examine the 
levels of MMPs, 
Two-phase 
study  
Part 1 phase: 
Wound environment  
Reduction in size of ulcer surface 
area 
Hospital 
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MacAuley S., 
Bennett N., 
Gibson J., 
Burslem F., 
Murphy G. & 
Schultz G. (1999)  
  
 
wound 
environments
: the role of 
proteases 
and their 
inhibitors 
neutrophil 
elastase, and 
TIMPs in a large 
series of wound 
fluids from acute 
surgical wounds 
and chronic non-
healing cutaneous 
wounds.  
 
Part 2 phase: 
To examine 
changes in the 
levels of these 
proteases in 
wound fluid from 
a group of non-
healing chronic 
venous ulcers that 
subsequently 
entered a healing 
phase.  
 
To examine the 
effect of acute 
and chronic 
wound fluids on 
the degradation 
of peptide growth 
factors 
 
Quantitative 
case control 
 
Part 2 phase: 
Quantitative, 
prospective, 
descriptive, 
observational, 
cohort study 
 
 
Inclusion/  
Exclusion 
Criteria 
 Sample Size & 
Characteristics 
Study procedure Measurement 
equipment & 
other materials 
Data Analysis Results Conclusions 
Part 1 phase: 
Chronic 
wounds:  
Hospital 
inpatients 
 
Part 1 phase: 
Part 1 phase: 
Acute surgical wound fluid 
collection: 
Azocoll assay used 
to measure MMP 
activity. 
 
Mann 
Whitney U-
test 
 
Azocoll protease levels in wound 
fluid 
Part 1 phase: 
Using the Azocoll assay, 
MMP activity levels 
were statistically 
significantly higher by 
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>4-week 
duration 
Not clinically 
infected 
 
Acute 
Surgical 
wounds: 
Primary 
breast 
carcinoma 
without 
evidence of 
metastatic 
spread.  
No 
chemotherap
y, radiation, 
or hormonal 
manipulation 
prior to 
surgery. 
 
Part 2 phase: 
Non-healing/ 
healing phase 
chronic 
venous leg 
ulcer: 
Chronic leg 
ulcers in 
gaiter region 
excluding the 
foot 
8 patients with 
acute surgical 
wounds 
(median age 49 
years (range 31– 
67 years)). 
25 patients with 
chronic wounds 
(median age 63 
years (range 23–
83 years). (12 
females, 13 
males).  
Patients with: 
decubiti n=17, 
mixed vessel 
disease ulcers 
n=5, diabetic 
foot ulcers n=3.  
 
Part 2 phase: 
Non-healing/ 
healing phase 
chronic venous 
leg ulcer: 
15 patients 
(median age of 
the patients was 
77 years (range 
55–91 years)).  
5 females, 10 
males. 
Chronic venous 
leg ulcers in 
gaiter region 
with failure to 
respond to 
outpatient 
Wound fluid accumulated in a 
vacuum drain from the chest 
wall during an 8-hour period 
drained and stored at −80 °C. 
Samples collected during a 24-
hour period pooled 
immediately prior to analysis. 
Wound fluid samples collected 
for up to 7 days. Wound fluid 
collected during 8 hours in 
immediate postop period 
discarded due to blood 
contamination. 
 
Chronic wound fluid collection: 
Wound covered a transparent 
occlusive dressing for approx. 1 
hour. Accumulated fluid 
aspirated and stored at −80 °C. 
 
Part 2 phase:  
Non-healing/healing phase 
chronic venous leg ulcer wound 
fluid collection: 
Patients admitted to hospital 
for bed rest, 6 hourly saline 
compresses and skin grafting. 
Minimum of 2 weeks bed rest, 
ulcers showed clinical signs of 
healing such as reduction of 
slough, increased granulation 
tissue formation, and 
epithelialization, objectively 
measured as a reduction in the 
size of the ulcer surface area.  
Each patient provided their own 
control. 
Azocasein assay 
used to measure 
non-specific 
protease activity. 
 
Specificity of the 
protease activity 
tested using the 
specific MMP 
inhibitor 
Illomostat 
(Galardin) 
 
Gelatin and casein 
zymography 
 
Neutrophil 
elastase activity 
assay 
 
Cathepsin G 
activity 
determination 
 
TIMP-1 
determination by 
ELISA 
 
Degradation of 
cytokines in 
wound fluid 
measured using I-
epidermal growth 
factor (Chiron 
Corp., CA) 
 
Other materials: 
Transparent 
Wilcoxon 
matched pairs 
signed ranks 
test 
 
Spearman 
correlation 
Acute wound fluid: Mean protease 
level 0.75 μg MMP Eq/ml ± 0.3 
(median 0.76 μg MMP Eq/ ml). 
Chronic wound fluid: Mean protease 
level 59.9 μg MMP Eq/ml ± 70.9 
(median 22.8 μg MMP Eq/ml). 
Statistically significant difference p < 
0.001. 
Part 2 phase: 
12% median size reduction in wound 
size at 2 weeks.  
Non-healing wound fluid: Mean MMP 
level of activity 38 ± 10 μg MMP Eq/ml 
(median 23.3 μg MMP Eq/ml, range 
1.3–140.4 μg MMP Eq/ml).  
Healing wound fluid: Protease levels 
decreased in 12 of 15 patients with a 
mean of 11 ± 4 μg MMP Eq/ ml (mean 
percentage reduction was 49%) 
(median 4.8 μg MMP Eq/ml, range 
0.3–64.9 μg MMP Eq/ml). This 
decrease in MMP activity during 
healing was found to be statistically 
significant p < 0.01 
Mean reduction in protease levels in 
all samples of 0.31 ± 0.04 μg MMP 
Eq/ml (median 0.26 μ g MMP Eq/ml, 
range 0.06–1.01 μ g MMP Eq/ml) with 
MMP inhibitor Illomostat (Galardin) 
overall reduction approximately 90% 
 
Azocasein protease levels in wound 
fluid 
Azocasein protease level mean 
decrease from 322 ± 94 μg trypsin 
Eq/ml to 190 ± 35 μg trypsin Eq/ml 
(medians 226.7 μ g trypsin Eq/ml and 
30 fold in chronic 
wounds compared to 
acute wounds. 
 
Statistically significant 
decrease in mean MMP 
activity in wounds 
progressing from a non-
healing to a healing 
phase. 
 
As MMP inhibitor 
Illomostat decreased 
the MMP activity by 
approximately 90% in 
all samples, it appears 
that the majority of 
proteolytic activity 
measured was due to 
MMPs. 
 
A significantly higher 
degradation of EGF in 
chronic wound fluid 
samples (mean 28.1%) 
compared to acute 
samples (mean 0.6%) 
correlated to the 
epidermal growth 
factor activity of these 
wound fluid samples (p 
< 0.001, r = 0.64). 
 
The statistically 
significant differences 
in MMP levels between 
non-healing and 
healing wounds 
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treatment with 
compression 
therapy defined 
by no reduction 
in the size of the 
ulcer in more 
than 3 months 
or a continued 
increase in the 
size of the ulcer. 
  
Patients with 
purely venous 
ulcers n= 7  
patients with 
venous ulcers 
with some 
minor arterial 
disease also 
present 
(dopplers > 0.6 
and < 0.9) n=8.  
Wound fluid collected within 24 
hours of admission and after 2 
weeks of regular dressings and 
bed rest.  
Patient was fasted from 
midnight, and a transparent 
occlusive film placed over the 
wound at 08:00 hours.  
Patient leg placed in a 
dependent position and the 
patient was encouraged to drink 
one litre of water.  
Fluid aspirated from beneath 
the dressing after a period of 1-
hour, transferred into plain 
collection tubes, centrifuged at 
14,000 ×g for 5 minutes, and 
stored in aliquots at −80 °C. 
 
All ulcers photographed on 
admission and after 2 weeks. 
 
Ulcer surface area measured on 
admission and at 2 weeks by 
tracing around the edge of the 
ulcer onto clear plastic and then 
photocopying the tracing onto 
paper. Surface area calculated 
using a Kent digital planimeter 
and percentage reduction in 
surface area of the ulcer after 2 
weeks calculated. 
 
occlusive dressing 
(Opsite, Smith & 
Nephew, Hull, 
UK). 
 
Kent digital 
planimeter (Jayco, 
Westride, 
Australia). 
189.5 μg trypsin Eq/ml, respectively 
(not statistically significant (p > 0.05)). 
 
Gelatin and casein zymography of 
wound fluid 
Gelatin zymography of non-healing 
samples consistently showed six 
intense bands of > 200, 150, 100, 85, 
65 and 45 kDa which decreased in 
intensity in the paired healing 
samples from the 12 patients that 
showed a decrease in azocoll protease 
levels during healing. 
 
Casein zymograms showed band 
formation at 150, 100, 65 and 29 kDa, 
without any significant difference 
between the non-healing and healing 
phase (data not shown). 
 
Neutrophil elastase activity 
Median neutrophil elastase levels 
decreased from 1.4 μg/ml (range, < 1–
11.9 μg/ml) in the non-healing 
samples to 0.6 μg/ml (range, < 1–8.6 
μg/ml) in the healing samples (not 
statistically significant (p > 0.05)). 
 
Cathepsin G analysis of wound fluid 
Levels of cathepsin G activity in all 
patients with acute wounds < 1 μg/ml, 
and levels elevated in 4 patients with 
chronic wounds. 
 
TIMP levels in wound fluid 
Median TIMP-1 level in acute wounds 
was 44.0 μg/ml and in chronic wounds 
0.8 μg/ml. 
suggests that they may 
be potential 
biomarkers in 
predicting wound 
outcome.  
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Elevated TIMP-1 levels correlated 
with low MMP levels and elevated 
MMP levels correlated with low TIMP-
1 levels (p = 0.02, r = – 0.78, Spearman 
correlation). 
 
Cytokine degradation 
Median percentage of degradation of 
EGF by acute wound fluid 0.6%, range, 
0.2%–1.2% (mean: 0.6%). Median 
degradation in chronic wound fluid 
8.5%, range, 1.2%–100% (mean 
28.1%) (p < 0.001). 
 
Author(s) & 
Publication Year 
Title 
Source/  
Journal 
Geographical Location Objectives 
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Methodology 
& Design 
Outcome Measures 
Care Setting 
 
 
Wyffels J. T., Fries 
K. M., Randall J. 
S., Ha D. S., 
Lodwig C. A., 
Brogan M. S., 
Shero M. & 
Edsberg L. E. 
(2010)  
  
Analysis of 
pressure 
ulcer wound 
fluid using 
two-
dimensional 
electrophores
is 
International 
Wound Journal 
United States of America To analyse 
wound fluid 
samples from 
pressure 
ulcers over 42 
days using two-
dimensional 
polyacrylamide 
gel 
electrophoresis 
(2D-PAGE). 
 
Quantitative, 
prospective, 
descriptive, 
observational, 
cohort study 
Wound healing  Not stated 
Inclusion/  
Exclusion 
Criteria 
 Sample Size & 
Characteristics 
Study procedure Measurement 
equipment & 
other materials 
Data Analysis Results Conclusions 
Not stated 34 subjects:  
10 men, 24 
women (mean 
age 72.3 years. 
Wounds assessed during 42 
days (days 0, 1, 2, 3, 4, 7, 8, 9, 
10, 11, 14, 21, 28, 35 and 42).  
Two-dimensional 
polyacrylamide 
gel 
electrophoresis 
 
Patients 
categorised 
by wound 
(Temporal comparisons available for 
19 wounds): 
The results of this 
study identified 
differences within the 
proteome of healing 
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Comorbidities: 
Hypertension 
52·2%, 
diabetes 54·3% 
and coronary 
artery disease 
30·4%. 
 
Total of 46 
pressure ulcers 
≥4-week 
duration.  
Stage 2 (32%), 
stage 3 (23%) 
and stage 4 
(45%).  
Onset data 
available for 30 
ulcers showed 
duration of 
ulcer, at most, 
to be 620 days 
prior to 
enrolment. 
 
Subset for 
temporal study 
of protein 
expression 
involved 17 
subjects with 19 
pressure 
ulcers.  
(6 men, 11 
women) (mean 
age 73·5 years) 
Assessment involved wound 
fluid collection from the 
interior and periphery of the 
pressure ulcers, digital 
photography of the wound and 
sampled (wound fluid 
collection method not reported 
in this article and referenced 
article unavailable) and 
proteins were fractionated 
using two-dimensional 
polyacrylamide gel 
electrophoresis. 
 
. 
(2D-PAGE) 
 
Wound size 
measurement: 
Wound images 
analysed using 
VeV MD (Version 
1.1.14, Vista 
Medical Ltd., 
Manitoba, 
Winnipeg, 
Canada). 
 
outcome by 
percentage 
change in 
wound from 
day 0; not 
healed, 
healing or 
healed. 
 
Paired t-tests 
for 
correlations.  
 
Healed wounds: temporal trend 
showing increased number of protein 
spots coincident with wound closure. 
Unhealed wounds: no temporal 
trend.  
(Temporal effects showed 
statistically significant difference 
between healed and unhealed 
wounds). 
  
Interaction between stain and 
location (peripheral (P) vs internal 
(I)): 12 of 19 wounds showed 
statistically significant differences for 
super-spot abundance.  
Protein S100A9 identified as a 
potential biomarker of wound 
healing. 
versus non healing 
pressure ulcers 
suggesting the 
potential of these 
analytes to act as 
indicators of wound 
outcome. 
Specifically, protein 
S100A9 was identified 
as a potential 
biomarker of wound 
healing. 
 
However, based on the 
understanding that the 
balance between build 
and destroy of proteins 
in wound healing 
involves coupling the 
measurement of 
degrading proteins 
such as matrix metallic 
proteinases along with 
their inhibitors, this 
study suggests that it is 
unlikely that a single 
protein will be useful as 
a biomarker, but rather 
a set of proteins that 
represent multiple 
stages of healing. 
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Pressure ulcer 
stage 2 (42%), 
stage 3 (21%), 
stage 4 (37%). 
Comorbidities: 
Hypertension 
52·2%, diabetes 
54·3%, coronary 
artery disease 
30·4%. 
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Appendix 20: Data Extraction Table for Temperature 
Author(s) & 
Publication Year 
Title 
Source/  
Journal 
Geographical Location Objectives 
Study 
Methodology 
& Design 
Outcome Measures 
Care Setting 
 
 
Armstrong D. G. 
& Lavery L. A. 
(1996) 
  
 
Monitoring 
neuropathic 
ulcer healing 
with infrared 
dermal 
thermometry 
Journal of Foot 
and Ankle 
Surgery 
USA To prospectively 
evaluate skin 
temperatures at 
the site of 
neuropathic 
ulceration before, 
during, and after 
wound healing 
using the 
contralateral 
extremity as a 
physiological 
control and to 
evaluate variables 
that may 
influence skin 
temperature. 
Quantitative, 
prospective, 
descriptive, 
observational, 
cohort design 
Wound healing  Not stated 
Inclusion/  
Exclusion 
Criteria 
 Sample Size & 
Characteristics 
Study procedure Measurement 
equipment & 
other materials 
Data Analysis Results Conclusions 
Inclusion 
criteria:  
Not stated 
 
Exclusion 
criteria: 
Acute 
Charcot’s 
arthropathy, 
Soft tissue or 
bone 
infection 
25 consecutive 
diabetic 
patients with 
plantar 
neuropathic 
ulceration 
 
17 males, 8 
females 
 
Age 52.4 ± 11.6 
years 
All patients treated with TCCs 
until ulcer healing. Casts were 
changed at weekly intervals, at 
which time the wound was 
evaluated and debrided as 
necessary. After ulcer healing, 
patients were given prescribed 
shoe gear. Patients were 
followed at 2, 4, and 8 week 
intervals after ulcer healing. 
 
Hand-held 
infrared skin 
temperature 
probe (Exergen DT 
1001) with the 
digital analogue 
display at the top 
of the device 
displaying in 
increments of 
0.01°F with an 
The Mann-
Whitney test 
used to 
compare sex, 
maximum 
pressure, 
haemoglobin 
A1C, and 
initial 
temperature 
gradient (99 
N/cm2 cut-off 
Affected side compared to 
corresponding site on the 
contralateral limb:  
Initial skin temperature: 
mean of 6.9°F higher (91.1 vs. 84.2°F, 
t=8.9, p<0.0001, 95% CI 5.3 to 8.5). 
Following ulcer healing skin 
temperature: 
(83.4 vs. 85.3°F, t= -1.35, not 
significant difference, 95% CI -7.5 to 
3.9). 
 
The results of this study 
indicate the difference 
in temperature 
between the ulceration 
site compared to 
corresponding site on 
the contralateral limb 
decreases as the 
surface area of the 
wound decreases. 
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Type1 DM n=4, 
Type2 DM n=21 
 
Mean duration 
of DM 13.8 ± 7.8 
years 
 
Subjects treated 
previously by a 
primary care 
physician prior 
to referral to the 
study. 
 
Wounds grade I 
(full thickness 
skin loss not 
involving 
tendon, bone or 
capsule) 
(Meggitt-
Wagner grading 
system) 
 
Ulcer 
characteristics: 
Vibration 
perception 
threshold (45.8 
± 5.2), Toe-
brachial 
pressure index 
(0.68 ± 0.14) 
Mean surface 
area (7.7 ± 
4cm2) 
Skin temperatures were 
evaluated with a hand-held 
infrared skin temperature 
probe (Exergen DT 1001). 
Temperatures were recorded in 
degrees Farenheit, 
corresponding with the digital 
analogue display at the top of 
the device. The temperature 
probe displays increments of 
0.01°F and is accurate to within 
± 0.2°F.  
 
Measurement procedure: 
Temperature measurements 
were made after patients were 
allowed to rest for 15 minutes in 
the examination room. Ambient 
air temperature was 
thermostatically controlled 
between 70°F ± 2°F during the 
test period.  
 
Skin temperature monitoring 
was performed during the first 4 
months after return to shoe 
gear. Each patient’s 
contralateral extremity served 
as its own control. The anatomic 
site of ulceration was matched 
on the contralateral extremity 
for comparison.  
accuracy to within 
± 0.2°F. 
point for 
maximum 
pressure, 9% 
cut-off point 
for 
glycosylated 
haemoglobin)
. 
 Pearson’s 
test. 
 
Student’s t-
test for 
matched 
samples to 
compare 
temperature 
differences 
between 
limbs 
 
For all ulcers, the largest temperature 
gradient and absolute temperature 
were at the site of ulceration. 
Patients with toe-brachial indices 
<0.60 had greater skin temperature 
gradients at the site of the ulcer than 
those with higher indices (9.4 ± 4.0°F 
vs. 5.8 ± 3.4°F, p= 0.01). 
 
Mean temperature differences during 
treatment at weekly visits and cast 
changes presented using a linear 
graph.    
 
This temperature 
measurement 
technique may 
therefore offer a 
valuable simple way of 
monitoring wound 
healing and potentially 
predicting wound 
healing outcomes.  
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Mean maximum 
plantar pressure 
(92.7 ± 14.3 
N/cm2)  
Mean ulcer 
duration (88.5 ± 
98.4 days) 
Mean time to 
healing in TCC 
(38.8 ± 21.3 
days) 
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Armstrong D. G., 
Lipsky B. A., Polis 
A. B. & Abramson 
M. A. (2006) 
  
 
 
Does dermal 
thermometry 
predict 
clinical 
outcome in 
diabetic foot 
infection? 
Analysis of 
data from the 
SIDESTEP* 
trial 
International 
Wound Journal 
USA  To assess whether 
differences in skin 
temperature of 
the affected foot 
as compared to 
the corresponding 
site on the 
contralateral foot 
correlates with 
infection severity, 
certain laboratory 
markers for 
inflammation or 
clinical response 
to antimicrobial 
therapy 
 
Quantitative 
prospective 
descriptive, 
observational 
cohort study 
as part of a 
larger multi-
centre, 
randomised, 
double-
blinded study 
Proportion of patients with a 
reduction in would infection severity 
at the DCIV assessment. 
Multiple settings- not 
defined 
Inclusion/  
Exclusion 
Criteria 
 Sample Size & 
Characteristics 
Study procedure Measurement 
equipment & 
other materials 
Data Analysis Results Conclusions 
(Criteria 
reported in 
original study 
362 patients in 
initial 
assessment 
Investigators and study 
coordinators attended training 
An infrared 
thermometer 
(Thermo 
Difference in 
surface skin 
temperatures 
-Baseline skin temperature 
differential between limbs similar in 
moderate diabetic foot wounds (3.04 
According to the report 
of these results, mean 
temperature 
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(Lipsky et al. 
2005))  
Inclusion 
criteria: 
Diabetes 
mellitus with 
foot infection 
not extending 
above the 
knee.  
Exclusion 
criteria: 
patients with: 
mild 
infections 
and not 
requiring 
parenteral 
antibiotic 
therapy; 
known at 
entry to be 
caused by 
pathogens 
resistant to 
either study 
drug; 
predominantl
y caused by 
thermal 
burns; 
categorised 
as necrotising 
fasciitis; 
known or 
suspected to 
be associated 
with 
 
332 (92%) 
patients in 
follow-up 
assessment  
 
Male= 64% 
Mean age = 59 
years 
 
Diabetic foot 
infections not 
extending 
above the knee. 
about DFIs and the study 
protocol. 
 
Subjects removed their shoes 
and rested supine in a chair or 
on an examination table or bed 
for 3–5 minutes.  
The investigator held an 
infrared thermometer 
approximately 1 inch above the 
skin. 
 
Temperature measurements on 
the affected foot were taken as 
close as possible to the area of 
the DFI. 
 
Temperature was measured in 
the corresponding area on the 
unaffected contralateral foot. 
For patients with an 
amputation on the 
contralateral limb, temperature 
was measured on the distal 
aspect of the residual limb. 
 
DCIV assessment conducted a 
mean of 11.7 ± 7.5 days after 
baseline assessment. 
TraceTM; 
Deltatrak, 
Pleasanton, CA, 
USA). 
 
Other materials: 
Intravenous 
ertapenem 
 
Intravenous 
piperacillin/tazob
actam 
calculated by 
subtracting 
unaffected 
foot 
temperature 
measurement 
from the 
affected foot 
measurement
. 
Mean 
temperature 
changes from 
baseline to 
DCIV 
measured 
using paired t-
test and 95% 
confidence 
intervals (CIs) 
calculated. 
 
To compare 
treatment 
groups with 
regard to the 
mean change 
in skin 
temperature 
difference 
from baseline 
to DCIV, 
analysis of 
covariance 
model with a 
factor for 
treatment 
± 5.88°F) compared to severe (3.09 ± 
5.38°F). 
-Baseline assessment, mean 
temperature differential between 
limbs 2.81 ± 5.75°F.  
-DCIV assessment, mean 
temperature differential 2.43 ± 
4.84°F. 
-Mean change -0.37°F (95% CI:-0.98, 
0.23; P = 0.225).  
 
No correlation found between skin 
temperature differential at the 
baseline assessment and the 
systemic markers of inflammation 
(i.e. WBC, C-reactive protein, 
erythrocyte sedimentation rate or 
the DFI wound score (r = 0.058, 
0.148, -0.002, 0.067, respectively). 
 
Overall, no trend observed between 
skin temperature differential at 
baseline and clinical success rate at 
DCIV assessment. (statistical data not 
reported). 
 
Subset analysis of patients with 
baseline temperature differential 
≥10°F and <10°F, favourable clinical 
response 81.4% versus 94.3%, 
respectively (difference between 
groups: 12.9%; 95% CI: 3.5%, 27.3%; 
P = 0.007). Number of subjects in 
subset not reported) 
 
differential between 
affected and 
unaffected limbs in 
patients with a DFI is 
not helpful in 
predicting the severity 
of an infection or the 
outcome of treatment  
 
Evidence suggesting a 
threshold effect (<10°F 
versus >10°F) between 
baseline dermal 
thermometry 
differential and clinical 
outcome may assist in 
the local evaluation 
and prediction of 
clinical outcome of 
diabetic foot 
infections. 
 
Insufficient data is 
reported in this article 
to determine the 
correlation between 
skin temperature 
differential at baseline 
and clinical success 
rate at DCIV 
assessment. 
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underlying 
osteomyelitis, 
unless all the 
infected bone 
was removed 
within 48 h 
after 
initiating 
study; 
therapy; 
complicated 
by indwelling 
foreign or 
prosthetic 
material; or 
associated 
with 
gangrenous 
tissue that 
could not be 
adequately 
removed by 
surgical 
debridement. 
Pregnant 
women or 
women 
nursing, or 
fertile and 
not using 
contraception
, patients 
with: a 
history of a 
serious 
reaction to 
any lactam 
antibiotic; a 
group and 
covariate for 
baseline 
severity. 
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need for any 
additional 
concomitant 
systemic 
antibacterial 
agent other 
than the 
study drug(s) 
or 
vancomycin; 
diabetes or 
impaired 
glucose 
tolerance 
that was 
secondary; 
arterial 
perfusion 
insufficiency 
of the 
affected limb, 
requiring a 
revascularisat
ion 
procedure; 
any rapidly 
progressive 
or terminal 
illness; a 
requirement 
for dialysis; 
immunosuppr
ession of any 
cause; or 
receiving 
corticosteroid 
therapy (≥40 
mg 
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prednisone 
daily or its 
equivalent). 
Patients with 
laboratory 
variables: 
markedly 
abnormal 
liver function 
tests; 
haematocrit 
of less than 
25%, 
haemoglobin 
of less than 8 
g/L, platelet 
count of less 
than 75 
000/mm3; or 
coagulation 
test results 
more than 
1·5 times the 
upper limit of 
normal 
(unless on 
anticoagulant 
therapy).  
Patients 
treated for 
more than 24 
hours with 
systemic 
antibiotic 
therapy likely 
to be 
effective for 
their 
388 
 
infection 
within the 72 
hours before 
study 
screening, 
unless there 
was clinical 
evidence of 
treatment 
failure with 
an associated 
deep-tissue 
culture that 
yielded 
pathogen 
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Dini V., Salvo P., 
Janowska A., Di 
Francesco F., 
Barbini A. & 
Romanelli M. 
(2015) 
  
 
Correlation 
between 
wound 
temperature 
obtained with 
an infrared 
camera and 
clinical 
wound bed 
score in 
venous leg 
ulcers 
Wounds Italy To correlate the 
mean wound bed 
temperature, 
assessed by using 
an infrared 
camera, to the 
items of the 
wound bed score 
that referred to 
the wound bed 
(i.e. healing 
edges, black 
eschar, greatest 
wound depth/ 
granulation 
tissue, pink 
wound bed) and 
the mean 
perilesional skin 
Quantitative 
Clinical Trial  
Correlations between temperature 
and wound bed score. 
Not stated 
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temperature to 
the items of the 
wound bed score 
for the 
surrounding skin 
(i.e. exudate, 
oedema, 
periwound 
dermatitis, callus) 
 
Inclusion/  
Exclusion 
Criteria 
 Sample Size & 
Characteristics 
Study procedure Measurement 
equipment & 
other materials 
Data Analysis Results Conclusions 
Inclusion 
Criteria: 
Patients > 18 
years  
Venous leg 
ulcer > 6 
months 
standard 
treatment 
 
Exclusion 
Criteria: 
Clinical signs 
of infection 
Ankle 
brachial 
pressure 
index < 0.8. 
 
Active acute 
inflammatory 
disorder. 
18 patients with 
total of 24 
chronic venous 
leg ulcers  
 
The wound 
surface area 
ranged from 5 
cm2 to 51.5 
cm2, with an 
average of 34.6 
cm2 
All patients received the same 
wound management 
performed according to 
standard treatment with a 
compression multilayer system 
and moist wound healing. 
 
Wound size measured using a 
validated 3-dimensional 
imaging system. 
 
Wound bed condition 
measured using a validated 
wound bed scoring system 
(Falanga, 2006). 
 
Measurement procedure: 
Temperature measurements 
recorded using an infrared 
camera in an air-conditioned 
facility (mean room 
temperature 22°C) after a 15-
minute period of patient rest 
immediately after dressing 
removal. 
Infrared camera 
(FLIR T620 
Thermal Imager, 
FLIR Systems, 
Boston, MA): 
camera has a 
thermal 
sensitivity (noise 
equivalent 
temperature 
difference) < 
0.04°C at 30°C 
and an accuracy 
within + 2% of 
reading.  
 
Wound size 
measurement: a 
validated 3-
dimensional 
imaging system7 
(Silhouette, Aranz 
Medical, New 
Zealand). 
Statistical 
analysis 
performed in 
MATLAB 
(Mathworks, 
Natick, MA) 
 
The least- 
square 
algorithm 
used to obtain 
a linear 
regression 
model of the 
temperatures 
of the wound 
bed or 
perilesional 
skin versus 
the wound 
bed score. 
 
The validity of 
assuming a 
linear 
The wound bed temperature range 
after dressing removal was between 
31°C and 35°C, and the perilesional 
skin temperature range was 31°C-
34°C.  
 
The wound bed score range was 5-14 
(14 patients > 10; 11 patients ≤ 10). 
  
Results presented using scatter plots: 
The Spearman’s rank-order 
coefficient, ρ, is 0.805 with a P value 
of 2 x10-6 (confidence level 95%). 
This result proves a monotonic 
increasing relationship between the 
wound bed score and the 
temperature of the wound bed. 
 
The dataset composed of the wound 
bed score and the temperature of 
the perilesional skin returned ρ=0.55 
and P value = 0.005 (confidence level 
95%).  
The scatter plot for the wound bed 
score and the temperature of the 
This study found an 
increasing relationship 
between the wound 
bed score and the 
wound bed 
temperature obtained 
using an infrared 
camera. A handheld 
infrared camera can 
therefore assist the 
early identification of 
hard-to-heal wounds, 
allowing for timely 
intervention and 
facilitating the 
monitoring of ongoing 
treatment responses. 
 
Further study with a 
larger dataset is 
required. 
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correlation, 
expressed by 
the Pearson’s 
coefficient 
analysis, 
checked by 
the 
Kolmogorov- 
Smirnov test 
at a 95% 
confidence 
level to 
determine if 
the variables 
were bivariate 
normal 
distributed. 
 
Monotonicity 
of data 
benchmarked 
by the 
Spearman’s 
rank-order 
coefficient. 
perilesional skin not linear (R2 = 
0.35). 
 
Thus, an increasing relationship was 
seen between the wound bed score 
and the wound bed temperature 
however, the correlation between 
the wound bed score and the 
perilesional skin temperature was 
weaker. 
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Horzic M., Bunoza 
D. & Maric K. 
(1996)  
Contact 
thermograph
y in a study of 
primary 
healing of 
surgical 
wounds 
Ostomy Wound 
Management 
Croatia  To establish if 
there is regularity 
in temperature 
changes in 
wounds healing 
by primary 
intention. 
Semi-
quantitative, 
prospective, 
descriptive, 
observational 
cohort design  
Post-operative wound days Hospital  
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Inclusion/  
Exclusion 
Criteria 
 Sample Size & 
Characteristics 
Study procedure Measurement 
equipment & 
other materials 
Data Analysis Results Conclusions 
Inclusion 
criteria: 
Wounds 
healing by 
primary 
intention, 
No 
appearance 
of 
intercurrent 
diseases. 
 
Exclusion 
criteria:  
Post-
operative 
wound 
haemorrhagi
ng 
30 patients 
undergoing 
gallstone 
surgery 
 
(27 female, 3 
male) 
 
Average age 38 
± 4.1 years  
 
No 
comorbidities 
Temperature was measured 
pre-operatively at the 
presumed site of incision, and 
for eight days post-operatively 
at the incision site and its 
immediate surroundings at a 
fixed time each day (13 hours) 
and in the same room where the 
air temperature was 22 ± 1°C. 
 
Measurement procedure: 
Skin was dried of sweat before 
each measurement. 
 
Two liquid crystal strips with a 
temperature range of 34-35°C 
(lower strip) and 35-36°C (upper 
strip), corresponding to the 
different skin temperatures in 
the upper and lower areas of 
the wound, were placed in the 
centre of the incision site 
perpendicular to the direction 
of the wound.  
Contact 
thermography 
method using 
liquid crystal 
strips, accurate to 
0.1°C 
temperature 
difference. 
Tricoire’s liquid 
crystals:  
Warm colours, 
e.g. reds and 
browns, 
correspond to 
lower 
temperatures, 
and cool colours, 
e.g. deep blue, 
correspond to 
higher 
temperatures.  
Liquid crystal 
strips are resistant 
to mechanical 
damage and 
humidity. 
Temperature 
colour response 
occurs within 
seconds following 
application of the 
strip to the 
examinee. 
   
Each patient 
was their own 
control. 
Data presented descriptively and 
visually in the form of a linear graph. 
 
 The findings demonstrated that there 
were few differences among the 
collective thermal images of 
individual examines for any given 
post-operative day.  
During the first 3 post-operative days, 
the temperatures rose, with few 
differences between the 
temperatures of the wounds and their 
wider surroundings.  
From day 4 through 8, the 
temperatures of the wounds and 
surroundings fell gradually. The zones 
of warmer skin around the wounds 
became narrower and the wound 
zones were more and more 
pronounced with sharply separated 
nuances.   
Stitches were removed on day 7, and 
on day 8 only the narrow zones of the 
incision sites were warmer than the 
surroundings. 
 
A line graph is presented showing the 
average temperature of wounds 
measured from day 1 to day 8 
postoperative in the 30 patients. Line 
graph appears to increase from day 1 
to day 3 and then gradually decreases 
until day 8.   
 
The persistence of a 
wider zone of increased 
temperature after day 4 
may predict the 
possibility of wound 
infection and disturbed 
healing.  
 
This study therefore 
demonstrates the value 
of temperature 
measurement in 
wounds to predict 
wound healing 
outcomes. 
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Strip size: 20cm 
long and 5cm 
wide. 
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Horzic M., Bunoza 
D. & Maric K. 
(1996)  
Three-
dimensional 
observation 
of wound 
temperature 
in primary 
healing 
Ostomy Wound 
Management 
Croatia To establish 
changes in wound 
temperature 
during healing and 
the influence of 
the thickness of 
fatty tissue on skin 
temperature 
Quantitative 
prospective 
descriptive 
observational 
cohort design 
Post-operative wound days Hospital 
Inclusion/  
Exclusion 
Criteria 
 Sample Size & 
Characteristics 
Study procedure Measurement 
equipment & 
other materials 
Data Analysis Results Conclusions 
Not stated 30 patients (9 
males, 21 
females) 
undergoing, 
upper medial 
laparotomy for 
cholelithiasis 
 
Average age 
40.5 ± 12.92 
years 
Temperature at the presumed 
site for surgical incision in the 
epigastric region was measured 
pre-operatively four times over 
four days.  
 
Post-operatively, the 
temperature of the upper 
medial incision site and its 
surroundings was measured 
daily for the eight post-
operative days (meaning every 
examinee acted as their own 
control).  
 
Measurement procedure: 
Measuring and recording were 
performed in a separate room 
with a temperature of 18-20°C, 
and patients were retained 
AGA 780 
thermovision 
system.  
This system 
enables the 
measurement of 
temperature in 
real-time meaning 
the thermal image 
changes 
simultaneously as 
the scene or 
infrared radiation 
from the observed 
object changes.  
Data recorded can 
be digitalised and 
analysed.  
Temperature 
distribution can 
Pre-operative 
data 
presented for 
each day in 
ranges of 
degrees 
Celsius.  
Automatic 
system for 
thermogram 
analysis 
involved 
conversion 
from grey-
scale to 
thermal scale 
to 
temperature. 
 
Average preoperative temperature 
measured 4 times over 4 days: 32.67 
±1.07 °C to 32.8 ±1.11°C. 
 
Mean thickness of fatty tissue: 26.4 ± 
12.98 mm. 
 
Post-operative results are presented 
visually in the form of a qualitative 
presentation of the temperature 
distribution of the zone of interest as 
well as using relative co-ordinate 
graphs. 
 
4 day preoperative temperature 
averages:  
32.67 ±1.07 °C to 32.8 ±1.11°C. 
8 day postoperative temperature 
averages: 
It is not possible to 
quantitatively compare 
pre-operative and post-
operative temperature 
readings due to the 
methods of data 
analysis and reporting 
used in this study.  
 
However, this study 
identified a pattern of 
thermal changes for a 
group of wounds 
healing that had no 
reported cases of 
wound healing 
complications and 
suggests that a rise in 
temperature or the 
persistence in 
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prior to measurement for 10 to 
15 minutes.  
Thermograms were taken with 
the patient in the supine 
position on day 1 post-
operatively and then in the 
upright position on all other 
days.  
 
Thickness of fatty tissue 
measured ultrasonically.  
 
A detailed register was 
compiled of every patient, 
including the conditions during 
recording and the obtained 
results. The thermovision 
image for every patient was 
recorded on a standard video 
recorder. All relevant data 
about the image was also 
recorded on the audio channel. 
 
Every measurement of 
temperature distribution 
involved the exposure of the 
presumed area of surgical 
incision and the wound. 
Excluding the preparations, 
measuring and video recording 
took a maximum of 60 seconds.  
be represented in 
grey scale or 
colour. 
Apparatus can be 
adjusted in colour 
display. 
Temperature 
range can 
measure very 
wide reaching 
1000K. 
 
On the basis 
of the 
measurement 
of the highest 
and the 
lowest 
temperature 
in every 
thermogram 
in relation to 
the time that 
passed from 
the day of 
surgery to the 
eighth post-
operative day, 
quantitative 
analysis of 
thermogram 
readings was 
established 
and was 
presented 
graphically. 
 
The absolute 
values of the 
difference in 
the 
temperatures 
of the wound 
and its’ 
surroundings 
were 
established 
and presented 
graphically. 
  
Graph curves show a rise in 
temperature up to day 3 followed by 
a gradual temperature decline until 
day 8. 
(presented visually using a 3D image, 
a post-operative wound at day 5, and 
relative co-ordinate graphs, day 1 to 
8). 
increased temperature 
after the third post-
operative day may 
indicate disturbed 
healing. 
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Nakagami G., 
Sanada H., Iizaka 
S., Kadono T., 
Koyanagi H. & 
Haga N. (2010)  
 
Predicting 
delayed 
pressure 
ulcer healing 
using 
thermograph
y: a 
prospective 
cohort study 
Journal of 
Wound Care 
Japan To investigate 
whether 
thermography can 
be used to detect 
latent 
inflammation in 
pressure ulcers 
and predict 
pressure ulcer 
prognosis in a 
clinical setting 
Quantitative 
prospective, 
descriptive, 
observational, 
cohort study 
Wound reduction rate University hospital 
Inclusion/  
Exclusion 
Criteria 
 Sample Size & 
Characteristics 
Study procedure Measurement 
equipment & 
other materials 
Data Analysis Results Conclusions 
Exclusion 
criteria: 
Severe 
medical 
conditions 
including 
terminal 
conditions or 
circulatory 
shock 
PUs on 
extremities 
PUs covered 
by black 
eschar 
35 patients (2 
excluded as 
developed 
infection) (33 
subjects 
included). 
 
 
2 subcategories 
of PUs: 
PUs with a lower 
temperature in 
the wound bed 
than in the 
periwound skin 
(low 
temperature 
group) n=21 
(60.0%) 
 
Thermographic image obtained 
using infrared thermography 
once only, at the start of the 
study and then followed up for 
3 weeks. 
Procedure conducted in a 
normal patient room without 
rigorous air conditioning.  
Measurement temperature 
range automatically adjusted 
according to the environmental 
temperature, which ranged 
from 22.3ºC to 39.4ºC. 
 
Wound assessment: 
Wound surface area measured 
weekly by planimetry for 3 
weeks. Wound reduction rate 
calculated as: wound reduction 
Infrared 
thermography 
(Thermotracer 
TH5108ME, 
NEC Avio Infrared 
Technology Co. 
Ltd., Tokyo, 
Japan); 
measurable 
range: 0–70ºC, 
error range: ± 
0.7ºC, accuracy: 
0.1ºC. 
 
Wound surface 
area 
measurement 
using planimetry 
(Visitrak, Smith 
and Nephew, UK). 
Kappa 
coefficients 
used to 
evaluate the 
intra- and 
inter-rater 
reliability for 
temperature 
assessment. 
 
The Wilcoxon 
rank sum test 
or chi-square 
test used to 
compare 
demographic 
and baseline 
PU variables, 
including the 
Thermographic assessment:  
21 patients (60.0%) classified to low 
temperature group,  
14 (40.0%) to high temperature 
group.  
Kappa coefficients for temperature 
classification 0.93 for intra-rater 
reliability and 0.94 for inter-rater 
reliability (indicating high reliability of 
the thermographic assessment). 
 
In the 33 patients, no difference at 
baseline in the subscales of the 
*DESIGN scores between the high and 
low temperature groups.  
 
Healing wounds:  
High temperature 3 (25%) 
Low temperature 14 (66.7%) 
Delayed healing wounds:  
The high positive 
predictive value 
suggests that PUs with 
high wound 
temperatures have a 
high probability of 
exhibiting delayed 
wound healing within 
three weeks.  
 
The small sample size 
may limit the 
generalisability of the 
conclusions drawn 
from the results of this 
study. 
 
Only included subjects 
with PUs on the torso 
therefore not 
395 
 
PUs with a 
higher 
temperature in 
the wound bed 
than in the 
periwound skin 
(the high 
temperature 
group) n=14 
(40.0%) 
 
 
rate (%) = (baseline area – area 
at week 3)/ baseline area x 100. 
PUs healing normally: a wound 
area reduction of ≥30% 
compared with baseline after 3 
weeks.  
PUs delayed healing: no 
changes or an increase in the 
wound area despite optimal 
treatment.  
Infected wounds: surface area 
did not decrease and there were 
typical signs and symptoms, 
including redness, surrounding 
skin pain and purulent 
discharge. 
 
To assess wound severity: 
*DESIGN Pressure Ulcer 
classification system. 
 
Measurement procedure: 
Thermography performed 
immediately after removal of 
dressings by the WOC nurse. 
The wound gently cleansed and 
visually assessed using the 
DESIGN tool, and the wound 
area measured by one 
researcher not involved in the 
thermographic assessment. 
 
 After initial assessment, the 
treatment provided based on 
conventional assessment. 
 
DESIGN 
subscores, 
and the 
wound areas 
between the 
high and 
low 
temperature 
groups. 
 
To assess the 
predictive 
usefulness of 
a high 
temperature, 
sensitivity, 
specificity, 
and positive 
predictive 
values were 
calculated.  
 
All statistical 
analyses 
performed 
using 
Statistical 
Analysis 
System 
Version 9.1 
(SAS Institute 
Inc., USA). 
High temperature 9 (75%) 
Low temperature 7 (33.3%) 
 
Relative risk of delayed healing in the 
high temperature PUs group: 2.25 
(95% CI: 1.13–4.47, p=0.021). 
Sensitivity 0.56, specificity 0.82, 
positive predictive value 0.75, and 
the negative predictive value 0.67. 
 
 
generalizable to other 
PUs or wound types. 
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Author(s) & 
Publication Year 
Title 
Source/  
Journal 
Geographical Location Objectives 
Study 
Methodology 
& Design 
Outcome Measures 
Care Setting 
 
 
Robicsek F., 
Masters T. N. & 
Daugherty H. K. 
(1984)  
The value of 
thermograph
y in the early 
diagnosis of 
postoperative 
sternal 
wound 
infections 
Thoracic and 
Cardiovascular 
Surgeon 
USA To ascertain 
temperature 
fluctuations 
associated with 
normal sternal 
wound healing 
and to present a 
pattern found 
typical to deep-
seated wound 
infections 
Quantitative 
prospective, 
descriptive, 
observational 
cohort design 
Post-operative wound healing days. 
Post-operative development of 
wound infection. 
Hospital 
Inclusion/  
Exclusion 
Criteria 
 Sample Size & 
Characteristics 
Study procedure Measurement 
equipment & 
other materials 
Data Analysis Results Conclusions 
Not reported  150 open-heart 
surgery patients 
 
Sample 
demographics/ 
characteristics 
not reported 
Measurement procedure: 
Patients were prepared for 
thermography by removing all 
clothing from the chest area for 
a period of 15 minutes before 
the thermograms were 
recorded. Air currents in the 
patients’ rooms were held to a 
minimum and no attempt was 
made to wipe the surface of the 
skin with alcohol or water. 
Thermograms were quantitated 
by placing on the polaroid 
picture a grid which permitted 
temperature measurements at 
8 positions along the sternum. 
Temperatures were determined 
by comparing with the 
reference colour to the average 
colour in each portion of the 
AGA 
Thermovision-680 
system (thermal 
dissolution power 
up to 0.1°C 
accuracy) 
Temperature 
measurement
s recorded at 
8 positions 
along the 
sternum. 
 
Temperatures 
determined 
by 
comparison of 
the reference 
colour to the 
average 
colour in each 
portion of the 
grid which 
increased or 
decrease by 
0.5°C per 
Pre-operative sternal skin 
temperatures for the total sample of 
150 patients: 33.7 ±0.1 °C. 
 
Post-operative day 7 temperatures 
(pre- and post-operative difference): 
Subgroup A: 35 ± 0.1 °C (p<0.001); 
Subgroup B: 35.4 ± 0.1 °C (p<0.001). 
 
Post-operative day 14 temperatures 
(pre- and post-operative difference): 
Subgroup A: returned to pre-
operative readings; 
Subgroup B: 35.1 ± 0.1 °C. 
 
3-month follow-up period:  
Subgroup A: No infections developed  
Subgroup B: 5 of 25 patients 
developed wound infections, as 
confirmed by clinical signs and 
Close thermographic 
observation of the 
incision in patients may 
represent normal 
wound healing and/or 
aid earlier identification 
of suspected wound 
infection, which may 
assist in predicting 
wound healing 
outcomes and support 
more accurate and 
earlier intervention for 
wound infections. 
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grid which increased or 
decrease by 0.5°C per colour 
change. The 8 temperatures 
thus derived were averaged for 
a total sternal temperature at 
each designated time period. 
 
Peristernal skin temperatures 
were recorded postoperatively 
by infrared thermography in 
150 patients who underwent 
open-heart surgery for various 
reasons between the months of 
February and June 1983. 
Thermograms were conducted 
on all patients on the day before 
surgery, one week post 
operatively, and two weeks 
postoperatively.  
 
For patients with suspected 
infection additional 
thermograms were recorded 
and followed daily while 
treated.  
All patients received 
prophylactic antibiotics the 
night prior to the operation and 
continued until all chest tubes 
were removed, usually on the 
second to forth postoperative 
day.  
Depending on the 
postoperative values of their 
peristernal skin temperatures, 
the patients were divided into 2 
subgroups (A and B) by 
retrospective analysis: those 
colour 
change.  
symptoms of infection (The 
peristernal temperatures of these 5 
patients remained elevated beyond 
the 3rd and 4th post-operative 
weeks).  
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whose temperature returned 
within 2 weeks to preoperative 
control levels (subgroup A = 125 
patients) and those in whom the 
peristernal skin temperature 
remained elevated (Subgroup 
B= 25 patients). 
Author(s) & 
Publication Year 
Title 
Source/  
Journal 
Geographical Location Objectives 
Study 
Methodology 
& Design 
Outcome Measures 
Care Setting 
 
 
Siah C. J. R. & 
Childs C. (2015)  
Thermograph
ic mapping of 
the abdomen 
in healthy 
subjects and 
patients after 
enterostoma 
Journal of 
Wound Care 
Singapore To map the 
temperature of 
the healing 
surgical wound 
and to provide 
confirmatory data 
of optimum IR 
imaging distance 
from skin 
temperature 
target field of 
view, body 
composition 
effects on 
abdominal skin 
surface 
temperature 
readings and 
thermal mapping 
characteristics of 
infected versus 
non-infected 
wounds post 
stoma-closure. 
 
Quantitative, 
prospective, 
exploratory 
pilot study  
 
Thermal mapping characteristics Acute colorectal 
surgical ward 
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Inclusion/  
Exclusion 
Criteria 
 Sample Size & 
Characteristics 
Study procedure Measurement 
equipment & 
other materials 
Data Analysis Results Conclusions 
Inclusion 
criteria for 
healthy adult 
subjects: 
Afebrile with 
no evidence 
of concurrent 
inflammatory 
disease or 
significant co-
morbid 
conditions. 
Inclusion 
criteria for 
adult patient 
subjects: 
admitted to 
the acute 
colorectal 
surgical ward, 
for closure of 
enterostoma 
(ileostomy or 
colostomy). 
 
Exclusion 
criteria not 
stated 
  
 
 
30 healthy adult 
volunteer 
subjects  
(aged 19–52 
(median: 29) 
years)  
tympanic 
temperatures 
35.8–37.1°C 
(mean 36.6°C). 
 
10 patients  
admitted to the 
acute colorectal 
surgical ward, 
for closure of 
enterostoma 
(ileostomy or 
colostomy).  
aged 59–78 
years (median: 
71.5 years), 7 of 
Chinese and 3 of 
Malay race, who 
were admitted 
to hospital for 
surgical 
closure of 
enterostoma 
(ileostomy n=9, 
colostomy 
n=1) 
eight patients 
with a ‘normal’ 
range 
Healthy adult volunteer 
sample: 
Requested to refrain from 
smoking, ingesting caffeine 
containing beverages, active 
exercise or application of lotion 
over the abdomen for four 
hours before the start of the 
study.  
 
Measurement procedure: 
Rested for 10 minutes in 
ambient conditions in a room 
before first thermal image 
acquired. Distance from the 
camera measured at 30cm, 
60cm and 100cm.  
Procedure for each volunteer 
was 25 minutes. 
 
Ambient conditions of the study 
room, air velocity, temperature, 
relative humidity (RH%) were 
monitored (Hot-Wire 
Anemometer, model TES-1341, 
TES Pte, Taipei). Potential 
sources of reflected IR radiant 
heat sources were eliminated. 
 
Height (cm) and weight (Kg) 
were measured. For adults, a 
BMI less than 18.5 considered 
as lean, BMI from 18.6–24.9, 
normal and BMI above 25 
overweight (and obese ≥30). 
A long-wave 
InfraRed Camera 
FLIR T640 25° (ALX 
Pte, Singapore) 
with image 
resolution of 
640 x 480 pixels 
and spatial 
resolution of 
0.68mrad. 
 
Body temperature 
measured using a 
tympanic 
thermometer 
(Genius 2, Tyco 
Healthcare, 
Singapore). 
Thermal 
images were 
saved for 
post-
acquisition 
processing 
and analysis 
using 
Research 
IRTM 
software 
(FLIR Systems 
Inc., Sweden). 
 
Analyses 
performed 
using the 
Statistical 
Package 
for the Social 
Sciences 
version 18 
(SPSS, v18).  
 
For 
quantitative 
data, 
descriptive 
statistics were 
used. 
 
Where 
appropriate 
tests for 
normality 
Abdominal temperature in healthy 
subjects 
The umbilicus was identified in the 
majority of the images as a central 
‘hot spot’.  
The mean abdominal skin 
temperature reduced as BMI 
increased. 
 
Before surgery, there was no 
difference between patients and 
healthy controls for tympanic 
temperature (p=0.913), the highest 
(p=0.105) or lowest (p=0.277) 
abdominal skin surface temperature. 
Postoperative, scar length ranged 
from 4.5–7.0cm (median: 5.7cm). Half 
(n=5) the patients developed wound 
infection. 
 
Qualitative IR thermogram for lean 
(<18.5) and normal range (BMI 18.5-
24.9) patients 
In the majority of the series of thermal 
images, the umbilicus is identifiable, 
centrally, as a ‘hot (white) spot’. 
 
Before surgery the stoma site is at the 
lowest temperature within the FOV 
(map shows green/blue). Immediately 
after surgery, a ‘cold’ linear scar site is 
identifiable within the ROI, again 
coloured green/blue and 
commensurate with temperatures in 
the region of 32°C.  
Development of ‘cold’ 
spots by day 3 could be 
an objective indication 
of a potential surgical 
site infection and thus 
temperature 
measurement by 
infrared thermography 
may be a valuable 
predictor of wound 
healing outcomes. 
 
As this is a pilot study, 
further research with 
larger sample sizes are 
required to confirm 
these findings.  
 
As the temperature 
measurements are 
reported descriptively 
and visually using IR 
images, it is difficult to 
accurately quantify 
these results. 
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BMI (18.5–24.9) 
and two with a 
BMI of >25 
 
Body temperature measured 
using a tympanic thermometer 
(Genius 2, Tyco Healthcare, 
Singapore). 2 measurement 
‘pairs’ (left and right ear) were 
taken in each subject, two 
minutes apart. 
 
Patient sample: 
Measurement procedure: 
Based on results from healthy 
subjects, all thermal images on 
patients were taken at a 
distance of 100cm.  
The same protocol for 
measurement of body 
(tympanic) temperature, 
ambient temperature, relative 
humidity and air velocity in 
patient studies was as for 
subjects. 
 
The operational temperature 
range span of the IR camera was 
narrowed to 8°C to improve the 
colour contrast of the imaging 
map (30-38°C). 
 
Wound dressings/ care: not 
stated 
determined 
before 
undertaking 
parametric 
tests.  
 
In healthy 
subjects, the 
effect of 
distance on IR 
temperature 
readings 
produced 
from the 
thermal maps 
analysed 
using one-way 
repeated 
measures 
ANOVA. 
Statistical 
significance 
was set at the 
level of 
p<0.05.  
 
A one-way 
between-
group analysis 
of variance 
conducted to 
explore for 
the effect of 
BMI on 
abdominal 
skin surface 
temperature. 
On days 1–2, the scar site emerges as 
a ‘cold spot’ (yellow, green/blue) 
within the hotter (red) surrounding 
abdominal skin. 
For patients (1,5,10) with no 
identifiable focus of infection (NI) the 
area of skin ‘warming’ surrounding 
the post-operative scar continued to 
increase in size up to days 3 or day 4 
and on the last three days of IR 
thermal imaging is little more than a 
few ‘dots’ of yellow amidst a ‘red’ 
thermal map. 
 
Qualitative IR thermogram in 
patients with a high BMI (>24.9): 
The surgical scar remained green/blue 
coloured (changing to yellow by day 6 
only) and to a red (blending to the 
surrounding skin temperature by day 
7). 
 
Patients with a confirmed wound 
infection (I) (CDC criteria, purulent 
exudate from the skin and 
subcutaneous tissue within 30 days 
after the operative procedure): 
Similar thermal imaging maps 
immediately after surgery. The 
thermal image along the incisions 
revealed ‘cold’ spots along the 
incision at day 2. By day 3, patients (2, 
6, 8 and 9) had either an increased 
‘cold’ spot size along the surgical site 
or failed to show the warming of the 
skin as characterised by an increasing 
area of ‘red’ on the thermal image. 
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Purulent exudate was drained from 
the ‘cold spot’ on day 7 in patient 7, 
and confirmed the diagnosis of 
surgical wound infection. 
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Appendix 21: EBL Quality Appraisal Checklist- Gethin et al. (2008)  
 
EBL Critical Appraisal Checklist- Gethin G. T., Cowman S. & Conroy 
R. M. (2008) The impact of Manuka honey dressings on the 
surface pH of chronic wounds 
Yes 
(Y) 
No 
(N) 
Unclear 
(U) 
N/A 
 Is the study population representative of all users, actual and eligible, 
who might be included in the study? 
  U  
Are inclusion and exclusion criteria definitively outlined? Y    
Is the sample size large enough for sufficiently precise estimates? Y    
Is the response rate large enough for sufficiently precise estimates?    N/A 
Is the choice of population bias-free?   U  
If a comparative study: 
Were participants randomized into groups? 
Were the groups comparable at baseline? 
If groups were not comparable at baseline, was incomparability 
addressed by the authors in the analysis? 
   N/A 
   N/A 
   N/A 
Was informed consent obtained? Y    
 
 
 
 
 
 
 
 
 
Are data collection methods clearly described? Y    
If a face-to-face survey, were inter-observer and intra-observer bias 
reduced? 
   N/A 
Is the data collection instrument validated?   U  
If based on regularly collected statistics, are the statistics free from 
subjectivity? 
   N/A 
Does the study measure the outcome at a time appropriate for 
capturing the intervention’s effect? 
  U  
Is the instrument included in the publication?    N/A   
Are questions posed clearly enough to be able to elicit precise 
answers? 
   N/A 
Were those involved in data collection not involved in delivering a 
service to the target population? 
  U  
 
 
 
 
 
Is the study type / methodology utilized appropriate? Y    
Is there face validity? Y    
Is the research methodology clearly stated at a level of detail that 
would allow its replication? 
Y    
Was ethics approval obtained? Y    
Are the outcomes clearly stated and discussed in relation to the data 
collection? 
Y    
 
 
 
 
 
 
Are all the results clearly outlined?  N   
Are confounding variables accounted for?   U  
Do the conclusions accurately reflect the analysis? Y    
Is subset analysis a minor, rather than a major, focus of the article?    N/A 
Are suggestions provided for further areas to research? Y    
Is there external validity?  N   
Calculation for section validity: (Y+N+U=T) 
If Y/T <75% or if N+U/T > 25% then you can safely conclude that 
the section identifies significant omissions and that the study’s 
validity is questionable. It is important to look at the overall 
validity as well as section validity. 
Calculation for overall validity: (Y+N+U=19) 
 
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid. 
 
Section A validity calculation: Y/T= 60% or N+U/T= 40% 
Section B validity calculation:  Y/T= 25% or N+U/T= 75% 
Section C validity calculation:  Y/T= 100% or N+U/T= 0% 
Section D validity calculation:  Y/T= 40% or N+U/T= 60% 
Overall validity calculation:  
Y/T= 57.89% or N+U/T = 42.11% 
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Appendix 22: EBL Quality Appraisal Checklist- Ono et al. (2015) 
 
EBL Critical Appraisal Checklist- Ono S., Imai R., Ida Y., Shibata D., 
Komiya T. & Matsumura H. (2015) Increased wound pH as an 
indicator of local wound infection in second degree burns 
Yes 
(Y) 
No 
(N) 
Unclear 
(U) 
N/A 
 Is the study population representative of all users, actual and eligible, 
who might be included in the study? 
  U  
Are inclusion and exclusion criteria definitively outlined?  N   
Is the sample size large enough for sufficiently precise estimates?   U  
Is the response rate large enough for sufficiently precise estimates?    N/A 
Is the choice of population bias-free?   U  
If a comparative study: 
Were participants randomized into groups? 
Were the groups comparable at baseline? 
If groups were not comparable at baseline, was incomparability 
addressed by the authors in the analysis? 
   N/A 
   N/A 
   N/A 
Was informed consent obtained?   U  
 
 
 
 
 
 
 
 
 
Are data collection methods clearly described? Y    
If a face-to-face survey, were inter-observer and intra-observer bias 
reduced? 
   N/A 
Is the data collection instrument validated?   U  
If based on regularly collected statistics, are the statistics free from 
subjectivity? 
   N/A 
Does the study measure the outcome at a time appropriate for 
capturing the intervention’s effect? 
   N/A 
Is the instrument included in the publication?     N/A 
Are questions posed clearly enough to be able to elicit precise 
answers? 
   N/A 
Were those involved in data collection not involved in delivering a 
service to the target population? 
  U  
 
 
 
 
 
Is the study type / methodology utilized appropriate? Y    
Is there face validity? Y    
Is the research methodology clearly stated at a level of detail that 
would allow its replication? 
Y    
Was ethics approval obtained? Y    
Are the outcomes clearly stated and discussed in relation to the data 
collection? 
Y    
 
 
 
 
 
 
Are all the results clearly outlined?  N   
Are confounding variables accounted for?   U  
Do the conclusions accurately reflect the analysis? Y    
Is subset analysis a minor, rather than a major, focus of the article?    N/A 
Are suggestions provided for further areas to research? Y    
Is there external validity?   U  
Calculation for section validity: (Y+N+U=T) 
If Y/T <75% or if N+U/T > 25% then you can safely conclude that 
the section identifies significant omissions and that the study’s 
validity is questionable. It is important to look at the overall 
validity as well as section validity. 
Calculation for overall validity: (Y+N+U=18) 
 
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid. 
 
Section A validity calculation: Y/T= 0% or N+U/T= 100% 
Section B validity calculation:  Y/T= 33.33% or N+U/T= 66.66% 
Section C validity calculation:  Y/T= 100% or N+U/T= 0% 
Section D validity calculation:  Y/T= 40% or N+U/T= 60% 
Overall validity calculation:  
Y/T = 44.44% or N+U/T = 55.56% 
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Appendix 23: EBL Quality Appraisal Checklist- Shukla et al. (2007) 
 
EBL Critical Appraisal Checklist- Shukla V. K., Shukla D., Tiwary S. 
K., Agrawal S. & Rastogi A. (2007) Evaluation of pH measurement 
as a method of wound assessment 
Yes 
(Y) 
No 
(N) 
Unclear 
(U) 
N/A 
 Is the study population representative of all users, actual and eligible, 
who might be included in the study? 
  U  
Are inclusion and exclusion criteria definitively outlined? Y    
Is the sample size large enough for sufficiently precise estimates?   U  
Is the response rate large enough for sufficiently precise estimates?    N/A 
Is the choice of population bias-free?   U  
If a comparative study: 
Were participants randomized into groups? 
Were the groups comparable at baseline? 
If groups were not comparable at baseline, was incomparability 
addressed by the authors in the analysis? 
   N/A 
   N/A 
   N/A 
Was informed consent obtained? Y    
 
 
 
 
 
 
 
 
 
Are data collection methods clearly described? Y    
If a face-to-face survey, were inter-observer and intra-observer bias 
reduced? 
   N/A 
Is the data collection instrument validated?   U  
If based on regularly collected statistics, are the statistics free from 
subjectivity? 
   N/A 
Does the study measure the outcome at a time appropriate for 
capturing the intervention’s effect? 
   N/A 
Is the instrument included in the publication?    N/A   
Are questions posed clearly enough to be able to elicit precise 
answers? 
   N/A 
Were those involved in data collection not involved in delivering a 
service to the target population? 
  U  
 
 
 
 
 
Is the study type / methodology utilized appropriate? Y    
Is there face validity? Y    
Is the research methodology clearly stated at a level of detail that 
would allow its replication? 
Y    
Was ethics approval obtained? Y    
Are the outcomes clearly stated and discussed in relation to the data 
collection? 
Y    
 
 
 
 
 
 
Are all the results clearly outlined? Y    
Are confounding variables accounted for?   U  
Do the conclusions accurately reflect the analysis? Y    
Is subset analysis a minor, rather than a major, focus of the article?    N/A 
Are suggestions provided for further areas to research? Y    
Is there external validity?   U  
Calculation for section validity: (Y+N+U=T) 
If Y/T <75% or if N+U/T > 25% then you can safely conclude that 
the section identifies significant omissions and that the study’s 
validity is questionable. It is important to look at the overall 
validity as well as section validity. 
Calculation for overall validity: (Y+N+U=18) 
 
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid. 
 
Section A validity calculation: Y/T= 40% or N+U/T= 60% 
Section B validity calculation:  Y/T= 33.33% or N+U/T= 66.66% 
Section C validity calculation:  Y/T= 100% or N+U/T= 0% 
Section D validity calculation:  Y/T= 60% or N+U/T= 40% 
Overall validity calculation:  
Y/T =61.12% or N+U/T = 38.89% 
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Appendix 24: EBL Quality Appraisal Checklist- Bernatchez et al. (2013) 
 
EBL Critical Appraisal Checklist- Bernatchez S.F., Menon V., Stoffel 
J., Walters S.A.H., Lindroos W. E., Crossland M.C., Shawler L. G., 
Crossland S. P. & Boykin J. V. (2013) Nitric oxide levels in wound 
fluid may reflect the healing trajectory 
Yes 
(Y) 
No 
(N) 
Unclear 
(U) 
N/A 
 
Is the study population representative of all users, actual and eligible, 
who might be included in the study? 
  U  
Are inclusion and exclusion criteria definitively outlined?  N   
Is the sample size large enough for sufficiently precise estimates?   U  
Is the response rate large enough for sufficiently precise estimates?    N/A 
Is the choice of population bias-free?   U  
If a comparative study: 
Were participants randomized into groups? 
Were the groups comparable at baseline? 
If groups were not comparable at baseline, was incomparability 
addressed by the authors in the analysis? 
   N/A 
   N/A 
   N/A 
Was informed consent obtained? Y    
 
 
 
 
 
 
 
 
 
Are data collection methods clearly described? Y    
If a face-to-face survey, were inter-observer and intra-observer bias 
reduced? 
   N/A 
Is the data collection instrument validated?   U  
If based on regularly collected statistics, are the statistics free from 
subjectivity? 
   N/A 
Does the study measure the outcome at a time appropriate for 
capturing the intervention’s effect? 
   N/A 
Is the instrument included in the publication?    N/A   
Are questions posed clearly enough to be able to elicit precise 
answers? 
   N/A 
Were those involved in data collection not involved in delivering a 
service to the target population? 
  U  
 
 
 
 
 
Is the study type / methodology utilized appropriate? Y    
Is there face validity? Y    
Is the research methodology clearly stated at a level of detail that 
would allow its replication? 
Y    
Was ethics approval obtained? Y    
Are the outcomes clearly stated and discussed in relation to the data 
collection? 
Y    
 
 
 
 
 
 
Are all the results clearly outlined?  N   
Are confounding variables accounted for?   U  
Do the conclusions accurately reflect the analysis? Y    
Is subset analysis a minor, rather than a major, focus of the article?    N/A 
Are suggestions provided for further areas to research? Y    
Is there external validity?   U  
Calculation for section validity: (Y+N+U=T) 
If Y/T <75% or if N+U/T > 25% then you can safely conclude that 
the section identifies significant omissions and that the study’s 
validity is questionable. It is important to look at the overall 
validity as well as section validity. 
Calculation for overall validity: (Y+N+U=18) 
 
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid. 
 
Section A validity calculation: Y/T= 20% or N+U/T= 80% 
Section B validity calculation:  Y/T= 33.33% or N+U/T= 66.66% 
Section C validity calculation:  Y/T= 100% or N+U/T= 0% 
Section D validity calculation:  Y/T= 40% or N+U/T= 60% 
Overall validity calculation:  
Y/T= 50% or N+U/T= 50% 
Se
ct
io
n
 A
: 
P
o
p
u
la
ti
o
n
 
Se
ct
io
n
 B
: 
D
at
a 
C
o
lle
ct
io
n
 
Se
ct
io
n
 C
: 
St
u
d
y 
D
e
si
gn
 
Se
ct
io
n
 D
: 
R
e
su
lt
s 
406 
 
Appendix 25: EBL Quality Appraisal Checklist- Edsberg et al. (2012) 
 
EBL Critical Appraisal Checklist- Edsberg L. E., Wyffels J. T., Brogan 
M. S. & Fries K. M. (2012) Analysis of the proteomic profile of 
chronic pressure ulcers 
Yes 
(Y) 
No 
(N) 
Unclear 
(U) 
N/A 
 
Is the study population representative of all users, actual and eligible, 
who might be included in the study? 
  U  
Are inclusion and exclusion criteria definitively outlined?  N   
Is the sample size large enough for sufficiently precise estimates?   U  
Is the response rate large enough for sufficiently precise estimates?    N/A 
Is the choice of population bias-free?   U  
If a comparative study: 
Were participants randomized into groups? 
Were the groups comparable at baseline? 
If groups were not comparable at baseline, was incomparability 
addressed by the authors in the analysis? 
   N/A 
   N/A 
   N/A 
Was informed consent obtained?   U  
 
 
 
 
 
 
 
 
 
Are data collection methods clearly described? Y    
If a face-to-face survey, were inter-observer and intra-observer bias 
reduced? 
   N/A 
Is the data collection instrument validated?   U  
If based on regularly collected statistics, are the statistics free from 
subjectivity? 
   N/A 
Does the study measure the outcome at a time appropriate for 
capturing the intervention’s effect? 
   N/A 
Is the instrument included in the publication?    N/A   
Are questions posed clearly enough to be able to elicit precise 
answers? 
   N/A 
Were those involved in data collection not involved in delivering a 
service to the target population? 
  U  
 
 
 
 
 
Is the study type / methodology utilized appropriate? Y    
Is there face validity? Y    
Is the research methodology clearly stated at a level of detail that 
would allow its replication? 
Y    
Was ethics approval obtained? Y    
Are the outcomes clearly stated and discussed in relation to the data 
collection? 
Y    
 
 
 
 
 
 
Are all the results clearly outlined?   U  
Are confounding variables accounted for?   U  
Do the conclusions accurately reflect the analysis? Y    
Is subset analysis a minor, rather than a major, focus of the article?    N/A 
Are suggestions provided for further areas to research? Y    
Is there external validity?   U  
Calculation for section validity: (Y+N+U=T) 
If Y/T <75% or if N+U/T > 25% then you can safely conclude that 
the section identifies significant omissions and that the study’s 
validity is questionable. It is important to look at the overall 
validity as well as section validity. 
Calculation for overall validity: (Y+N+U=18) 
 
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid. 
 
Section A validity calculation: Y/T= 0% or N+U/T= 100% 
Section B validity calculation:  Y/T=33.33% or N+U/T= 66.66% 
Section C validity calculation:  Y/T= 100% or N+U/T= 0% 
Section D validity calculation: Y/T=40% or N+U/T=60% 
Overall validity calculation:  
Y/T= 44.45% or N+U/T= 55.56% 
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Appendix 26: EBL Quality Appraisal Checklist- Hoffman et al. (1999) 
 
EBL Critical Appraisal Checklist- Hoffman R., Noble J. & Eagle M. 
(1999) The use of proteases as prognostic markers for the healing 
of venous leg ulcers 
Yes 
(Y) 
No 
(N) 
Unclear 
(U) 
N/A 
 
Is the study population representative of all users, actual and eligible, 
who might be included in the study? 
  U  
Are inclusion and exclusion criteria definitively outlined?  N   
Is the sample size large enough for sufficiently precise estimates?   U  
Is the response rate large enough for sufficiently precise estimates?    N/A 
Is the choice of population bias-free?   U  
If a comparative study: 
Were participants randomized into groups? 
Were the groups comparable at baseline? 
If groups were not comparable at baseline, was incomparability 
addressed by the authors in the analysis? 
   N/A 
   N/A 
   N/A 
Was informed consent obtained?   U  
 
 
 
 
 
 
 
 
 
Are data collection methods clearly described? Y    
If a face-to-face survey, were inter-observer and intra-observer bias 
reduced? 
   N/A 
Is the data collection instrument validated?   U  
If based on regularly collected statistics, are the statistics free from 
subjectivity? 
   N/A 
Does the study measure the outcome at a time appropriate for 
capturing the intervention’s effect? 
   N/A 
Is the instrument included in the publication?    N/A 
Are questions posed clearly enough to be able to elicit precise 
answers? 
   N/A 
Were those involved in data collection not involved in delivering a 
service to the target population? 
  U  
 
 
 
 
 
Is the study type / methodology utilized appropriate? Y    
Is there face validity? Y    
Is the research methodology clearly stated at a level of detail that 
would allow its replication? 
Y    
Was ethics approval obtained? Y    
Are the outcomes clearly stated and discussed in relation to the data 
collection? 
Y    
 
 
 
 
 
 
Are all the results clearly outlined?  N   
Are confounding variables accounted for?   U  
Do the conclusions accurately reflect the analysis? Y     
Is subset analysis a minor, rather than a major, focus of the article?    N/A 
Are suggestions provided for further areas to research? Y    
Is there external validity?   U  
Calculation for section validity: (Y+N+U=T) 
If Y/T <75% or if N+U/T > 25% then you can safely conclude that 
the section identifies significant omissions and that the study’s 
validity is questionable. It is important to look at the overall 
validity as well as section validity. 
Calculation for overall validity: (Y+N+U=18) 
 
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid. 
 
Section A validity calculation: Y/T= 0% or N+U/T= 100% 
Section B validity calculation:  Y/T=33.33% or N+U/T=66.66% 
Section C validity calculation:  Y/T= 100% or N+U/T= 0% 
Section D validity calculation:  Y/T= 40% or N+U/T= 60% 
Overall validity calculation:  
Y/T= 44.45% or N+U/T = 55.56% 
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Appendix 27: EBL Quality Appraisal Checklist- James et al. (2000) 
 
EBL Critical Appraisal Checklist   James T. J., Hughes M. A., Cherry 
G. W. & Taylor R. P. (2000) Simple biochemical markers to assess 
chronic wounds 
Yes 
(Y) 
No 
(N) 
Unclear 
(U) 
N/A 
 
Is the study population representative of all users, actual and eligible, 
who might be included in the study? 
  U  
Are inclusion and exclusion criteria definitively outlined?  N   
Is the sample size large enough for sufficiently precise estimates?   U  
Is the response rate large enough for sufficiently precise estimates?    N/A 
Is the choice of population bias-free?   U  
If a comparative study: 
Were participants randomized into groups? 
Were the groups comparable at baseline? 
If groups were not comparable at baseline, was incomparability 
addressed by the authors in the analysis? 
   N/A 
   N/A 
   N/A 
Was informed consent obtained?   U  
 
 
 
 
 
 
 
 
 
Are data collection methods clearly described? Y    
If a face-to-face survey, were inter-observer and intra-observer bias 
reduced? 
   N/A 
Is the data collection instrument validated?   U  
If based on regularly collected statistics, are the statistics free from 
subjectivity? 
   N/A 
Does the study measure the outcome at a time appropriate for 
capturing the intervention’s effect? 
   N/A 
Is the instrument included in the publication?    N/A 
Are questions posed clearly enough to be able to elicit precise 
answers? 
   N/A 
Were those involved in data collection not involved in delivering a 
service to the target population? 
  U  
 
 
 
 
 
Is the study type / methodology utilized appropriate? Y    
Is there face validity? Y    
Is the research methodology clearly stated at a level of detail that 
would allow its replication? 
Y    
Was ethics approval obtained? Y    
Are the outcomes clearly stated and discussed in relation to the data 
collection? 
Y    
 
 
 
 
 
 
Are all the results clearly outlined? Y    
Are confounding variables accounted for?   U  
Do the conclusions accurately reflect the analysis? Y    
Is subset analysis a minor, rather than a major, focus of the article?    N/A 
Are suggestions provided for further areas to research? Y    
Is there external validity?   U  
Calculation for section validity: (Y+N+U=T) 
If Y/T <75% or if N+U/T > 25% then you can safely conclude that 
the section identifies significant omissions and that the study’s 
validity is questionable. It is important to look at the overall 
validity as well as section validity. 
Calculation for overall validity: (Y+N+U=18) 
 
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid. 
 
Section A validity calculation: Y/T= 0% or N+U/T= 100% 
Section B validity calculation:  Y/T= 33.33% or N+U/T= 66.66% 
Section C validity calculation:  Y/T= 100% or N+U/T= 0% 
Section D validity calculation:  Y/T= 60% or N+U/T= 40% 
Overall validity calculation:  
Y/T = 50% or N+U/T = 50% 
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Appendix 28: EBL Quality Appraisal Checklist- Ladwig et al. (2002) 
EBL Critical Appraisal Checklist -  Ladwig, G. P., Robson, M. 
C., Liu, R., Kuhn, M. A., Muir, D. F. & Schultz, G. S. (2002) 
‘Ratios of activated matrix metalloproteinase-9 to tissue 
inhibitor of matrix metalloproteinase-1 in wound fluids are 
inversely correlated with healing of pressure ulcers’ 
Yes 
(Y) 
No 
(N) 
Unclear 
(U) 
N/A 
 
Is the study population representative of all users, actual and 
eligible, who might be included in the study? 
  U  
Are inclusion and exclusion criteria definitively outlined?  N   
Is the sample size large enough for sufficiently precise 
estimates? 
  U  
Is the response rate large enough for sufficiently precise 
estimates? 
   N/A 
Is the choice of population bias-free?   U  
If a comparative study: 
Were participants randomized into groups? 
Were the groups comparable at baseline? 
If groups were not comparable at baseline, was 
incomparability addressed by the authors in the analysis? 
   N/A 
   N/A 
   N/A 
Was informed consent obtained?   U  
 
 
 
 
 
 
 
 
 
Are data collection methods clearly described? Y    
If a face-to-face survey, were inter-observer and intra-
observer bias reduced? 
   N/A 
Is the data collection instrument validated?   U  
If based on regularly collected statistics, are the statistics free 
from subjectivity? 
   N/A 
Does the study measure the outcome at a time appropriate for 
capturing the intervention’s effect? 
   N/A 
Is the instrument included in the publication?    N/A   
Are questions posed clearly enough to be able to elicit precise 
answers? 
   N/A 
Were those involved in data collection not involved in 
delivering a service to the target population? 
  U  
 
 
 
 
 
Is the study type / methodology utilized appropriate? Y    
Is there face validity? Y    
Is the research methodology clearly stated at a level of detail 
that would allow its replication? 
 N   
Was ethics approval obtained?  N   
Are the outcomes clearly stated and discussed in relation to 
the data collection? 
Y    
 
 
 
 
 
 
Are all the results clearly outlined? Y    
Are confounding variables accounted for?   U  
Do the conclusions accurately reflect the analysis? Y    
Is subset analysis a minor, rather than a major, focus of the 
article? 
Y    
Are suggestions provided for further areas to research? Y    
Is there external validity?   U  
Calculation for section validity: (Y+N+U=T) 
If Y/T <75% or if N+U/T > 25% then you can safely conclude that 
the section identifies significant omissions and that the study’s 
validity is questionable. It is important to look at the overall 
validity as well as section validity. 
Calculation for overall validity: (Y+N+U=19) 
 
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid. 
 
Section A validity calculation: Y/T= 0% or N+U/T= 100% 
Section B validity calculation: Y/T=33.33% or N+U/T=66.66% 
Section C validity calculation:  Y/T= 60% or N+U/T=40% 
Overall validity calculation:  
Y/T= 42.11% or N+U/T=57.89% 
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Appendix 29: EBL Quality Appraisal Checklist- Liu et al. (2009) 
 
Section D validity calculation:  Y/T= 66.66% or N+U/T=33.33% 
EBL Critical Appraisal Checklist- Liu Y., Min D., Bolton T., Nubé V., 
Twigg S. M., Yue D. K. & McLennan S. V. (2009) Increased matrix 
metalloproteinase-9 predicts poor wound healing in diabetic foot 
ulcers 
Yes 
(Y) 
No 
(N) 
Unclear 
(U) 
N/A 
 
Is the study population representative of all users, actual and eligible, 
who might be included in the study? 
  U  
Are inclusion and exclusion criteria definitively outlined?  N   
Is the sample size large enough for sufficiently precise estimates?   U  
Is the response rate large enough for sufficiently precise estimates?    N/A 
Is the choice of population bias-free?   U  
If a comparative study: 
Were participants randomized into groups? 
Were the groups comparable at baseline? 
If groups were not comparable at baseline, was incomparability 
addressed by the authors in the analysis? 
   N/A 
   N/A 
   N/A 
Was informed consent obtained?   U  
 
 
 
 
 
 
 
 
 
Are data collection methods clearly described?  N   
If a face-to-face survey, were inter-observer and intra-observer bias 
reduced? 
   N/A 
Is the data collection instrument validated?   U  
If based on regularly collected statistics, are the statistics free from 
subjectivity? 
   N/A 
Does the study measure the outcome at a time appropriate for 
capturing the intervention’s effect? 
   N/A 
Is the instrument included in the publication?    N/A 
Are questions posed clearly enough to be able to elicit precise 
answers? 
   N/A 
Were those involved in data collection not involved in delivering a 
service to the target population? 
  U  
 
 
 
 
 
Is the study type / methodology utilized appropriate? Y    
Is there face validity? Y    
Is the research methodology clearly stated at a level of detail that 
would allow its replication? 
 N   
Was ethics approval obtained?   U  
Are the outcomes clearly stated and discussed in relation to the data 
collection? 
Y    
 
 
 
 
 
 
Are all the results clearly outlined?  N   
Are confounding variables accounted for?   U  
Do the conclusions accurately reflect the analysis? Y    
Is subset analysis a minor, rather than a major, focus of the article?    N/A 
Are suggestions provided for further areas to research? Y    
Is there external validity?   U  
Calculation for section validity: (Y+N+U=T) 
If Y/T <75% or if N+U/T > 25% then you can safely conclude that 
the section identifies significant omissions and that the study’s 
validity is questionable. It is important to look at the overall 
validity as well as section validity. 
Calculation for overall validity: (Y+N+U=18) 
 
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid. 
 
Section A validity calculation: Y/T= 0% or N+U/T= 100% 
Section B validity calculation:  Y/T= 0% or N+U/T= 100% 
Section C validity calculation:  Y/T= 60% or N+U/T= 40% 
Section D validity calculation:  Y/T= 40% or N+U/T= 60% 
Overall validity calculation:  
Y/T = 27.78% or N+U/T = 72.22% 
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Appendix 30: EBL Quality Appraisal Checklist- Muller et al. (2008) 
 
EBL Critical Appraisal Checklist - Muller M., Trocme C., Lardy B., 
Morel F., Halimi S. & Benhamou P. Y. (2008) Matrix 
metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 
to TIMP-1 is a predictor of wound healing 
Yes 
(Y) 
No 
(N) 
Unclear 
(U) 
N/A 
 
Is the study population representative of all users, actual and eligible, 
who might be included in the study? 
  U  
Are inclusion and exclusion criteria definitively outlined? Y    
Is the sample size large enough for sufficiently precise estimates?   U  
Is the response rate large enough for sufficiently precise estimates?    N/A 
Is the choice of population bias-free?   U  
If a comparative study: 
Were participants randomized into groups? 
Were the groups comparable at baseline? 
If groups were not comparable at baseline, was incomparability 
addressed by the authors in the analysis? 
   N/A 
   N/A 
   N/A 
Was informed consent obtained? Y    
 
 
 
 
 
 
 
 
 
Are data collection methods clearly described? Y    
If a face-to-face survey, were inter-observer and intra-observer bias 
reduced? 
   N/A 
Is the data collection instrument validated?   U  
If based on regularly collected statistics, are the statistics free from 
subjectivity? 
   N/A 
Does the study measure the outcome at a time appropriate for 
capturing the intervention’s effect? 
   N/A 
Is the instrument included in the publication?    N/A 
Are questions posed clearly enough to be able to elicit precise 
answers? 
   N/A 
Were those involved in data collection not involved in delivering a 
service to the target population? 
  U  
 
 
 
 
 
Is the study type / methodology utilized appropriate? Y    
Is there face validity? Y    
Is the research methodology clearly stated at a level of detail that 
would allow its replication? 
Y    
Was ethics approval obtained? Y    
Are the outcomes clearly stated and discussed in relation to the data 
collection? 
Y    
 
 
 
 
 
 
Are all the results clearly outlined? Y    
Are confounding variables accounted for? Y    
Do the conclusions accurately reflect the analysis? Y    
Is subset analysis a minor, rather than a major, focus of the article?    N/A 
Are suggestions provided for further areas to research?   U  
Is there external validity?  N   
Calculation for section validity: (Y+N+U=T) 
If Y/T <75% or if N+U/T > 25% then you can safely conclude that 
the section identifies significant omissions and that the study’s 
validity is questionable. It is important to look at the overall 
validity as well as section validity. 
Calculation for overall validity: (Y+N+U=18) 
 
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid. 
 
Section A validity calculation: Y/T= 40% or N+U/T= 60% 
Section B validity calculation:  Y/T=33.33% or N+U/T=66.66% 
Section C validity calculation:  Y/T= 100% or N+U/T= 0% 
Section D validity calculation:  Y/T= 60% or N+U/T= 40% 
Overall validity calculation:  
Y/T = 61.11% or N+U/T = 38.89% 
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Appendix 31: EBL Quality Appraisal Checklist- Tarlton et al. (1997) 
 
EBL Critical Appraisal Checklist- Tarlton, J. F., Vickery, C. J., Leaper, 
D. J. & Bailey, A. J. (1997) ‘Postsurgical wound progression 
monitored by temporal changes in the expression of matrix 
metalloproteinase-9’ 
Yes 
(Y) 
No 
(N) 
Unclear 
(U) 
N/A 
 
Is the study population representative of all users, actual and eligible, 
who might be included in the study? 
  U  
Are inclusion and exclusion criteria definitively outlined?  N   
Is the sample size large enough for sufficiently precise estimates?   U  
Is the response rate large enough for sufficiently precise estimates?    N/A 
Is the choice of population bias-free?   U  
If a comparative study: 
Were participants randomized into groups? 
Were the groups comparable at baseline? 
If groups were not comparable at baseline, was incomparability 
addressed by the authors in the analysis? 
   N/A 
   N/A 
   N/A 
Was informed consent obtained? Y    
 
 
 
 
 
 
 
 
 
Are data collection methods clearly described? Y    
If a face-to-face survey, were inter-observer and intra-observer bias 
reduced? 
   N/A 
Is the data collection instrument validated?   U  
If based on regularly collected statistics, are the statistics free from 
subjectivity? 
   N/A 
Does the study measure the outcome at a time appropriate for 
capturing the intervention’s effect? 
   N/A 
Is the instrument included in the publication?    N/A 
Are questions posed clearly enough to be able to elicit precise 
answers? 
   N/A 
Were those involved in data collection not involved in delivering a 
service to the target population? 
  U  
 
 
 
 
 
Is the study type / methodology utilized appropriate? Y    
Is there face validity? Y    
Is the research methodology clearly stated at a level of detail that 
would allow its replication? 
Y    
Was ethics approval obtained? Y    
Are the outcomes clearly stated and discussed in relation to the data 
collection? 
Y    
 
 
 
 
 
 
Are all the results clearly outlined?  N   
Are confounding variables accounted for?   U  
Do the conclusions accurately reflect the analysis? Y    
Is subset analysis a minor, rather than a major, focus of the article?    N/A 
Are suggestions provided for further areas to research?  N   
Is there external validity?   U  
Calculation for section validity: (Y+N+U=T) 
If Y/T <75% or if N+U/T > 25% then you can safely conclude that 
the section identifies significant omissions and that the study’s 
validity is questionable. It is important to look at the overall 
validity as well as section validity. 
Calculation for overall validity: (Y+N+U=18) 
 
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid. 
 
Section A validity calculation: Y/T = 20% or N+U/T = 80% 
Section B validity calculation:  Y/T= 33.33% or N+U/T= 66.66% 
Section C validity calculation:  Y/T= 100% or N+U/T= 0% 
Section D validity calculation:  Y/T= 20% or N+U/T= 80% 
Overall validity calculation:  
Y/T = 44.44% or N+U/T = 55.55% 
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Appendix 32: EBL Quality Appraisal Checklist- Tarlton et al. (1999) 
 
EBL Critical Appraisal Checklist- Tarlton J. F., Bailey A. J., Crawford 
E., Jones D., Moore K. & Harding K. D. (1999) Prognostic value of 
markers of collagen remodeling in venous ulcers 
Yes 
(Y) 
No 
(N) 
Unclear 
(U) 
N/A 
 
Is the study population representative of all users, actual and eligible, 
who might be included in the study? 
  U  
Are inclusion and exclusion criteria definitively outlined?  N   
Is the sample size large enough for sufficiently precise estimates?   U  
Is the response rate large enough for sufficiently precise estimates?    N/A 
Is the choice of population bias-free?   U  
If a comparative study: 
Were participants randomized into groups? 
Were the groups comparable at baseline? 
If groups were not comparable at baseline, was incomparability 
addressed by the authors in the analysis? 
   N/A 
   N/A 
   N/A 
Was informed consent obtained? Y    
 
 
 
 
 
 
 
 
 
Are data collection methods clearly described? Y    
If a face-to-face survey, were inter-observer and intra-observer bias 
reduced? 
Y    
Is the data collection instrument validated?   U  
If based on regularly collected statistics, are the statistics free from 
subjectivity? 
   N/A 
Does the study measure the outcome at a time appropriate for 
capturing the intervention’s effect? 
   N/A 
Is the instrument included in the publication?    N/A 
Are questions posed clearly enough to be able to elicit precise 
answers? 
   N/A 
Were those involved in data collection not involved in delivering a 
service to the target population? 
  U  
 
 
 
 
 
Is the study type / methodology utilized appropriate? Y    
Is there face validity? Y    
Is the research methodology clearly stated at a level of detail that 
would allow its replication? 
Y    
Was ethics approval obtained? Y     
Are the outcomes clearly stated and discussed in relation to the data 
collection? 
Y    
 
 
 
 
 
 
Are all the results clearly outlined?   U  
Are confounding variables accounted for?   U  
Do the conclusions accurately reflect the analysis? Y    
Is subset analysis a minor, rather than a major, focus of the article? Y    
Are suggestions provided for further areas to research?  N   
Is there external validity?   U  
Calculation for section validity: (Y+N+U=T) 
If Y/T <75% or if N+U/T > 25% then you can safely conclude that 
the section identifies significant omissions and that the study’s 
validity is questionable. It is important to look at the overall 
validity as well as section validity. 
Calculation for overall validity: (Y+N+U=20) 
 
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid. 
 
Section A validity calculation: Y/T= 20% or N+U/T= 80% 
Section B validity calculation:  Y/T= 50% or N+U/T= 50% 
Section C validity calculation:  Y/T= 100% or N+U/T= 0% 
Section D validity calculation:  Y/T= 33.33% or N+U/T = 66.66% 
Overall validity calculation:  
Y/T = 50% or N+U/T = 50% 
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Appendix 33: EBL Quality Appraisal Checklist- Tregove et al. (1996) 
 
EBL Critical Appraisal Checklist- Trengove, N. J., Langton, S. R. & 
Stacey, M. C. (1996) Biochemical analysis of wound fluid from 
nonhealing and healing chronic leg ulcers 
Yes 
(Y) 
No 
(N) 
Unclear 
(U) 
N/A 
 
Is the study population representative of all users, actual and eligible, 
who might be included in the study? 
  U  
Are inclusion and exclusion criteria definitively outlined?  N   
Is the sample size large enough for sufficiently precise estimates?  N   
Is the response rate large enough for sufficiently precise estimates?    N/A 
Is the choice of population bias-free?   U  
If a comparative study: 
Were participants randomized into groups? 
Were the groups comparable at baseline? 
If groups were not comparable at baseline, was incomparability 
addressed by the authors in the analysis? 
   N/A 
   N/A 
   N/A 
Was informed consent obtained? Y    
 
 
 
 
 
 
 
 
 
Are data collection methods clearly described? Y    
If a face-to-face survey, were inter-observer and intra-observer bias 
reduced? 
   N/A 
Is the data collection instrument validated?   U  
If based on regularly collected statistics, are the statistics free from 
subjectivity? 
   N/A 
Does the study measure the outcome at a time appropriate for 
capturing the intervention’s effect? 
   N/A 
Is the instrument included in the publication?    N/A 
Are questions posed clearly enough to be able to elicit precise 
answers? 
   N/A 
Were those involved in data collection not involved in delivering a 
service to the target population? 
  U  
 
 
 
 
 
Is the study type / methodology utilized appropriate? Y    
Is there face validity? Y    
Is the research methodology clearly stated at a level of detail that 
would allow its replication? 
Y    
Was ethics approval obtained? Y    
Are the outcomes clearly stated and discussed in relation to the data 
collection? 
Y    
 
 
 
 
 
 
Are all the results clearly outlined?  N   
Are confounding variables accounted for?   U  
Do the conclusions accurately reflect the analysis? Y    
Is subset analysis a minor, rather than a major, focus of the article? Y    
Are suggestions provided for further areas to research? Y    
Is there external validity?  N   
Calculation for section validity: (Y+N+U=T) 
If Y/T <75% or if N+U/T > 25% then you can safely conclude that 
the section identifies significant omissions and that the study’s 
validity is questionable. It is important to look at the overall 
validity as well as section validity. 
Calculation for overall validity: (Y+N+U=19) 
 
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid. 
 
Section A validity calculation: Y/T= 20% or N+U/T= 80% 
Section B validity calculation:  Y/T= 33.33% or N+U/T= 66.66% 
Section C validity calculation:  Y/T= 100% or N+U/T= 0% 
Section D validity calculation:  Y/T= 500% or N+U/T= 50% 
Overall validity calculation:  
Y/T = 52.63% or N+U/T = 47.37% 
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Appendix 34: EBL Quality Appraisal Checklist- Tregove et al. (1999) 
 
EBL Critical Appraisal Checklist-  Trengove N. J., Stacey M. C., 
MacAuley S., Bennett N., Gibson J., Burslem F., Murphy G. & 
Schultz G. (1999) Analysis of the acute and chronic wound 
environments: the role of proteases and their inhibitors 
Yes 
(Y) 
No 
(N) 
Unclear 
(U) 
N/A 
 
Is the study population representative of all users, actual and eligible, 
who might be included in the study? 
  U  
Are inclusion and exclusion criteria definitively outlined?  N   
Is the sample size large enough for sufficiently precise estimates?   U  
Is the response rate large enough for sufficiently precise estimates?    N/A 
Is the choice of population bias-free?   U  
If a comparative study: 
Were participants randomized into groups? 
Were the groups comparable at baseline? 
If groups were not comparable at baseline, was incomparability 
addressed by the authors in the analysis? 
   N/A 
   N/A 
   N/A 
Was informed consent obtained? Y    
 
 
 
 
 
 
 
 
 
Are data collection methods clearly described? Y    
If a face-to-face survey, were inter-observer and intra-observer bias 
reduced? 
   N/A 
Is the data collection instrument validated?   U  
If based on regularly collected statistics, are the statistics free from 
subjectivity? 
   N/A 
Does the study measure the outcome at a time appropriate for 
capturing the intervention’s effect? 
   N/A 
Is the instrument included in the publication?    N/A   
Are questions posed clearly enough to be able to elicit precise 
answers? 
   N/A 
Were those involved in data collection not involved in delivering a 
service to the target population? 
  U  
 
 
 
 
 
Is the study type / methodology utilized appropriate? Y    
Is there face validity? Y    
Is the research methodology clearly stated at a level of detail that 
would allow its replication? 
Y    
Was ethics approval obtained?   U  
Are the outcomes clearly stated and discussed in relation to the data 
collection? 
Y    
 
 
 
 
 
 
Are all the results clearly outlined? Y    
Are confounding variables accounted for?   U  
Do the conclusions accurately reflect the analysis? Y    
Is subset analysis a minor, rather than a major, focus of the article? Y    
Are suggestions provided for further areas to research? Y    
Is there external validity?   U  
Calculation for section validity: (Y+N+U=T) 
If Y/T <75% or if N+U/T > 25% then you can safely conclude that 
the section identifies significant omissions and that the study’s 
validity is questionable. It is important to look at the overall 
validity as well as section validity. 
Calculation for overall validity: (Y+N+U=19) 
 
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid. 
 
Section A validity calculation: Y/T= 20% or N+U/T= 80% 
Section B validity calculation:  Y/T=33.33% or N+U/T=66.66% 
Section C validity calculation:  Y/T= 80% or N+U/T= 20% 
Section D validity calculation:  Y/T= 66.66% or N+U/T= 33.33% 
Overall validity calculation:  
Y/T= 52.63% or N+U/T= 47.37% 
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Appendix 35: EBL Quality Appraisal Checklist- Wyffels et al. (2010) 
 
EBL Critical Appraisal Checklist - Wyffels J. T., Fries K. M., Randall 
J. S., Ha D. S., Lodwig C. A., Brogan M. S., Shero M. & Edsberg L. 
E. (2010) Analysis of pressure ulcer wound fluid using two-
dimensional electrophoresis 
Yes 
(Y) 
No 
(N) 
Unclear 
(U) 
N/A 
 
Is the study population representative of all users, actual and eligible, 
who might be included in the study? 
  U  
Are inclusion and exclusion criteria definitively outlined?  N   
Is the sample size large enough for sufficiently precise estimates?   U  
Is the response rate large enough for sufficiently precise estimates?    N/A 
Is the choice of population bias-free?   U  
If a comparative study: 
Were participants randomized into groups? 
Were the groups comparable at baseline? 
If groups were not comparable at baseline, was incomparability 
addressed by the authors in the analysis? 
   N/A 
   N/A 
   N/A 
Was informed consent obtained?   U  
 
 
 
 
 
 
 
 
 
Are data collection methods clearly described? Y    
If a face-to-face survey, were inter-observer and intra-observer bias 
reduced? 
   N/A 
Is the data collection instrument validated?   U  
If based on regularly collected statistics, are the statistics free from 
subjectivity? 
   N/A 
Does the study measure the outcome at a time appropriate for 
capturing the intervention’s effect? 
   N/A 
Is the instrument included in the publication?    N/A   
Are questions posed clearly enough to be able to elicit precise 
answers? 
   N/A 
Were those involved in data collection not involved in delivering a 
service to the target population? 
  U  
 
 
 
 
 
Is the study type / methodology utilized appropriate? Y    
Is there face validity? Y    
Is the research methodology clearly stated at a level of detail that 
would allow its replication? 
Y    
Was ethics approval obtained? Y    
Are the outcomes clearly stated and discussed in relation to the data 
collection? 
Y    
 
 
 
 
 
 
Are all the results clearly outlined?   U  
Are confounding variables accounted for?   U  
Do the conclusions accurately reflect the analysis? Y    
Is subset analysis a minor, rather than a major, focus of the article?    N/A 
Are suggestions provided for further areas to research?  N   
Is there external validity?   U  
Calculation for section validity: (Y+N+U=T) 
If Y/T <75% or if N+U/T > 25% then you can safely conclude that 
the section identifies significant omissions and that the study’s 
validity is questionable. It is important to look at the overall 
validity as well as section validity. 
Calculation for overall validity: (Y+N+U=18) 
 
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid. 
 
Section A validity calculation: Y/T= 0% or N+U/T= 100% 
Section B validity calculation:  Y/T=33.33% or N+U/T=66.66% 
Section C validity calculation:  Y/T= 100% or N+U/T= 0% 
Section D validity calculation:  Y/T= 20% or N+U/T= 80% 
Overall validity calculation:  
Y/T = 38.89% or N+U/T = 61.11% 
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Appendix 36: EBL Quality Appraisal Checklist- Armstrong et al (1996) 
 
EBL Critical Appraisal Checklist- Armstrong D. G. & Lavery L. A. 
(1996) Monitoring neuropathic ulcer healing with infrared 
dermal thermometry 
Yes 
(Y) 
No 
(N) 
Unclear 
(U) 
N/A 
 Is the study population representative of all users, actual and eligible, 
who might be included in the study? 
  U  
Are inclusion and exclusion criteria definitively outlined?  N   
Is the sample size large enough for sufficiently precise estimates?   U  
Is the response rate large enough for sufficiently precise estimates?    N/A 
Is the choice of population bias-free?   U  
If a comparative study: 
Were participants randomized into groups? 
Were the groups comparable at baseline? 
If groups were not comparable at baseline, was incomparability 
addressed by the authors in the analysis? 
   N/A 
   N/A 
   N/A 
Was informed consent obtained?   U  
 
 
 
 
 
 
 
 
 
Are data collection methods clearly described?  N   
If a face-to-face survey, were inter-observer and intra-observer bias 
reduced? 
   N/A 
Is the data collection instrument validated?   U  
If based on regularly collected statistics, are the statistics free from 
subjectivity? 
   N/A 
Does the study measure the outcome at a time appropriate for 
capturing the intervention’s effect? 
    
Is the instrument included in the publication?    N/A 
Are questions posed clearly enough to be able to elicit precise 
answers? 
   N/A 
Were those involved in data collection not involved in delivering a 
service to the target population? 
  U  
 
 
 
 
 
Is the study type / methodology utilized appropriate? Y    
Is there face validity? Y    
Is the research methodology clearly stated at a level of detail that 
would allow its replication? 
 N   
Was ethics approval obtained?   U  
Are the outcomes clearly stated and discussed in relation to the data 
collection? 
Y    
 
 
 
 
 
 
Are all the results clearly outlined?  N   
Are confounding variables accounted for? Y    
Do the conclusions accurately reflect the analysis? Y    
Is subset analysis a minor, rather than a major, focus of the article?    N/A 
Are suggestions provided for further areas to research? Y    
Is there external validity?   U  
Calculation for section validity: (Y+N+U=T) 
If Y/T <75% or if N+U/T > 25% then you can safely conclude that 
the section identifies significant omissions and that the study’s 
validity is questionable. It is important to look at the overall 
validity as well as section validity. 
Calculation for overall validity: (Y+N+U=18) 
 
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid. 
 
Section A validity calculation: Y/T= 0% or N+U/T= 100% 
Section B validity calculation:  Y/T= 0% or N+U/T= 100% 
Section C validity calculation:  Y/T= 60% or N+U/T= 40% 
Section D validity calculation:  Y/T= 60% or N+U/T= 40% 
Overall validity calculation:  
Y/T = 33.33% or N+U/T = 66.67% 
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Appendix 37: EBL Quality Appraisal Checklist- Armstrong et al (2006) 
 
EBL Critical Appraisal Checklist-Armstrong D. G., Lipsky B. A., Polis 
A. B. & Abramson M. A. (2006) Does dermal thermometry predict 
clinical outcome in diabetic foot infection? Analysis of data from 
the SIDESTEP* trial 
Yes 
(Y) 
No 
(N) 
Unclear 
(U) 
N/A 
 Is the study population representative of all users, actual and eligible, 
who might be included in the study? 
  U  
Are inclusion and exclusion criteria definitively outlined?   U  
Is the sample size large enough for sufficiently precise estimates?   U  
Is the response rate large enough for sufficiently precise estimates?    N/A 
Is the choice of population bias-free?   U  
If a comparative study: 
Were participants randomized into groups? 
Were the groups comparable at baseline? 
If groups were not comparable at baseline, was incomparability 
addressed by the authors in the analysis? 
   N/A 
   N/A 
   N/A 
Was informed consent obtained?   U  
 
 
 
 
 
 
 
 
 
Are data collection methods clearly described? Y    
If a face-to-face survey, were inter-observer and intra-observer bias 
reduced? 
   N/A 
Is the data collection instrument validated?   U  
If based on regularly collected statistics, are the statistics free from 
subjectivity? 
   N/A 
Does the study measure the outcome at a time appropriate for 
capturing the intervention’s effect? 
   N/A 
Is the instrument included in the publication?    N/A 
Are questions posed clearly enough to be able to elicit precise 
answers? 
   N/A 
Were those involved in data collection not involved in delivering a 
service to the target population? 
 N   
 
 
 
 
 
Is the study type / methodology utilized appropriate? Y    
Is there face validity? Y    
Is the research methodology clearly stated at a level of detail that 
would allow its replication? 
Y    
Was ethics approval obtained? Y    
Are the outcomes clearly stated and discussed in relation to the data 
collection? 
Y    
 
 
 
 
 
 
Are all the results clearly outlined?  N   
Are confounding variables accounted for?   U  
Do the conclusions accurately reflect the analysis? Y    
Is subset analysis a minor, rather than a major, focus of the article?    N/A 
Are suggestions provided for further areas to research? Y    
Is there external validity?   U  
Calculation for section validity: (Y+N+U=T) 
If Y/T <75% or if N+U/T > 25% then you can safely conclude that 
the section identifies significant omissions and that the study’s 
validity is questionable. It is important to look at the overall 
validity as well as section validity. 
Calculation for overall validity: (Y+N+U=18) 
 
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid. 
 
Section A validity calculation: Y/T= 0% or N+U/T= 100% 
Section B validity calculation:  Y/T=33.33% or N+U/T=66.66% 
Section C validity calculation:  Y/T= 100% or N+U/T= 0% 
Section D validity calculation:  Y/T= 40% or N+U/T= 60% 
Overall validity calculation:  
Y/T = 44.44% or N+U/T = 66.66% 
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Appendix 38: EBL Quality Appraisal Checklist- Dini et al (2015) 
 
EBL Critical Appraisal Checklist- Dini V., Salvo P., Janowska A., Di 
Francesco F., Barbini A. & Romanelli M. (2015) Correlation 
between wound temperature obtained with an infrared camera 
and clinical wound bed score in venous leg ulcers 
Yes 
(Y) 
No 
(N) 
Unclear 
(U) 
N/A 
 Is the study population representative of all users, actual and 
eligible, who might be included in the study? 
 N   
Are inclusion and exclusion criteria definitively outlined? Y    
Is the sample size large enough for sufficiently precise estimates?  N   
Is the response rate large enough for sufficiently precise estimates?    N/A 
Is the choice of population bias-free?   U  
If a comparative study: 
Were participants randomized into groups? 
Were the groups comparable at baseline? 
If groups were not comparable at baseline, was incomparability 
addressed by the authors in the analysis? 
   N/A 
   N/A 
   N/A 
Was informed consent obtained?   U  
 
 
 
 
 
 
 
 
 
Are data collection methods clearly described?  N   
If a face-to-face survey, were inter-observer and intra-observer bias 
reduced? 
   N/A 
Is the data collection instrument validated?   U  
If based on regularly collected statistics, are the statistics free from 
subjectivity? 
   N/A 
Does the study measure the outcome at a time appropriate for 
capturing the intervention’s effect? 
    
Is the instrument included in the publication?    N/A 
Are questions posed clearly enough to be able to elicit precise 
answers? 
   N/A 
Were those involved in data collection not involved in delivering a 
service to the target population? 
  U  
 
 
 
 
 
Is the study type / methodology utilized appropriate? Y    
Is there face validity? Y    
Is the research methodology clearly stated at a level of detail that 
would allow its replication? 
 N   
Was ethics approval obtained?   U  
Are the outcomes clearly stated and discussed in relation to the 
data collection? 
Y    
 
 
 
 
 
 
Are all the results clearly outlined?  N   
Are confounding variables accounted for?   U  
Do the conclusions accurately reflect the analysis? Y    
Is subset analysis a minor, rather than a major, focus of the article?    N/A 
Are suggestions provided for further areas to research? Y    
Is there external validity?   U  
Calculation for section validity: (Y+N+U=T) 
If Y/T <75% or if N+U/T > 25% then you can safely conclude that 
the section identifies significant omissions and that the study’s 
validity is questionable. It is important to look at the overall 
validity as well as section validity. 
Calculation for overall validity: (Y+N+U=18) 
 
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid. 
 
Section A validity calculation: Y/T= 20% or N+U/T= 80% 
Section B validity calculation:  Y/T= 0% or N+U/T= 100% 
Section C validity calculation:  Y/T= 60% or N+U/T= 40% 
Section D validity calculation:  Y/T= 40% or N+U/T= 60% 
Overall validity calculation:  
Y/T = 33.33% or N+U/T = 66.67% 
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Appendix 39: EBL Quality Appraisal Checklist- Horzic et al (1996) 
 
EBL Critical Appraisal Checklist- Horzic M., Bunoza D. & Maric K. 
(1996) Contact thermography in a study of primary healing of 
surgical wounds 
Yes 
(Y) 
No 
(N) 
Unclear 
(U) 
N/A 
 Is the study population representative of all users, actual and eligible, 
who might be included in the study? 
  U  
Are inclusion and exclusion criteria definitively outlined? Y    
Is the sample size large enough for sufficiently precise estimates?   U  
Is the response rate large enough for sufficiently precise estimates?    N/A 
Is the choice of population bias-free?   U  
If a comparative study: 
Were participants randomized into groups? 
Were the groups comparable at baseline? 
If groups were not comparable at baseline, was incomparability 
addressed by the authors in the analysis? 
   N/A 
   N/A 
   N/A 
Was informed consent obtained?   U  
 
 
 
 
 
 
 
 
 
Are data collection methods clearly described? Y    
If a face-to-face survey, were inter-observer and intra-observer bias 
reduced? 
   N/A 
Is the data collection instrument validated?   U  
If based on regularly collected statistics, are the statistics free from 
subjectivity? 
   N/A 
Does the study measure the outcome at a time appropriate for 
capturing the intervention’s effect? 
    
Is the instrument included in the publication?    N/A 
Are questions posed clearly enough to be able to elicit precise 
answers? 
   N/A 
Were those involved in data collection not involved in delivering a 
service to the target population? 
  U  
 
 
 
 
 
Is the study type / methodology utilized appropriate? Y    
Is there face validity? Y    
Is the research methodology clearly stated at a level of detail that 
would allow its replication? 
Y    
Was ethics approval obtained?   U  
Are the outcomes clearly stated and discussed in relation to the data 
collection? 
Y    
 
 
 
 
 
 
Are all the results clearly outlined?  N   
Are confounding variables accounted for?   U  
Do the conclusions accurately reflect the analysis? Y    
Is subset analysis a minor, rather than a major, focus of the article?    N/A 
Are suggestions provided for further areas to research?  N   
Is there external validity?   U  
Calculation for section validity: (Y+N+U=T) 
If Y/T <75% or if N+U/T > 25% then you can safely conclude that 
the section identifies significant omissions and that the study’s 
validity is questionable. It is important to look at the overall 
validity as well as section validity. 
Calculation for overall validity: (Y+N+U=18) 
 
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid. 
 
Section A validity calculation: Y/T= 20% or N+U/T= 80% 
Section B validity calculation:  Y/T=33.33% or N+U/T=66.66% 
Section C validity calculation:  Y/T= 80% or N+U/T= 20% 
Section D validity calculation:  Y/T= 20% or N+U/T= 80% 
Overall validity calculation:  
Y/T = 38.89% or N+U/T = 61.11% 
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Appendix 40: EBL Quality Appraisal Checklist- Horzic et al (1996) 
 
EBL Critical Appraisal Checklist- Horzic M., Bunoza D. & Maric K. 
(1996) Three-dimensional observation of wound temperature in 
primary healing 
Yes 
(Y) 
No 
(N) 
Unclear 
(U) 
N/A 
 Is the study population representative of all users, actual and 
eligible, who might be included in the study? 
  U  
Are inclusion and exclusion criteria definitively outlined?  N   
Is the sample size large enough for sufficiently precise estimates?   U  
Is the response rate large enough for sufficiently precise estimates?    N/A 
Is the choice of population bias-free?   U  
If a comparative study: 
Were participants randomized into groups? 
Were the groups comparable at baseline? 
If groups were not comparable at baseline, was incomparability 
addressed by the authors in the analysis? 
   N/A 
   N/A 
   N/A 
Was informed consent obtained?   U  
 
 
 
 
 
 
 
 
 
Are data collection methods clearly described? Y    
If a face-to-face survey, were inter-observer and intra-observer bias 
reduced? 
   N/A 
Is the data collection instrument validated?   U  
If based on regularly collected statistics, are the statistics free from 
subjectivity? 
   N/A 
Does the study measure the outcome at a time appropriate for 
capturing the intervention’s effect? 
    
Is the instrument included in the publication?    N/A 
Are questions posed clearly enough to be able to elicit precise 
answers? 
   N/A 
Were those involved in data collection not involved in delivering a 
service to the target population? 
  U  
 
 
 
 
 
Is the study type / methodology utilized appropriate? Y    
Is there face validity? Y    
Is the research methodology clearly stated at a level of detail that 
would allow its replication? 
 N   
Was ethics approval obtained?   U  
Are the outcomes clearly stated and discussed in relation to the 
data collection? 
Y    
 
 
 
 
 
 
Are all the results clearly outlined?  N   
Are confounding variables accounted for?   U  
Do the conclusions accurately reflect the analysis? Y    
Is subset analysis a minor, rather than a major, focus of the article?    N/A 
Are suggestions provided for further areas to research?  N   
Is there external validity?   U  
Calculation for section validity: (Y+N+U=T) 
If Y/T <75% or if N+U/T > 25% then you can safely conclude that 
the section identifies significant omissions and that the study’s 
validity is questionable. It is important to look at the overall 
validity as well as section validity. 
Calculation for overall validity: (Y+N+U=18) 
 
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid. 
 
Section A validity calculation: Y/T= 0% or N+U/T= 100% 
Section B validity calculation:  Y/T=33.33% or N+U/T=66.66% 
Section C validity calculation:  Y/T= 60% or N+U/T= 40% 
Section D validity calculation:  Y/T= 20% or N+U/T= 80% 
Overall validity calculation:  
Y/T = 27.78% or N+U/T = 72.22% 
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Appendix 41: EBL Quality Appraisal Checklist- Nakagami et al (2010) 
 
EBL Critical Appraisal Checklist- Nakagami G., Sanada H., Iizaka S., 
Kadono T., Koyanagi H. & Haga N. (2010) Predicting delayed 
pressure ulcer healing using thermography: a  prospective cohort 
study 
Yes 
(Y) 
No 
(N) 
Unclear 
(U) 
N/A 
 Is the study population representative of all users, actual and eligible, 
who might be included in the study? 
  U  
Are inclusion and exclusion criteria definitively outlined?  N   
Is the sample size large enough for sufficiently precise estimates?   U  
Is the response rate large enough for sufficiently precise estimates?    N/A 
Is the choice of population bias-free?   U  
If a comparative study: 
Were participants randomized into groups? 
Were the groups comparable at baseline? 
If groups were not comparable at baseline, was incomparability 
addressed by the authors in the analysis? 
   N/A 
   N/A 
   N/A 
Was informed consent obtained?   U  
 
 
 
 
 
 
 
 
 
Are data collection methods clearly described? Y    
If a face-to-face survey, were inter-observer and intra-observer bias 
reduced? 
   N/A 
Is the data collection instrument validated? Y    
If based on regularly collected statistics, are the statistics free from 
subjectivity? 
   N/A 
Does the study measure the outcome at a time appropriate for 
capturing the intervention’s effect? 
    
Is the instrument included in the publication?    N/A 
Are questions posed clearly enough to be able to elicit precise 
answers? 
   N/A 
Were those involved in data collection not involved in delivering a 
service to the target population? 
  U  
 
 
 
 
 
Is the study type / methodology utilized appropriate? Y    
Is there face validity? Y    
Is the research methodology clearly stated at a level of detail that 
would allow its replication? 
 N   
Was ethics approval obtained? Y    
Are the outcomes clearly stated and discussed in relation to the data 
collection? 
Y    
 
 
 
 
 
 
Are all the results clearly outlined?  N   
Are confounding variables accounted for?   U  
Do the conclusions accurately reflect the analysis? Y    
Is subset analysis a minor, rather than a major, focus of the article?    N/A 
Are suggestions provided for further areas to research? Y    
Is there external validity?  N   
Calculation for section validity: (Y+N+U=T) 
If Y/T <75% or if N+U/T > 25% then you can safely conclude that 
the section identifies significant omissions and that the study’s 
validity is questionable. It is important to look at the overall 
validity as well as section validity. 
Calculation for overall validity: (Y+N+U= 18) 
 
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid. 
 
Section A validity calculation: Y/T= 0% or N+U/T= 100% 
Section B validity calculation:  Y/T=66.66%or N+U/T=33.33%  
Section C validity calculation:  Y/T= 80% or N+U/T= 20% 
Section D validity calculation:  Y/T= 40% or N+U/T= 60% 
Overall validity calculation:  
Y/T = 44.44% or N+U/T= 66.66% 
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Appendix 42: EBL Quality Appraisal Checklist- Robicsek et al (1984) 
 
EBL Critical Appraisal Checklist-  Robicsek F., Masters T. N. & 
Daugherty H. K. (1984) The value of thermography in the early 
diagnosis of postoperative sternal wound infections 
Yes 
(Y) 
No 
(N) 
Unclear 
(U) 
N/A 
 Is the study population representative of all users, actual and 
eligible, who might be included in the study? 
  U  
Are inclusion and exclusion criteria definitively outlined?  N   
Is the sample size large enough for sufficiently precise estimates?   U  
Is the response rate large enough for sufficiently precise estimates?    N/A 
Is the choice of population bias-free?   U  
If a comparative study: 
Were participants randomized into groups? 
Were the groups comparable at baseline? 
If groups were not comparable at baseline, was incomparability 
addressed by the authors in the analysis? 
   N/A 
   N/A 
   N/A 
Was informed consent obtained?   U  
 
 
 
 
 
 
 
 
 
Are data collection methods clearly described?  N   
If a face-to-face survey, were inter-observer and intra-observer bias 
reduced? 
   N/A 
Is the data collection instrument validated?   U  
If based on regularly collected statistics, are the statistics free from 
subjectivity? 
   N/A 
Does the study measure the outcome at a time appropriate for 
capturing the intervention’s effect? 
   N/A 
Is the instrument included in the publication?    N/A  
Are questions posed clearly enough to be able to elicit precise 
answers? 
   N/A 
Were those involved in data collection not involved in delivering a 
service to the target population? 
  U  
 
 
 
 
 
Is the study type / methodology utilized appropriate? Y    
Is there face validity? Y    
Is the research methodology clearly stated at a level of detail that 
would allow its replication? 
 N   
Was ethics approval obtained?   U  
Are the outcomes clearly stated and discussed in relation to the 
data collection? 
 N   
 
 
 
 
 
 
Are all the results clearly outlined?  N   
Are confounding variables accounted for?   U  
Do the conclusions accurately reflect the analysis? Y    
Is subset analysis a minor, rather than a major, focus of the article? Y    
Are suggestions provided for further areas to research?  N   
Is there external validity?   U  
Calculation for section validity: (Y+N+U=T) 
If Y/T <75% or if N+U/T > 25% then you can safely conclude that 
the section identifies significant omissions and that the study’s 
validity is questionable. It is important to look at the overall 
validity as well as section validity. 
Calculation for overall validity: (Y+N+U=19) 
 
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid. 
 
Section A validity calculation: Y/T= 0% or N+U/T= 100% 
Section B validity calculation:  Y/T= 0% or N+U/T= 100% 
Section C validity calculation:  Y/T= 40% or N+U/T= 60% 
Section D validity calculation:  Y/T= 33.33% or N+U/T= 66.66% 
Overall validity calculation:  
Y/T = 21.05% or N+U/T = 78.95% 
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Appendix 43: EBL Quality Appraisal Checklist- Siah et al (2015) 
 
EBL Critical Appraisal Checklist- Siah C. J. R. & Childs C. (2015) 
Thermographic mapping of the abdomen in healthy subjects 
and patients after enterostoma 
Yes 
(Y) 
No 
(N) 
Unclear 
(U) 
N/A 
 Is the study population representative of all users, actual and 
eligible, who might be included in the study? 
 N   
Are inclusion and exclusion criteria definitively outlined?  N   
Is the sample size large enough for sufficiently precise estimates?  N   
Is the response rate large enough for sufficiently precise 
estimates? 
   N/A 
Is the choice of population bias-free?   U  
If a comparative study: 
Were participants randomized into groups? 
Were the groups comparable at baseline? 
If groups were not comparable at baseline, was incomparability 
addressed by the authors in the analysis? 
   N/A 
   N/A 
   N/A 
Was informed consent obtained?   U  
 
 
 
 
 
 
 
 
 
Are data collection methods clearly described? Y    
If a face-to-face survey, were inter-observer and intra-observer 
bias reduced? 
   N/A 
Is the data collection instrument validated?   U  
If based on regularly collected statistics, are the statistics free from 
subjectivity? 
   N/A 
Does the study measure the outcome at a time appropriate for 
capturing the intervention’s effect? 
   N/A 
Is the instrument included in the publication?    N/A  
Are questions posed clearly enough to be able to elicit precise 
answers? 
   N/A 
Were those involved in data collection not involved in delivering a 
service to the target population? 
  U  
 
 
 
 
 
Is the study type / methodology utilized appropriate? Y    
Is there face validity? Y    
Is the research methodology clearly stated at a level of detail that 
would allow its replication? 
Y    
Was ethics approval obtained? Y    
Are the outcomes clearly stated and discussed in relation to the 
data collection? 
Y    
 
 
 
 
 
 
Are all the results clearly outlined? Y    
Are confounding variables accounted for?   U  
Do the conclusions accurately reflect the analysis? Y    
Is subset analysis a minor, rather than a major, focus of the article?    N/A 
Are suggestions provided for further areas to research? Y    
Is there external validity?  N   
Calculation for section validity: (Y+N+U=T) 
If Y/T <75% or if N+U/T > 25% then you can safely conclude that 
the section identifies significant omissions and that the study’s 
validity is questionable. It is important to look at the overall 
validity as well as section validity. 
Calculation for overall validity: (Y+N+U=18) 
 
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid. 
 
Section A validity calculation: Y/T= 0% or N+U/T= 100% 
Section B validity calculation:  Y/T= 33.33% or N+U/T= 66.66% 
Section C validity calculation:  Y/T= 100% or N+U/T= 0% 
Section D validity calculation:  Y/T= 60% or N+U/T= 40% 
Overall validity calculation:  
Y/T = 50% or N+U/T = 50% 
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Appendix 44. Table of Analytes Measured in Exudate Composition Studies 
 Bernatchez et 
al. (2013)  
Edsberg et 
al. (2012)  
Hoffman et 
al. (1999)  
James et al. 
(2000)  
Ladwig et 
al. (2002)  
Liu et al. 
(2009)  
Muller et 
al. (2008) 
Tarlton et 
al. (1997) 
Tarlton et 
al. (1999)  
Trengove et 
al. (1996)  
Trengove et 
al. (1999)  
Wyffels et 
al. (2010) 
Albumin            
ALP            
ALT            
AST            
Αlpha-1-Globulin            
Αlpha-2-Globulin            
Βeta-Globulin            
Bicarbonate            
Bilirubin            
Calcium            
Cathepsin G            
Chloride            
Cholesterol            
CICP            
C3            
C4            
CK            
Creatinine            
CRP            
EGF            
Gamma-Globulin            
GGT            
Glucose            
HCOˉ3            
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 Bernatchez et 
al. (2013)  
Edsberg et 
al. (2012)  
Hoffman et 
al. (1999)  
James et al. 
(2000)  
Ladwig et 
al. (2002)  
Liu et al. 
(2009)  
Muller et 
al. (2008) 
Tarlton et 
al. (1997) 
Tarlton et 
al. (1999)  
Trengove et 
al. (1996)  
Trengove et 
al. (1999)  
Wyffels et 
al. (2010) 
Lactate            
LDH            
Magnesium            
MMP-1            
MMP-2            
MMP-3            
MMP-8            
MMP-9            
MMP-10            
MMP-13            
MMP/TIMP ratio            
NOx             
NE            
Phosphate            
Potassium            
Proteomics            
Sodium            
TGF-β1            
TIMP            
Total Protein            
Triglycerides            
Trypsin            
Urea            
Uric Acid            
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Appendix 45: PRISMA 2009 Systematic Review Checklist for pH, Exudate Composition and 
Temperature in Wounds 
Section/topic  # Checklist item  
Reported 
on page 
#  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  1 
ABSTRACT   
Structured 
summary  
2 Provide a structured summary including, as applicable: background; 
objectives; data sources; study eligibility criteria, participants, and 
interventions; study appraisal and synthesis methods; results; 
limitations; conclusions and implications of key findings; systematic 
review registration number.  
12 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already 
known.  
15 - 57 
Objectives  4 Provide an explicit statement of questions being addressed with 
reference to participants, interventions, comparisons, outcomes, and 
study design (PICOS).  
116 -123 
METHODS   
Protocol and 
registration  
5 Indicate if a review protocol exists, if and where it can be accessed (e.g., 
Web address), and, if available, provide registration information 
including registration number.  
NA 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report 
characteristics (e.g., years considered, language, publication status) used 
as criteria for eligibility, giving rationale.  
117 -118 
Information 
sources  
7 Describe all information sources (e.g., databases with dates of coverage, 
contact with study authors to identify additional studies) in the search 
and date last searched.  
118 - 120 
Search  8 Present full electronic search strategy for at least one database, 
including any limits used, such that it could be repeated.  
330, 331 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, 
included in systematic review, and, if applicable, included in the meta-
analysis).  
117 - 120 
Data collection 
process  
10 Describe method of data extraction from reports (e.g., piloted forms, 
independently, in duplicate) and any processes for obtaining and 
confirming data from investigators.  
120 -122 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, 
funding sources) and any assumptions and simplifications made.  
120 - 122 
Risk of bias in 
individual studies  
12 Describe methods used for assessing risk of bias of individual studies 
(including specification of whether this was done at the study or 
outcome level), and how this information is to be used in any data 
synthesis.  
121 - 122 
Summary 
measures  
13 State the principal summary measures (e.g., risk ratio, difference in 
means).  
NA 
Synthesis of 
results  
14 Describe the methods of handling data and combining results of studies, 
if done, including measures of consistency (e.g., I2) for each meta-
analysis.  
NA 
Risk of bias across 
studies  
15 Specify any assessment of risk of bias that may affect the cumulative 
evidence (e.g., publication bias, selective reporting within studies).  
NA 
Additional 
analyses  
16 Describe methods of additional analyses (e.g., sensitivity or subgroup 
analyses, meta-regression), if done, indicating which were pre-specified.  
NA 
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Section/topic  # Checklist item  
Reported 
on page 
#  
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included 
in the review, with reasons for exclusions at each stage, ideally with a 
flow diagram.  
125 - 140 
Study 
characteristics  
18 For each study, present characteristics for which data were extracted 
(e.g., study size, PICOS, follow-up period) and provide the citations.  
141 - 179 
Risk of bias within 
studies  
19 Present data on risk of bias of each study and, if available, any outcome 
level assessment (see item 12).  
180 -185 
Results of 
individual studies  
20 For all outcomes considered (benefits or harms), present, for each 
study: (a) simple summary data for each intervention group (b) effect 
estimates and confidence intervals, ideally with a forest plot.  
NA 
Synthesis of 
results  
21 Present results of each meta-analysis done, including confidence 
intervals and measures of consistency.  
NA 
Risk of bias across 
studies  
22 Present results of any assessment of risk of bias across studies (see Item 
15).  
180 - 185 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup 
analyses, meta-regression [see Item 16]).  
NA 
DISCUSSION   
Summary of 
evidence  
24 Summarize the main findings including the strength of evidence for each 
main outcome; consider their relevance to key groups (e.g., healthcare 
providers, users, and policy makers).  
224 -274 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at 
review-level (e.g., incomplete retrieval of identified research, reporting 
bias).  
270 - 272 
Conclusions  26 Provide a general interpretation of the results in the context of other 
evidence, and implications for future research.  
275 -279 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support 
(e.g., supply of data); role of funders for the systematic review.  
13 
 
